target_id,target_gene,organism,pdb_uniprot,allosteric_pdb,modulator_serial,modulator_alias,modulator_chain,modulator_class,modulator_feature,modulator_name,modulator_resi,function,position,pubmed_id,ref_title,site_overlap,allosteric_site_residue,resolution,has_assembly,chain_count_residue
ASD00020000_1,aroG,Escherichia coli,P0AB91,1KFL,ASD02170001,PHE,A,Lig,Inhibitor,(2S)-2-amino-3-phenyl-propanoic acid,1354,Inner Protein Regulator,Protein-Protein Interaction,12126632,Allosteric inhibition of 3-deoxy-D-arabino-heptulosonate-7-phosphate synthase alters the coordination of both substrates.,No,"Chain A:PRO150,GLN151,ALA154,GLY178,LEU179,SER180,PHE209,SER211,LYS214,VAL221; Chain B:ASP6,ASP7,ILE10",2.8,True,2
ASD00020000_4,aroF,Thermotoga maritima,Q9WYH8,3PG9,ASD00690002,TYR,A,Lig,Inhibitor,(2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid,339,Inner Protein Regulator,Protein-Protein Interaction,21282100,Tyrosine latching of a regulatory gate affords allosteric control of aromatic amino acid biosynthesis,No,"Chain A:SER31,GLY33,GLN34,GLU35,ARG36,VAL38; Chain F:MET1,ILE2,GLY40,ILE41,ILE42,GLY43,ASP45,VAL65,LEU66",2.35,True,2
ASD00020000_5,ARO4,Saccharomyces cerevisiae,P32449,1OF6,ASD00020003,DTY,A,Lig,Inhibitor,(2R)-2-amino-3-(4-hydroxyphenyl)propanoic acid,1370,Inner Protein Regulator,Protein-Protein Interaction,,Crystal Structure of the Double Complex of the Tyrosine Sensitive Dahp Synthase from Yeast,No,"Chain A:THR162,GLN166,ALA169,GLY193,LEU194,SER195,PHE224,GLY226,VAL227; Chain B:GLU21,ASP22,ILE25,TYR28",2.1,True,2
ASD00020000_5,ARO4,Saccharomyces cerevisiae,P32449,1OFR,ASD02170001,PHE,H,Lig,Inhibitor,(2S)-2-amino-3-phenyl-propanoic acid,1002,Inner Protein Regulator,Protein-Protein Interaction,15019786,Substrate and Metal Complexes of 3-Deoxy-D-Arabino-Heptulosonate-7-Phosphate Synthase from Saccharomyces Cerevisiae Provide New Insights Into the Catalytic Mechanism.,No,"Chain G:THR162,PRO165,GLN166,ALA169,LEU190,GLY193,LEU194,SER195; Chain H:GLU21,ASP22,ILE25",2.7,True,2
ASD00020000_5,ARO4,Saccharomyces cerevisiae,P32449,1OG0,ASD02170001,PHE,A,Lig,Inhibitor,(2S)-2-amino-3-phenyl-propanoic acid,1012,Inner Protein Regulator,Protein-Protein Interaction,,Crystal Structure of the Mutant G226S of the Tyrosine-Regulated 3-Deoxy-D-Arabino-Heptulosonate -7-Phosphate Synthase from Saccharomyces Cerevisiae Complexed with Phenylalanine and Manganese,No,"Chain A:THR162,GLN166,ALA169,LEU190,GLY193,LEU194,SER195,SER226,LYS229; Chain B:GLU21,ASP22,ILE25,TYR28",2.7,True,2
ASD00020000_6,aroG,Neisseria meningitidis serogroup B,Q9K169,4UC5,ASD10090002,PHE,A,Lig,Inhibitor,PHENYLALANINE,1354,Allosteric Function,Allosteric Position,26794122,Calculated Pka Variations Expose Dynamic Allosteric Communication Networks.,No,"Chain B:THR7,ILE12,ILE10,ASP8,VAL15,ASP9",2.19,True,1
ASD00230000_2,Ache,Mus musculus,P21836,1J07,ASD00230007,DCU,A,Lig,Inhibitor,"10-(3,8-diamino-6-phenyl-phenanthridin-5-ium-5-yl)decyl-trimethyl-azanium",951,Inner Protein Regulator,Inner Protein,12505979,Structural insights into ligand interactions at the acetylcholinesterase peripheral anionic site,Yes,"Chain A:TYR72,TRP286,HIS287,LEU289,GLN291,GLU292,SER293",2.35,True,1
ASD00230000_2,Ache,Mus musculus,P21836,1N5M,ASD00230008,GMN,A,Lig,Inhibitor,"2-[2,6-bis(2-triethylazaniumylethoxy)phenoxy]ethyl-triethyl-azanium",951,Inner Protein Regulator,Inner Protein,12505979,Structural insights into ligand interactions at the acetylcholinesterase peripheral anionic site,Yes,"Chain A:TYR72,ASP74,TYR124,TRP286,TYR341",2.2,True,1
ASD00230000_2,Ache,Mus musculus,P21836,1N5R,ASD00230009,PRM,A,Lig,Inhibitor,"3-(3,8-diamino-6-phenyl-phenanthridin-5-ium-5-yl)propyl-diethyl-methyl-azanium",951,Inner Protein Regulator,Inner Protein,12505979,Structural insights into ligand interactions at the acetylcholinesterase peripheral anionic site,Yes,"Chain A:TYR72,TRP286,HIS287,LEU289,SER293,TYR341",2.25,True,1
ASD00230000_2,Ache,Mus musculus,P21836,2HA0,ASD00230014,CHH,A,Lig,Regulator,trimethyl-(4-oxopentyl)azanium,1602,Inner Protein Regulator,Inner Protein,16837465,Substrate and product trafficking through the active center gorge of acetylcholinesterase analyzed by crystallography and equilibrium binding,Yes,"Chain A:TYR72,ASP74,TYR124,TRP286,TYR341",2.2,True,1
ASD00230000_2,Ache,Mus musculus,P21836,2HA2,ASD00230017,SCK,A,Lig,Regulator,trimethyl-[2-[4-oxo-4-(2-trimethylazaniumylethoxy)butanoyl]oxyethyl]azanium,901,Inner Protein Regulator,Inner Protein,16837465,Substrate and product trafficking through the active center gorge of acetylcholinesterase analyzed by crystallography and equilibrium binding,Yes,"Chain A:TYR72,ASP74,TRP86,TYR124,TRP286,PHE297,TYR337,PHE338,TYR341,HIS447",2.05,True,1
ASD00230000_2,Ache,Mus musculus,P21836,2HA3,ASD00230015,CHT,A,Lig,Regulator,2-hydroxyethyl-trimethyl-azanium,952,Inner Protein Regulator,Inner Protein,16837465,Substrate and product trafficking through the active center gorge of acetylcholinesterase analyzed by crystallography and equilibrium binding,Yes,"Chain A:TYR72,ASP74,TYR124,TRP286,TYR341",2.25,True,1
ASD00230000_2,Ache,Mus musculus,P21836,2HA4,ASD00230019,ACH,A,Lig,Regulator,2-acetyloxyethyl-trimethyl-azanium,545,Inner Protein Regulator,Inner Protein,16837465,Substrate and product trafficking through the active center gorge of acetylcholinesterase analyzed by crystallography and equilibrium binding,Yes,"Chain A:TYR72,TYR124,TRP286,PHE297,PHE338,TYR341",2.56,True,1
ASD00230000_2,Ache,Mus musculus,P21836,2HA5,ASD00230012,ETM,A,Lig,Regulator,trimethyl-(2-sulfanylethyl)azanium,1905,Inner Protein Regulator,Inner Protein,16837465,Substrate and product trafficking through the active center gorge of acetylcholinesterase analyzed by crystallography and equilibrium binding,Yes,"Chain A:TYR72,TYR124,TRP286,TYR341",2.15,True,1
ASD00230000_2,Ache,Mus musculus,P21836,2HA6,ASD00230017,SCK,A,Lig,Regulator,trimethyl-[2-[4-oxo-4-(2-trimethylazaniumylethoxy)butanoyl]oxyethyl]azanium,901,Inner Protein Regulator,Inner Protein,16837465,Substrate and product trafficking through the active center gorge of acetylcholinesterase analyzed by crystallography and equilibrium binding,Yes,"Chain A:TYR72,ASP74,TRP86,GLY121,TYR124,GLU202,ALA203,TRP286,PHE297,TYR337,PHE338,TYR341",2.25,True,1
ASD00230000_2,Ache,Mus musculus,P21836,2HA7,ASD00230016,BCH,A,Lig,Regulator,2-butanoylsulfanylethyl-trimethyl-azanium,910,Inner Protein Regulator,Inner Protein,16837465,Substrate and product trafficking through the active center gorge of acetylcholinesterase analyzed by crystallography and equilibrium binding,Yes,"Chain A:TYR72,TYR124,TRP286,TYR337,TYR341",2.66,True,1
ASD00230000_3,ache,Torpedo californica,P04058,2C4H,ASD00230010,AT3,A,Lig,Regulator,2-ethanoylsulfanylethyl-trimethyl-azanium,1541,Inner Protein Regulator,Inner Protein,16763558,Structural Insights Into Substrate Traffic and Inhibition in Acetylcholinesterase.,Yes,"Chain A:TYR70,TYR121,TRP279,PHE330,TYR334",2.15,True,1
ASD00230000_3,ache,Torpedo californica,P04058,2C58,ASD00230010,AT3,A,Lig,Regulator,2-ethanoylsulfanylethyl-trimethyl-azanium,1537,Inner Protein Regulator,Inner Protein,16763558,Structural Insights Into Substrate Traffic and Inhibition in Acetylcholinesterase.,Yes,"Chain A:TYR70,TYR121,TRP279,PHE330,PHE331",2.3,True,1
ASD00230000_3,ache,Torpedo californica,P04058,2C5F,ASD00230014,CHH,A,Lig,Regulator,trimethyl-(4-oxopentyl)azanium,1542,Inner Protein Regulator,Inner Protein,16763558,Structural Insights Into Substrate Traffic and Inhibition in Acetylcholinesterase.,Yes,"Chain A:TYR70,TYR121,TRP279,PHE331,TYR334",2.6,True,1
ASD00230000_3,ache,Torpedo californica,P04058,2C5G,ASD00230012,ETM,A,Lig,Regulator,trimethyl-(2-sulfanylethyl)azanium,1538,Inner Protein Regulator,Inner Protein,16763558,Structural Insights Into Substrate Traffic and Inhibition in Acetylcholinesterase.,Yes,"Chain A:TYR70,TYR121,TRP279",1.95,True,1
ASD00230000_3,ache,Torpedo californica,P04058,2J3Q,ASD00230021,TFL,A,Lig,Activator,"2-(4-dimethylaminophenyl)-3-methyl-1,3-benzothiazol-3-ium-6-ol",1538,Inner Protein Regulator,Inner Protein,18512913,Crystal Structure of Thioflavin T Bound to the Peripheral Site of Torpedo Californica Acetylcholinesterase Reveals How Thioflavin T Acts as a Sensitive Fluorescent Reporter of Ligand Binding to the Acylation Site.,Yes,"Chain A:TYR70,TYR121,TRP279,PHE330,PHE331,TYR334",2.8,True,1
ASD00250000_6,,Solanum tuberosum,P23509,1YP2,ASD02880002;ASD02880002,SO4;SO4,A;A,Ion,Activator,sulfate;sulfate,2000;2008,Inner Protein Regulator,Protein-Protein Interaction,15692569,Crystal structure of potato tuber ADP-glucose pyrophosphorylase.,No,"Chain A:ARG41,PRO47,ARG53,HIS84,GLN314,ARG316,ASP370,LYS404,LYS441",2.11,True,1
ASD00250000_6,,Solanum tuberosum,P23509,1YP2,ASD02880002,SO4,A,Ion,Activator,sulfate,2007,Inner Protein Regulator,Inner Protein,15692569,Crystal structure of potato tuber ADP-glucose pyrophosphorylase.,No,"Chain A:LYS69,GLU133,HIS134,THR135; Chain D:ARG83",2.11,True,2
ASD00250000_6,,Solanum tuberosum,P23509,1YP3,ASD02880002;ASD02880002,SO4;SO4,A;A,Ion,Activator,sulfate;sulfate,1000;1008,Inner Protein Regulator,Protein-Protein Interaction,15692569,Crystal structure of potato tuber ADP-glucose pyrophosphorylase.,No,"Chain A:ARG41,PRO47,ARG53,SER80,HIS84,GLN314,ARG316,ASP370,LYS404,LYS441",2.6,True,1
ASD00250000_6,,Solanum tuberosum,P23509,1YP3,ASD02880002,SO4,A,Ion,Activator,sulfate,1007,Inner Protein Regulator,Inner Protein,15692569,Crystal structure of potato tuber ADP-glucose pyrophosphorylase.,No,"Chain A:LYS69,GLU133,HIS134,THR135; Chain D:ARG83",2.6,True,2
ASD00250000_6,,Solanum tuberosum,P23509,1YP4,ASD02880002;ASD02880002,SO4;SO4,A;A,Ion,Activator,sulfate;sulfate,1000;1008,Inner Protein Regulator,Protein-Protein Interaction,15692569,Crystal structure of potato tuber ADP-glucose pyrophosphorylase.,No,"Chain A:ARG41,PRO47,ARG53,SER80,ARG83,HIS84,GLN314,ARG316,ASP370,LYS404,LYS441",2.3,True,1
ASD00250000_6,,Solanum tuberosum,P23509,1YP4,ASD02880002,SO4,A,Ion,Activator,sulfate,1007,Inner Protein Regulator,Inner Protein,15692569,Crystal structure of potato tuber ADP-glucose pyrophosphorylase.,No,"Chain A:LYS69,GLU133,HIS134,THR135",2.3,True,1
ASD00250000_7,glgC,Rhizobium radiobacter,P39669,3BRK,ASD02880002,SO4,X,Ion,Activator,sulfate,601,Inner Protein Regulator,Inner Protein,18355040,Structural analysis of ADP-glucose pyrophosphorylase from the bacterium Agrobacterium tumefaciens.,No,"Chain X:ARG33,TYR39,ARG45,SER72,HIS379",2.1,True,1
ASD00250000_7,glgC,Rhizobium radiobacter,P39669,5W5R,ASD00340002,PYR,A,Lig,Activator,PYRUVIC ACID,503,Allosteric function,Allosteric position,30401744,Structural analysis reveals a pyruvate-binding activator site in theAgrobacterium tumefaciensADP-glucose pyrophosphorylase.,No,"Chain P:THR307,GLY330,VAL328,SER329,ALA310,PRO309,LYS44,ASP331,PRO308",1.754,True,1
ASD00280000_1,purF,Bacillus subtilis,P00497,1AO0,ASD01720027,ADP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl phosphono hydrogen phosphate",468,Inner Protein Regulator,Protein-Protein Interaction,9271502,Mechanism of the synergistic end-product regulation of Bacillus subtilis glutamine phosphoribosylpyrophosphate amidotransferase by nucleotides.,Yes,"Chain A:HIS25,TYR242,SER244,ARG245,PRO246,ARG259,PRO281,ASP282,SER283,LYS305,LYS328; Chain B:ILE304,LYS305,ASN306,ARG307",2.8,True,2
ASD00280000_2,purF,Escherichia coli,P0AG16,1ECB,ASD00860008,5GP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl dihydrogen phosphate",506,Inner Protein Regulator,Protein-Protein Interaction,9333323,Coupled formation of an amidotransferase interdomain ammonia channel and a phosphoribosyltransferase active site.,Yes,"Chain A:HIS25,TYR258,ALA260,ARG261,PRO262,ARG275,PRO302,GLU303,THR304,LYS326,ASP367; Chain B:VAL325,LYS326,ASN327,ARG328",2.7,True,2
ASD00310000_1,Prkag1,Rattus norvegicus,P80385,2V8Q,ASD00030001,AMP,E,Lig,Activator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",1329,Protein-Protein Interaction Regulator,Inner Protein,17851531,Structural Basis for AMP Binding to Mammalian AMP-Activated Protein Kinase,No,"Chain E:HIS150,THR199,ASN202,ILE203,ALA204,VAL224,SER225,ALA226,PRO228,HIS297,ILE311,SER313,SER315,ASP316",2.1,True,1
ASD00310000_1,Prkag1,Rattus norvegicus,P80385,2V92,ASD00030001,AMP,E,Lig,Activator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",1329,Protein-Protein Interaction Regulator,Inner Protein,17851531,Structural Basis for AMP Binding to Mammalian AMP-Activated Protein Kinase,No,"Chain E:HIS150,THR199,ASN202,ILE203,ALA204,VAL224,SER225,ALA226,PRO228,HIS297,ILE311,SER313,SER315,ASP316",2.4,True,1
ASD00310000_1,Prkag1,Rattus norvegicus,P80385,2V9J,ASD00030001,AMP,E,Lig,Activator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",1329,Protein-Protein Interaction Regulator,Inner Protein,17851531,Structural Basis for AMP Binding to Mammalian AMP-Activated Protein Kinase,No,"Chain E:HIS150,THR199,ASN202,ILE203,ALA204,VAL224,SER225,ALA226,PRO228,HIS297,ILE311,SER313,SER315,ASP316",2.53,True,1
ASD00310000_1,Prkag1,Rattus norvegicus,P80385,2Y8L,ASD00030001,AMP,E,Lig,Activator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",1329,Protein-Protein Interaction Regulator,Inner Protein,21399626,Structure of Mammalian Ampk and its Regulation by Adp,No,"Chain E:HIS150,THR199,ASN202,ILE203,ALA204,VAL224,SER225,ALA226,PRO228,HIS297,ILE311,SER313,SER315,ASP316",2.5,True,1
ASD00310000_1,Prkag1,Rattus norvegicus,P80385,2Y8Q,ASD00030001,AMP,E,Lig,Activator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",1328,Protein-Protein Interaction Regulator,Inner Protein,21399626,Structure of Mammalian Ampk and its Regulation by Adp,No,"Chain E:HIS150,THR199,ASN202,ILE203,ALA204,VAL224,SER225,ALA226,PRO228,ILE311,SER313,SER315,ASP316",2.8,True,1
ASD00310000_1,Prkag1,Rattus norvegicus,P80385,2YA3,ASD00030001,AMP,E,Lig,Activator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",1327,Protein-Protein Interaction Regulator,Inner Protein,21399626,Structure of Mammalian Ampk and its Regulation by Adp,No,"Chain E:HIS150,THR199,ASN202,ILE203,ALA204,VAL224,SER225,ALA226,PRO228,HIS297,ILE311,SER313,SER315,ASP316",2.51,True,1
ASD00310000_1,Prkag1,Rattus norvegicus,P80385,4EAG,ASD00150001,ATP,C,Lig,Activator,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",402,Protein-Protein Interaction Regulator,Inner Protein,22659875,AMP-activated protein kinase undergoes nucleotide-dependent conformational changes,No,"Chain C:HIS150,HIS168,THR199,ASN202,ILE203,ALA204,VAL224,SER225,ALA226,LEU227,PRO228,HIS297,ARG298,ILE311,SER313,LEU314,SER315,ASP316",2.701,True,1
ASD00310000_1,Prkag1,Rattus norvegicus,P80385,4EAJ,ASD00030001,AMP,C,Lig,Activator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",403,Protein-Protein Interaction Regulator,Inner Protein,,AMP-activated protein kinase undergoes nucleotide-dependent conformational changes,No,"Chain C:HIS150,THR199,ASN202,ILE203,ALA204,VAL224,SER225,ALA226,PRO228,HIS297,ILE311,SER313,SER315,ASP316",2.609,True,1
ASD00310000_1,Prkag1,Rattus norvegicus,P80385,4EAK,ASD00150001,ATP,C,Lig,Activator,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",402,Protein-Protein Interaction Regulator,Inner Protein,22659875,AMP-activated protein kinase undergoes nucleotide-dependent conformational changes,No,"Chain C:HIS150,HIS168,THR199,ASN202,ILE203,ALA204,VAL224,SER225,ALA226,PRO228,HIS297,ARG298,ILE311,SER313,LEU314,SER315,ASP316",2.5,True,1
ASD00310000_1,Prkag1,Rattus norvegicus,P80385,4EAL,ASD00030001,AMP,C,Lig,Activator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",402,Protein-Protein Interaction Regulator,Inner Protein,22659875,AMP-activated protein kinase undergoes nucleotide-dependent conformational changes,No,"Chain C:HIS150,THR199,ILE203,ALA204,VAL224,SER225,ALA226,PRO228,ILE311,SER313,SER315,ASP316",2.506,True,1
ASD00310000_6,MJ1225,Methanocaldococcus jannaschii,Q58622,3KH5,ASD00030001,AMP,A,Lig,Activator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",282,Inner Protein Regulator,Inner Protein,20382158,The crystal structure of protein MJ1225 from Methanocaldococcus jannaschii shows strong conservation of key structural features seen in the eukaryal gamma-AMPK.,No,"Chain A:ARG180,ARG181,ILE193,THR195,THR197,ASP198,LYS201,LYS230,ASP232,VAL233,ILE234,ILE254,ALA256",2.1,True,1
ASD00320000_1,trpE,Salmonella typhimurium,P00898,1I1Q,ASD00320001,TRP,A,Lig,Inhibitor,(2S)-2-amino-3-(1H-indol-3-yl)propanoic acid,1001,Inner Protein Regulator,Inner Protein,11224570,Structure of the cooperative allosteric anthranilate synthase from Salmonella typhimurium.,No,"Chain A:LEU38,GLU39,SER40,ASP48,LEU49,LYS50,PRO291,TYR292,MET293,VAL453,GLY454,TYR455,ASP463,CYS465",1.9,True,1
ASD00320000_3,trpE,Serratia marcescens,P00897,1I7S,ASD00320001,TRP,A,Lig,Inhibitor,(2S)-2-amino-3-(1H-indol-3-yl)propanoic acid,601,Inner Protein Regulator,Inner Protein,11371633,"The structures of anthranilate synthase of Serratia marcescens crystallized in the presence of (i) its substrates, chorismate and glutamine, and a product, glutamate, and (ii) its end-product inhibitor, L-tryptophan.",No,"Chain A:LEU38,GLU39,SER40,LEU49,GLN50,PRO291,TYR292,MET293,VAL453,GLY454,TYR455,ASP463,CYS465",2.4,True,1
ASD00330000_2,pyrI,Escherichia coli,E8Y329,4KGV,ASD00150001,ATP,B,Lig,Activator,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",202,Inner Protein Regulator,Inner Protein,24138583,New Paradigm for Allosteric Regulation of Escherichia coli Aspartate Transcarbamoylase.,No,"Chain B:ALA11,ILE12,VAL17,ASP19,HIS20,LYS60,ASN84,ILE86,TYR89,VAL91,LYS94",2.1,True,1
ASD00330000_2,pyrI,Escherichia coli,E8Y329,4KGX,ASD00150003,CTP,B,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",202,Inner Protein Regulator,Inner Protein,24138583,New Paradigm for Allosteric Regulation of Escherichia coli Aspartate Transcarbamoylase.,No,"Chain B:GLU10,ALA11,ILE12,VAL17,ASP19,HIS20,LYS60,THR82,ASN84,ILE86,TYR89,VAL91,LYS94",2.202,True,1
ASD00330000_2,pyrI,Escherichia coli,E8Y329,4KH0,ASD00330030;ASD01140145;ASD00330030,ATP;MG;ATP,B;B;B,Lig,Activator,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate;magnesium(+2) cation;[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",202;203;204,Inner Protein Regulator,Inner Protein,24138583,New Paradigm for Allosteric Regulation of Escherichia coli Aspartate Transcarbamoylase.,No,"Chain B:ALA11,ILE12,VAL17,ASP19,HIS20,THR43,GLY45,LEU48,PRO49,SER50,GLY51,GLU52,LYS56,LYS60,ASN84,ILE86,TYR89,VAL91,LYS94; Chain D:LYS6,LEU7,GLN8,VAL9,THR43",2.25,True,2
ASD00330000_2,pyrI,Escherichia coli,E8Y329,4KH1,ASD00150003;ASD00150002;ASD00330030,CTP;MG;UTP,B;B;B,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate;magnesium(+2) cation;[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",202;203;204,Inner Protein Regulator,Inner Protein,24138583,New Paradigm for Allosteric Regulation of Escherichia coli Aspartate Transcarbamoylase.,No,"Chain B:LEU7,GLN8,VAL9,ALA11,ILE12,VAL17,ASP19,HIS20,LEU48,PRO49,SER50,GLY51,GLU52,LYS56,LEU58,LYS60,ASN84,ILE86,TYR89,VAL91,LYS94",2.2,True,1
ASD00330000_3,pyrI,Escherichia coli,P0A7F3,1RAA,ASD00150003,CTP,B,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",999,Inner Protein Regulator,Inner Protein,8441751,Crystal structure of CTP-ligated T state aspartate transcarbamoylase at 2.5 A resolution: implications for ATCase mutants and the mechanism of negative cooperativity.,No,"Chain B:VAL9,ALA11,ILE12,VAL17,ASP19,LYS60,THR82,ASN84,ILE86,TYR89,VAL91,LYS94",2.5,True,1
ASD00330000_3,pyrI,Escherichia coli,P0A7F3,1RAB,ASD00150003,CTP,B,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",999,Inner Protein Regulator,Inner Protein,8441751,Crystal structure of CTP-ligated T state aspartate transcarbamoylase at 2.5 A resolution: implications for ATCase mutants and the mechanism of negative cooperativity.,No,"Chain B:VAL9,ALA11,ILE12,VAL17,ASP19,LYS60,THR82,ASN84,ILE86,TYR89,VAL91,LYS94",2.5,True,1
ASD00330000_3,pyrI,Escherichia coli,P0A7F3,1RAC,ASD00150003,CTP,B,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",999,Inner Protein Regulator,Inner Protein,8441751,Crystal structure of CTP-ligated T state aspartate transcarbamoylase at 2.5 A resolution: implications for ATCase mutants and the mechanism of negative cooperativity.,No,"Chain B:VAL9,ALA11,ILE12,VAL17,ASP19,LYS60,THR82,ASN84,ILE86,TYR89,VAL91,LYS94",2.5,True,1
ASD00330000_3,pyrI,Escherichia coli,P0A7F3,1RAD,ASD00150003,CTP,B,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",999,Inner Protein Regulator,Inner Protein,8441751,Crystal structure of CTP-ligated T state aspartate transcarbamoylase at 2.5 A resolution: implications for ATCase mutants and the mechanism of negative cooperativity.,No,"Chain B:VAL9,ALA11,ILE12,VAL17,ASP19,LYS60,THR82,ASN84,ILE86,TYR89,VAL91,LYS94",2.5,True,1
ASD00330000_3,pyrI,Escherichia coli,P0A7F3,1RAE,ASD00150003,CTP,B,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",999,Inner Protein Regulator,Inner Protein,8441751,Crystal structure of CTP-ligated T state aspartate transcarbamoylase at 2.5 A resolution: implications for ATCase mutants and the mechanism of negative cooperativity.,No,"Chain B:VAL9,ALA11,ILE12,VAL17,ASP19,LYS60,THR82,ASN84,ILE86,TYR89,VAL91,LYS94",2.5,True,1
ASD00330000_3,pyrI,Escherichia coli,P0A7F3,1RAF,ASD00150003,CTP,B,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",999,Inner Protein Regulator,Inner Protein,8441751,Crystal structure of CTP-ligated T state aspartate transcarbamoylase at 2.5 A resolution: implications for ATCase mutants and the mechanism of negative cooperativity.,No,"Chain B:VAL9,ALA11,ILE12,VAL17,ASP19,HIS20,LYS60,THR82,ASN84,ILE86,TYR89,VAL91,LYS94",2.5,True,1
ASD00330000_3,pyrI,Escherichia coli,P0A7F3,1RAG,ASD00150003,CTP,B,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",999,Inner Protein Regulator,Inner Protein,8441751,Crystal structure of CTP-ligated T state aspartate transcarbamoylase at 2.5 A resolution: implications for ATCase mutants and the mechanism of negative cooperativity.,No,"Chain B:VAL9,ALA11,ILE12,VAL17,ASP19,HIS20,LYS60,THR82,ASN84,ILE86,TYR89,VAL91,LYS94",2.5,True,1
ASD00330000_3,pyrI,Escherichia coli,P0A7F3,1RAH,ASD00150003,CTP,B,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",999,Inner Protein Regulator,Inner Protein,8441751,Crystal structure of CTP-ligated T state aspartate transcarbamoylase at 2.5 A resolution: implications for ATCase mutants and the mechanism of negative cooperativity.,No,"Chain B:VAL9,ALA11,ILE12,VAL17,ASP19,HIS20,LYS60,THR82,ASN84,ILE86,TYR89,VAL91,LYS94",2.5,True,1
ASD00330000_3,pyrI,Escherichia coli,P0A7F3,1RAI,ASD00150003,CTP,B,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",999,Inner Protein Regulator,Inner Protein,8441751,Crystal structure of CTP-ligated T state aspartate transcarbamoylase at 2.5 A resolution: implications for ATCase mutants and the mechanism of negative cooperativity.,No,"Chain B:VAL9,ALA11,ILE12,VAL17,ASP19,HIS20,LYS60,THR82,ASN84,ILE86,TYR89,VAL91,LYS94",2.5,True,1
ASD00330000_3,pyrI,Escherichia coli,P0A7F3,1TUG,ASD00150003,CTP,B,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",1156,Inner Protein Regulator,Inner Protein,15288791,Monitoring the Transition from the T to the R State in E.coli Aspartate Transcarbamoylase by X-ray Crystallography: Crystal Structures of the E50A Mutant Enzyme in Four Distinct Allosteric States.,No,"Chain B:MET1,THR2,ALA11,ILE12,VAL17,ASP19,HIS20,LYS60,ASN84,ILE86,TYR89,GLU90,VAL91,LYS94",2.1,True,1
ASD00330000_3,pyrI,Escherichia coli,P0A7F3,1ZA1,ASD00150003,CTP,B,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",901,Inner Protein Regulator,Inner Protein,15951418,Structural basis for ordered substrate binding and cooperativity in aspartate transcarbamoylase,No,"Chain B:THR2,ALA11,ILE12,VAL17,ASP19,HIS20,LEU58,LYS60,ILE86,TYR89,VAL91,LYS94",2.2,True,1
ASD00330000_3,pyrI,Escherichia coli,P0A7F3,1ZA2,ASD00150003,CTP,B,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",155,Inner Protein Regulator,Inner Protein,15951418,Structural basis for ordered substrate binding and cooperativity in aspartate transcarbamoylase,No,"Chain B:ALA11,ILE12,VAL17,ASP19,HIS20,LEU58,LYS60,ASN84,ILE86,TYR89,VAL91,LYS94",2.5,True,1
ASD00330000_3,pyrI,Escherichia coli,P0A7F3,2FZC,ASD00150003,CTP,B,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",901,Inner Protein Regulator,Inner Protein,16906764,T-state Inhibitors of E. coli Aspartate Transcarbamoylase that Prevent the Allosteric Transition.,No,"Chain B:THR2,HIS3,GLU10,ALA11,ILE12,VAL17,ASP19,HIS20,LYS60,ASN84,ILE86,TYR89,VAL91,LYS94",2.1,True,1
ASD00330000_3,pyrI,Escherichia coli,P0A7F3,2FZG,ASD00150003,CTP,B,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",901,Inner Protein Regulator,Inner Protein,16906764,T-state Inhibitors of E. coli Aspartate Transcarbamoylase that Prevent the Allosteric Transition.,No,"Chain B:THR2,ASP4,ALA11,ILE12,VAL17,ASP19,HIS20,LEU58,LYS60,ASN84,ILE86,TYR89,VAL91,LYS94",2.25,True,1
ASD00330000_3,pyrI,Escherichia coli,P0A7F3,2FZK,ASD00150003,CTP,B,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",901,Inner Protein Regulator,Inner Protein,16906764,T-state Inhibitors of E. coli Aspartate Transcarbamoylase that Prevent the Allosteric Transition.,No,"Chain B:THR2,ASP4,ALA11,ILE12,VAL17,HIS20,LYS60,ASN84,ILE86,TYR89,VAL91,LYS94",2.5,True,1
ASD00330000_3,pyrI,Escherichia coli,P0A7F3,4AT1,ASD00150001,ATP,B,Lig,Activator,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",155,Inner Protein Regulator,Inner Protein,2271528,Structural consequences of effector binding to the T state of aspartate carbamoyltransferase: crystal structures of the unligated and ATP- and CTP-complexed enzymes at 2.6-A resolution.,No,"Chain B:VAL9,GLU10,ALA11,ILE12,VAL17,ASP19,LEU58,LYS60,ASN84,TYR89,VAL91,LYS94",2.6,True,1
ASD00330000_3,pyrI,Escherichia coli,P0A7F3,4FYV,ASD00900001,DCP,B,Lig,Inhibitor,"[(2R,3S,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3-hydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",202,Inner Protein Regulator,Inner Protein,22906065,Metal Ion Involvement in the Allosteric Mechanism of Escherichia coli Aspartate Transcarbamoylase.,No,"Chain B:ALA11,ILE12,VAL17,LYS60,ILE86,TYR89,GLU90",2.0976,True,1
ASD00330000_3,pyrI,Escherichia coli,P0A7F3,4FYW,ASD00150003,CTP,B,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",202,Inner Protein Regulator,Inner Protein,22906065,Metal Ion Involvement in the Allosteric Mechanism of Escherichia coli Aspartate Transcarbamoylase.,No,"Chain B:ALA11,ILE12,VAL17,ASP19,HIS20,LEU58,LYS60,ASN84,ILE86,TYR89,VAL91,LYS94",2.1,True,1
ASD00330000_3,pyrI,Escherichia coli,P0A7F3,4FYX,ASD00150002;ASD00900001;ASD00330030,UTP;MG;DCP,B;B;B,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate;magnesium(+2) cation;[(2R,3S,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3-hydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",202;203;204,Inner Protein Regulator,Inner Protein,22906065,Metal Ion Involvement in the Allosteric Mechanism of Escherichia coli Aspartate Transcarbamoylase.,No,"Chain B:LYS6,LEU7,GLN8,VAL9,ALA11,ILE12,VAL17,ASP19,HIS20,LEU48,PRO49,SER50,GLY51,GLU52,LYS56,LEU58,LYS60,THR82,ASN84,ILE86,TYR89,VAL91,LYS94",2.0889,True,1
ASD00330000_3,pyrI,Escherichia coli,P0A7F3,4FYY,ASD00150002;ASD00150003;ASD00330030,UTP;MG;CTP,B;B;B,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate;magnesium(+2) cation;[(2R,3S,4R,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",202;203;204,Inner Protein Regulator,Inner Protein,22906065,Metal Ion Involvement in the Allosteric Mechanism of Escherichia coli Aspartate Transcarbamoylase.,No,"Chain B:LEU7,GLN8,VAL9,ALA11,ILE12,VAL17,ASP19,HIS20,LEU48,PRO49,SER50,GLY51,GLU52,LYS56,LEU58,LYS60,THR82,ASN84,ILE86,TYR89,VAL91,LYS94",1.9395,True,1
ASD00330000_3,pyrI,Escherichia coli,P0A7F3,5AT1,ASD00150003,CTP,B,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",155,Inner Protein Regulator,Inner Protein,2271528,Structural consequences of effector binding to the T state of aspartate carbamoyltransferase: crystal structures of the unligated and ATP- and CTP-complexed enzymes at 2.6-A resolution.,No,"Chain B:GLU10,ALA11,ILE12,VAL17,ASP19,SER50,GLY51,LEU58,LYS60,ASN84,ILE86,TYR89,VAL91,LYS94",2.6,True,1
ASD00330000_3,pyrI,Escherichia coli,P0A7F3,7AT1,ASD00150001,ATP,B,Lig,Activator,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",155,Inner Protein Regulator,Inner Protein,2271529,"Crystal structures of aspartate carbamoyltransferase ligated with phosphonoacetamide, malonate, and CTP or ATP at 2.8-A resolution and neutral pH.",No,"Chain B:GLU10,ALA11,ILE12,VAL17,ASP19,HIS20,GLU52,LEU58,LYS60,ASN84,ILE86,TYR89,VAL91,LYS94",2.8,True,1
ASD00330000_3,pyrI,Escherichia coli,P0A7F3,8AT1,ASD00150003,CTP,B,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",155,Inner Protein Regulator,Inner Protein,2271529,"Crystal structures of aspartate carbamoyltransferase ligated with phosphonoacetamide, malonate, and CTP or ATP at 2.8-A resolution and neutral pH.",No,"Chain B:GLU10,ILE12,ASP19,HIS20,LYS60,ASN84,ILE86,TYR89,VAL91,LYS94",2.8,True,1
ASD00330000_4,pyrI,Sulfolobus acidocaldarius,P74766,2BE9,ASD00150003,CTP,B,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",401,Inner Protein Regulator,Inner Protein,18477471,Crystal structure of Sulfolobus acidocaldarius aspartate carbamoyltransferase in complex with its allosteric activator CTP.,No,"Chain B:LYS14,ILE15,VAL20,ASP22,HIS23,LYS64,ASN88,VAL90,TYR93,VAL95,LYS98",2.6,True,1
ASD00350000_1,MJ0571,Methanocaldococcus jannaschii,Q57991,3C1N,ASD00350001,THR,A,Lig,Inhibitor,"(2S,3R)-2-amino-3-hydroxy-butanoic acid",471,Inner Protein Regulator,Protein-Protein Interaction,18334478,The structural basis for allosteric inhibition of a threonine-sensitive aspartokinase.,No,"Chain A:MET414,GLY416,ALA417,GLY419,ILE420,ALA421,GLN440,GLU444; Chain B:ASN434,ILE435",2.72,True,2
ASD00350000_2,AK1,Arabidopsis thaliana,Q9LYU8,2CDQ,ASD00350007,SAM,A,Lig,Inhibitor,"(2S)-2-amino-4-[[(2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl-methyl-sulfonio]butanoate",1500,Inner Protein Regulator,Protein-Protein Interaction,16731588,A Novel Organization of Act Domains in Allosteric Enzymes Revealed by the Crystal Structure of Arabidopsis Aspartate Kinase,No,Chain B:VAL355,2.85,True,1
ASD00350000_3,lysC,Synechocystis sp.,P74569,3L76,ASD00910001,LYS,A,Lig,Inhibitor,[(5S)-5-amino-6-hydroxy-6-oxo-hexyl]azanium,603,Inner Protein Regulator,Inner Protein,20398676,A new mode of dimerization of allosteric enzymes with ACT domains revealed by the crystal structure of the aspartate kinase from Cyanobacteria,No,"Chain A:ASP298,ILE299,ASP300,MET537,HIS540,PRO541,GLY542,VAL543,ALA544,THR563,SER564,GLU565,ILE568",2.54,True,1
ASD00350000_3,lysC,Synechocystis sp.,P74569,3L76,ASD00910001,LYS,A,Lig,Inhibitor,[(5S)-5-amino-6-hydroxy-6-oxo-hexyl]azanium,604,Inner Protein Regulator,Inner Protein,20398676,A new mode of dimerization of allosteric enzymes with ACT domains revealed by the crystal structure of the aspartate kinase from Cyanobacteria,No,"Chain A:MET365,ARG368,PRO369,GLY370,ILE371,ALA372,SER392,GLU393,SER472,VAL473,ASP474",2.54,True,1
ASD00350000_3,lysC,Synechocystis sp.,P74569,3L76,ASD00350001,THR,A,Lig,Inhibitor,"(2S,3R)-2-amino-3-hydroxy-butanoic acid",601,Inner Protein Regulator,Inner Protein,20398676,A new mode of dimerization of allosteric enzymes with ACT domains revealed by the crystal structure of the aspartate kinase from Cyanobacteria,No,"Chain A:ASP280,ARG281,PRO282,GLY283,VAL284,ALA285,GLN304,ASN557,ILE558",2.54,True,1
ASD00350000_3,lysC,Synechocystis sp.,P74569,3L76,ASD00350001,THR,A,Lig,Inhibitor,"(2S,3R)-2-amino-3-hydroxy-butanoic acid",602,Inner Protein Regulator,Inner Protein,20398676,A new mode of dimerization of allosteric enzymes with ACT domains revealed by the crystal structure of the aspartate kinase from Cyanobacteria,No,"Chain A:ASN385,ILE386,VAL452,ASP454,ARG455,PRO456,GLY457,MET458,ALA459,GLN478",2.54,True,1
ASD00370000_1,met3,Penicillium chrysogenum,Q12650,1I2D,ASD01720025,ADX,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl sulfo hydrogen phosphate",575,Inner Protein Regulator,Inner Protein,11389593,Crystal structure of ATP sulfurylase from Penicillium chrysogenum: insights into the allosteric regulation of sulfate assimilation.,No,"Chain A:MET405,ASP434,ARG437,PHE446,ARG451,ASN454,PRO476,ILE477,ALA478,PRO479,ILE517,LYS527,GLY528,PHE529,THR530",2.81,True,1
ASD00370000_1,met3,Penicillium chrysogenum,Q12650,1M8P,ASD00370003,PPS,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxy-oxolan-2-yl]methyl sulfo hydrogen phosphate",574,Inner Protein Regulator,Inner Protein,12426581,Allosteric inhibition via R-state destabilization in ATP sulfurylase from Penicillium chrysogenum.,No,"Chain A:MET405,ASP434,ARG437,PHE446,ARG451,ASN454,ILE455,PRO476,ILE477,ALA478,PRO479,ARG515,ILE517,ILE526,LYS527,GLY528,PHE529,THR530",2.6,True,1
ASD00430000_1,ACC1,Saccharomyces cerevisiae,Q00955,1W96,ASD00431046,S1A,A,Lig,Inhibitor,"(1R,2S,5S,10S,11R,12E,14S,15S,16S,17S,18R)-1,17-dihydroxy-10,11,18-trimethoxy-2,14,16-trimethyl-5-phenyl-4,19-dioxabicyclo[13.3.1]nonadec-12-en-3-one",1567,Inner Protein Regulator,Inner Protein,15610732,"A mechanism for the potent inhibition of eukaryotic acetyl-coenzyme A carboxylase by soraphen A, a macrocyclic polyketide natural product.",No,"Chain A:ILE69,LYS73,ARG76,SER77,PRO389,GLU392,MET393,GLY396,VAL397,ASN398,CYS454,ASN485,TRP487,PHE510,PHE512",1.8,True,1
ASD00440000_1,,Escherichia coli,P06709,2EWN,ASD00440002,BTX,A,Lig,Activator,"((2R,3S,4R,5R)-5-(6-AMINO-9H-PURIN-9-YL)- 3,4-DIHYDROXY-TETRAHYDROFURAN-2-YL)METHYL 5- ((3AS,4S,6AR)-2-OXO-HEXAHYDRO-1H-THIENO[3,4- D]IMIDAZOL-4-YL)PENTYL HYDROGEN PHOSPHATE",501,Protein-Protein Interaction Regulator,Inner Protein,16438984,Co-repressor induced order and biotin repressor dimerization: a case for divergent followed by convergent evolution.,No,"Chain A:ALA185,LYS172,GLY206,ILE187,GLY117,ASN220,GLN92,GLY186,ASP176,VAL219,PRO126,ILE224,LEU188,ALA205,TRP223,LYS122,SER125,LEU131,SER89,ARG116,SER134,LEU133,GLN221,GLY222,PHE124,VAL214,MET211,TYR132,GLU313,ARG118,ILE207,ALA114,LEU184,ARG121,ASN130,ASN208,GLN112,LYS183,TRP123,GLU190,VAL218,ARG119,ILE203,ASP88,GLY204,GLY115,THR90,ASN91",2.8,True,1
ASD00440000_1,,Escherichia coli,P06709,4WF2,ASD00440002,BTX,A,Lig,Activator,"((2R,3S,4R,5R)-5-(6-AMINO-9H-PURIN-9-YL)- 3,4-DIHYDROXY-TETRAHYDROFURAN-2-YL)METHYL 5- ((3AS,4S,6AR)-2-OXO-HEXAHYDRO-1H-THIENO[3,4- D]IMIDAZOL-4-YL)PENTYL HYDROGEN PHOSPHATE",501,Protein-Protein Interaction Regulator,Inner Protein,25746672,Allosteric Coupling via Distant Disorder-to-Order Transitions.,No,"Chain A:ALA185,LYS172,GLY206,ILE187,GLY117,GLN92,GLY186,ASP176,PRO126,ILE224,LEU188,ALA205,TRP223,LYS122,SER125,LEU131,SER89,ARG116,SER134,LEU133,PHE124,MET211,TYR132,ARG118,ILE207,ASN175,ALA114,LEU184,ARG121,ASN130,ASN208,GLN112,LYS183,TRP123,ARG119,ILE203,ASP88,GLY204,GLY115,THR90,ASN91",2.31,True,1
ASD00440000_2,,Pyrococcus horikoshii,O57883,1WQW,ASD00440001,BT5,A,Lig,Activator,BIOTINYL-5-AMP,1301,Protein-Protein Interaction Regulator,Inner Protein,16169557,Crystal Structures of Biotin Protein Ligase from Pyrococcus horikoshii OT3 and its Complexes: Structural Basis of Biotin Activation,No,"Chain A:ASN134,GLY139,GLN42,THR141,LEU60,GLY47,VAL115,LEU62,VAL136,THR20,GLY127,GLY114,ARG51,TRP53,PRO137,ALA140,SER55,GLY129,ARG48,GLY45,HIS46,TRP61,ILE112,MET44,LEU130,LYS111,ASP104,ASN103,PRO56,ALA113,LEU49,SER63,GLU54,ILE128,GLU24,LYS52,THR22,SER21,ASN131,ASN23,LYS135,LEU116",1.45,True,1
ASD00440000_2,,Pyrococcus horikoshii,O57883,2DEQ,ASD00440001,BT5,B,Lig,Activator,BIOTINYL-5-AMP,1301,Protein-Protein Interaction Regulator,Inner Protein,,Ligand Structures Of Biotin Protein Ligase From Pyrococcus Horikoshii OT3,No,"Chain A:ASN134,GLN42,THR141,LEU60,GLY47,VAL115,GLY111,LEU62,VAL136,THR20,GLY127,GLY114,ARG51,TRP53,PRO137,ALA140,SER55,GLY129,ARG48,GLY45,HIS46,TRP61,ILE112,MET44,LEU130,ASP104,ASN103,PRO56,ALA113,LEU49,SER63,GLU54,ILE128,GLU24,LYS52,THR22,SER21,ASN131,ASN23,LYS135,LEU116",1.85,True,1
ASD00440000_2,,Pyrococcus horikoshii,O57883,2DJZ,ASD00440001,BT5,A,Lig,Activator,BIOTINYL-5-AMP,1301,Protein-Protein Interaction Regulator,Inner Protein,,Ligand Structures Of Biotin Protein Ligase From Pyrococcus Horikoshii OT3,No,"Chain A:ASN134,ALA111,GLN42,THR141,LEU60,GLY47,VAL115,LEU62,VAL136,THR20,GLY127,GLY114,ARG51,TRP53,PRO137,ALA140,SER55,GLY129,ARG48,GLY45,HIS46,TRP61,ILE112,MET44,LEU130,ASP104,ASN103,PRO56,ALA113,LEU49,LYS135,SER63,GLU54,ILE128,SER231,GLU24,LYS52,THR22,SER21,ASN131,ASN23,GLU118,LEU116",1.85,True,1
ASD00440000_2,,Pyrococcus horikoshii,O57883,2DKG,ASD00440001,BT5,B,Lig,Activator,BIOTINYL-5-AMP,1301,Protein-Protein Interaction Regulator,Inner Protein,,Ligand Structures Of Biotin Protein Ligase From Pyrococcus Horikoshii Ot3,No,"Chain A:ASN134,GLN42,THR141,LEU60,GLY47,VAL115,LEU62,VAL136,THR20,GLY127,GLY114,ARG51,TRP53,PRO137,ALA140,SER55,GLY129,ARG48,GLY45,HIS46,TRP61,ILE112,MET44,LEU130,LYS111,ASP104,ASN103,PRO56,ALA113,LEU49,SER63,GLU54,ILE128,GLU24,LYS52,THR22,SER21,ASN131,ASN23,LYS135,LEU116",2.0,True,1
ASD00440000_2,,Pyrococcus horikoshii,O57883,2DTI,ASD00440001,BT5,B,Lig,Activator,BIOTINYL-5-AMP,1301,Protein-Protein Interaction Regulator,Inner Protein,,Ligand Structures Of Biotin Protein Ligase From Pyrococcus Horikoshii OT3,No,"Chain A:ASN134,GLN42,LEU60,GLY47,VAL115,LEU62,VAL136,THR20,GLY127,GLY114,ARG51,TRP53,PRO137,ALA140,SER55,GLY129,ARG48,GLY45,HIS46,TRP61,ILE112,MET44,THR141,LYS111,ASP104,ASN103,PRO56,ALA113,LEU49,SER63,GLU54,ILE128,GLU24,LYS52,THR22,SER21,ASN131,ASN23,LYS135,LEU116",2.2,True,1
ASD00440000_2,,Pyrococcus horikoshii,O57883,2DVE,ASD00440001,BT5,B,Lig,Activator,BIOTINYL-5-AMP,1301,Protein-Protein Interaction Regulator,Inner Protein,,Ligand Structures of Biotin Protein Ligase From Pyrococcus Horikoshii OT3,No,"Chain A:ASN134,GLY139,GLN42,THR141,LEU60,GLY47,VAL115,LEU62,VAL136,THR20,GLY127,GLY114,TRP53,PRO137,ALA140,SER55,GLY129,ARG48,GLY45,ALA51,HIS46,TRP61,ILE112,MET44,LEU130,LYS111,ASP104,ASN103,PRO56,ALA113,LEU49,TYR227,SER63,GLU54,ILE128,GLU24,LYS52,THR22,SER21,ASN131,ASN23,LYS135,LEU116",1.6,True,1
ASD00440000_2,,Pyrococcus horikoshii,O57883,2DXU,ASD00440001,BT5,B,Lig,Activator,BIOTINYL-5-AMP,2301,Protein-Protein Interaction Regulator,Inner Protein,18372281,Protein biotinylation visualized by a complex structure of biotin protein ligase with a substrate,No,"Chain A:ASN134,GLY139,GLN42,THR141,LEU60,GLY47,VAL115,LEU62,VAL136,THR20,GLY127,GLY114,ARG51,TRP53,PRO137,ALA140,SER55,GLY129,GLY45,HIS46,TRP61,ILE112,MET44,LEU130,LYS111,ASP104,ASN103,PRO56,ALA113,LEU49,SER63,GLU54,ILE128,GLU24,ALA48,LYS52,THR22,ASN138,SER21,ASN131,ASN23,LYS135,LEU116",1.28,True,1
ASD00440000_2,,Pyrococcus horikoshii,O57883,2DZ9,ASD00440001,BT5,B,Lig,Activator,BIOTINYL-5-AMP,1001,Protein-Protein Interaction Regulator,Inner Protein,,Ligand Structures Of Biotin Protein Ligase From Pyrococcus Horikoshii Ot3,No,"Chain A:ASN134,GLY139,GLN42,ALA104,THR141,LEU60,GLY47,VAL115,LEU62,VAL136,THR20,GLY127,GLY114,ARG51,TRP53,PRO137,ALA140,SER55,GLY129,ARG48,GLY45,HIS46,TRP61,ILE112,MET44,LEU130,LYS111,LEU116,ASN103,PRO56,ALA113,LEU49,SER63,GLU54,ILE128,GLU24,LYS52,THR22,ASN138,SER21,ASN131,ASN23,LYS135",1.84,True,1
ASD00440000_3,,Mycobacterium tuberculosis,I6YFP0,4OP0,ASD00440001,BT5,A,Lig,Activator,BIOTINYL-5-AMP,301,Protein-Protein Interaction Regulator,Inner Protein,24723382,Active site conformational changes upon reaction intermediate biotinyl-5'-AMP binding in biotin protein ligase from Mycobacterium tuberculosis.,No,"Chain A:ARG69,GLN161,ALA170,TRP74,LEU139,VAL155,LEU153,SER38,LYS138,ALA41,THR171,ARG67,THR39,ALA76,ASP167,ALA140,ASN158,LEU84,GLN81,ALA75,ALA65,GLY66,ILE83,GLY156,ASN40,ASP169,GLY154,GLY73,LEU157,SER85,ASN130,ILE142,LEU143,ASP131,GLY37,GLY68,VAL166,ILE82,GLN63,ARG72,GLY141,HIS70",1.7,True,1
ASD00480000_1,crp,Escherichia coli,P0ACJ8,1G6N,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",621,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,11124031,Modeling the cAMP-induced allosteric transition using the crystal structure of CAP-cAMP at 2.1 A resolution.,No,"Chain A:VAL49,LEU61,SER62,LEU64,ILE70,GLY71,GLU72,LEU73,GLY74,ARG82,SER83,ALA84,VAL86,ARG123,THR127; Chain B:LEU424,SER428",2.1,True,2
ASD00480000_1,crp,Escherichia coli,P0ACJ8,1HW5,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",210,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,11124966,The structure of the T127L/S128A mutant of cAMP receptor protein facilitates promoter site binding.,No,"Chain A:VAL49,LEU61,SER62,LEU64,ILE70,GLY71,GLU72,LEU73,GLY74,ARG82,SER83,ALA84,VAL86,TYR99,ARG123,LEU127; Chain B:LEU124",1.82,True,2
ASD00480000_1,crp,Escherichia coli,P0ACJ8,1I5Z,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",301,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,,The effect of the D53H point mutation on the macroscopic motions of E. coli Cyclic AMP Receptor Protein,No,"Chain A:ILE30,VAL49,LEU61,SER62,ILE70,GLY71,GLU72,LEU73,ARG82,SER83,ALA84,VAL86,ARG123,THR127; Chain B:LEU124,SER128",1.9,True,2
ASD00480000_1,crp,Escherichia coli,P0ACJ8,1I6X,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",301,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,,The effect of the D53H point mutation on the macroscopic motions of E. coli Cyclic AMP Receptor Protein,No,"Chain A:ILE30,VAL49,LEU61,SER62,LEU64,ILE70,GLY71,GLU72,LEU73,ARG82,SER83,ALA84,VAL86,TYR99,ARG123,THR127; Chain B:LEU124,SER128",2.2,True,2
ASD00480000_1,crp,Escherichia coli,P0ACJ8,1J59,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",762,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,8757802,Structure of the CAP-DNA complex at 2.5 angstroms resolution: a complete picture of the protein-DNA interface.,No,"Chain A:ILE30,ALA36,VAL49,LEU61,SER62,GLY71,GLU72,LEU73,ARG82,SER83,VAL86,ARG123,THR127; Chain B:LEU124,SER128",2.5,True,2
ASD00480000_1,crp,Escherichia coli,P0ACJ8,1O3T,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",762,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,11724532,Indirect readout of DNA sequence at the primary-kink site in the CAP-DNA complex: alteration of DNA binding specificity through alteration of DNA kinking.,No,"Chain A:VAL49,LEU61,ILE70,GLY71,GLU72,LEU73,ARG82,SER83,ALA84,VAL86,THR127; Chain B:LEU124,SER128",2.8,True,2
ASD00480000_1,crp,Escherichia coli,P0ACJ8,1RUN,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",679,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,8836098,Aromatic hydrogen bond in sequence-specific protein DNA recognition.,No,"Chain A:VAL49,SER62,ILE70,GLY71,GLU72,LEU73,GLY74,ARG82,SER83,ALA84,THR127; Chain B:LEU124,SER128",2.7,True,2
ASD00480000_1,crp,Escherichia coli,P0ACJ8,1RUO,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",210,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,8836098,Aromatic hydrogen bond in sequence-specific protein DNA recognition.,No,"Chain A:VAL49,LEU61,SER62,PHE69,ILE70,GLY71,GLU72,LEU73,ARG82,SER83,ALA84,VAL86,ARG123,THR127; Chain B:LEU124,SER128",2.7,True,2
ASD00480000_1,crp,Escherichia coli,P0ACJ8,1ZRC,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",210,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,16427082,Indirect readout of DNA sequence at the primary-kink site in the CAP-DNA complex: recognition of pyrimidine-purine and purine-purine steps.,No,"Chain A:VAL49,LEU61,ILE70,GLY71,GLU72,LEU73,GLY74,ARG82,SER83,ALA84,VAL86,ARG123,THR127; Chain B:LEU124,SER128",2.8,True,2
ASD00480000_1,crp,Escherichia coli,P0ACJ8,1ZRD,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",210,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,16427082,Indirect readout of DNA sequence at the primary-kink site in the CAP-DNA complex: recognition of pyrimidine-purine and purine-purine steps.,No,"Chain A:VAL49,LEU61,SER62,ILE70,GLY71,GLU72,LEU73,GLY74,GLU81,ARG82,SER83,ALA84,VAL86,ARG123,THR127; Chain B:LEU124,SER128",2.8,True,2
ASD00480000_1,crp,Escherichia coli,P0ACJ8,1ZRE,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",210,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,16427082,Indirect readout of DNA sequence at the primary-kink site in the CAP-DNA complex: recognition of pyrimidine-purine and purine-purine steps.,No,"Chain A:ILE30,VAL49,LEU61,SER62,ILE70,GLY71,GLU72,LEU73,GLY74,ARG82,SER83,ALA84,VAL86,TYR99,ARG123,THR127; Chain B:LEU124,SER128",2.8,True,2
ASD00480000_1,crp,Escherichia coli,P0ACJ8,1ZRF,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",622,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,16427082,Indirect readout of DNA sequence at the primary-kink site in the CAP-DNA complex: recognition of pyrimidine-purine and purine-purine steps.,No,"Chain A:ILE30,VAL49,LEU61,SER62,ILE70,GLY71,GLU72,LEU73,ARG82,SER83,ALA84,VAL86,TYR99,ARG123,THR127; Chain B:LEU124,SER128",2.1,True,2
ASD00480000_1,crp,Escherichia coli,P0ACJ8,2CGP,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",621,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,9096308,The structure of a CAP-DNA complex having two cAMP molecules bound to each monomer.,No,"Chain A:ILE30,VAL49,LEU61,SER62,ILE70,GLY71,GLU72,LEU73,ARG82,SER83,ALA84,VAL86,ARG123,THR127",2.2,True,1
ASD00480000_1,crp,Escherichia coli,P0ACJ8,2GZW,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",1301,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,,Crystal structure of activated CRP protein from E coli,No,"Chain A:ILE30,VAL49,LEU61,SER62,ILE70,GLY71,GLU72,LEU73,ARG82,SER83,ALA84,VAL86,TYR99,ARG123,THR127; Chain B:LEU124,SER128",2.21,True,2
ASD00480000_1,crp,Escherichia coli,P0ACJ8,3KCC,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",301,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,,The Structure of a D138L Mutant of Catabolite Gene Activator Protein Reveals two cAMP Binding Sites in each monomer,No,"Chain A:ILE30,VAL49,LEU61,SER62,ILE70,GLY71,GLU72,LEU73,GLY74,ARG82,SER83,ALA84,VAL86,ARG123,THR127; Chain B:LEU124,SER128",1.66,True,2
ASD00480000_1,crp,Escherichia coli,P0ACJ8,3N4M,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",210,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,,Combined structural model for a transcription activation assembly,No,"Chain A:ILE30,VAL49,LEU61,SER62,ILE70,GLY71,GLU72,LEU73,GLY74,ARG82,SER83,ALA84,VAL86,TYR99,ARG123,THR127",2.987,True,1
ASD00480000_1,crp,Escherichia coli,P0ACJ8,3QOP,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",301,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,,Domain-Domain Flexibility Leads to Allostery within the Camp Receptor Protein (Crp),No,"Chain A:ILE30,VAL49,LEU61,PHE62,ILE70,GLY71,GLU72,LEU73,GLY74,ARG82,SER83,ALA84,VAL86,ARG123,THR127; Chain B:LEU124,SER128",1.96,True,2
ASD00480000_1,crp,Escherichia coli,P0ACJ8,3RDI,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",301,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,,Domain-Domain Flexibility Leads to Allostery within the Cam Receptor Protein (Crp),No,"Chain A:ILE30,VAL49,LEU61,PHE62,ILE70,GLY71,GLU72,LEU73,ARG82,SER83,ALA84,VAL86,ARG123,THR127; Chain B:LEU124,SER128",2.95,True,2
ASD00480000_1,crp,Escherichia coli,P0ACJ8,3ROU,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",301,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,,Domain-Domain Flexibility Leads to Allostery within the Cam Receptor Protein (Crp),No,"Chain A:ILE30,VAL49,LEU61,PHE62,ILE70,GLY71,GLU72,LEU73,GLY74,ARG82,SER83,ALA84,VAL86,TYR99,ARG123,THR127; Chain B:LEU124,SER128",2.1,True,2
ASD00480000_1,crp,Escherichia coli,P0ACJ8,3RPQ,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",301,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,,Domain-Domain Flexibility Leads to Allostery within the Cam Receptor Protein (Crp),No,"Chain A:ILE30,VAL49,LEU61,PHE62,ILE70,GLY71,GLU72,LEU73,ARG82,SER83,ALA84,VAL86,ARG123,THR127; Chain B:LEU124,SER128",2.61,True,2
ASD00480000_1,crp,Escherichia coli,P0ACJ8,3RYP,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",301,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,,Domain-Domain Flexibility Leads to Allostery within the Cam Receptor Protein (Crp),No,"Chain A:ILE30,VAL49,LEU61,SER62,LEU64,ILE70,GLY71,GLU72,LEU73,GLY74,ARG82,SER83,ALA84,VAL86,TYR99,ARG123,THR127; Chain B:LEU124,SER128",1.6,True,2
ASD00480000_1,crp,Escherichia coli,P0ACJ8,3RYR,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",301,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,,Domain-Domain Flexibility Leads to Allostery within the Cam Receptor Protein (Crp),No,"Chain A:ILE30,VAL49,LEU61,SER62,ILE70,GLY71,GLU72,LEU73,ARG82,SER83,ALA84,VAL86,ARG123,THR127; Chain B:LEU124,SER128",2.7,True,2
ASD00480000_1,crp,Escherichia coli,P0ACJ8,4FT8,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",301,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,24817710,Structure of catabolite activator protein with cobalt(II) and sulfate.,No,"Chain A:ILE30,VAL49,LEU61,SER62,ILE70,GLY71,GLU72,LEU73,GLY74,ARG82,SER83,ALA84,VAL86,TYR99,ARG123,THR127; Chain B:LEU124,SER128",1.966,True,2
ASD00480000_1,crp,Escherichia coli,P0ACJ8,4HZF,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",301,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,24058293,Modulation of global low-frequency motions underlies allosteric regulation: demonstration in CRP/FNR family transcription factors.,No,"Chain A:ILE31,VAL50,LEU62,SER63,LEU65,ILE71,GLY72,GLU73,LEU74,GLY75,ARG83,SER84,ALA85,VAL87,ARG124,THR128; Chain B:LEU125,SER129",1.48,True,2
ASD00480000_1,crp,Escherichia coli,P0ACJ8,4I01,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",301,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,24058293,Modulation of global low-frequency motions underlies allosteric regulation: demonstration in CRP/FNR family transcription factors.,No,"Chain A:ILE31,VAL50,LEU62,SER63,ILE71,GLY72,GLU73,LEU74,ARG83,SER84,ALA85,VAL87,ARG124,THR128; Chain B:LEU125,SER129",2.3,True,2
ASD00480000_1,crp,Escherichia coli,P0ACJ8,4I02,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",301,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,24058293,Modulation of global low-frequency motions underlies allosteric regulation: demonstration in CRP/FNR family transcription factors.,No,"Chain A:ILE31,VAL50,LEU62,SER63,ILE71,GLY72,GLU73,LEU74,GLY75,ARG83,SER84,ALA85,VAL87,TYR100,ARG124,THR128; Chain E:LEU125,SER129",1.75,True,2
ASD00480000_1,crp,Escherichia coli,P0ACJ8,4I09,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",301,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,24058293,Modulation of global low-frequency motions underlies allosteric regulation: demonstration in CRP/FNR family transcription factors.,No,"Chain A:ILE31,VAL50,LEU62,SER63,LEU65,ILE71,GLY72,GLU73,LEU74,GLY75,ARG83,SER84,ALA85,VAL87,TYR100,ARG124,THR128; Chain B:LEU125,SER129",2.05,True,2
ASD00480000_1,crp,Escherichia coli,P0ACJ8,4I0A,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",301,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,24058293,Modulation of global low-frequency motions underlies allosteric regulation: demonstration in CRP/FNR family transcription factors.,No,"Chain A:ILE31,VAL50,LEU62,SER63,LEU65,ILE71,GLY72,GLU73,LEU74,GLY75,ARG83,SER84,ALA85,VAL87,TYR100,ARG124,THR128; Chain B:LEU125,SER129",2.2,True,2
ASD00480000_1,crp,Escherichia coli,P0ACJ8,4I0B,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",301,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,24058293,Modulation of global low-frequency motions underlies allosteric regulation: demonstration in CRP/FNR family transcription factors.,No,"Chain A:ILE31,VAL50,LEU62,SER63,ILE71,GLY72,GLU73,LEU74,GLY75,ARG83,SER84,ALA85,VAL87,TYR100,ARG124,THR128; Chain B:LEU125,SER129",1.5,True,2
ASD00480000_1,crp,Escherichia coli,P0ACJ8,4R8H,ASD00480004,SP1,"A, B",Lig,Inhibitor,"6-(6-AMINO-PURIN-9-YL)-2-THIOXO-TETRAHYDRO-2-FURO[3,2-D][1,3,2]DIOXAPHOSPHININE-2,7-DIOL",301,Protein-Protein Interaction,Protein-Protein Interaction,26187469,The Role of Protein-Ligand Contacts in Allosteric Regulation of the Escherichia coli Catabolite Activator Protein.,No,"Chain B:LEU125,SER129,GLN126",1.46,True,1
ASD00480000_2,crp,Mycobacterium tuberculosis,P9WMH3,3I54,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",301,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,19740754,Structural Insights into the Mechanism of the Allosteric Transitions of Mycobacterium tuberculosis cAMP Receptor Protein.,No,"Chain A:PHE38,ILE57,LEU69,THR70,MET72,PHE78,GLY79,GLU80,LEU81,SER82,ARG89,THR90,SER91,ARG130,THR134; Chain B:ASN135",2.2,True,2
ASD00480000_2,crp,Mycobacterium tuberculosis,P9WMH3,3I59,ASD00480042,N6R,A,Lig,Inhibitor,"(1S,4R,6R,7R,8R)-4-hydroxy-4-oxo-8-[6-[[(2R)-1-phenylpropan-2-yl]amino]purin-9-yl]-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",301,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,19740754,Structural Insights into the Mechanism of the Allosteric Transitions of Mycobacterium tuberculosis cAMP Receptor Protein.,No,"Chain A:PHE38,ILE57,LEU69,PHE78,GLY79,GLU80,LEU81,SER82,ARG89,THR90,SER91,ARG130,THR134,ASN137,LEU141; Chain B:ASN135",2.29,True,2
ASD00480000_2,crp,Mycobacterium tuberculosis,P9WMH2,3MZH,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",623,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,,Crystal Structure of Camp Receptor Protein from Mycobacterium Tuberculosis in Complex with DNA and cAMP,No,"Chain A:PHE38,ILE57,LEU69,PHE78,GLY79,GLU80,LEU81,SER82,ARG89,THR90,SER91,ARG130,THR134; Chain B:LEU131,ARG132,ASN135",2.9,True,2
ASD00480000_2,P425_03821,Mycobacterium tuberculosis,I6Y496,4A2U,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",280,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,,A New Crystal Form of Crp from M. Tuberculosis and Conformational Effects of Crystal Packing,No,"Chain A:PHE38,ILE57,LEU69,THR70,MET72,PHE78,GLY79,GLU80,LEU81,SER82,ARG89,THR90,SER91,ARG130,THR134; Chain B:LEU131,ASN135",2.63,True,2
ASD00480000_3,vfr,Pseudomonas aeruginosa,P55222,2OZ6,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",301,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,21665969,Crystal Structure of the Pseudomonas aeruginosa Virulence Factor Regulator.,No,"Chain A:ILE32,CYS38,ILE51,ILE63,PHE72,GLY73,GLU74,LEU75,GLY76,ARG87,SER88,ALA89,VAL91,TYR104,ARG128,THR132",2.8,True,1
ASD00490000_1,carB,Escherichia coli,P00968,1A9X,ASD00490004,ORN,A,Lig,Activator,"(2S)-2,5-bis(azanyl)pentanoic acid",1920,Inner Protein Regulator,Inner Protein,10029528,Carbamoyl phosphate synthetase: caught in the act of glutamine hydrolysis.,No,"Chain A:GLU783,ASP791,ALA793,GLU892,VAL893,LEU907,TYR1040,ASP1041,THR1042",1.8,True,1
ASD00490000_1,carB,Escherichia coli,P00968,1BXR,ASD00490004,ORN,A,Lig,Activator,"(2S)-2,5-bis(azanyl)pentanoic acid",1085,Inner Protein Regulator,Inner Protein,10029528,Carbamoyl phosphate synthetase: closure of the B-domain as a result of nucleotide binding.,No,"Chain A:GLU783,ASP791,SER792,ALA793,GLU892,VAL893,LEU907,TYR1040,ASP1041,THR1042",2.1,True,1
ASD00490000_1,carB,Escherichia coli,P00968,1C30,ASD00490004,ORN,A,Lig,Activator,"(2S)-2,5-bis(azanyl)pentanoic acid",4010,Inner Protein Regulator,Inner Protein,10587438,The small subunit of carbamoyl phosphate synthetase: snapshots along the reaction pathway.,No,"Chain A:GLU783,ASP791,SER792,ALA793,GLU892,VAL893,LEU895,LEU907,TYR1040,ASP1041,THR1042",2.0,True,1
ASD00490000_1,carB,Escherichia coli,P00968,1C3O,ASD00490004,ORN,A,Lig,Activator,"(2S)-2,5-bis(azanyl)pentanoic acid",4011,Inner Protein Regulator,Inner Protein,10587438,The small subunit of carbamoyl phosphate synthetase: snapshots along the reaction pathway.,No,"Chain A:GLU783,ASP791,ALA793,GLU892,VAL893,LEU895,LEU907,HIS1039,TYR1040,ASP1041,THR1042",2.1,True,1
ASD00490000_1,carB,Escherichia coli,P00968,1CE8,ASD00490004,ORN,A,Lig,Activator,"(2S)-2,5-bis(azanyl)pentanoic acid",5011,Inner Protein Regulator,Inner Protein,10428826,The binding of inosine monophosphate to Escherichia coli carbamoyl phosphate synthetase.,No,"Chain A:GLU783,ASP791,ALA793,GLU892,VAL893,LEU895,LEU907,HIS1039,TYR1040,ASP1041,THR1042",2.1,True,1
ASD00490000_1,carB,Escherichia coli,P00968,1CE8,ASD01320076,IMP,A,Lig,Regulator,"[(2R,3S,4R,5R)-3,4-dihydroxy-5-(6-oxo-1H-purin-9-yl)oxolan-2-yl]methyl dihydrogen phosphate",5012,Inner Protein Regulator,Inner Protein,10428826,The binding of inosine monophosphate to Escherichia coli carbamoyl phosphate synthetase.,No,"Chain A:SER948,VAL949,LYS954,THR974,HIS975,GLY976,THR977,LYS993,VAL994,HIS995,ILE1001,ASN1015,THR1016,THR1017,ASP1025,SER1026,VAL1028,ILE1029,ARG1030",2.1,True,1
ASD00490000_1,carB,Escherichia coli,P00968,1CS0,ASD00490004,ORN,A,Lig,Activator,"(2S)-2,5-bis(azanyl)pentanoic acid",5010,Inner Protein Regulator,Inner Protein,10587438,The small subunit of carbamoyl phosphate synthetase: snapshots along the reaction pathway.,No,"Chain A:GLU783,ASP791,SER792,ALA793,GLU892,VAL893,LEU895,LEU907,HIS1039,TYR1040,ASP1041,THR1042",2.0,True,1
ASD00490000_1,carB,Escherichia coli,P00968,1JDB,ASD00490004,ORN,B,Lig,Activator,"(2S)-2,5-bis(azanyl)pentanoic acid",1095,Inner Protein Regulator,Inner Protein,10089390,The structure of carbamoyl phosphate synthetase determined to 2.1 A resolution.,No,"Chain B:GLU782,ASP790,ALA792,GLU891,VAL892,LEU894,LEU906,TYR1039,ASP1040,THR1041",2.1,True,1
ASD00490000_1,carB,Escherichia coli,P00968,1KEE,ASD00490004,ORN,A,Lig,Activator,"(2S)-2,5-bis(azanyl)pentanoic acid",5011,Inner Protein Regulator,Inner Protein,11729189,Inactivation of the amidotransferase activity of carbamoyl phosphate synthetase by the antibiotic acivicin.,No,"Chain A:GLU783,ASP791,ALA793,GLU892,VAL893,LEU895,LEU907,TYR1040,ASP1041,THR1042",2.1,True,1
ASD00490000_1,carB,Escherichia coli,P00968,1M6V,ASD00490004,ORN,A,Lig,Activator,"(2S)-2,5-bis(azanyl)pentanoic acid",4011,Inner Protein Regulator,Inner Protein,12130656,Carbamoyl-phosphate synthetase. Creation of an escape route for ammonia.,No,"Chain A:GLU783,ASP791,ALA793,GLU892,VAL893,LEU907,TYR1040,ASP1041,THR1042",2.1,True,1
ASD00490000_1,carB,Escherichia coli,P00968,1T36,ASD00490004,ORN,A,Lig,Activator,"(2S)-2,5-bis(azanyl)pentanoic acid",1089,Inner Protein Regulator,Inner Protein,15322282,Long-range allosteric transitions in carbamoyl phosphate synthetase.,No,"Chain A:GLU783,ASP791,SER792,ALA793,GLU892,VAL893,LEU907,TYR1040,ASP1041,THR1042",2.1,True,1
ASD00490000_1,carB,Escherichia coli,P00968,1T36,ASD00490001,U,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl dihydrogen phosphate",1091,Inner Protein Regulator,Inner Protein,15322282,Long-range allosteric transitions in carbamoyl phosphate synthetase.,No,"Chain A:SER948,VAL949,ARG950,LYS954,THR974,HIS975,GLY976,THR977,LYS993,HIS995,ASN1015,THR1016,THR1017,ALA1022,ASP1025,SER1026,ILE1029",2.1,True,1
ASD00600000_2,CCR5,Clostridium pasteurianum,P00268,4MBS,ASD00600010,MRV,A,Lig,Inhibitor,"4,4-bis(fluoranyl)-N-[(1S)-3-[(1R,5S)-3-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenyl-propyl]cyclohexane-1-carboxamide",1101,Inner Protein Regulator,Inner Protein,24030490,Structure of the CCR5 chemokine receptor-HIV entry inhibitor maraviroc complex.,No,"Chain A:TYR37,TRP86,TYR89,TYR108,PHE109,PHE112,PHE182,LYS191,GLN194,THR195,ILE198,TRP248,TYR251,LEU255,THR259,MET279,GLU283,THR284,MET287",2.71,True,1
ASD00690000_1,ARO7,Saccharomyces cerevisiae,P32178,1CSM,ASD00320001,TRP,B,Lig,Activator,(2S)-2-amino-3-(1H-indol-3-yl)propanoic acid,501,Inner Protein Regulator,Protein-Protein Interaction,7971967,The crystal structure of allosteric chorismate mutase at 2.2-A resolution.,No,"Chain A:HIS71,ILE74,ARG75,ARG76,SER79,GLU82,TYR100; Chain B:ASN138,ASN139,PHE140,GLY141,SER142,THR145",2.2,True,2
ASD00690000_1,ARO7,Saccharomyces cerevisiae,P32178,2CSM,ASD00690002,TYR,A,Lig,Inhibitor,(2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid,300,Inner Protein Regulator,Protein-Protein Interaction,9384560,Crystal structure of the T state of allosteric yeast chorismate mutase and comparison with the R state.,No,"Chain A:ILE74,ARG75,ARG76",2.8,True,1
ASD00690000_1,ARO7,Saccharomyces cerevisiae,P32178,4CSM,ASD00690002,TYR,A,Lig,Inhibitor,(2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid,300,Inner Protein Regulator,Protein-Protein Interaction,9384560,Mechanisms of catalysis and allosteric regulation of yeast chorismate mutase from crystal structures.,No,"Chain A:HIS71,ILE74,ARG75,ARG76,SER79,GLU82,ILE98,TYR100",2.8,True,1
ASD00690000_1,ARO7,Saccharomyces cerevisiae,P32178,5CSM,ASD00320001,TRP,A,Lig,Activator,(2S)-2-amino-3-(1H-indol-3-yl)propanoic acid,300,Inner Protein Regulator,Protein-Protein Interaction,9384560,Mechanisms of catalysis and allosteric regulation of yeast chorismate mutase from crystal structures.,No,"Chain A:HIS71,ILE74,ARG76,GLU82",2.0,True,1
ASD00710000_1,gltA,Escherichia coli,P0ABH7,1NXG,ASD06128001,NAI,A,Lig,Inhibitor,"[[(2R,3S,4R,5R)-5-(3-aminocarbonyl-4H-pyridin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl hydrogen phosphate",3000,Inner Protein Regulator,Inner Protein,12741811,Insights into the evolution of allosteric properties. The NADH binding site of hexameric type II citrate synthases.,No,"Chain A:THR106,THR108,ARG109,HIS110,THR111,MET112,ILE113,HIS114,TYR145,ILE159,PHE162,ARG163,LYS167,ASN189",2.5,True,1
ASD00710000_1,gltA,Escherichia coli,P0ABH7,1OWB,ASD01720006,NAD,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(3-aminocarbonylpyridin-1-ium-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphate",3000,Inner Protein Regulator,Inner Protein,12824188,Probing the roles of key residues in the unique regulatory NADH binding site of type II citrate synthase of Escherichia coli.,No,"Chain A:THR106,THR108,LEU109,HIS110,THR111,MET112,ILE113,HIS114,TYR145,ASP147,ILE159,PHE162,ARG163,LYS167,ASN189",2.2,True,1
ASD00710000_1,gltA,Escherichia coli,P0ABH7,4JAF,ASD06128001,NAI,A,Lig,Inhibitor,"[[(2R,3S,4R,5R)-5-(3-aminocarbonyl-4H-pyridin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl hydrogen phosphate",503,Inner Protein Regulator,Inner Protein,23954305,Enzyme-substrate complexes of allosteric citrate synthase: Evidence for a novel intermediate in substrate binding.,No,"Chain A:THR106,THR108,ARG109,HIS110,THR111,MET112,ILE113,HIS114,TYR145,ARG155,GLU158,ILE159,PHE162,ARG163,LYS167,ASN189",2.3,True,1
ASD00740000_1,SRC,Gallus gallus,P00523,2OIQ,ASD00740007,STI,A,Lig,Inhibitor,4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide,1001,Inner Protein Regulator,Inner Protein,17355866,c-Src binds to the cancer drug imatinib with an inactive Abl/c-Kit conformation and a distributed thermodynamic penalty.,Yes,"Chain A:LEU273,VAL281,ALA293,ILE294,LYS295,GLU310,VAL313,MET314,LEU317,ILE336,THR338,TYR340,MET341,GLY344,VAL383,HIS384,ARG385,LEU393,ALA403,ASP404,PHE405",2.07,True,1
ASD00740000_1,SRC,Gallus gallus,P00523,3EL8,ASD09800002,PD5,A,Lig,Inhibitor,"1-[4-(4-amino-1-propan-2-yl-pyrazolo[5,4-d]pyrimidin-3-yl)phenyl]-3-[3-(trifluoromethyl)phenyl]urea",601,Inner Protein Regulator,Inner Protein,,Small Molecule Recognition of c-Src via the Imatinib-Binding Conformation,Yes,"Chain A:LEU273,VAL281,ALA293,LYS295,GLU310,VAL313,MET314,LEU317,LEU322,VAL323,THR338,GLU339,TYR340,MET341,LEU393,VAL402,ALA403,ASP404,GLY406",2.3,True,1
ASD00740000_1,SRC,Gallus gallus,P00523,3F3T,ASD00740003,1AU,A,Lig,Inhibitor,3-[2-(3-aminophenyl)-5-tert-butyl-pyrazol-3-yl]-1-naphthalen-1-yl-urea,1,Inner Protein Regulator,Inner Protein,19396179,A new screening assay for allosteric inhibitors of cSrc.,Yes,"Chain A:ALA293,LYS295,GLU310,VAL313,MET314,LEU317,LEU322,ILE336,THR338,TYR382,VAL402,ALA403,ASP404,PHE405,GLY406",2.5,True,1
ASD00740000_1,SRC,Gallus gallus,P00523,3F3U,ASD00740002,1AW,A,Lig,Inhibitor,3-[2-(3-aminophenyl)-5-tert-butyl-pyrazol-3-yl]-1-phenyl-urea,1,Inner Protein Regulator,Inner Protein,19396179,A new screening assay for allosteric inhibitors of cSrc.,Yes,"Chain A:GLU310,MET314,LEU317,LEU322,VAL323,THR338,TYR382,HIS384,VAL402,ALA403,ASP404,PHE405,GLY406",2.5,True,1
ASD00740000_1,SRC,Gallus gallus,P00523,3F3V,ASD00740016,1BU,A,Lig,Inhibitor,3-[4-[(6-aminoquinazolin-4-yl)amino]phenyl]-1-[5-tert-butyl-2-(3-methylphenyl)pyrazol-3-yl]urea,1,Inner Protein Regulator,Inner Protein,19462975,Hybrid compound design to overcome the gatekeeper T338M mutation in cSrc.,Yes,"Chain A:LEU273,ALA293,GLU310,MET314,LEU322,GLU339,TYR340,MET341,GLY344,TYR382,LEU393,VAL402,ALA403,ASP404,PHE405,GLY406",2.6,True,1
ASD00740000_1,SRC,Gallus gallus,P00523,3F3W,ASD00740016,1BU,A,Lig,Inhibitor,3-[4-[(6-aminoquinazolin-4-yl)amino]phenyl]-1-[5-tert-butyl-2-(3-methylphenyl)pyrazol-3-yl]urea,1,Inner Protein Regulator,Inner Protein,19462975,Hybrid compound design to overcome the gatekeeper T338M mutation in cSrc.,Yes,"Chain A:VAL281,ALA293,GLU310,MET314,LEU322,MET338,GLU339,MET341,GLY344,TYR382,HIS384,LEU393,VAL402,ALA403,ASP404,PHE405,GLY406",2.6,True,1
ASD00740000_1,SRC,Gallus gallus,P00523,3G6G,ASD00740024,G6G,A,Lig,Inhibitor,"N-[3-[[3-[4-[(4-methoxyphenyl)amino]-1,3,5-triazin-2-yl]pyridin-2-yl]amino]-4-methyl-phenyl]-4-[(4-methylpiperazin-1-yl)methyl]benzamide",1,Inner Protein Regulator,Inner Protein,19276351,Equally potent inhibition of c-Src and Abl by compounds that recognize inactive kinase conformations.,Yes,"Chain A:VAL281,ALA293,LYS295,GLU310,MET314,LEU317,LEU322,VAL323,ILE336,THR338,GLU339,TYR340,MET341,GLY344,VAL383,HIS384,ARG385,LEU393,ALA403,ASP404,PHE405",2.31,True,1
ASD00740000_1,SRC,Gallus gallus,P00523,3TZ8,ASD00740029,AQM,A,Lig,Inhibitor,N-[4-[[4-[[2-(3-aminophenyl)-5-tert-butyl-pyrazol-3-yl]carbamoylamino]phenyl]amino]quinazolin-6-yl]-3-(4-methylpiperazin-1-yl)propanamide,1,Inner Protein Regulator,Inner Protein,,Overcoming Gatekeeper Mutations in cSrc and Abl by Hybrid Compound Design,Yes,"Chain A:ALA293,THR338,ALA311,LEU317,VAL402,MET341,LEU322,VAL313,ASP348,PHE405,GLY406,HIS384,VAL281,VAL383,GLU339,LYS343,GLY274,LEU393,VAL377,VAL323,MET314,GLU310,CYS345,TYR382,LYS295,SER342,TYR340,ASP404,GLY344,LEU273,ALA403,GLN309",2.7,True,1
ASD00740000_1,SRC,Gallus gallus,P00523,4AGW,ASD00740025,NG7,A,Lig,Inhibitor,"3-[2-(cyclopropylcarbonylamino)-[1,3]thiazolo[5,4-b]pyridin-5-yl]-N-[4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]benzamide",1534,Inner Protein Regulator,Inner Protein,20299508,"Discovery of a Small-Molecule Type II Inhibitor of Wild-Type and Gatekeeper Mutants of Bcr-Abl, Pdgfralpha, Kit, and Src Kinases: Novel Type II Inhibitor of Gatekeeper Mutants.",Yes,"Chain A:LEU273,ALA293,LYS295,GLU310,VAL313,MET314,LEU317,LEU322,VAL323,THR338,GLU339,TYR340,MET341,SER342,LYS343,GLY344,TYR382,VAL383,HIS384,ARG385,LEU393,VAL402,ALA403,ASP404,PHE405",2.6,True,1
ASD00740000_1,SRC,Gallus gallus,P00523,5J5S,ASD09800026,6G3,A,Lig,Inhibitor,"N-{4-[8-amino-3-(propan-2-yl)imidazo[1,5-a]pyrazin-1-yl]naphthalen-1-yl}-N'-[3-(trifluoromethyl)phenyl]urea",601,Allosteric Fuction,Allosteric Position,,Structural and Functional Analysis of the Allosteric Modulation of IRE1a with ATP-Competitive Kinase Inhibitors,No,"Chain A:ALA293,PHE278,THR338,ALA311,SER345,MET341,GLU310,LEU297,ASP348,GLY276,GLY279,PHE307,GLN312,VAL281,SER342,CYS277,ILE294,GLU339,GLY274,LEU393,MET302,TRP282,MET314,ILE334,GLN275,VAL337,LYS295,ILE336,VAL323,TYR340,ASP404,GLY344,LEU273,ALA403",2.153,True,1
ASD00750000_1,pyrG,Escherichia coli,P0A7E5,5TKV,ASD00150003,CTP,A,Lig,Inhibitor,CYTIDINE-5'-TRIPHOSPHATE,601,Allosteric function,Allosteric position,28459447,Human CTP synthase filament structure reveals the active enzyme conformation.,Yes,"Chain A:GLY352,GLN513,MET439,GLN383,GLU403,ILE378,GLU472,HIS469,TYR471,ARG468,GLY351,CYS379,PRO350,PHE353,VAL413,GLY381,LEU380,HIS515,ARG470,GLY354,PHE404",2.7,True,1
ASD00850000_1,eryF,Saccharopolyspora erythraea,Q00441,1EGY,ASD00850001,9AP,A,Lig,Activator,phenanthren-9-amine,801,Inner Protein Regulator,Inner Protein,10716705,Crystal structures of ligand complexes of P450eryF exhibiting homotropic cooperativity.,Yes,"Chain A:ALA74,PHE78,PHE86,ARG185,VAL237,ALA241,LEU391",2.35,True,1
ASD00850000_1,eryF,Saccharopolyspora erythraea,Q00441,1EUP,ASD09650004,ASD,A,Lig,Activator,"(8R,9S,10R,13S,14S)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione",452,Inner Protein Regulator,Inner Protein,10716705,Crystal structures of ligand complexes of P450eryF exhibiting homotropic cooperativity.,Yes,"Chain A:ALA74,TYR75,PHE86,SER171,ILE174,LEU175,LEU240,GLU244,LEU391",2.1,True,1
ASD00880000_1,ddl,Staphylococcus aureus,Q5HEB7,2I80,ASD00880002,G1L,A,Lig,Inhibitor,"3-chloro-2,2-dimethyl-N-[4-(trifluoromethyl)phenyl]propanamide",400,Inner Protein Regulator,Inner Protein,17015835,Allosteric inhibition of Staphylococcus aureus D-alanine:D-alanine ligase revealed by crystallographic studies.,Yes,"Chain A:VAL19,SER20,THR23,PHE92,PRO93,LEU94,LEU95,HIS96,VAL117,GLY118,LEU289,MET310,PRO311,GLY312,PHE313,LEU337",2.19,True,1
ASD00890000_2,,Hepatitis C virus,O92972,3GNV,ASD00898002,XNZ,A,Lig,Inhibitor,"(6R)-6-(2-chloro-4-phenylmethoxy-phenyl)-5-ethanoyl-1-hydroxy-9,9-dimethyl-6,8,10,11-tetrahydrobenzo[b][1,4]benzodiazepin-7-one",579,Inner Protein Regulator,Inner Protein,19507864,Structure-based design of a benzodiazepine scaffold yields a potent allosteric inhibitor of hepatitis C NS5B RNA polymerase.,Yes,"Chain A:PHE193,PRO197,ARG200,CYS366,SER367,SER368,LEU384,ARG386,SER407,GLY410,ASN411,MET414,TYR415,GLN446,ILE447,TYR448,GLY449",2.75,True,1
ASD00890000_2,,Hepatitis C virus,O92972,3GNW,ASD00898001,XNC,A,Lig,Inhibitor,"[(5S)-5-(2-fluoro-4-phenylmethoxy-phenyl)-10-hydroxy-2,2-dimethyl-4,4-dioxo-1,3,5,11-tetrahydrothiopyrano[2,3-c][1,5]benzodiazepin-6-yl]-(6-methylpyridin-2-yl)methanone",579,Inner Protein Regulator,Inner Protein,19507864,Structure-based design of a benzodiazepine scaffold yields a potent allosteric inhibitor of hepatitis C NS5B RNA polymerase.,Yes,"Chain A:ARG158,PHE193,PRO197,ARG200,SER365,CYS366,SER367,SER368,LEU384,ARG386,SER407,GLY410,ASN411,MET414,TYR415,GLN446,ILE447,TYR448,GLY449,SER556",2.39,True,1
ASD00890000_2,,Hepatitis C virus,O92972,3MWW,ASD00890012,BIW,B,Lig,Inhibitor,1-[2-(4-carboxypiperidin-1-yl)-2-oxo-ethyl]-3-cyclohexyl-2-furan-3-yl-indole-6-carboxylic acid,577,Inner Protein Regulator,Inner Protein,20942454,Importance of ligand bioactive conformation in the discovery of potent indole-diamide inhibitors of the hepatitis C virus NS5B.,No,"Chain B:MET36,VAL37,ALA395,ALA396,HIS428,LEU492,GLY493,VAL494,PRO495,TRP500,ARG503",2.8,True,1
ASD00890000_2,,Hepatitis C virus,Q9HXM5,4DQW,ASD01140145;ASD00890024;ASD01140145;ASD00890024,ATP;MN;ATP;MN,A;A;A;A,Lig,Regulator,ADENOSINE-5'-TRIPHOSPHATE;MANGANESE (II) ION;ADENOSINE-5'-TRIPHOSPHATE;MANGANESE (II) ION;,501;502;503;504,Inner Protein Regulator,Inner Protein,23643948,MgATP Regulates Allostery and Fiber Formation in IMPDHs.,No,"Chain B:GLU180,ARG136,ARG178",2.51,True,1
ASD00890000_2,,Hepatitis C virus,O92972,4JJS,ASD00890010,1M9,A,Lig,Inhibitor,2-[(4-methylcyclohexyl)carbonyl-propan-2-yl-amino]-5-[2-(trifluoromethyl)phenoxy]benzoic acid,601,Inner Protein Regulator,Inner Protein,23768906,Structure-based design of novel HCV NS5B thumb pocket 2 allosteric inhibitors with submicromolar gt1 replicon potency: Discovery of a quinazolinone chemotype.,No,"Chain A:LEU419,ARG422,MET423,LEU474,HIS475,SER476,TYR477,ILE482,VAL485,ALA486,LEU489,LEU497,TRP528",2.2,True,1
ASD00890000_2,,Hepatitis C virus,O92972,4JJU,ASD00890014,1MB,A,Lig,Inhibitor,"1-[[2,4-bis(fluoranyl)phenyl]methyl]-6-[3-(trifluoromethyl)pyridin-2-yl]oxy-quinazolin-4-one",3002,Inner Protein Regulator,Inner Protein,23768906,Structure-based design of novel HCV NS5B thumb pocket 2 allosteric inhibitors with submicromolar gt1 replicon potency: Discovery of a quinazolinone chemotype.,No,"Chain A:LEU419,ARG422,MET423,LEU474,HIS475,SER476,TYR477,ILE482,VAL485,ALA486,LEU489,LEU497,TRP528",1.91,True,1
ASD00890000_2,,Hepatitis C virus,O92972,4JTY,ASD01410428,1NV,A,Lig,Inhibitor,"3-[4-oxidanylidene-1-[[2,4,6-tris(fluoranyl)phenyl]methyl]quinazolin-6-yl]oxy-2-(trifluoromethyl)benzamide",3002,Inner Protein Regulator,Inner Protein,23773186,Molecular Dynamics Simulations and Structure-Based Rational Design Lead to Allosteric HCV NS5B Polymerase Thumb Pocket 2 Inhibitor with Picomolar Cellular Replicon Potency.,No,"Chain A:LEU419,ARG422,MET423,LEU474,HIS475,SER476,TYR477,ILE482,VAL485,ALA486,LEU489,PRO496,LEU497,TRP528",2.6,True,1
ASD00890000_2,,Hepatitis C virus,O92972,4JTZ,ASD01410430,1NW,A,Lig,Inhibitor,"3-[4-oxidanylidene-1-[[2,4,6-tris(fluoranyl)phenyl]methyl]quinazolin-6-yl]oxy-N-pyridin-3-yl-2-(trifluoromethyl)benzamide",3002,Inner Protein Regulator,Inner Protein,23773186,Molecular Dynamics Simulations and Structure-Based Rational Design Lead to Allosteric HCV NS5B Polymerase Thumb Pocket 2 Inhibitor with Picomolar Cellular Replicon Potency.,No,"Chain A:LEU419,ARG422,MET423,LEU474,HIS475,SER476,TYR477,ILE482,VAL485,ALA486,ARG490,PRO496,LEU497,TRP528",2.8,True,1
ASD00890000_2,,Hepatitis C virus,O92972,4JU1,ASD01410432,1NZ,A,Lig,Inhibitor,"6-[3-([1,3]oxazolo[4,5-b]pyridin-2-yl)-2-(trifluoromethyl)phenoxy]-1-[[2,4,6-tris(fluoranyl)phenyl]methyl]quinazolin-4-one",3002,Inner Protein Regulator,Inner Protein,23773186,Molecular Dynamics Simulations and Structure-Based Rational Design Lead to Allosteric HCV NS5B Polymerase Thumb Pocket 2 Inhibitor with Picomolar Cellular Replicon Potency.,No,"Chain A:LEU419,ARG422,MET423,LEU474,HIS475,SER476,TYR477,ILE482,VAL485,ALA486,LEU489,ARG490,VAL494,PRO495,PRO496,LEU497,TRP528",2.9,True,1
ASD00890000_2,,Hepatitis C virus,O92972,4JU2,ASD01410440,1O0,A,Lig,Inhibitor,"6-[3-pyridin-2-yl-2-(trifluoromethyl)phenoxy]-1-[[2,4,6-tris(fluoranyl)phenyl]methyl]quinazolin-4-one",3002,Inner Protein Regulator,Inner Protein,23773186,Molecular Dynamics Simulations and Structure-Based Rational Design Lead to Allosteric HCV NS5B Polymerase Thumb Pocket 2 Inhibitor with Picomolar Cellular Replicon Potency.,No,"Chain A:LEU419,ARG422,MET423,LEU474,HIS475,SER476,TYR477,ILE482,VAL485,ALA486,LEU489,VAL494,PRO495,PRO496,LEU497,TRP528",2.7,True,1
ASD00890000_2,,Hepatitis C virus,O92972,4JVQ,ASD01410464,1ML,A,Lig,Inhibitor,5-[4-[(4-methoxyphenyl)carbonylamino]phenoxy]-2-[(4-methylcyclohexyl)carbonyl-propan-2-yl-amino]benzoic acid,3002,Inner Protein Regulator,Inner Protein,24024973,Enantiomeric Atropisomers Inhibit HCV Polymerase and/or HIV Matrix: Characterizing Hindered Bond Rotations and Target Selectivity.,No,"Chain A:LEU419,ARG422,MET423,LEU474,HIS475,SER476,TYR477,ILE482,LEU489,ARG490,VAL494,PRO496,LEU497,TRP528",2.4,True,1
ASD00890000_2,,Hepatitis C virus,O92972,5CZB,ASD00890015,55W,"A,B",Lig,Inhibitor,"1-[4-(7-amino-5-methylpyrazolo[1,5-a]pyrimidin- 2-yl)phenyl]-3-{[(R)-(2,4-dimethylphenyl)(methoxy)phosphoryl]amino}- 1H-pyrazole-4-carboxylic acid",601,Inner Protein Regulator,Allosteric Position,27520942,Synthesis of potent and broad genotypically active NS5B HCV non-nucleoside inhibitors binding to the thumb domain allosteric site 2 of the viral polymerase.,No,Chain A:MET423,1.96,True,1
ASD00900000_3,comEB,Streptococcus mutans serotype c,Q8DSE5,2HVW,ASD00900001,DCP,A,Lig,Activator,"[(2R,3S,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3-hydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",1201,Inner Protein Regulator,Inner Protein,18255096,Crystal structures of Streptococcus mutans 2'-deoxycytidylate deaminase and its complex with substrate analog and allosteric regulator dCTP x Mg2+.,No,"Chain A:ARG21,THR23,GLY43,TYR44,GLY46,GLY47,ALA49,ASP50,ASN53,ASN75; Chain B:GLN108",1.67,True,2
ASD00900000_3,,Streptococcus mutans serotype c,Q8DSE5,4P9D,ASD02040015,TTP,A,Lig,Inhibitor,THYMIDINE-5'-TRIPHOSPHATE,203,Inner Protein Regulator,Protein-Protein Interaction,25404739,The First Crystal Structure of a dTTP-bound Deoxycytidylate Deaminase Validates and Details the Allosteric-Inhibitor Binding Site.,No,Chain D:GLN104,2.9,True,1
ASD00900000_3,comEB,Streptococcus mutans serotype c,Q8DSE5,5C2O,ASD02040015,TTP,"A,B",Lig,modulator,THYMIDINE-5'-TRIPHOSPHATE,704,Allosteric Function,Allosteric Position,,Mechanism of the allosteric regulation of Streptococcus mutans 2'-deoxycytidylate deaminase,No,"Chain B:ASN45,ALA72,GLY43,GLN79,ASN75,GLY46,TYR44,ALA76,ALA41,ASN53,THR42,THR51,ASP50,GLY47,VAL70,THR23,ILE18,ARG21,GLN108,VAL48,ALA49",2.35,True,1
ASD00910000_1,,Escherichia coli,P0A6L2,1YXD,ASD00910001,LYS,B,Lig,Inhibitor,LYSINE,2300,Inner Protein Regulator,Inner Protein,16041077,The crystal structures of native and (S)-lysine-bound dihydrodipicolinate synthase from Escherichia coli with improved resolution show new features of biological significance.,No,Chain B:ALA83,2.0,True,1
ASD00910000_1,,Escherichia coli,P0A6L2,2ATS,ASD00910002,DLY,A,Lig,Inhibitor,LYSINE,3001,Inner Protein Regulator,Inner Protein,,The co-crystallisation of (S)-lysine-bound dihydrodipicolinate synthase from E. coli indicates that domain movements are not responsible for (S)-lysine inhibition,No,Chain B:ALA83,1.9,True,1
ASD00910000_3,,Pseudomonas aeruginosa,Q9I4W3,3PUO,ASD00910001,LYS,A,Lig,Inhibitor,LYSINE,293,Inner Protein Regulator,Inner Protein,21396954,Biochemical studies and crystal structure determination of dihydrodipicolinate synthase from Pseudomonas aeruginosa,No,"Chain B:GLU84,SER81,ASN80,TYR106",2.65,True,1
ASD00910000_3,,Pseudomonas aeruginosa,Q9I4W3,3TCE,ASD00910005,LYZ,A,Lig,Inhibitor,LYSINE,4990,Inner Protein Regulator,Inner Protein,,Crystal structure of the complex of Dihydrodipicolinate synthase from Acinetobacter baumannii with 5-Hydroxylysine at 2.6 A resolution,No,"Chain B:GLU84,TYR107,ASN80,TYR106",2.6,True,1
ASD00910000_3,,Pseudomonas aeruginosa,Q9I4W3,4DPQ,ASD00910001,LYS,A,Lig,Inhibitor,LYSINE,404,Inner Protein Regulator,Inner Protein,22792278,Characterisation of the first enzymes committed to lysine biosynthesis in Arabidopsis thaliana,No,"Chain B:SER144,GLU147,SER142,TYR169,ASN143,TYR170",2.202,True,1
ASD00910000_3,,Pseudomonas aeruginosa,Q9I4W3,4FHA,ASD00910001,LYS,A,Lig,Inhibitor,LYSINE,401,Inner Protein Regulator,Inner Protein,,"Structure, Function, Stability and Knockout Phenotype of Dihydrodipicolinate Synthase from Streptococcus pneumoniae",No,"Chain B:TYR114,THR85,ASP87,TYR113,ASN86",1.88,True,1
ASD00910000_3,,Pseudomonas aeruginosa,Q9I4W3,4HNN,ASD00910001,LYS,A,Lig,Inhibitor,LYSINE,401,Inner Protein Regulator,Inner Protein,23354837,"Structural, kinetic and computational investigation of Vitis vinifera DHDPS reveals new insight into the mechanism of lysine-mediated allosteric inhibition.",No,"Chain B:TYR131,SER106,GLU109,SER104,ASN105,TYR132",2.4,True,1
ASD00910000_3,,Pseudomonas aeruginosa,Q9I4W3,4I7W,ASD00910001,LYS,A,Lig,Inhibitor,LYSINE,301,Inner Protein Regulator,Inner Protein,,"Structure, function and allostery of the bona fide DHDPS from the plant pathogen Agrobacterium tumefaciens",No,"Chain B:ASN81,TYR107,SER79,GLU84,ASN80,TYR106",1.3,True,1
ASD00910000_3,,Pseudomonas aeruginosa,Q9I4W3,4M19,ASD00910001,LYS,A,Lig,Inhibitor,LYSINE,301,Inner Protein Regulator,Inner Protein,25369463,Tyrosine 110 Plays a Critical Role in Regulating the Allosteric Inhibition of Campylobacter jejuni Dihydrodipicolinate Synthase by Lysine.,No,"Chain B:ASN84,ALA85,SER83,GLU88,TYR111,TYR110",2.0,True,1
ASD00910000_3,,Pseudomonas aeruginosa,Q9I4W3,4MLR,ASD00910001,LYS,A,Lig,Inhibitor,LYSINE,301,Inner Protein Regulator,Inner Protein,25369463,Tyrosine 110 Plays a Critical Role in Regulating the Allosteric Inhibition of Campylobacter jejuni Dihydrodipicolinate Synthase by Lysine.,No,"Chain D:SER83,TYR111,PHE110,GLU88,ASN84,ALA85",2.2,True,1
ASD00910000_4,dapA,Campylobacter jejuni subsp. jejuni serotype O:2,Q9PPB4,5F1U,ASD00910006,3VN,"A,D",Lig,Inhibitor,"(2R,5R)-2,5-diamino-2,5-bis(4-aminobutyl)hexanedioic acid",301,Inner Protein Regulator,Allosteric Position,26836694,Biomimetic Design Results in a Potent Allosteric Inhibitor of Dihydrodipicolinate Synthase from Campylobacter jejuni.,No,"Chain D:HIS59,SER83,GLU50,THR53,GLU88,THR55,ASN84,LEU92,GLY82,PHE110,TYR111,SER51,VAL45,ALA52,LEU54,HIS56,ALA85",2.35,True,1
ASD00910000_4,dapA,Campylobacter jejuni subsp. jejuni serotype O:2,Q9PPB4,5F1V,ASD00910006,3VN,A,Lig,Regulator,"(2R,5R)-2,5-diamino-2,5-bis(4-aminobutyl)hexanedioic acidbis-Lysine (Synonym)",304,Allosteric Function,Allosteric Position,26836694,Biomimetic Design Results in a Potent Allosteric Inhibitor of Dihydrodipicolinate Synthase from Campylobacter jejuni.,No,"Chain C:LEU54,VAL45,SER83,GLY82,TYR111,TYR110,ALA52,HIS59,THR53,HIS56,THR55,LEU92,ALA85,ASN84,SER51,GLU88",2.2,True,1
ASD01070000_1,fecA,Escherichia coli,P13036,1KMP,ASD01070001,FDC,A,Lig,Regulator,iron(+3) cation;iron(+3) cation,742,Inner Protein Regulator,Inner Protein,11872840,Structural basis of gating by the outer membrane transporter FecA.,No,"Chain A:THR138,GLN176,GLN178,SER180,ARG365,LEU369,GLN371,ARG380,ARG438,SER521,GLN570,ASP573,ASN721",2.5,True,1
ASD01070000_1,fecA,Escherichia coli,P13036,1PO0,ASD00360007;ASD00360007,FLC;FLC,A;A,Ion,Regulator,"2-hydroxypropane-1,2,3-tricarboxylate;2-hydroxypropane-1,2,3-tricarboxylate",742;743,Inner Protein Regulator,Inner Protein,12948487,Structural evidence for iron-free citrate and ferric citrate binding to the TonB-dependent outer membrane transporter FecA.,No,"Chain A:THR138,ARG155,LEU156,GLN176,GLN178,ARG365,ARG380,ARG438,SER521,ASP720",2.15,True,1
ASD01120000_3,FBP1,Sus scrofa,P00636,1EYJ,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",341,Inner Protein Regulator,Inner Protein,10913263,"Crystal structures of fructose 1,6-bisphosphatase: mechanism of catalysis and allosteric inhibition revealed in product complexes.",No,"Chain A:VAL17,GLU20,GLY21,ALA24,GLY26,THR27,GLY28,GLU29,MET30,THR31,LYS112,TYR113,ARG140,VAL160,MET177",2.28,True,1
ASD01120000_3,FBP1,Sus scrofa,P00636,1EYK,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",341,Inner Protein Regulator,Inner Protein,10913263,"Crystal structures of fructose 1,6-bisphosphatase: mechanism of catalysis and allosteric inhibition revealed in product complexes.",No,"Chain A:VAL17,GLU20,GLY21,ALA24,GLY26,THR27,GLY28,GLU29,MET30,THR31,LYS112,TYR113,ARG140,VAL160,MET177",2.23,True,1
ASD01120000_3,FBP1,Sus scrofa,P00636,1FBP,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",337,Inner Protein Regulator,Inner Protein,2164670,"Crystal structure of fructose-1,6-bisphosphatase complexed with fructose 6-phosphate, AMP, and magnesium.",No,"Chain A:VAL17,GLN20,GLY21,ALA24,GLY26,THR27,GLY28,GLU29,MET30,THR31,LYS112,TYR113,ARG140,MET177",2.5,True,1
ASD01120000_3,FBP1,Sus scrofa,P00636,1FJ9,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",401,Inner Protein Regulator,Inner Protein,10998248,"Tryptophan fluorescence reveals the conformational state of a dynamic loop in recombinant porcine fructose-1,6-bisphosphatase.",No,"Chain A:VAL17,GLU20,GLY21,ALA24,GLY26,THR27,GLY28,GLU29,MET30,THR31,LYS112,TYR113,ARG140,VAL160,MET177",2.5,True,1
ASD01120000_3,FBP1,Sus scrofa,P00636,1FPD,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",339,Inner Protein Regulator,Inner Protein,7703244,"Structural aspects of the allosteric inhibition of fructose-1,6-bisphosphatase by AMP: the binding of both the substrate analogue 2,5-anhydro-D-glucitol 1,6-bisphosphate and catalytic metal ions monitored by X-ray crystallography.",No,"Chain A:VAL17,GLN20,GLY21,ALA24,GLY26,THR27,GLY28,GLU29,MET30,THR31,LYS112,TYR113,ARG140,VAL160,MET177",2.1,True,1
ASD01120000_3,FBP1,Sus scrofa,P00636,1FPE,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",339,Inner Protein Regulator,Inner Protein,7703244,"Structural aspects of the allosteric inhibition of fructose-1,6-bisphosphatase by AMP: the binding of both the substrate analogue 2,5-anhydro-D-glucitol 1,6-bisphosphate and catalytic metal ions monitored by X-ray crystallography.",No,"Chain A:VAL17,GLN20,GLY21,ALA24,GLY26,THR27,GLY28,GLU29,MET30,THR31,LEU34,LYS112,TYR113,ARG140,VAL160,MET177",2.2,True,1
ASD01120000_3,FBP1,Sus scrofa,P00636,1FPF,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",339,Inner Protein Regulator,Inner Protein,7703244,"Structural aspects of the allosteric inhibition of fructose-1,6-bisphosphatase by AMP: the binding of both the substrate analogue 2,5-anhydro-D-glucitol 1,6-bisphosphate and catalytic metal ions monitored by X-ray crystallography.",No,"Chain A:VAL17,GLN20,GLY21,ALA24,GLY26,THR27,GLY28,GLU29,MET30,THR31,LYS112,TYR113,ARG140,VAL160,MET177",2.1,True,1
ASD01120000_3,FBP1,Sus scrofa,P00636,1FPG,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",339,Inner Protein Regulator,Inner Protein,7703244,"Structural aspects of the allosteric inhibition of fructose-1,6-bisphosphatase by AMP: the binding of both the substrate analogue 2,5-anhydro-D-glucitol 1,6-bisphosphate and catalytic metal ions monitored by X-ray crystallography.",No,"Chain A:VAL17,GLN20,GLY21,ALA24,GLY26,THR27,GLY28,GLU29,MET30,THR31,LYS112,TYR113,ARG140,VAL160,MET177",2.3,True,1
ASD01120000_3,FBP1,Sus scrofa,P00636,1FPI,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",339,Inner Protein Regulator,Inner Protein,7568043,"Crystallographic evidence for the action of potassium, thallium, and lithium ions on fructose-1,6-bisphosphatase.",No,"Chain A:VAL17,GLN20,GLY21,ALA24,GLY26,THR27,GLY28,GLU29,MET30,THR31,LYS112,TYR113,ARG140,VAL160,MET177",2.3,True,1
ASD01120000_3,FBP1,Sus scrofa,P00636,1FPJ,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",338,Inner Protein Regulator,Inner Protein,7568043,"Crystallographic evidence for the action of potassium, thallium, and lithium ions on fructose-1,6-bisphosphatase.",No,"Chain A:VAL17,GLN20,GLY21,GLY26,THR27,GLY28,GLU29,MET30,THR31,LYS112,TYR113,ARG140,VAL160,MET177",2.2,True,1
ASD01120000_3,FBP1,Sus scrofa,P00636,1FPL,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",339,Inner Protein Regulator,Inner Protein,7568043,"Crystallographic evidence for the action of potassium, thallium, and lithium ions on fructose-1,6-bisphosphatase.",No,"Chain A:VAL17,GLN20,GLY21,ALA24,GLY26,THR27,GLY28,GLU29,MET30,THR31,LYS112,TYR113,ARG140,VAL160,MET177",2.3,True,1
ASD01120000_3,FBP1,Sus scrofa,P00636,1FRP,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",338,Inner Protein Regulator,Inner Protein,7809062,"Crystal structure of fructose-1,6-bisphosphatase complexed with fructose 2,6-bisphosphate, AMP, and Zn2+ at 2.0-A resolution: aspects of synergism between inhibitors.",No,"Chain A:VAL17,GLN20,GLY21,ALA24,GLY26,THR27,GLY28,GLU29,MET30,THR31,LYS112,TYR113,ARG140,VAL160,MET177",2.0,True,1
ASD01120000_3,FBP1,Sus scrofa,P00636,1FSA,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",340,Inner Protein Regulator,Inner Protein,8931152,"Evidence for an active T-state pig kidney fructose 1,6-bisphosphatase: interface residue Lys-42 is important for allosteric inhibition and AMP cooperativity.",No,"Chain A:VAL17,GLN20,GLY21,GLY26,THR27,GLY28,GLU29,MET30,THR31,LYS112,TYR113,ARG140,VAL160",2.3,True,1
ASD01120000_3,FBP1,Sus scrofa,P00636,1KZ8,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",737,Inner Protein Regulator,Inner Protein,12190310,"ANILINOQUINAZOLINE INHIBITORS OF FRUCTOSE 1,6-BISPHOSPHATASE BIND AT A NOVEL ALLOSTERIC SITE: SYNTHESIS, IN VITRO CHARACTERIZATION, AND X-RAY CRYSTALLOGRAPHY",No,"Chain A:VAL17,GLN20,GLY21,ALA24,GLY26,THR27,GLY28,GLU29,MET30,THR31,LYS112,TYR113,ARG140,VAL160,MET177",2.0,True,1
ASD01120000_3,FBP1,Sus scrofa,P00636,1KZ8,ASD01120014,PFE,A,Lig,Inhibitor,"[4-[3-[(6,7-diethoxyquinazolin-4-yl)amino]phenyl]-1,3-thiazol-2-yl]methanol",738,Inner Protein Regulator,Protein-Protein Interaction,12190310,"ANILINOQUINAZOLINE INHIBITORS OF FRUCTOSE 1,6-BISPHOSPHATASE BIND AT A NOVEL ALLOSTERIC SITE: SYNTHESIS, IN VITRO CHARACTERIZATION, AND X-RAY CRYSTALLOGRAPHY",No,"Chain A:ALA47,LYS50,ALA51,GLY52,ILE53,HIS55,LEU56,VAL70,LYS71,LYS72,LEU73,LEU76",2.0,True,1
ASD01120000_3,FBP1,Sus scrofa,P00636,1LEV,ASD01120167,CLI,A,Lig,Inhibitor,"3-(2-carboxyethyl)-4,6-dichloro-1H-indole-2-carboxylic acid",342,Inner Protein Regulator,Inner Protein,12781194,"3-(2-carboxyethyl)-4,6-dichloro-1H-indole-2-carboxylic acid: an allosteric inhibitor of fructose-1,6-bisphosphatase at the AMP site.",No,"Chain A:PHE16,VAL17,GLU20,GLY21,GLY26,THR27,GLY28,GLU29,MET30,THR31,LEU34,TYR113,LEU175,MET177",2.15,True,1
ASD01120000_3,FBP1,Sus scrofa,P00636,1NV7,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",3337,Inner Protein Regulator,Inner Protein,12595529,"Interaction of Tl+ with product complexes of fructose-1,6-bisphosphatase",No,"Chain A:VAL1017,GLU1020,GLY1021,ALA1024,GLY1026,THR1027,GLY1028,GLU1029,MET1030,THR1031,LYS1112,TYR1113,ARG1140,VAL1160,MET1177",2.15,True,1
ASD01120000_3,FBP1,Sus scrofa,P00636,1Q9D,ASD01120405,OI1,B,Lig,Inhibitor,"(3S,11aS)-2-[(2S)-1-[2-(4-hydroxyphenyl)ethylamino]-1-oxo-pentan-2-yl]-3-[(4-hydroxyphenyl)methyl]-4-oxo-3,6,11,11a-tetrahydropyrazino[4,3-b]isoquinolin-2-ium-1-olate",406,Inner Protein Regulator,Protein-Protein Interaction,14530289,"Inhibition of fructose-1,6-bisphosphatase by a new class of allosteric effectors",No,"Chain A:GLY52,ALA54,HIS55,ILE59; Chain B:ASP187,ALA189,ILE190",2.35,True,2
ASD01120000_3,FBP1,Sus scrofa,P00636,1RDY,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",339,Inner Protein Regulator,Inner Protein,8844845,"Crystal structures of the active site mutant (Arg-243-->Ala) in the T and R allosteric states of pig kidney fructose-1,6-bisphosphatase expressed in Escherichia coli.",No,"Chain A:VAL17,GLN20,GLY21,ALA24,GLY26,THR27,GLY28,GLU29,MET30,THR31,LYS112,TYR113,ARG140,VAL160",2.2,True,1
ASD01120000_3,FBP1,Sus scrofa,P00636,1RDZ,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",339,Inner Protein Regulator,Inner Protein,8844845,"Crystal structures of the active site mutant (Arg-243-->Ala) in the T and R allosteric states of pig kidney fructose-1,6-bisphosphatase expressed in Escherichia coli.",No,"Chain A:VAL17,GLN20,GLY21,ALA24,GLY26,THR27,GLY28,GLU29,MET30,THR31,LYS112,TYR113,ARG140,VAL160",2.05,True,1
ASD01120000_3,FBP1,Sus scrofa,P00636,1YYZ,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",435,Inner Protein Regulator,Inner Protein,15767255,"R-state AMP complex reveals initial steps of the quaternary transition of fructose-1,6-bisphosphatase.",No,"Chain A:VAL17,GLU20,GLY21,ALA24,GLY26,THR27,GLY28,GLU29,MET30,THR31,LYS112,TYR113,ARG140,MET177",1.85,True,1
ASD01120000_3,FBP1,Sus scrofa,P00636,1YZ0,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",1844,Inner Protein Regulator,Inner Protein,15767255,"R-state AMP complex reveals initial steps of the quaternary transition of fructose-1,6-bisphosphatase.",No,"Chain A:VAL17,GLU20,GLY21,ALA24,GLY26,THR27,GLY28,GLU29,MET30,THR31,LYS112,TYR113,ARG140,VAL160,MET177",2.07,True,1
ASD01120000_3,FBP1,Sus scrofa,P00636,2F3D,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",435,Inner Protein Regulator,Inner Protein,Not in PubMed,"Mechanism of displacement of a catalytically essential loop from the active site of fructose-1,6-bisphosphatase",No,"Chain A:VAL17,GLU20,GLY21,ALA24,GLY26,THR27,GLY28,GLU29,MET30,THR31,LYS112,TYR113,ARG140,MET177",1.83,True,1
ASD01120000_3,FBP1,Sus scrofa,P00636,4FBP,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",338,Inner Protein Regulator,Inner Protein,1850623,"Conformational transition of fructose-1,6-bisphosphatase: structure comparison between the AMP complex (T form) and the fructose 6-phosphate complex (R form).",No,"Chain A:VAL17,GLN20,GLY21,ALA24,GLY26,THR27,GLY28,GLU29,MET30,THR31,LYS112,TYR113,ARG140,VAL160,MET177",2.5,True,1
ASD01120000_3,FBP1,Sus scrofa,P00636,4GBV,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",405,Inner Protein Regulator,Inner Protein,,"Water Structure of the Central Hydrophobic Cavity of Mammalian Fructose-1,6-bisphosphatase: a Potential Thermodynamic Determinant of Allowed Quaternary States",No,"Chain A:VAL17,GLU20,GLY21,ALA24,GLY26,THR27,GLY28,GLU29,MET30,THR31,LYS112,TYR113,ARG140,MET177",2.9,True,1
ASD01120000_3,FBP1,Sus scrofa,P00636,4GBW,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",406,Inner Protein Regulator,Inner Protein,,"Water Structure of the Central Hydrophobic Cavity of Mammalian Fructose-1,6-bisphosphatase: a Potential Thermodynamic Determinant of Allowed Quaternary States",No,"Chain A:VAL17,MET18,GLU20,GLY21,ALA24,GLY26,THR27,GLY28,GLU29,MET30,THR31,LYS112,TYR113,ARG140,VAL160,MET177",2.0,True,1
ASD01120000_3,FBP1,Sus scrofa,P00636,4GWS,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",403,Inner Protein Regulator,Inner Protein,,"Hydrophobic Central Cavity in Fructose-1,6-bisphosphatase is Essential for the Synergism in AMP/Fructose 2,6-bisphosphate Inhibition",No,"Chain A:VAL17,GLU20,GLY21,ALA24,GLY26,THR27,GLY28,GLU29,MET30,THR31,LYS112,TYR113,ARG140,VAL160,MET177",2.75,True,1
ASD01120000_3,FBP1,Sus scrofa,P00636,4GWZ,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",404,Inner Protein Regulator,Inner Protein,,"Functional Importance of Subunit Pair Rotation in Regulation of Tetrameric Mammalian Fructose-1,6-bisphosphatase",No,"Chain A:VAL17,GLU20,GLY21,ALA24,GLY26,THR27,GLY28,GLU29,MET30,THR31,LYS112,TYR113,ARG140,VAL160,MET177",2.6,True,1
ASD01120000_3,FBP1,Sus scrofa,P00636,4GX4,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",404,Inner Protein Regulator,Inner Protein,,"Dimer-dimer Interface in Porcine Liver Fructose-1,6-bisphosphatase is Essential in Cooperative Binding of AMP",No,"Chain A:VAL17,GLU20,GLY21,ALA24,GLY26,THR27,GLY28,GLU29,MET30,THR31,LYS112,TYR113,ARG140,VAL160,MET177",2.5,True,1
ASD01120000_3,FBP1,Sus scrofa,P00636,4GX6,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",404,Inner Protein Regulator,Inner Protein,,"Dimer-dimer Interface in Porcine Liver Fructose-1,6-bisphosphatase is Essential in Cooperative Binding of AMP",No,"Chain A:VAL17,GLU20,GLY21,ALA24,GLY26,THR27,GLY28,GLU29,MET30,THR31,LYS112,TYR113,ARG140,VAL160,MET177",2.5,True,1
ASD01120000_3,FBP1,Sus scrofa,P00636,4H46,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",404,Inner Protein Regulator,Inner Protein,,"Fluorescent 2',3'-O-(2,4,6-trinitrophenyl) (TNP)-AMP Is an Active Site Inhibitor for Porcine Liver Fructose-1,6-bisphosphatase Rather Than Allosteric Inhibitor",No,"Chain A:VAL17,GLU20,GLY21,ALA24,GLY26,THR27,GLY28,GLU29,MET30,THR31,LEU34,LYS112,TYR113,ARG140,VAL160,MET177",2.5,True,1
ASD01120000_3,FBP1,Sus scrofa,P00636,4KXP,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",405,Inner Protein Regulator,Inner Protein,23844654,"Mechanism of Displacement of a Catalytically Essential Loop from the Active Site of Mammalian Fructose-1,6-bisphosphatase.",No,"Chain A:VAL17,GLU20,GLY21,ALA24,GLY26,THR27,GLY28,GLU29,MET30,THR31,LYS112,TYR113,ARG140,VAL160,MET177",2.7,True,1
ASD01120000_7,fbp,Escherichia coli,P0A993,2GQ1,ASD02880002,SO4,A,Ion,Activator,sulfate,344,Inner Protein Regulator,Protein-Protein Interaction,16670087,"Novel Allosteric Activation Site in Escherichia coli Fructose-1,6-bisphosphatase.",No,"Chain A:THR3,LEU4,GLY5,LYS30",1.45,True,1
ASD01120000_7,fbp,Escherichia coli,P0A993,2Q8M,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",341,Inner Protein Regulator,Inner Protein,17567577,"Structure of Inhibited Fructose-1,6-bisphosphatase from Escherichia coli: DISTINCT ALLOSTERIC INHIBITION SITES FOR AMP AND GLUCOSE 6-PHOSPHATE AND THE CHARACTERIZATION OF A GLUCONEOGENIC SWITCH.",No,"Chain A:ILE8,LYS11,GLN12,PHE15,ALA18,THR19,GLY20,GLU21,LEU22,THR23,LYS104,TYR105,ARG132,THR171",2.05,True,1
ASD01120000_7,fbp,Escherichia coli,P0A993,2Q8M,ASD01120373,BG6,A,Lig,Inhibitor,"[(2R,3S,4S,5R,6R)-3,4,5,6-tetrahydroxyoxan-2-yl]methyl dihydrogen phosphate",340,Inner Protein Regulator,Protein-Protein Interaction,17567577,"Structure of Inhibited Fructose-1,6-bisphosphatase from Escherichia coli: DISTINCT ALLOSTERIC INHIBITION SITES FOR AMP AND GLUCOSE 6-PHOSPHATE AND THE CHARACTERIZATION OF A GLUCONEOGENIC SWITCH.",No,"Chain A:GLU207,TYR210,ILE221,LYS222,GLN225",2.05,True,1
ASD01170000_1,glmU,Haemophilus influenzae,P43889,2VD4,ASD01170010,P21,A,Lig,Inhibitor,"4-chloro-N-(3-methoxypropyl)-N-[(1S,3S)-1-phenethylpiperidin-3-yl]benzamide",1454,Inner Protein Regulator,Inner Protein,18218712,Structure of a Small-Molecule Inhibitor Complexed with Glmu from Haemophilus Influenzae Reveals an Allosteric Binding Site.,Yes,"Chain A:TYR139,ASN169,THR170,VAL220,MET221,VAL223,GLU224,GLY225,GLN231,ALA234,LEU235",1.9,True,1
ASD01170000_2,Tb11.02.0120,Trypanosoma brucei brucei,Q386Q8,4BQH,ASD01170009,9VU,A,Lig,Inhibitor,"(3S)-3-[2-(1,3-benzodioxol-5-yl)-2-oxidanylidene-ethyl]-4-bromanyl-5-methyl-3-oxidanyl-1H-indol-2-one",1539,Inner Protein Regulator,Inner Protein,23834437,A Novel Allosteric Inhibitor of the Uridine Diphosphate N-Acetylglucosamine Pyrophosphorylase from Trypanosoma Brucei.,No,"Chain A:GLY44,VAL45,ASP46,HIS49,PHE50,SER207,VAL209,GLY232,GLY233,GLY235,ALA236,PHE238,ALA239,ALA242,ALA367,MET370,LYS371,TYR376,ALA397",1.75,True,1
ASD01210000_1,nagB,Escherichia coli,P0A759,1FRZ,ASD01218001,16G,A,Lig,Activator,"[(2R,3S,4R,5R,6S)-5-acetamido-3,4,6-trihydroxy-oxan-2-yl]methyl dihydrogen phosphate",1267,Inner Protein Regulator,Protein-Protein Interaction,11752775,"Structural flexibility, an essential component of the allosteric activation in Escherichia coli glucosamine-6-phosphate deaminase.",No,"Chain A:MET1,ARG2",2.2,True,1
ASD01210000_1,nagB,Escherichia coli,P0A759,1FS5,ASD01218001,16G,A,Lig,Activator,"[(2R,3S,4R,5R,6S)-5-acetamido-3,4,6-trihydroxy-oxan-2-yl]methyl dihydrogen phosphate",1267,Inner Protein Regulator,Protein-Protein Interaction,11752775,"Structural flexibility, an essential component of the allosteric activation in Escherichia coli glucosamine-6-phosphate deaminase.",No,"Chain A:MET1,ARG2,LEU258",1.73,True,1
ASD01210000_1,nagB,Escherichia coli,P0A759,1HOT,ASD01218001,16G,A,Lig,Activator,"[(2R,3S,4R,5R,6S)-5-acetamido-3,4,6-trihydroxy-oxan-2-yl]methyl dihydrogen phosphate",269,Inner Protein Regulator,Protein-Protein Interaction,8747459,Structure and catalytic mechanism of glucosamine 6-phosphate deaminase from Escherichia coli at 2.1 A resolution.,No,"Chain A:MET1,ARG2",2.4,True,1
ASD01210000_1,nagB,Escherichia coli,P0A759,2WU1,ASD01218001,16G,A,Lig,Activator,"[(2R,3S,4R,5R,6S)-5-acetamido-3,4,6-trihydroxy-oxan-2-yl]methyl dihydrogen phosphate",1267,Inner Protein Regulator,Protein-Protein Interaction,Not in PubMed,Glucosamine-6-Phosphate Deaminase Mechanism: The Substrate Piranosic Ring Opening,No,"Chain A:MET1,ARG2",2.2,True,1
ASD01230000_2,Gria2,Rattus norvegicus,P19491,1LBC,ASD01238024,CYZ,A,Lig,Activator,"(3S)-3-[(1S,4S,6S)-6-bicyclo[2.2.1]hept-2-enyl]-6-chloro-1,1-dioxo-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine-7-sulfonamide",330,Inner Protein Regulator,Protein-Protein Interaction,12015593,Mechanism of glutamate receptor desensitization.,No,"Chain A:LYS104,PRO105,PHE106,MET107,SER108,LEU239,SER242,LEU247,ASP248,LYS251; Chain C:ILE92,SER217,LYS218,GLY219",1.8,True,2
ASD01230000_2,Gria2,Rattus norvegicus,P19491,2AL4,ASD01230247,CX6,C,Lig,Activator,"2,3,6A,7,8,9-HEXAHYDRO-11H-[1,4]DIOXINO[2,3- G]PYRROLO[2,1-B][1,3]BENZOXAZIN-11-ONE",801,Inner Protein Regulator,Protein-Protein Interaction,16192394,Mechanism of positive allosteric modulators acting on AMPA receptors.,No,"Chain A:PRO105,PHE106,MET107,SER108,SER217,LYS218,GLY219,ASN242; Chain C:PRO105,PHE106,MET107,SER108,SER217,LYS218,GLY219,ASN242",1.7,True,2
ASD01230000_2,Gria2,Rattus norvegicus,P19491,2AL5,ASD01230001,4MP,A,Lig,Activator,1-(4-methoxyphenyl)carbonylpyrrolidin-2-one,801,Inner Protein Regulator,Protein-Protein Interaction,16192394,Mechanism of positive allosteric modulators acting on AMPA receptors.,No,"Chain A:PRO105,MET107,SER108,SER217,LYS218,GLY219,ASN242; Chain B:PRO105,SER108,SER217,LYS218,GLY219,ASN242",1.65,True,2
ASD01230000_2,Gria2,Rattus norvegicus,P19491,2XX7,ASD01230281,1ND,A,Lig,Activator,"pyrrolidin-1-yl-[4-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]phenyl]methanone",310,Inner Protein Regulator,Protein-Protein Interaction,21128618,Integration of Lead Optimization with Crystallography for a Membrane-Bound Ion Channel Target: Discovery of a New Class of Ampa Receptor Positive Allosteric Modulators.,No,"Chain A:ILE92,LYS104,PRO105,PHE106,MET107,SER108,SER217,LYS218,GLY219,LEU239,SER242,LEU247; Chain C:ILE92,LYS104,PRO105,PHE106,MET107,SER108,SER217,LYS218,GLY219,LEU239,SER242,LEU247",2.2,True,2
ASD01230000_2,Gria2,Rattus norvegicus,P19491,2XX8,ASD01230283,1NE,A,Lig,Activator,"N,N-dimethyl-4-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]benzamide",310,Inner Protein Regulator,Protein-Protein Interaction,21128618,Integration of Lead Optimization with Crystallography for a Membrane-Bound Ion Channel Target: Discovery of a New Class of Ampa Receptor Positive Allosteric Modulators.,No,"Chain A:ILE92,LYS104,PRO105,PHE106,MET107,SER108,SER217,LYS218,GLY219,LEU239,SER242; Chain C:ILE92,LYS104,PRO105,PHE106,MET107,SER108,SER217,LYS218,GLY219,LEU239,SER242",1.55,True,2
ASD01230000_2,Gria2,Rattus norvegicus,P19491,2XX9,ASD01230284,1NF,A,Lig,Activator,"1-[[2-fluoro-4-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]phenyl]methyl]pyrrolidin-2-one",310,Inner Protein Regulator,Protein-Protein Interaction,21128618,Integration of Lead Optimization with Crystallography for a Membrane-Bound Ion Channel Target: Discovery of a New Class of Ampa Receptor Positive Allosteric Modulators.,No,"Chain A:ILE92,LYS104,PRO105,PHE106,MET107,SER108,SER217,LYS218,GLY219,LEU239,SER242,LEU247; Chain C:ILE92,LYS104,PRO105,PHE106,MET107,SER108,SER217,LYS218,GLY219,LEU239,SER242,LEU247",1.97,True,2
ASD01230000_2,Gria2,Rattus norvegicus,P19491,2XXH,ASD01230285,1NG,A,Lig,Activator,"1-pyrrolidin-1-yl-2-[4-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]phenyl]ethanone",310,Inner Protein Regulator,Protein-Protein Interaction,21128618,Integration of Lead Optimization with Crystallography for a Membrane-Bound Ion Channel Target: Discovery of a New Class of Ampa Receptor Positive Allosteric Modulators.,No,"Chain A:ILE92,LYS104,PRO105,PHE106,MET107,SER108,SER217,LYS218,GLY219,LEU239,SER242,LEU247; Chain C:ILE92,LYS104,PRO105,PHE106,SER108,SER217,LYS218,GLY219,LEU239,SER242,LEU247",1.5,True,2
ASD01230000_2,Gria2,Rattus norvegicus,P19491,2XXI,ASD01230286,JAC,A,Lig,Activator,"1-[[4-[3-(trifluoromethyl)-6,7-dihydro-4H-pyrano[3,4-d]pyrazol-1-yl]phenyl]methyl]pyrrolidin-2-one",1302,Inner Protein Regulator,Protein-Protein Interaction,21128618,Integration of Lead Optimization with Crystallography for a Membrane-Bound Ion Channel Target: Discovery of a New Class of Ampa Receptor Positive Allosteric Modulators.,No,"Chain A:ILE92,LYS104,PRO105,PHE106,MET107,SER108,SER217,LYS218,GLY219,LEU239,SER242,LEU247; Chain C:ILE92,LYS104,PRO105,PHE106,MET107,SER108,SER217,LYS218,GLY219,LEU239,SER242,LEU247",1.6,True,2
ASD01230000_2,Gria2,Rattus norvegicus,P19491,3BBR,ASD01230134,BHY,A,Lig,Activator,N-[(2R)-2-[4-[4-[(2R)-1-(methylsulfonylamino)propan-2-yl]phenyl]phenyl]propyl]methanesulfonamide,268,Inner Protein Regulator,Protein-Protein Interaction,18022568,Structural proof of a dimeric positive modulator bridging two identical AMPA receptor-binding sites,No,"Chain A:LYS104,PRO105,PHE106,MET107,SER108,SER217,LYS218,GLY219,LEU239; Chain B:ILE92,LYS104,PRO105,PHE106,MET107,SER108,SER217,LYS218,GLY219,LEU239,SER242",2.25,True,2
ASD01230000_2,Gria2,Rattus norvegicus,P19491,3H6T,ASD01238024,CYZ,A,Lig,Activator,"(3S)-3-[(1S,4S,6S)-6-bicyclo[2.2.1]hept-2-enyl]-6-chloro-1,1-dioxo-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine-7-sulfonamide",265,Inner Protein Regulator,Protein-Protein Interaction,19591837,Distinct structural features of cyclothiazide are responsible for effects on peak current amplitude and desensitization kinetics at iGluR2.,No,"Chain A:LYS104,PRO105,PHE106,MET107,SER108,LEU239,SER242,LEU247,ASP248,LYS251; Chain C:ILE92,SER217,LYS218,GLY219",2.25,True,2
ASD01230000_2,Gria2,Rattus norvegicus,P19491,3H6U,ASD01238019,NS3,A,Lig,Activator,"(3S)-3-cyclopentyl-6-methyl-7-(4-methylpiperazin-1-yl)sulfonyl-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine 1,1-dioxide",265,Inner Protein Regulator,Protein-Protein Interaction,19591837,Distinct structural features of cyclothiazide are responsible for effects on peak current amplitude and desensitization kinetics at iGluR2.,No,"Chain A:LYS104,PRO105,MET107,SER108,LEU239,SER242,LEU247,ASP248,LYS251",1.85,True,1
ASD01230000_2,Gria2,Rattus norvegicus,P19491,3H6V,ASD01238020,NS6,A,Lig,Activator,"(3R)-3-cyclopentyl-7-(4-methylpiperazin-1-yl)sulfonyl-3,4-dihydro-2H-benzo[e][1,2]thiazine 1,1-dioxide",265,Inner Protein Regulator,Protein-Protein Interaction,19591837,Distinct structural features of cyclothiazide are responsible for effects on peak current amplitude and desensitization kinetics at iGluR2.,No,"Chain A:PRO105,PHE106,MET107,SER108,LEU239,SER242,LEU247,ASP248,LYS251; Chain B:ILE92,SER217,LYS218",2.1,True,2
ASD01230000_2,Gria2,Rattus norvegicus,P19491,3H6W,ASD01238021,NS7,A,Lig,Activator,"(3R)-3-cyclopentyl-6-methyl-7-(4-methylpiperazin-1-yl)sulfonyl-3,4-dihydro-2H-benzo[e][1,2]thiazine 1,1-dioxide",265,Inner Protein Regulator,Protein-Protein Interaction,19591837,Distinct structural features of cyclothiazide are responsible for effects on peak current amplitude and desensitization kinetics at iGluR2.,No,"Chain A:LYS104,PRO105,PHE106,MET107,SER108,LEU239,SER242,LEU247,ASP248,LYS251",1.49,True,1
ASD01230000_2,Gria2,Rattus norvegicus,P19491,3IJO,ASD01230003;ASD01230003,B4D;B4D,B;B,Lig;Lig,Activator,"(3S)-6-chloro-1,1-dioxo-3-(prop-2-enylsulfanylmethyl)-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine-7-sulfonamide",401;800,Inner Protein Regulator,Protein-Protein Interaction,19673491,Probing the allosteric modulator binding site of GluR2 with thiazide derivatives,No,"Chain B:ILE92,THR93,LYS104,PRO105,PHE106,MET107,SER108,SER217,LEU239,SER242,LEU247,ASP248,LYS251; Chain E:ILE92,PRO105,PHE106,MET107,SER108,SER217,LEU239,SER242,LEU247,ASP248,LYS251",2.003,True,2
ASD01230000_2,Gria2,Rattus norvegicus,P19491,3IJX,ASD01230004,HCZ,B,Lig,Activator,"6-chloro-1,1-dioxo-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine-7-sulfonamide",800,Inner Protein Regulator,Protein-Protein Interaction,19673491,Probing the allosteric modulator binding site of GluR2 with thiazide derivatives,No,"Chain B:LYS104,PRO105,SER108,LEU239,SER242; Chain D:ILE92,PRO105,SER108,SER217,LYS218,GLY219",2.881,True,2
ASD01230000_2,Gria2,Rattus norvegicus,P19491,3IK6,ASD01230004;ASD01230004,HCZ;HCZ,B;B,Lig;Lig,Activator,"6-chloro-1,1-dioxo-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine-7-sulfonamide",262;800,Inner Protein Regulator,Protein-Protein Interaction,19673491,Probing the allosteric modulator binding site of GluR2 with thiazide derivatives,No,"Chain B:ILE92,LYS104,PRO105,SER108,SER217,LYS218,GLY219,LEU239,SER242; Chain E:ILE92,LYS104,PRO105,MET107,SER108,SER217,LYS218,GLY219,LEU239,SER242",2.101,True,2
ASD01230000_2,Gria2,Rattus norvegicus,P19491,3IL1,ASD01230202;ASD01230202,B5D;B5D,B;B,Lig;Lig,Activator,"(3S)-7-chloro-3-methyl-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine 1,1-dioxide",262;801,Inner Protein Regulator,Protein-Protein Interaction,19673491,Probing the allosteric modulator binding site of GluR2 with thiazide derivatives,No,"Chain B:ILE92,LYS104,PRO105,SER108,SER217,LYS218,GLY219,VAL238,SER242; Chain E:ILE92,LYS104,PRO105,SER108,SER217,LYS218,GLY219,VAL238,LEU239,SER242",1.998,True,2
ASD01230000_2,Gria2,Rattus norvegicus,P19491,3ILT,ASD01230209,TRU,B,Lig,Activator,"(3R)-6-chloro-3-(dichloromethyl)-1,1-dioxo-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine-7-sulfonamide",800,Inner Protein Regulator,Protein-Protein Interaction,19673491,Probing the allosteric modulator binding site of GluR2 with thiazide derivatives,No,"Chain B:LYS104,PRO105,PHE106,MET107,SER108,LEU239,SER242,LEU247,ASP248,LYS251; Chain E:ILE92,SER217,LYS218",2.107,True,2
ASD01230000_2,Gria2,Rattus norvegicus,P19491,3ILU,ASD01230008,HFZ,B,Lig,Activator,"1,1-dioxo-6-(trifluoromethyl)-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine-7-sulfonamide",800,Inner Protein Regulator,Protein-Protein Interaction,19673491,Probing the allosteric modulator binding site of GluR2 with thiazide derivatives,No,"Chain B:LYS104,PRO105,PHE106,MET107,SER108,LEU239,SER242; Chain E:ILE92,PRO105,SER108,SER217,LYS218,GLY219",2.003,True,2
ASD01230000_2,Gria2,Rattus norvegicus,P19491,3KGC,ASD01230318,LY7,A,Lig,Activator,N-[(2S)-2-[4-(4-cyanophenyl)phenyl]propyl]propane-2-sulfonamide,264,Inner Protein Regulator,Protein-Protein Interaction,19946266,"X-ray structure, symmetry and mechanism of an AMPA-subtype glutamate receptor",No,"Chain A:ILE92,PRO105,SER108,SER217,LYS218,GLY219,SER242,LEU247; Chain B:LYS104,PRO105,MET107,SER108,SER217,LYS218,GLY219,LEU239,SER242",1.55,True,2
ASD01230000_2,Gria2,Rattus norvegicus,P19491,3LSF,ASD04920002,PZI,E,Lig,Activator,2-(2-oxopyrrolidin-1-yl)ethanamide,800,Inner Protein Regulator,Protein-Protein Interaction,20163115,Piracetam Defines a New Binding Site for Allosteric Modulators of alpha-Amino-3-hydroxy-5-methyl-4-isoxazole-propionic Acid (AMPA) Receptors.,No,"Chain B:PRO105,SER108,SER217,LYS218,GLY219; Chain E:PRO105,PHE106,MET107,SER108,SER242,LEU247,ASP248,LYS251",1.851,True,2
ASD01230000_2,Gria2,Rattus norvegicus,P19491,3LSF,ASD04920002,PZI,E,Lig,Activator,2-(2-oxopyrrolidin-1-yl)ethanamide,802,Inner Protein Regulator,Protein-Protein Interaction,20163115,Piracetam Defines a New Binding Site for Allosteric Modulators of alpha-Amino-3-hydroxy-5-methyl-4-isoxazole-propionic Acid (AMPA) Receptors.,No,"Chain B:ASP248,ASN252; Chain E:ASP216,SER217",1.851,True,2
ASD01230000_2,Gria2,Rattus norvegicus,P19491,3LSL,ASD04920002,PZI,A,Lig,Activator,2-(2-oxopyrrolidin-1-yl)ethanamide,801,Inner Protein Regulator,Protein-Protein Interaction,20163115,Piracetam Defines a New Binding Site for Allosteric Modulators of alpha-Amino-3-hydroxy-5-methyl-4-isoxazole-propionic Acid (AMPA) Receptors.,No,"Chain A:ILE92,PRO105,MET107,SER108,SER217,LYS218,GLY219; Chain D:PRO105,PHE106,MET107,SER108,ASN242",2.122,True,2
ASD01230000_2,Gria2,Rattus norvegicus,P19491,3LSL,ASD04920002,PZI,A,Lig,Activator,2-(2-oxopyrrolidin-1-yl)ethanamide,802,Inner Protein Regulator,Protein-Protein Interaction,20163115,Piracetam Defines a New Binding Site for Allosteric Modulators of alpha-Amino-3-hydroxy-5-methyl-4-isoxazole-propionic Acid (AMPA) Receptors.,No,"Chain A:ASP248,ASN252; Chain D:ASP216,SER217",2.122,True,2
ASD01230000_2,Gria2,Rattus norvegicus,P19491,3M3L,ASD04920003,P99,A,Lig,Activator,"2-[2,6-difluoro-4-[2-(phenylsulfonylamino)ethylsulfanyl]phenoxy]ethanamide",800,Inner Protein Regulator,Protein-Protein Interaction,20199107,Molecular mechanism of flop selectivity and subsite recognition for an AMPA receptor allosteric modulator: structures of GluA2 and GluA3 in complexes with PEPA.,No,"Chain A:ILE92,LYS104,PRO105,PHE106,MET107,SER108,SER217,LYS218,GLY219,VAL238,LEU239,ASN242; Chain D:ILE92,LYS104,PRO105,PHE106,MET107,SER108,SER217,LYS218,GLY219,VAL238,LEU239,ASN242",1.85,True,2
ASD01230000_2,Gria2,Rattus norvegicus,P19491,3O28,ASD01238011,O28,A,Lig,Activator,"2-[2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]ethanoylamino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide",264,Inner Protein Regulator,Protein-Protein Interaction,20805031,A novel series of positive modulators of the AMPA receptor: discovery and structure based hit-to-lead studies.,No,"Chain A:ILE92,PRO105,PHE106,MET107,SER108,SER217,LYS218,GLY219,LEU239,SER242",2.0,True,1
ASD01230000_2,Gria2,Rattus norvegicus,P19491,3O29,ASD01238012,O29,A,Lig,Activator,"N-(2-dimethylaminoethyl)-2-[2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]ethanoylamino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide",271,Inner Protein Regulator,Protein-Protein Interaction,20805031,A novel series of positive modulators of the AMPA receptor: discovery and structure based hit-to-lead studies.,No,"Chain A:ILE92,PRO105,PHE106,MET107,SER108,SER217,LYS218,GLY219,LEU239,SER242,LEU247,ASP248",2.02,True,1
ASD01230000_2,Gria2,Rattus norvegicus,P19491,3O2A,ASD01230270,O30,A,Lig,Activator,"N-(3-azanylpropyl)-2-[2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]ethanoylamino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide",264,Inner Protein Regulator,Protein-Protein Interaction,20805031,A novel series of positive modulators of the AMPA receptor: discovery and structure based hit-to-lead studies.,No,"Chain A:ILE92,PRO105,PHE106,MET107,SER108,SER217,LYS218,GLY219,LEU239,SER242,LEU247,ASP248",1.9,True,1
ASD01230000_2,Gria2,Rattus norvegicus,P19491,3O6G,ASD01230251,O27,A,Lig,Activator,"N-[(3R)-pyrrolidin-3-yl]-2-[2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]ethanoylamino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide",268,Inner Protein Regulator,Protein-Protein Interaction,20817521,A novel series of positive modulators of the AMPA receptor: structure-based lead optimization.,No,"Chain A:ILE92,PRO105,PHE106,MET107,SER108,SER217,LYS218,GLY219,LEU239,SER242,LEU247,ASP248",1.8,True,1
ASD01230000_2,Gria2,Rattus norvegicus,P19491,3O6H,ASD01238009,O25,A,Lig,Activator,"2-[2-[4-(ethylaminomethyl)-3-(trifluoromethyl)pyrazol-1-yl]ethanoylamino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide",268,Inner Protein Regulator,Protein-Protein Interaction,20817521,A novel series of positive modulators of the AMPA receptor: structure-based lead optimization.,No,"Chain A:ILE92,PRO105,PHE106,MET107,SER108,SER217,LYS218,GLY219,LEU239,SER242",2.1,True,1
ASD01230000_2,Gria2,Rattus norvegicus,P19491,3O6I,ASD01238010,O26,A,Lig,Activator,"2-[2-[3-tert-butyl-4-(methylaminomethyl)pyrazol-1-yl]ethanoylamino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide",265,Inner Protein Regulator,Protein-Protein Interaction,20817521,A novel series of positive modulators of the AMPA receptor: structure-based lead optimization.,No,"Chain A:ILE92,PRO105,PHE106,MET107,SER108,SER217,LYS218,GLY219,LEU239,SER242",1.8,True,1
ASD01230000_2,Gria2,Rattus norvegicus,P19491,3PMV,ASD01238005,557,A,Lig,Activator,N-[(2S)-2-[4-[4-(hydroxymethyl)-3-(trifluoromethyl)pyrazol-1-yl]phenyl]propyl]propane-2-sulfonamide,270,Inner Protein Regulator,Protein-Protein Interaction,21190850,Structure based evolution of a novel series of positive modulators of the AMPA receptor.,No,"Chain A:ILE92,PRO105,PHE106,MET107,SER108,SER217,LYS218,GLY219,SER242,LEU247",1.8,True,1
ASD01230000_2,Gria2,Rattus norvegicus,P19491,3PMW,ASD01238007,G69,A,Lig,Activator,"N-[(2S)-5-[[4-(hydroxymethyl)-3-(trifluoromethyl)pyrazol-1-yl]methyl]-2,3-dihydro-1H-inden-2-yl]propane-2-sulfonamide",274,Inner Protein Regulator,Protein-Protein Interaction,21190850,Structure based evolution of a novel series of positive modulators of the AMPA receptor.,No,"Chain A:ILE92,LYS104,PRO105,MET107,SER108,SER217,LYS218,GLY219,VAL238,LEU239,SER242",2.2,True,1
ASD01230000_2,Gria2,Rattus norvegicus,P19491,3PMX,ASD01238006,808,A,Lig,Activator,"N-[(2S)-5-[[5-(trifluoromethyl)furan-2-yl]methyl]-2,3-dihydro-1H-inden-2-yl]propane-2-sulfonamide",277,Inner Protein Regulator,Protein-Protein Interaction,21190850,Structure based evolution of a novel series of positive modulators of the AMPA receptor.,No,"Chain A:ILE92,LYS104,PRO105,SER217,LYS218,GLY219,LEU239",1.87,True,1
ASD01230000_2,Gria2,Rattus norvegicus,P19491,3TDJ,ASD01238023,3TJ,B,Lig,Activator,"4-ethyl-7-fluoranyl-2,3-dihydro-1$l^{6},2,4-benzothiadiazine 1,1-dioxide",265,Inner Protein Regulator,Protein-Protein Interaction,21895609,Thermodynamics and structural analysis of positive allosteric modulation of the ionotropic glutamate receptor GluA2.,No,"Chain A:ILE92,PRO105,MET107,SER108,SER217,LYS218,GLY219; Chain B:LYS104,PRO105,PHE106,MET107,SER108,LEU239,SER242",1.95,True,2
ASD01230000_2,Gria2,Rattus norvegicus,P19491,3TKD,ASD01238024,CYZ,A,Lig,Activator,"(3S)-3-[(1S,4S,6S)-6-bicyclo[2.2.1]hept-2-enyl]-6-chloro-1,1-dioxo-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine-7-sulfonamide",266,Inner Protein Regulator,Protein-Protein Interaction,21895609,Thermodynamics and structural analysis of positive allosteric modulation of the ionotropic glutamate receptor GluA2.,No,"Chain A:LYS104,PRO105,PHE106,MET107,SER108,VAL238,LEU239,SER242,LEU247,ASP248,LYS251; Chain B:ILE92,THR93,PRO105,SER217,LYS218,GLY219",1.45,True,2
ASD01230000_2,Gria2,Rattus norvegicus,P19491,4FAT,ASD01230298,496,A,Lig,Activator,"2-[2-[4-(hydroxymethyl)-3-(trifluoromethyl)pyrazol-1-yl]ethanoylamino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide",302,Inner Protein Regulator,Protein-Protein Interaction,22735771,Functional analysis of a novel positive allosteric modulator of AMPA receptors derived from a structure-based drug design strategy.,No,"Chain A:ILE92,PRO105,PHE106,MET107,SER108,SER217,LYS218,GLY219,LEU239,SER242",1.4,True,1
ASD01230000_2,Gria2,Rattus norvegicus,P19491,4IY5,ASD01230300,CX5,B,Lig,Activator,piperidin-1-yl(quinoxalin-6-yl)methanone,301,Inner Protein Regulator,Protein-Protein Interaction,23999288,Structural analysis of the positive AMPA receptor modulators CX516 and Me-CX516 in complex with the GluA2 ligand-binding domain,No,"Chain A:PRO105,PHE106,MET107,SER108,SER217,LYS218,GLY219; Chain B:PRO105,PHE106,MET107,SER108,SER217,LYS218,GLY219",2.0,True,2
ASD01230000_2,Gria2,Rattus norvegicus,P19491,4IY6,ASD01230301,MQR,A,Lig,Activator,[(3R)-3-methylpiperidin-1-yl]-quinoxalin-6-yl-methanone,301,Inner Protein Regulator,Protein-Protein Interaction,23999288,Structural analysis of the positive AMPA receptor modulators CX516 and Me-CX516 in complex with the GluA2 ligand-binding domain,No,"Chain A:PRO105,PHE106,MET107,SER108,SER217,LYS218,SER242,LEU247",1.72,True,1
ASD01230000_2,Gria2,Rattus norvegicus,P19491,4LZ5,ASD01238016,1YV,B,Lig,Activator,N-[(2R)-2-[4-(4-cyanophenyl)phenyl]propyl]propane-2-sulfonamide,805,Inner Protein Regulator,Protein-Protein Interaction,24215237,Discovery and Characterization of a Novel Dihydroisoxazole Class of alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) Receptor Potentiators.,No,"Chain B:ILE481,PRO494,PHE495,MET496,SER497,SER729,LYS730,GLY731,ASN754,LEU759",1.5,True,1
ASD01230000_2,Gria2,Rattus norvegicus,P19491,4LZ7,ASD01230322,1YW,C,Lig,Activator,"N-[[(5S)-3-(3-fluoranyl-4-pyrrolidin-1-yl-phenyl)-4,5-dihydro-1,2-oxazol-5-yl]methyl]ethanamide",804,Inner Protein Regulator,Protein-Protein Interaction,24215237,Discovery and Characterization of a Novel Dihydroisoxazole Class of alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) Receptor Potentiators.,No,"Chain A:LYS493,PRO494,PHE495,MET496,SER497,SER729,LYS730,GLY731,ASN754; Chain C:LYS493,PRO494,PHE495,MET496,SER497,SER729,LYS730,GLY731,ASN754",2.1,True,2
ASD01230000_2,Gria2,Rattus norvegicus,P19491,4LZ8,ASD01230325,1YX,A,Lig,Activator,"N-[(3S)-1-[2-fluoranyl-4-[(5S)-5-[(propan-2-ylsulfonylamino)methyl]-4,5-dihydro-1,2-oxazol-3-yl]phenyl]pyrrolidin-3-yl]ethanamide",802,Inner Protein Regulator,Protein-Protein Interaction,24215237,Discovery and Characterization of a Novel Dihydroisoxazole Class of alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) Receptor Potentiators.,No,"Chain A:ILE481,LYS493,PRO494,PHE495,MET496,SER497,SER729,LYS730,GLY731,VAL750,LEU751,ASN754; Chain C:LYS493,PRO494,PHE495,MET496,SER497,SER729,LYS730,GLY731,VAL750,LEU751,ASN754",1.85,True,2
ASD01230000_2,Gria2,Rattus norvegicus,P19491,4N07,ASD01200253,2J9,A,Lig,Activator,"4-cyclopropyl-7-fluoranyl-2,3-dihydro-1$l^{6},2,4-benzothiadiazine 1,1-dioxide",301,Inner Protein Regulator,Protein-Protein Interaction,24131202,"Synthesis, pharmacological and structural characterization, and thermodynamic aspects of GluA2-positive allosteric modulators with a 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide scaffold.",No,"Chain A:LYS104,PRO105,PHE106,MET107,SER108,LEU239,SER242,LEU247",1.87,True,1
ASD01230000_2,Gria2,Rattus norvegicus,P19491,4U4S,ASD01230047,3C1,"A,B",Lig,Activator,"4-ethyl-3,4-dihydro-2H-pyrido[4,3-e][1,2,4]thiadiazine 1,1-dioxide",774,Allosteric Function,Allosteric Position,25375781,"Positive Allosteric Modulators of 2-Amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic Acid Receptors Belonging to 4-Cyclopropyl-3,4-dihydro-2H-1,2,4-pyridothiadiazine Dioxides and Diversely Chloro-Substituted 4-Cyclopropyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-Dioxides.",No,"Chain B:CYS773,CYS718,GLY774,GLY771,SER775,GLN714,GLU772,TYR768",1.9,True,1
ASD01230000_2,Gria2,Rattus norvegicus,P19491,4U4X,ASD01230046,3C2,"A,B",Lig,Activator,"4-ethyl-3,4-dihydro-2H-pyrido[3,2-e][1,2,4]thiadiazine 1,1-dioxide",801,Allosteric Function,Allosteric Position,25375781,"Positive Allosteric Modulators of 2-Amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic Acid Receptors Belonging to 4-Cyclopropyl-3,4-dihydro-2H-1,2,4-pyridothiadiazine Dioxides and Diversely Chloro-Substituted 4-Cyclopropyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-Dioxides.",No,"Chain B:PRO494,LEU498,SER729,LYS493,THR482,ILE481,SER754,TYR732,PHE495,VAL750,SER497,LEU751,LYS730,LEU759,GLY731,MET496",1.56,True,1
ASD01230000_2,Gria2,Rattus norvegicus,P19491,4X48,ASD01230383,XPF,B,Lig,Activator,"N-{(3S,4S)-4-[4-(5-cyanothiophen-2-yl)phenoxy]tetrahydrofuran- 3-yl}propane-2-sulfonamide",804,Allosteric Function,Inner Protein,25905800,"The Discovery and Characterization of the alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Potentiator N-{(3S,4S)-4-[4-(5-Cyano-2-thienyl)phenoxy]tetrahydrofuran-3-yl}propane-2-sulfonamide (PF-04958242).",No,"Chain B:LEU751,LYS730,TYR732,LEU759,PRO494,LYS493,GLU755,GLY731,SER729,PHE495,MET496,ASP760,VAL750,ASN754,LEU498,SER497",1.89,True,1
ASD01230000_2,Gria2,Rattus norvegicus,P19491,5BUU,ASD01230178,4V6,A,Lig,Activator,"(3R)-7-chloro-2,3,4-trimethyl-3,4-dihydro- 2H-1,2,4-benzothiadiazine 1,1-dioxide",801,Allosteric Function,Allosteric Position,26771108,"Synthesis and Pharmacology of Mono-, Di-, and Trialkyl-Substituted 7-Chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-Dioxides Combined with X-ray Structure Analysis to Understand the Unexpected Structure-Activity Relationship at AMPA Receptors.",No,"Chain B:LEU751,PRO494,LYS493,GLU755,PHE495,VAL750,SER754,LEU759,MET496,SER497",2.07,True,1
ASD01230000_2,Gria2,Rattus norvegicus,P19491,5ELV,ASD01230232,5PX,"A,B",Lig,Activator,"4-Cyclopropyl-3,4-dihydro-7-hydroxy-2H-1,2,4- benzothiadiazine 1,1-dioxide",312,Inner Protein Regulator,Allosteric Position,27276258,Enthalpy-Entropy Compensation in the Binding of Modulators at Ionotropic Glutamate Receptor GluA2.,No,"Chain B:ILE92,LEU109,SER217,SER108,LYS104,LEU239,SER242,LYS218,GLY219,LEU247,MET107,PRO105,PHE106,VAL238,THR93,TYR220",1.92,True,1
ASD01230000_2,Gria2,Rattus norvegicus,P19491,5O9A,ASD01230049,7M6,A,Lig,Activator,"7-chloro-4-(2-fluoroethyl)-2,3-dihydro-1,2,4-benzothiadiazine 1,1-dioxide",305,Inner Protein regulator,Inner Protein,29256599,"7-Phenoxy-Substituted 3,4-Dihydro-2H-1,2,4-benzothiadiazine 1,1-Dioxides as Positive Allosteric Modulators of alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors with Nanomolar Potency.",No,"Chain B:LEU109,SER217,SER108,PHE106,THR93,MET107,GLY219,LYS218,ILE92,PRO105,TYR220",1.78,True,1
ASD01230000_2,Gria2,Rattus norvegicus,P19491,5OEW,ASD01230259,9TE,B,Lig,Activator,"4-cyclopropyl-7-(3-methoxyphenoxy)-2,3-dihydro-1$l^{6},2,4-benzothiadiazine 1,1-dioxide",901,Allosteric function,Allosteric position,29256599,"7-Phenoxy-Substituted 3,4-Dihydro-2H-1,2,4-benzothiadiazine 1,1-Dioxides as Positive Allosteric Modulators of alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors with Nanomolar Potency.",No,"Chain B:ILE92,LEU109,SER217,SER108,LYS104,LEU239,LYS218,GLY219,LEU247,ASN242,MET107,PRO105,PHE106,VAL238,THR93,TYR220",2.0,True,1
ASD01240000_1,GLUD1,Bos taurus,P00366,3ETD,ASD01240023;ASD01240023,B1T;B1T,A;E,Lig,Inhibitor,"2,4-dichloro-6-(3,5-dichloro-2-hydroxy-phenyl)sulfanyl-phenol",552;552,Inner Protein Regulator,Protein-Protein Interaction,19531491,Novel Inhibitors Complexed with Glutamate Dehydrogenase: ALLOSTERIC REGULATION BY CONTROL OF PROTEIN DYNAMICS,No,"Chain A:GLU142,ARG146,ASP181,SER185; Chain E:ARG146,ARG147",2.5,True,2
ASD01240000_1,GLUD1,Bos taurus,P00366,3ETD,ASD00290006,GTP,A,Lig,Inhibitor,"[[(2R,3S,4R,5R)-5-(2-azanyl-6-oxidanylidene-1H-purin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] phosphono hydrogen phosphate",553,Inner Protein Regulator,Inner Protein,19531491,Novel Inhibitors Complexed with Glutamate Dehydrogenase: ALLOSTERIC REGULATION BY CONTROL OF PROTEIN DYNAMICS,No,"Chain A:HIS209,GLY210,ILE212,ARG217,ARG261,TYR262,ARG265,GLU292,HIS450",2.5,True,1
ASD01240000_1,GLUD1,Bos taurus,P00366,3ETG,ASD01240022;ASD01240022,GWD;GWD,A;E,Lig,Inhibitor,"(3E)-3-[(3,5-dibromo-4-hydroxy-phenyl)methylidene]-5-iodo-1H-indol-2-one",552;552,Inner Protein Regulator,Protein-Protein Interaction,19531491,Novel Inhibitors Complexed with Glutamate Dehydrogenase: ALLOSTERIC REGULATION BY CONTROL OF PROTEIN DYNAMICS,No,"Chain A:GLU142,ARG146,ARG147,MET150,ASP181,SER185",2.5,True,1
ASD01240000_1,GLUD1,Bos taurus,P00366,3ETG,ASD00290006,GTP,A,Lig,Inhibitor,"[[(2R,3S,4R,5R)-5-(2-azanyl-6-oxidanylidene-1H-purin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] phosphono hydrogen phosphate",553,Inner Protein Regulator,Inner Protein,19531491,Novel Inhibitors Complexed with Glutamate Dehydrogenase: ALLOSTERIC REGULATION BY CONTROL OF PROTEIN DYNAMICS,No,"Chain A:HIS209,GLY210,SER213,ARG217,LEU257,HIS258,ARG261,TYR262,ARG265,LYS289,GLU292,HIS450",2.5,True,1
ASD01260000_4,gapN,Thermoproteus tenax,O57693,1UXN,ASD00030001,AMP,A,Lig,Activator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",1502,Inner Protein Regulator,Inner Protein,15288789,Structural Basis of Allosteric Regulation and Substrate Specificity of the Non-Phosphorylating Glyceraldehyde 3-Phosphate Dehydrogenase from Thermoproteus Tenax,No,"Chain A:ARG72,ARG79,ILE133,GLY134,ARG154,ARG155,GLU156,TYR184,VAL479",2.3,True,1
ASD01260000_4,gapN,Thermoproteus tenax,O57693,1UXP,ASD00030001,AMP,A,Lig,Activator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",1502,Inner Protein Regulator,Inner Protein,15288789,Structural Basis of Allosteric Regulation and Substrate Specificity of the Non-Phosphorylating Glyceraldehyde 3-Phosphate Dehydrogenase from Thermoproteus Tenax,No,"Chain A:ARG72,ARG79,LYS132,ILE133,GLY134,GLY135,ARG154,ARG155,GLU156,PRO157,TYR184",2.55,True,1
ASD01260000_4,gapN,Thermoproteus tenax,O57693,1UXQ,ASD00360004,G1P,A,Lig,Activator,"[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] dihydrogen phosphate",1503,Inner Protein Regulator,Inner Protein,15288789,Structural Basis of Allosteric Regulation and Substrate Specificity of the Non-Phosphorylating Glyceraldehyde 3-Phosphate Dehydrogenase from Thermoproteus Tenax,No,"Chain A:ARG72,ARG79,ILE133,ARG154,ARG155,GLU156,PRO157,TYR184",2.4,True,1
ASD01260000_4,gapN,Thermoproteus tenax,O57693,1UXR,ASD01260013,F6P,A,Lig,Activator,"[(2R,3S,4S,5R)-3,4,5-trihydroxy-5-(hydroxymethyl)oxolan-2-yl]methyl dihydrogen phosphate",1503,Inner Protein Regulator,Inner Protein,15288789,Structural Basis of Allosteric Regulation and Substrate Specificity of the Non-Phosphorylating Glyceraldehyde 3-Phosphate Dehydrogenase from Thermoproteus Tenax,No,"Chain A:ARG72,ARG79,ILE133,ARG154,ARG155,GLU156,TYR184",2.3,True,1
ASD01260000_4,gapN,Thermoproteus tenax,O57693,1UXT,ASD00360004,G1P,A,Lig,Activator,"[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] dihydrogen phosphate",1502,Inner Protein Regulator,Inner Protein,15288789,Structural Basis of Allosteric Regulation and Substrate Specificity of the Non-Phosphorylating Glyceraldehyde 3-Phosphate Dehydrogenase from Thermoproteus Tenax,No,"Chain A:ARG72,ARG79,ILE133,ARG154,ARG155,GLU156,PRO157,TYR184",2.2,True,1
ASD01260000_4,gapN,Thermoproteus tenax,O57693,1UXU,ASD00030001,AMP,A,Lig,Activator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",503,Inner Protein Regulator,Inner Protein,15288789,Structural Basis of Allosteric Regulation and Substrate Specificity of the Non-Phosphorylating Glyceraldehyde 3-Phosphate Dehydrogenase from Thermoproteus Tenax,No,"Chain A:ARG72,ARG79,ILE133,GLY134,GLY135,ARG154,ARG155,GLU156,TYR184",2.25,True,1
ASD01260000_4,gapN,Thermoproteus tenax,O57693,1UXV,ASD00030001,AMP,A,Lig,Activator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",1503,Inner Protein Regulator,Inner Protein,15288789,Structural Basis of Allosteric Regulation and Substrate Specificity of the Non-Phosphorylating Glyceraldehyde 3-Phosphate Dehydrogenase from Thermoproteus Tenax,No,"Chain A:ARG72,ARG79,LYS132,ILE133,GLY134,GLY135,ARG154,ARG155,GLU156,PRO157,TYR184,VAL479",2.35,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,1ABB,ASD01320076,IMP,A,Lig,Activator,"[(2R,3S,4R,5R)-3,4-dihydroxy-5-(6-oxo-1H-purin-9-yl)oxolan-2-yl]methyl dihydrogen phosphate",920,Inner Protein Regulator,Inner Protein,1304390,Control of phosphorylase b conformation by a modified cofactor: crystallographic studies on R-state glycogen phosphorylase reconstituted with pyridoxal 5'-diphosphate.,No,"Chain A:TRP67,GLN71,GLN72,TYR75,GLU76,ARG242,ARG309,ARG310,LYS315; Chain B:ASP42,ASN44,VAL45",2.8,True,2
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,1B4D,ASD01320076,IMP,A,Lig,Activator,"[(2R,3S,4R,5R)-3,4-dihydroxy-5-(6-oxo-1H-purin-9-yl)oxolan-2-yl]methyl dihydrogen phosphate",930,Inner Protein Regulator,Inner Protein,10211820,Effects of commonly used cryoprotectants on glycogen phosphorylase activity and structure.,No,"Chain A:GLN72,TYR75,ARG309,ARG310",2.0,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,1C50,ASD01320079,CHI,A,Lig,Inhibitor,5-chloro-N-[(2S)-3-(4-fluorophenyl)-1-(4-hydroxypiperidin-1-yl)-1-oxo-propan-2-yl]-1H-indole-2-carboxamide,920,Inner Protein Regulator,Inner Protein,10873856,A new allosteric site in glycogen phosphorylase b as a target for drug interactions.,No,"Chain A:ARG60,VAL64,TRP67,PRO188,TRP189,GLU190,LYS191,ALA192,PRO229",2.3,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,1C8K,ASD01320080,CPB,A,Lig,Inhibitor,"2-(2-chlorophenyl)-5,7-dihydroxy-8-[(1S,3S,4R)-3-hydroxy-1-methyl-piperidin-4-yl]chromen-4-one",940,Inner Protein Regulator,Inner Protein,10924512,Flavopiridol inhibits glycogen phosphorylase by binding at the inhibitor site.,No,"Chain A:ASN282,ASN284,PHE285,ILE380,GLU382,HIS571,GLU572,ALA610,GLY612,TYR613,ARG770",1.76,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,1C8L,ASD01320023,BIN,A,Lig,Inhibitor,"4-(2-chlorophenyl)-1-ethyl-6-methyl-5-propan-2-yloxycarbonyl-pyridin-1-ium-2,3-dicarboxylic acid",930,Inner Protein Regulator,Inner Protein,11368311,Structural basis of the synergistic inhibition of glycogen phosphorylase a by caffeine and a potential antidiabetic drug.,No,"Chain A:TRP67,ILE68,GLN71,GLN72,TYR75,ARG193,GLU195,PHE196,ASP227,ARG242,ARG309,ARG310",2.3,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,1C8L,ASD01320044,CFF,A,Lig,Inhibitor,"1,3,7-trimethylpurine-2,6-dione",940,Inner Protein Regulator,Inner Protein,11368311,Structural basis of the synergistic inhibition of glycogen phosphorylase a by caffeine and a potential antidiabetic drug.,No,"Chain A:ASN282,ASP283,ASN284,PHE285,HIS571,ALA610,GLY612,TYR613",2.3,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,1E1Y,ASD01320080,CPB,A,Lig,Inhibitor,"2-(2-chlorophenyl)-5,7-dihydroxy-8-[(1S,3S,4R)-3-hydroxy-1-methyl-piperidin-4-yl]chromen-4-one",940,Inner Protein Regulator,Inner Protein,10924512,Flavopiridol Inhibits Glycogen Phosphorylase by Binding at the Inhibitor Site,No,"Chain A:ASN284,PHE285,LEU380,GLU382,GLU572,ALA610,GLY612,TYR613,ARG770,PHE771",2.23,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,1FTQ,ASD01320076,IMP,A,Lig,Activator,"[(2R,3S,4R,5R)-3,4-dihydroxy-5-(6-oxo-1H-purin-9-yl)oxolan-2-yl]methyl dihydrogen phosphate",930,Inner Protein Regulator,Inner Protein,16222658,Kinetic and crystallographic studies of glucopyranose spirohydantoin and glucopyranosylamine analogs inhibitors of glycogen phosphorylase.,No,"Chain A:GLN71,GLN72,TYR75,ARG309,ARG310",2.35,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,1GFZ,ASD01320076,IMP,A,Lig,Activator,"[(2R,3S,4R,5R)-3,4-dihydroxy-5-(6-oxo-1H-purin-9-yl)oxolan-2-yl]methyl dihydrogen phosphate",930,Inner Protein Regulator,Inner Protein,10924512,Flavopiridol inhibits glycogen phosphorylase by binding at the inhibitor site.,No,"Chain A:GLN71,GLN72,TYR75,ARG309,ARG310",2.3,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,1GFZ,ASD01320044,CFF,A,Lig,Inhibitor,"1,3,7-trimethylpurine-2,6-dione",940,Inner Protein Regulator,Inner Protein,10924512,Flavopiridol inhibits glycogen phosphorylase by binding at the inhibitor site.,No,"Chain A:ASN282,PHE285,HIS571,ALA610,GLY612,TYR613",2.3,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,1GG8,ASD01320076,IMP,A,Lig,Activator,"[(2R,3S,4R,5R)-3,4-dihydroxy-5-(6-oxo-1H-purin-9-yl)oxolan-2-yl]methyl dihydrogen phosphate",930,Inner Protein Regulator,Inner Protein,8180201,Design of inhibitors of glycogen phosphorylase: a study of alpha- and beta-C-glucosides and 1-thio-beta-D-glucose compounds.,No,"Chain A:GLN71,GLN72,TYR75,ARG309,ARG310",2.31,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,1GPY,ASD00360002,G6P,A,Lig,Inhibitor,"[(2R,3S,4S,5R,6S)-3,4,5,6-tetrahydroxyoxan-2-yl]methyl dihydrogen phosphate",998,Inner Protein Regulator,Inner Protein,8331662,Crystallographic binding studies on the allosteric inhibitor glucose-6-phosphate to T state glycogen phosphorylase b.,No,"Chain A:TRP67,ILE68,GLN71,ARG193,PHE196,ASP227,THR240,ARG242,ARG309,ARG310",2.4,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,1H5U,ASD01320079,CHI,A,Lig,Inhibitor,5-chloro-N-[(2S)-3-(4-fluorophenyl)-1-(4-hydroxypiperidin-1-yl)-1-oxo-propan-2-yl]-1H-indole-2-carboxamide,920,Inner Protein Regulator,Inner Protein,11886794,"The 1.76 A Resolution Crystal Structure of Glycogen Phosphorylase B Complexed with Glucose, and Cp320626, a Potential Antidiabetic Drug",No,"Chain A:ARG60,LEU63,VAL64,TRP67,PRO188,TRP189,GLU190,LYS191,ALA192,PRO229",1.76,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,1K06,ASD01328029,BZD,A,Lig,Inhibitor,"N-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]carbamoyl]benzamide",920,Inner Protein Regulator,Inner Protein,11895439,Binding of N-acetyl-N '-beta-D-glucopyranosyl urea and N-benzoyl-N '-beta-D-glucopyranosyl urea to glycogen phosphorylase b: kinetic and crystallographic studies.,No,"Chain A:ARG60,VAL64,TRP67,PRO188,TRP189,GLU190,LYS191,PRO229",1.8,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,1K08,ASD01328029,BZD,A,Lig,Inhibitor,"N-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]carbamoyl]benzamide",920,Inner Protein Regulator,Inner Protein,11895439,Binding of N-acetyl-N '-beta-D-glucopyranosyl urea and N-benzoyl-N '-beta-D-glucopyranosyl urea to glycogen phosphorylase b: kinetic and crystallographic studies.,No,"Chain A:ARG60,VAL64,TRP67,PRO188,TRP189,GLU190,LYS191,PRO229",2.26,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,1LWO,ASD01320079,CHI,A,Lig,Inhibitor,5-chloro-N-[(2S)-3-(4-fluorophenyl)-1-(4-hydroxypiperidin-1-yl)-1-oxo-propan-2-yl]-1H-indole-2-carboxamide,920,Inner Protein Regulator,Inner Protein,12686153,Crystal structure of rabbit muscle glycogen phosphorylase a in complex with a potential hypoglycaemic drug at 2.0 A resolution,No,"Chain A:ARG60,LEU63,VAL64,TRP67,PRO188,TRP189,GLU190,LYS191,ALA192,PRO229",2.0,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,1PYG,ASD00030001,AMP,A,Lig,Activator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",843,Inner Protein Regulator,Inner Protein,1962195,Structural basis for the activation of glycogen phosphorylase b by adenosine monophosphate.,No,"Chain A:TRP67,GLN71,GLN72,TYR75,ARG309,ARG310,LYS315,PHE316,GLY317,CYS318; Chain B:ASP42,ASN44,VAL45",2.87,True,2
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,1UZU,ASD01320152,INR,A,Lig,Inhibitor,(3Z)-2-oxo-3-(3-oxo-1H-indol-2-ylidene)-1H-indole-5-sulfonic acid,1000,Inner Protein Regulator,Inner Protein,15153119,Binding of the Potential Antitumour Agent Indirubin-5-Sulphonate at the Inhibitor Site of Rabbit Muscle Glycogen Phosphorylase B. Comparison with Ligand Binding to Pcdk2-Cyclin a Complex.,No,"Chain A:ASN282,PHE285,GLU287,GLU382,GLU572,ALA610,GLY612,TYR613",2.3,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,1WUT,ASD01328025,BN2,A,Lig,Inhibitor,"7-[2,6-dichloro-4-[(2-chlorophenyl)carbonylcarbamoylamino]phenoxy]heptanoic acid",930,Inner Protein Regulator,Inner Protein,15987904,"Crystallographic studies on acyl ureas, a new class of glycogen phosphorylase inhibitors, as potential antidiabetic drugs",No,"Chain A:TRP67,ILE68,GLN71,GLN72,TYR75,LYS191,ARG193",2.26,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,1WUY,ASD01328026,BN3,A,Lig,Inhibitor,"4-[3-chloro-4-[(2,4-dichlorophenyl)carbonylcarbamoylamino]phenoxy]butanoic acid",930,Inner Protein Regulator,Inner Protein,15987904,"Crystallographic studies on acyl ureas, a new class of glycogen phosphorylase inhibitors, as potential antidiabetic drugs",No,"Chain A:TRP67,ILE68,GLN71,GLN72,TYR75,LYS191,ARG193",2.26,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,1WV0,ASD01328027,BN4,A,Lig,Inhibitor,"4-[4-[(2,4-dichlorophenyl)carbonylcarbamoylamino]-2,3-dimethyl-phenoxy]butanoic acid",930,Inner Protein Regulator,Inner Protein,15987904,"Crystallographic studies on acyl ureas, a new class of glycogen phosphorylase inhibitors, as potential antidiabetic drugs",No,"Chain A:TRP67,ILE68,GLN71,GLN72,TYR75,LYS191,ARG193",2.26,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,1WV1,ASD01320090,BN5,A,Lig,Inhibitor,"5-[3-[(2,4-dichlorophenyl)carbonylcarbamoylamino]-2-methyl-phenoxy]pentanoic acid",930,Inner Protein Regulator,Inner Protein,15987904,"Crystallographic studies on acyl ureas, a new class of glycogen phosphorylase inhibitors, as potential antidiabetic drugs",No,"Chain A:TRP67,ILE68,GLN71,GLN72,TYR75,LYS191,ARG193",2.26,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,1XKX,ASD01320112,IMK,A,Lig,Inhibitor,"(2R,3S,4R,5R,6S)-2-(hydroxymethyl)-6-(5-methyl-1H-benzimidazol-2-yl)oxane-3,4,5-triol",920,Inner Protein Regulator,Inner Protein,15741340,"Kinetic and crystallographic studies on 2-(beta-D-glucopyranosyl)-5-methyl-1, 3, 4-oxadiazole, -benzothiazole, and -benzimidazole, inhibitors of muscle glycogen phosphorylase b. Evidence for a new binding site",No,"Chain A:ARG60,VAL64,TRP67,PRO188,TRP189,GLU190,LYS191",1.93,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,1Z62,ASD01320116;ASD01320116,IAA;IAA,A;A,Lig;Lig,Inhibitor,2-[[(2Z)-2-(2-oxo-7H-indol-3-ylidene)-7H-indol-3-ylidene]amino]oxyethanoic acid,990;991,Inner Protein Regulator,Inner Protein,,Indirubin-3'-Aminooxy-Acetate Inhibits Glycogen Phosphorylase by Binding at the Inhibitor and the Allosteric Site. Broad Specificities of the Two Sites,No,"Chain A:TRP67,ILE68,GLN71,GLN72,TYR75,ARG193,PHE196,ARG242,ASP306,ARG309,ARG310",1.9,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,1Z62,ASD01320116,IAA,A,Lig,Inhibitor,2-[[(2Z)-2-(2-oxo-7H-indol-3-ylidene)-7H-indol-3-ylidene]amino]oxyethanoic acid,992,Inner Protein Regulator,Inner Protein,,Indirubin-3'-Aminooxy-Acetate Inhibits Glycogen Phosphorylase by Binding at the Inhibitor and the Allosteric Site. Broad Specificities of the Two Sites,No,"Chain A:ASN282,PHE285,GLU382,GLU572,ALA610,GLY612,TYR613,ARG770",1.9,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,1Z6P,ASD01320091,194,A,Lig,Inhibitor,4-[2-[(3-nitrophenyl)carbonylamino]phenoxy]phthalic acid,843,Inner Protein Regulator,Inner Protein,15214781,"Identification, synthesis and chracterization of new glycogen phosphorylase inhibitors binding to the allosteric AMP site",No,"Chain A:TRP67,ILE68,GLN71,GLN72,TYR75,ARG81,TYR155,LYS191,ARG193,ARG309,ARG310",2.4,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,1Z6Q,ASD01320092,195,A,Lig,Inhibitor,"4-[2,4-bis[(3-nitrophenyl)carbonylamino]phenoxy]phthalic acid",843,Inner Protein Regulator,Inner Protein,15214781,"Identification, synthesis and chracterization of new glycogen phosphorylase inhibitors binding to the allosteric AMP site",No,"Chain A:TRP67,ILE68,GLN71,GLN72,TYR75,GLU76,ARG81,TYR155,LYS191,ARG193,ARG309,ARG310",2.03,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,2AMV,ASD01320023,BIN,A,Lig,Inhibitor,"4-(2-chlorophenyl)-1-ethyl-6-methyl-5-propan-2-yloxycarbonyl-pyridin-1-ium-2,3-dicarboxylic acid",930,Inner Protein Regulator,Inner Protein,9384557,"The structure of glycogen phosphorylase b with an alkyldihydropyridine-dicarboxylic acid compound, a novel and potent inhibitor.",No,"Chain A:TRP67,ILE68,GLN71,GLN72,TYR75,ARG193,GLU195,PHE196,ASP227,ARG242,ARG309,ARG310",2.3,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,2GJ4,ASD01320151,2TH,A,Lig,Inhibitor,"2-chloro-N-[(1R,2R)-1-hydroxy-2,3-dihydro-1H-inden-2-yl]-6H-thieno[3,2-d]pyrrole-5-carboxamide",949,Inner Protein Regulator,Inner Protein,16945526,"Novel thienopyrrole glycogen phosphorylase inhibitors: synthesis, in vitro SAR and crystallographic studies.",No,"Chain A:ARG60,TRP67,PRO188,GLU190,LYS191",1.6,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,2GM9,ASD01320148,3TH,A,Lig,Inhibitor,"2-chloro-N-[(3R)-2-oxo-3,4-dihydro-1H-quinolin-3-yl]-6H-thieno[3,2-d]pyrrole-5-carboxamide",1,Inner Protein Regulator,Inner Protein,16945526,"Novel thienopyrrole glycogen phosphorylase inhibitors: synthesis, in vitro SAR and crystallographic studies.",No,"Chain A:ARG60,VAL64,TRP67,TRP189,GLU190,LYS191,PRO229",2.3,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,2IEG,ASD01320161,FRY,A,Lig,Inhibitor,"N-[(3S)-1-(2-amino-2-oxo-ethyl)-2-oxo-3,4-dihydroquinolin-3-yl]-2-chloro-2H-thieno[3,2-d]pyrrole-5-carboxamide",901,Inner Protein Regulator,Inner Protein,17095214,"Development of potent, orally active 1-substituted-3,4-dihydro-2-quinolone glycogen phosphorylase inhibitors.",No,"Chain A:ARG60,LEU63,TRP67,PRO188,GLU190,LYS191,ALA192,PRO194,PRO229; Chain B:PHE37,THR38,LEU39,VAL40,PHE53,HIS57,TYR185,GLY186,PRO188",1.9,True,2
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,2IEI,ASD01320160,FRX,A,Lig,Inhibitor,"2-chloro-N-[(3S)-1-[2-(2-hydroxyethylamino)-2-oxo-ethyl]-2-oxo-3,4-dihydroquinolin-3-yl]-6H-thieno[3,2-d]pyrrole-5-carboxamide",904,Inner Protein Regulator,Inner Protein,17095214,"Development of potent, orally active 1-substituted-3,4-dihydro-2-quinolone glycogen phosphorylase inhibitors.",No,"Chain A:ARG60,LEU63,TRP67,PRO188,GLU190,LYS191,ALA192,MET224; Chain B:THR38,LEU39,VAL40,PHE53,HIS57,ARG184,TYR185,GLY186",1.91,True,2
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,2OFF,ASD01320095,OFF,A,Lig,Inhibitor,"(2R,3S)-2,3-bis[[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy]pentanedioic acid",930,Inner Protein Regulator,Inner Protein,17600143,"FR258900, a potential anti-hyperglycemic drug, binds at the allosteric site of glycogen phosphorylase",No,"Chain A:GLN71,GLN72,TYR75,TYR155,ARG193,PHE196,THR240,ARG242,ARG309,ARG310",2.2,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,2PRI,ASD01320103,D6G,A,Lig,Inhibitor,"[(2R,3S,4R,6S)-3,4,6-tris(oxidanyl)oxan-2-yl]methyl dihydrogen phosphate",930,Inner Protein Regulator,Inner Protein,7500360,The binding of 2-deoxy-D-glucose 6-phosphate to glycogen phosphorylase b: kinetic and crystallographic studies.,No,"Chain A:TRP67,ILE68,GLN71,TYR75,ARG193,ASP227,ARG242,ARG309,ARG310",2.3,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,2PRJ,ASD01320076,IMP,A,Lig,Activator,"[(2R,3S,4R,5R)-3,4-dihydroxy-5-(6-oxo-1H-purin-9-yl)oxolan-2-yl]methyl dihydrogen phosphate",930,Inner Protein Regulator,Inner Protein,8580837,N-acetyl-beta-D-glucopyranosylamine: a potent T-state inhibitor of glycogen phosphorylase. A comparison with alpha-D-glucose.,No,"Chain A:GLN71,GLN72,TYR75,ARG309,ARG310",2.3,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,2QN1,ASD01320096,0AS,A,Lig,Inhibitor,"(1S,2R,4aS,6aR,6aS,6bR,8aR,9R,10R,11R,12aR,14bS)-10,11-dihydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4a-carboxylic acid",930,Inner Protein Regulator,Inner Protein,18517260,"Naturally occurring pentacyclic triterpenes as inhibitors of glycogen phosphorylase: synthesis, structure-activity relationships, and X-ray crystallographic studies",No,"Chain A:ILE68,GLN71,GLN72,TYR75,PHE196,ARG309,ARG310",2.401,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,2QN2,ASD01320097,0MA,A,Lig,Inhibitor,"(4aR,6aS,6aR,6bR,8aR,10R,11R,12aR,14bS)-10,11-dihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,5,6,6a,7,8,8a,10,11,12,13,14b-dodecahydropicene-4a-carboxylic acid",930,Inner Protein Regulator,Inner Protein,18517260,"Naturally occurring pentacyclic triterpenes as inhibitors of glycogen phosphorylase: synthesis, structure-activity relationships, and X-ray crystallographic studies",No,"Chain A:ILE68,GLN71,GLN72,PHE196,ARG242,ARG309,ARG310",2.698,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,2QN7,ASD01320076,IMP,A,Lig,Activator,"[(2R,3S,4R,5R)-3,4-dihydroxy-5-(6-oxo-1H-purin-9-yl)oxolan-2-yl]methyl dihydrogen phosphate",930,Inner Protein Regulator,Inner Protein,,"N-(4-substituted-benzoyl)-N'-(beta-D-glucopyranosyl)ureas, inhibitors of glycogen phosphorylase: synthesis, kinetic and crystallographic evaluation",No,"Chain A:GLN71,GLN72,TYR75,ARG309,ARG310",1.83,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,2QN8,ASD01320158,NBY,A,Lig,Inhibitor,"4-nitro-N-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]carbamoyl]benzamide",920,Inner Protein Regulator,Inner Protein,,"N-(4-substituted-benzoyl)-N'-(beta-D-glucopyranosyl)ureas, inhibitors of glycogen phosphorylase: synthesis, kinetic and crystallographic evaluation",No,"Chain A:ARG60,LEU63,VAL64,TRP67,PRO188,TRP189,GLU190,LYS191,PRO229",1.9,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,2QN9,ASD01320076,IMP,A,Lig,Activator,"[(2R,3S,4R,5R)-3,4-dihydroxy-5-(6-oxo-1H-purin-9-yl)oxolan-2-yl]methyl dihydrogen phosphate",930,Inner Protein Regulator,Inner Protein,,"N-(4-substituted-benzoyl)-N'-(beta-D-glucopyranosyl)ureas, inhibitors of glycogen phosphorylase: synthesis, kinetic and crystallographic evaluation",No,"Chain A:GLN71,GLN72,TYR75,ARG309,ARG310",2.0,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,2QNB,ASD01328029,BZD,A,Lig,Inhibitor,"N-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]carbamoyl]benzamide",920,Inner Protein Regulator,Inner Protein,,"N-(4-substituted-benzoyl)-N'-(beta-D-glucopyranosyl)ureas, inhibitors of glycogen phosphorylase: synthesis, kinetic and crystallographic evaluation",No,"Chain A:ARG60,VAL64,TRP67,PRO188,TRP189,GLU190,LYS191,PRO229",1.8,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,2SKC,ASD01320076,IMP,A,Lig,Activator,"[(2R,3S,4R,5R)-3,4-dihydroxy-5-(6-oxo-1H-purin-9-yl)oxolan-2-yl]methyl dihydrogen phosphate",930,Inner Protein Regulator,Inner Protein,8976550,"Activator anion binding site in pyridoxal phosphorylase b: the binding of phosphite, phosphate, and fluorophosphate in the crystal.",No,"Chain A:GLN71,GLN72,TYR75,ARG309,ARG310",2.4,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,2SKD,ASD01320076,IMP,A,Lig,Activator,"[(2R,3S,4R,5R)-3,4-dihydroxy-5-(6-oxo-1H-purin-9-yl)oxolan-2-yl]methyl dihydrogen phosphate",930,Inner Protein Regulator,Inner Protein,8976550,"Activator anion binding site in pyridoxal phosphorylase b: the binding of phosphite, phosphate, and fluorophosphate in the crystal.",No,"Chain A:GLN71,GLN72,TYR75,ARG309,ARG310",2.4,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,2SKE,ASD01320076,IMP,A,Lig,Activator,"[(2R,3S,4R,5R)-3,4-dihydroxy-5-(6-oxo-1H-purin-9-yl)oxolan-2-yl]methyl dihydrogen phosphate",930,Inner Protein Regulator,Inner Protein,8976550,"Activator anion binding site in pyridoxal phosphorylase b: the binding of phosphite, phosphate, and fluorophosphate in the crystal.",No,"Chain A:GLN71,GLN72,TYR75,ARG309,ARG310",2.46,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,3AMV,ASD01320023,BIN,A,Lig,Inhibitor,"4-(2-chlorophenyl)-1-ethyl-6-methyl-5-propan-2-yloxycarbonyl-pyridin-1-ium-2,3-dicarboxylic acid",930,Inner Protein Regulator,Inner Protein,10548038,"Allosteric inhibition of glycogen phosphorylase a by the potential antidiabetic drug 3-isopropyl 4-(2-chlorophenyl)-1,4-dihydro-1-ethyl-2-methyl-pyridine-3,5,6-tricarbo xylate.",No,"Chain A:TRP67,ILE68,GLN71,GLN72,TYR75,ARG81,ARG193,GLU195,PHE196,ASP227,ARG242,ARG309,ARG310",2.1,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,3BCR,ASD01320145,AZZ,A,Lig,Inhibitor,"1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-pyrimidine-2,4-dione",940,Inner Protein Regulator,Inner Protein,,D-Glucopyranosyl pyrimidine nucleoside binding to muscle glycogen phosphorylase b,No,"Chain A:ASN282,PHE285,ALA610,GLY612,TYR613",2.14,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,3BCU,ASD01320159,THM,A,Lig,Inhibitor,"1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-pyrimidine-2,4-dione",940,Inner Protein Regulator,Inner Protein,,D-Glucopyranosyl pyrimidine nucleoside binding to muscle glycogen phosphorylase b,No,"Chain A:ASN282,PHE285,ALA610,GLY612,TYR613",2.03,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,3BD6,ASD01320149,RDD,A,Lig,Inhibitor,"1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-triazinane-2,4,6-trione",930,Inner Protein Regulator,Inner Protein,,D-Glucopyranosyl pyrimidine nucleoside binding to muscle glycogen phosphorylase b,No,"Chain A:TYR75,ARG242,ARG309,ARG310",2.0,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,3BD7,ASD01320146,CKB,A,Lig,Inhibitor,"5-methyl-1-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]pyrimidine-2,4-dione",940,Inner Protein Regulator,Inner Protein,,D-Glucopyranosyl pyrimidine nucleoside binding to muscle glycogen phosphorylase b,No,"Chain A:ASN282,PHE285,ALA610,GLY612,TYR613,HIS614",1.9,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,3BDA,ASD01320147,C4B,A,Lig,Inhibitor,"1-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-1,3,5-triazinane-2,4,6-trione",940,Inner Protein Regulator,Inner Protein,,D-Glucopyranosyl pyrimidine nucleoside binding to muscle glycogen phosphorylase b,No,"Chain A:PHE285,ALA610,GLY612,TYR613,HIS614",2.0,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,3CUW,ASD01320162,445,A,Lig,Inhibitor,"N-phenyl-N'-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]ethanediamide",920,Inner Protein Regulator,Inner Protein,,"Tracking structure activity relationships of glycogen phosphorylase inhibitors: synthesis, kinetic and crystallographic evaluation of analogues of N-(-D-glucopyranosyl)-N'-oxamides",No,"Chain A:ARG60,VAL64,TRP67,PRO188,TRP189,GLU190,LYS191,PRO229",2.0,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,3E3N,ASD00030001,AMP,A,Lig,Activator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",843,Inner Protein Regulator,Inner Protein,,The crystal structure of the octameric muscle glycogen phosphorylase-AMP complex: insights into enzyme activation,No,"Chain A:TRP67,GLN71,TYR75,ARG309,ARG310,LYS315,PHE316,GLY317,CYS318; Chain B:ASP42,ASN44,VAL45",2.7,True,2
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,3E3O,ASD01320076,IMP,A,Lig,Activator,"[(2R,3S,4R,5R)-3,4-dihydroxy-5-(6-oxo-1H-purin-9-yl)oxolan-2-yl]methyl dihydrogen phosphate",920,Inner Protein Regulator,Inner Protein,,The crystal structure of the octameric muscle glycogen phosphorylase-AMP complex: insights into enzyme activation,No,"Chain A:TRP67,GLN71,GLN72,TYR75,GLU76,ARG242,ARG309,ARG310; Chain B:ASP42,ASN44,VAL45",2.6,True,2
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,3EBO,ASD01328023,57D,A,Lig,Inhibitor,"5,7-dihydroxy-2-phenyl-chromen-4-one",940,Inner Protein Regulator,Inner Protein,,Crystallographic binding studies of flavonoids to glycogen phosphorylase,No,"Chain A:ASN282,ASN284,PHE285,GLU382,HIS571,ALA610,GLY612,TYR613,ARG770",1.9,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,3EBP,ASD01320080,CPB,A,Lig,Inhibitor,"2-(2-chlorophenyl)-5,7-dihydroxy-8-[(1S,3S,4R)-3-hydroxy-1-methyl-piperidin-4-yl]chromen-4-one",940,Inner Protein Regulator,Inner Protein,,Crystallographic binding studies of flavonoids to glycogen phosphorylase,No,"Chain A:ASN284,PHE285,LEU380,GLU382,HIS571,GLU572,ALA610,GLY612,TYR613,ARG770",2.0,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,3G2H,ASD01320076,IMP,A,Lig,Activator,"[(2R,3S,4R,5R)-3,4-dihydroxy-5-(6-oxo-1H-purin-9-yl)oxolan-2-yl]methyl dihydrogen phosphate",930,Inner Protein Regulator,Inner Protein,,"Amide-1,2,3-triazole bioisosterism: the glycogen phosphorylase case",No,"Chain A:GLN71,GLN72,TYR75,ARG309,ARG310",2.03,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,3MQF,ASD01328008,20X,A,Lig,Inhibitor,"1-[(E)-(4-fluorophenyl)methylideneamino]-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]thiourea",920,Inner Protein Regulator,Inner Protein,20947361,The binding of beta-D-glucopyranosyl-thiosemicarbazone derivatives to glycogen phosphorylase: a new class of inhibitors,No,"Chain A:ARG60,LEU63,VAL64,TRP67,ASN187,PRO188,TRP189,GLU190,LYS191,ALA192,TYR226,PRO229",1.951,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,3MRT,ASD01328001,12E,A,Lig,Inhibitor,"1-[(E)-pyridin-4-ylmethylideneamino]-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]thiourea",920,Inner Protein Regulator,Inner Protein,20947361,The binding of beta-D-glucopyranosyl-thiosemicarbazone derivatives to glycogen phosphorylase: a new class of inhibitors,No,"Chain A:ARG60,VAL64,TRP67,ASN187,PRO188,TRP189,GLU190,LYS191,ALA192,TYR226,PRO229",1.98,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,3MRV,ASD01320114,16F,A,Lig,Inhibitor,"1-[(Z)-(3-hydroxyphenyl)methylideneamino]-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]thiourea",920,Inner Protein Regulator,Inner Protein,20947361,The binding of beta-D-glucopyranosyl-thiosemicarbazone derivatives to glycogen phosphorylase: a new class of inhibitors,No,"Chain A:ARG60,VAL64,TRP67,ASN187,PRO188,TRP189,GLU190,LYS191,ALA192,TYR226,PRO229",1.94,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,3MRX,ASD01328004,17S,A,Lig,Inhibitor,"1-[(E)-(4-methoxyphenyl)methylideneamino]-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]thiourea",920,Inner Protein Regulator,Inner Protein,20947361,The binding of beta-D-glucopyranosyl-thiosemicarbazone derivatives to glycogen phosphorylase: a new class of inhibitors,No,"Chain A:ARG60,LEU63,VAL64,TRP67,ASN187,PRO188,GLU190,LYS191,ALA192,TYR226,PRO229",1.95,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,3MS2,ASD01320068,18S,A,Lig,Inhibitor,"1-[(E)-(4-methylphenyl)methylideneamino]-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]thiourea",920,Inner Protein Regulator,Inner Protein,20947361,The binding of beta-D-glucopyranosyl-thiosemicarbazone derivatives to glycogen phosphorylase: a new class of inhibitors,No,"Chain A:ARG60,LEU63,VAL64,TRP67,ASN187,PRO188,TRP189,GLU190,LYS191,ALA192,TYR226,PRO229",2.1,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,3MS4,ASD01328009,21N,A,Lig,Inhibitor,"1-[(E)-[4-(trifluoromethyl)phenyl]methylideneamino]-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]thiourea",920,Inner Protein Regulator,Inner Protein,20947361,The binding of beta-D-glucopyranosyl-thiosemicarbazone derivatives to glycogen phosphorylase: a new class of inhibitors,No,"Chain A:ARG60,LEU63,VAL64,TRP67,GLY186,ASN187,PRO188,TRP189,GLU190,LYS191,ALA192,TYR226,PRO229",2.07,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,3MS7,ASD01328010,22S,A,Lig,Inhibitor,"1-[(E)-(2-chlorophenyl)methylideneamino]-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]thiourea",920,Inner Protein Regulator,Inner Protein,20947361,The binding of beta-D-glucopyranosyl-thiosemicarbazone derivatives to glycogen phosphorylase: a new class of inhibitors,No,"Chain A:ARG60,VAL64,TRP67,ASN187,PRO188,TRP189,GLU190,LYS191,ALA192,TYR226,PRO229",1.95,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,3MSC,ASD01320030,24S,A,Lig,Inhibitor,"1-[(Z)-(2-nitrophenyl)methylideneamino]-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]thiourea",844,Inner Protein Regulator,Inner Protein,20947361,The binding of beta-d-glucopyranosyl-thiosemicarbazone derivatives to glycogen phosphorylase: A new class of inhibitors.,No,"Chain A:ARG60,VAL64,TRP67,PRO188,TRP189,GLU190,LYS191,ALA192,ASP227,PRO229",1.951,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,3MT7,ASD01328003,16O,A,Lig,Inhibitor,"1-[(E)-(4-bromophenyl)methylideneamino]-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]thiourea",920,Inner Protein Regulator,Inner Protein,20947361,The binding of beta-D-glucopyranosyl-thiosemicarbazone derivatives to glycogen phosphorylase: a new class of inhibitors,No,"Chain A:ARG60,LEU63,VAL64,TRP67,GLY186,ASN187,PRO188,GLU190,LYS191,ALA192,TYR226,PRO229",2.0,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,3MT8,ASD01328005,17T,A,Lig,Inhibitor,"1-[(E)-(4-chlorophenyl)methylideneamino]-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]thiourea",920,Inner Protein Regulator,Inner Protein,20947361,The binding of beta-D-glucopyranosyl-thiosemicarbazone derivatives to glycogen phosphorylase: a new class of inhibitors,No,"Chain A:ARG60,LEU63,VAL64,TRP67,ASN187,PRO188,GLU190,LYS191,ALA192,TYR226,PRO229",2.0,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,3MT9,ASD01320043,18O,A,Lig,Inhibitor,"1-[(E)-(4-nitrophenyl)methylideneamino]-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]thiourea",920,Inner Protein Regulator,Inner Protein,20947361,The binding of beta-D-glucopyranosyl-thiosemicarbazone derivatives to glycogen phosphorylase: a new class of inhibitors,No,"Chain A:ARG60,LEU63,VAL64,PRO188,TRP189,GLU190,LYS191,ALA192,TYR226,PRO229",2.05,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,3MTA,ASD01320048,22O,A,Lig,Inhibitor,"1-[(E)-(3-bromophenyl)methylideneamino]-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]thiourea",920,Inner Protein Regulator,Inner Protein,20947361,The binding of beta-D-glucopyranosyl-thiosemicarbazone derivatives to glycogen phosphorylase: a new class of inhibitors,No,"Chain A:ARG60,LEU63,VAL64,TRP67,GLY186,ASN187,PRO188,TRP189,GLU190,LYS191,ALA192,TYR226,PRO229",2.23,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,3MTB,ASD01328011,23V,A,Lig,Inhibitor,"1-[(E)-(3-chlorophenyl)methylideneamino]-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]thiourea",920,Inner Protein Regulator,Inner Protein,20947361,The binding of beta-D-glucopyranosyl-thiosemicarbazone derivatives to glycogen phosphorylase: a new class of inhibitors,No,"Chain A:ARG60,VAL64,TRP67,ASN187,PRO188,TRP189,GLU190,LYS191,ALA192,TYR226,PRO229",1.95,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,3MTD,ASD01320075,25E,A,Lig,Inhibitor,"1-[(Z)-(4-hydroxyphenyl)methylideneamino]-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]thiourea",844,Inner Protein Regulator,Inner Protein,20947361,The binding of beta-D-glucopyranosyl-thiosemicarbazone derivatives to glycogen phosphorylase: a new class of inhibitors,No,"Chain A:HIS57,ARG60,LEU63,VAL64,ASN187,PRO188,TRP189,GLU190,LYS191,ALA192,TYR226,PRO229",2.096,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,3NC4,ASD01328014,26O,A,Lig,Inhibitor,"1-[(E)-(2-hydroxyphenyl)methylideneamino]-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]thiourea",920,Inner Protein Regulator,Inner Protein,20947361,The binding of beta-D-glucopyranosyl-thiosemicarbazone derivatives to glycogen phosphorylase: a new class of inhibitors,No,"Chain A:ARG60,VAL64,TRP67,ASN187,PRO188,TRP189,GLU190,LYS191,ALA192,TYR226,PRO229",2.07,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,4MRA,ASD02820003,QUE,A,Lig,Inhibitor,"2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-chromen-4-one",901,Inner Protein Regulator,Inner Protein,24556570,Biochemical and biological assessment of the inhibitory potency of extracts from vinification byproducts of Vitis vinifera extracts against glycogen phosphorylase.,No,"Chain A:GLU121,GLU124,CYS495,LYS544,PHE545,TYR548,ARG551,GLU552,LYS655",2.34,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,8GPB,ASD00030001,AMP,A,Lig,Activator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",930,Inner Protein Regulator,Inner Protein,1900534,Structural mechanism for glycogen phosphorylase control by phosphorylation and AMP.,No,"Chain A:GLN71,GLN72,TYR75,ARG309,ARG310",2.2,True,1
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,8GPB,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",940,Inner Protein Regulator,Inner Protein,1900534,Structural mechanism for glycogen phosphorylase control by phosphorylation and AMP.,No,"Chain A:ASN282,ASP283,PHE285,GLU287,PRO611,GLY612,TYR613",2.2,True,1
ASD01360000_1,groL,Escherichia coli,P0A6F5,1PCQ,ASD01720027;ASD01360010,ADP;AF3,A;A,Lig;Ion,Regulator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl phosphono hydrogen phosphate;trifluoroalumane",600;602,Inner Protein Regulator,Inner Protein,14517228,"Role of the gamma-phosphate of ATP in triggering protein folding by GroEL-GroES: function, structure and energetics.",No,"Chain A:THR30,LEU31,GLY32,PRO33,LYS51,ASP52,GLY53,ASP87,GLY88,THR89,THR90,THR91,ILE150,ASP398,GLY414,GLY415,ILE454,TYR478,ASN479,ALA480,ALA481,ILE493,ASP495",2.808,True,1
ASD01360000_1,groL,Escherichia coli,P0A6F5,1SVT,ASD01720027;ASD01360010,ADP;AF3,A;A,Lig;Ion,Regulator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl phosphono hydrogen phosphate;trifluoroalumane",600;602,Inner Protein Regulator,Inner Protein,15313620,Exploring the structural dynamics of the E.coli chaperonin GroEL using translation-libration-screw crystallographic refinement of intermediate states.,No,"Chain A:THR30,LEU31,GLY32,PRO33,LYS51,ASP52,GLY53,ASP87,GLY88,THR89,THR90,THR91,ILE150,GLY414,GLY415,GLY416,ILE454,TYR478,ASN479,ALA480,ALA481,MET488,ILE493,ASP495",2.808,True,1
ASD01400000_1,can,Haemophilus influenzae,P45148,3E2A,ASD01400003,BCT,F,Ion,Inhibitor,hydrogen carbonate,232,Inner Protein Regulator,Inner Protein,19459702,Allosteric site variants of Haemophilus influenzae beta-carbonic anhydrase.,No,"Chain F:ARG64,ALA49,LEU60,GLU50,VAL47,VAL62,TRP39,PRO48",2.301,True,1
ASD01400000_1,can,Haemophilus influenzae,P45148,3E2W,ASD01400003,BCT,F,Ion,Inhibitor,hydrogen carbonate,231,Inner Protein Regulator,Inner Protein,Not in PubMed,Allosteric site mutants of H. influenzae beta-carbonic anhydrase,No,"Chain D:ARG64; Chain F:PRO48,ALA49,GLU50,ARG64",2.296,True,2
ASD01400000_1,can,Haemophilus influenzae,P45148,3E3F,ASD01400003,BCT,B,Ion,Inhibitor,hydrogen carbonate,231,Inner Protein Regulator,Inner Protein,20359198,Evidence for a bicarbonate,No,"Chain B:TRP39,SER45,ARG46,ALA47,ALA49,ARG64",2.3,True,1
ASD01400000_1,can,Haemophilus influenzae,P45148,3E3I,ASD01400003,BCT,B,Ion,Inhibitor,hydrogen carbonate,233,Inner Protein Regulator,Inner Protein,20359198,Evidence for a bicarbonate,No,"Chain B:TRP39,ALA41,VAL47,PRO48,ALA49,LEU52,ARG64,TYR181",2.0,True,1
ASD01410000_1,,Hepatitis C virus,D0PY27,3PHE,ASD01418010,C9A,A,Lig,Inhibitor,(4-chlorophenyl)methyl 6-fluoro-7-(4-methylpiperazin-1-yl)-1-[(4-methylsulfonylphenyl)methyl]-4-oxo-quinoline-3-carboxylate,999,Inner Protein Regulator,Inner Protein,21145235,Quinolones as HCV NS5B polymerase inhibitors.,No,"Chain A:LEU419,ARG422,MET423,LEU474,HIS475,SER476,TYR477,SER478,PRO479,ILE482,ASN483,VAL485,ALA486,LEU489,PRO496,LEU497,TRP528",2.2,True,1
ASD01470000_1,MET,Human immunodeficiency virus type 1,P08581,4O3T,ASD01470017,Chain P,P;P;P;P;P;P;P;P;P,Pep,Activator,IVGGYPWWM,495;496;497;498;499;500;501;502;503,Inner Protein Regulator,Inner Protein,24859116,An allosteric switch for pro-HGF/Met signaling using zymogen activator peptides.,No,"Chain P:VAL496,TRP501,GLY497,PRO500,TRP502,ILE495,GLY498,MET503,TYR499",2.99,True,1
ASD01510000_2,dnaK,Escherichia coli,P0A6Y8,4B9Q,ASD00150001,ATP,A,Lig,Inhibitor,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",700,Protein-Protein Interaction Regulator,Inner Protein,23123194,Structure and Dynamics of the ATP-Bound Open Conformation of Hsp70 Chaperones,No,"Chain A:GLY10,THR11,THR12,ASN13,LYS70,GLU171,GLY196,GLY197,GLY198,ALA199,GLY229,GLU267,LYS270,ILE271,SER274,GLY341,GLY342,GLN343,ARG345",2.4,True,1
ASD01510000_2,dnaK,Escherichia coli,P0A6Y8,4JN4,ASD00150001,ATP,A,Lig,Inhibitor,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",1002,Protein-Protein Interaction Regulator,Inner Protein,23708608,Allosteric opening of the polypeptide-binding site when an Hsp70 binds ATP.,No,"Chain A:GLY10,THR11,THR12,ASN13,LYS70,GLU171,GLY196,GLY197,GLY198,ALA199,GLY229,GLU267,LYS270,ILE271,SER274,GLY341,GLY342,GLN343,ARG345",2.3,True,1
ASD01510000_2,dnaK,Escherichia coli,P0A6Y8,4JNE,ASD00150001,ATP,A,Lig,Inhibitor,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",1002,Protein-Protein Interaction Regulator,Inner Protein,23708608,Allosteric opening of the polypeptide-binding site when an Hsp70 binds ATP.,No,"Chain A:GLY10,THR11,THR12,ASN13,LYS70,GLU171,GLY196,GLY197,GLY198,ALA199,GLY229,GLU267,LYS270,ILE271,SER274,GLY341,GLY342,GLN343,ARG345",1.96,True,1
ASD01580000_1,hutP,Bacillus subtilis,P10943,1VEA,ASD01580005,HBN,B,Lig,Activator,N-(2-NAPHTHYL)HISTIDINAMIDE,1001,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,15242603,Crystal structure of activated HutP; an RNA binding protein that regulates transcription of the hut operon in Bacillus subtilis.,No,"Chain B:VAL86,ALA82,HIS84,VAL143,GLY85,GLY142,GLY144,GLU81,ILE145,PHE141,MET80,LEU83",2.8,True,1
ASD01580000_1,hutP,Bacillus subtilis,P10943,1WMQ,ASD01580014,HIS,A,Lig,Activator,HISTIDINE,2001,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,15758992,Structural basis of HutP-mediated anti-termination and roles of the Mg2+ ion and L-histidine ligand.,No,"Chain B:GLU81,ILE145",1.6,True,1
ASD01580000_1,hutP,Bacillus subtilis,P10943,1WPU,ASD01580014,HIS,A,Lig,Activator,HISTIDINE,2001,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,Not in PubMed,Structural basis for the HutP antitermination Complex:Role of divalent metal ions in allosteric activation,No,"Chain B:GLU81,ILE145",1.48,True,1
ASD01580000_1,hutP,Bacillus subtilis,P10943,1WPV,ASD01580014,HIS,A,Lig,Activator,HISTIDINE,1001,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,15758992,Structural basis of HutP-mediated anti-termination and roles of the Mg2+ ion and L-histidine ligand.,No,"Chain C:TYR76,HIS77,SER72,HIS73,TYR69",1.7,True,1
ASD01630000_3,Npr1,Rattus norvegicus,P18910,1DP4,ASD01630003,CL,A,Ion,Activator,CHLORIDE ION,610,Inner Protein Regulator,Inner Protein,10894551,Structure of the dimerized hormone-binding domain of a guanylyl-cyclase-coupled receptor.,No,"Chain A:SER89,LEU9,CYS60,PRO10,GLY85,PRO84,VAL8,SER53,TRP18,CYS86",2.0,True,1
ASD01630000_3,Npr1,Rattus norvegicus,P18910,1T34,ASD01630003,CL,A,Ion,Activator,CHLORIDE ION,600,Inner Protein Regulator,Inner Protein,15117952,Crystal structure of hormone-bound atrial natriuretic peptide receptor extracellular domain: rotation mechanism for transmembrane signal transduction,No,"Chain A:SER89,LEU9,CYS60,PRO10,GLY85,PRO84,VAL8,SER53,TRP18,ALA90,CYS86",2.95,True,1
ASD01630000_3,Npr1,Rattus norvegicus,P18910,3A3K,ASD01330002,BR,B,Ion,Activator,BROMIDE ION,601,Inner Protein Regulator,Inner Protein,20066666,Reversibly bound chloride in the atrial natriuretic peptide receptor hormone-binding domain: Possible allosteric regulation and a conserved structural motif for the chloride-binding site.,No,"Chain B:LEU9,PRO84,VAL8,TRP18,GLY85,CYS86,SER53,SER89,PRO10,CYS60",2.5,True,1
ASD01660000_1,Ide,Rattus norvegicus,P35559,3TUV,ASD00150001,ATP,A,Lig,Activator,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",1020,Inner Protein Regulator,Inner Protein,22049080,Anion Activation Site of Insulin-degrading Enzyme.,Yes,"Chain A:ARG429,ASP895,LYS896,PRO897,LYS898,LYS899,SER901,ALA902,ALA905",2.27,True,1
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,1HYV,ASD01670077,TTA,A,Lig,Inhibitor,tetraphenylarsanium,304,Protein-Protein Interaction Regulator,Protein-Protein Interaction,11264582,Identification of a small-molecule binding site at the dimer interface of the HIV integrase catalytic domain.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,THR174",1.7,True,1
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,3ZCM,ASD01670068,PX3,A,Lig,Inhibitor,"5-[[[2-[(4-methoxyphenyl)methylcarbamoyl]phenyl]methyl-prop-2-enyl-amino]methyl]-1,3-benzodioxole-4-carboxylic acid",1214,Protein-Protein Interaction Regulator,Protein-Protein Interaction,22808106,Small Molecule Inhibitors of the Ledgf Site of Human Immunodeficiency Virus Integrase Identified by Fragment Screening and Structure Based Design.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,ALA98,TYR99,LEU102,THR125,ALA128,ALA129",1.8,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,3ZSO,ASD01670069,O2N,A,Lig,Inhibitor,"5-[[[2-[bis(4-methoxyphenyl)methylcarbamoyl]phenyl]methyl-prop-2-enyl-amino]methyl]-1,3-benzodioxole-4-carboxylic acid",1219,Protein-Protein Interaction Regulator,Protein-Protein Interaction,22808106,Small Molecule Inhibitors of the Ledgf Site of Human Immunodeficiency Virus Integrase Identified by Fragment Screening and Structure Based Design.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,LYS173,THR174; Chain B:GLN95,ALA98,TYR99,LEU102,THR125,ALA128,ALA129,TRP131,TRP132",1.75,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,3ZSQ,ASD01670070,O4N,A,Lig,Inhibitor,"5-[[[2-[[(1S)-1-(4-methoxyphenyl)butyl]carbamoyl]phenyl]methyl-prop-2-enyl-amino]methyl]-1,3-benzodioxole-4-carboxylic acid",1215,Protein-Protein Interaction Regulator,Protein-Protein Interaction,22808106,Small Molecule Inhibitors of the Ledgf Site of Human Immunodeficiency Virus Integrase Identified by Fragment Screening and Structure Based Design.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,ALA98,TYR99,LEU102,THR125,ALA128,ALA129,TRP131",1.7,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,3ZSR,ASD01670049,O3N,A,Lig,Inhibitor,"(2S)-2-(2-carboxyethyl)-6-[[[2-(cyclohexylmethylcarbamoyl)phenyl]methyl-prop-2-enyl-amino]methyl]-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid",1215,Protein-Protein Interaction Regulator,Protein-Protein Interaction,22808106,Small Molecule Inhibitors of the Ledgf Site of Human Immunodeficiency Virus Integrase Identified by Fragment Screening and Structure Based Design.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,GLU96,TYR99,THR125,TRP132",1.7,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,3ZSV,ASD01670058,ZSV,B,Lig,Inhibitor,"(R)-[(2S)-5-carboxy-2-(2-carboxyethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]methyl-[[2-[(4-methoxyphenyl)methylcarbamoyl]phenyl]methyl]-prop-2-enyl-azanium",1215,Protein-Protein Interaction Regulator,Protein-Protein Interaction,22808106,Small Molecule Inhibitors of the Ledgf Site of Human Immunodeficiency Virus Integrase Identified by Fragment Screening and Structure Based Design.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,GLU96,ALA98,TYR99,LEU102,THR125,ALA128,ALA129",1.75,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,3ZSW,ASD01670059,ZSW,A,Lig,Inhibitor,"(R)-[2-[[(2R)-butan-2-yl]carbamoyl]phenyl]methyl-[[(2S)-5-carboxy-2-(2-carboxyethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]methyl]-prop-2-enyl-azanium",1217,Protein-Protein Interaction Regulator,Protein-Protein Interaction,22808106,Small Molecule Inhibitors of the Ledgf Site of Human Immunodeficiency Virus Integrase Identified by Fragment Screening and Structure Based Design.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,GLU96,TYR99,THR125",1.8,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,3ZSX,ASD01670074,N44,A,Lig,Inhibitor,"5-[[[2-[(phenylmethyl)carbamoyl]phenyl]methyl-prop-2-enyl-amino]methyl]-1,3-benzodioxole-4-carboxylate",1215,Protein-Protein Interaction Regulator,Protein-Protein Interaction,22808106,Small Molecule Inhibitors of the Ledgf Site of Human Immunodeficiency Virus Integrase Identified by Fragment Screening and Structure Based Design.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,TYR99,THR125,ALA128,ALA129",1.95,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,3ZSY,ASD01670075,OM3,A,Lig,Inhibitor,"(R)-(4-carboxy-1,3-benzodioxol-5-yl)methyl-[[2-(cyclohexylmethylcarbamoyl)phenyl]methyl]-methyl-azanium",1214,Protein-Protein Interaction Regulator,Protein-Protein Interaction,22808106,Small Molecule Inhibitors of the Ledgf Site of Human Immunodeficiency Virus Integrase Identified by Fragment Screening and Structure Based Design.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,TYR99,THR125,ALA129,TRP132",2.2,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,3ZSZ,ASD01670076,OM2,A,Lig,Inhibitor,"(R)-[2-[[(2S)-butan-2-yl]carbamoyl]phenyl]methyl-[(4-carboxy-1,3-benzodioxol-5-yl)methyl]-methyl-azanium",1215,Protein-Protein Interaction Regulator,Protein-Protein Interaction,22808106,Small Molecule Inhibitors of the Ledgf Site of Human Immunodeficiency Virus Integrase Identified by Fragment Screening and Structure Based Design.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,TYR99,THR125,ALA129,TRP132",2.0,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,3ZT0,ASD01670067,ZT0,A,Lig,Inhibitor,"(4-carboxy-1,3-benzodioxol-5-yl)methyl-[[2-[(4-methoxyphenyl)methylcarbamoyl]phenyl]methyl]-methyl-azanium",1213,Protein-Protein Interaction Regulator,Protein-Protein Interaction,22808106,Small Molecule Inhibitors of the Ledgf Site of Human Immunodeficiency Virus Integrase Identified by Fragment Screening and Structure Based Design.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,LYS173,THR174; Chain B:GLN95,ALA98,TYR99,THR125,ALA128,ALA129",1.95,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,3ZT1,ASD01670007,OM1,A,Lig,Inhibitor,"(4-carboxy-1,3-benzodioxol-5-yl)methyl-[[2-[(4-methoxyphenyl)methylcarbamoyl]phenyl]methyl]azanium",1215,Protein-Protein Interaction Regulator,Protein-Protein Interaction,22808106,Small Molecule Inhibitors of the Ledgf Site of Human Immunodeficiency Virus Integrase Identified by Fragment Screening and Structure Based Design.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,ALA98,TYR99,LEU102,THR125,ALA128,ALA129",1.75,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,3ZT2,ASD01670061,ZT2,A,Lig,Inhibitor,"5-[(E)-(2-oxidanylidene-3H-inden-1-ylidene)methyl]-1,3-benzodioxole-4-carboxylic acid",1216,Protein-Protein Interaction Regulator,Protein-Protein Interaction,22808106,Small Molecule Inhibitors of the Ledgf Site of Human Immunodeficiency Virus Integrase Identified by Fragment Screening and Structure Based Design.,No,"Chain A:GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,TYR99,LEU102,THR125,ALA129,TRP132",1.7,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,3ZT2,ASD01670061,ZT2,A,Lig,Inhibitor,"5-[(E)-(2-oxidanylidene-3H-inden-1-ylidene)methyl]-1,3-benzodioxole-4-carboxylic acid",1217,Protein-Protein Interaction Regulator,Protein-Protein Interaction,22808106,Small Molecule Inhibitors of the Ledgf Site of Human Immunodeficiency Virus Integrase Identified by Fragment Screening and Structure Based Design.,No,"Chain A:TYR83,ASN184,HIS185,ARG187,SER195,GLY197,GLU198,VAL201; Chain B:GLY106,ARG107,TRP108,PRO109,ILE204,ILE208",1.7,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,3ZT3,ASD01670063,ZT4,A,Lig,Inhibitor,"5-[(E)-(2-oxidanyl-2,3-dihydroinden-1-ylidene)methyl]-1,3-benzodioxole-4-carboxylic acid",1216,Protein-Protein Interaction Regulator,Protein-Protein Interaction,22808106,Small Molecule Inhibitors of the Ledgf Site of Human Immunodeficiency Virus Integrase Identified by Fragment Screening and Structure Based Design.,No,"Chain A:GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,TYR99,LEU102,THR125,ALA129,TRP132",1.95,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,3ZT4,ASD01670061,ZT2,A,Lig,Inhibitor,"5-[(E)-(2-oxidanylidene-3H-inden-1-ylidene)methyl]-1,3-benzodioxole-4-carboxylic acid",1216,Protein-Protein Interaction Regulator,Protein-Protein Interaction,22808106,Small Molecule Inhibitors of the Ledgf Site of Human Immunodeficiency Virus Integrase Identified by Fragment Screening and Structure Based Design,No,"Chain A:GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,TYR99,LEU102,THR125,ALA129,TRP132",2.2,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,3ZT4,ASD01670061,ZT2,A,Lig,Inhibitor,"5-[(E)-(2-oxidanylidene-3H-inden-1-ylidene)methyl]-1,3-benzodioxole-4-carboxylic acid",1217,Protein-Protein Interaction Regulator,Protein-Protein Interaction,22808106,Small Molecule Inhibitors of the Ledgf Site of Human Immunodeficiency Virus Integrase Identified by Fragment Screening and Structure Based Design,No,"Chain A:TYR83,ASN184,HIS185,ARG187,SER195,GLY197,GLU198,VAL201; Chain B:GLY106,ARG107,TRP108,PRO109,LYS111,ILE204,ILE208",2.2,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CE9,ASD01670049,O3N,A,Lig,Inhibitor,"(2S)-2-(2-carboxyethyl)-6-[[[2-(cyclohexylmethylcarbamoyl)phenyl]methyl-prop-2-enyl-amino]methyl]-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid",1214,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,GLU96,TYR99,THR125,ALA128,ALA129,TRP132",2.1,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CEA,ASD01670059,ZSW,A,Lig,Inhibitor,"(R)-[2-[[(2R)-butan-2-yl]carbamoyl]phenyl]methyl-[[(2S)-5-carboxy-2-(2-carboxyethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]methyl]-prop-2-enyl-azanium",1217,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,GLU96,TYR99,THR125",1.8,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CEB,ASD01670058,ZSV,B,Lig,Inhibitor,"(R)-[(2S)-5-carboxy-2-(2-carboxyethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]methyl-[[2-[(4-methoxyphenyl)methylcarbamoyl]phenyl]methyl]-prop-2-enyl-azanium",1215,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,GLU96,ALA98,TYR99,LEU102,THR125,ALA128,ALA129",1.75,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CEC,ASD01670057,2SS,A,Lig,Inhibitor,"(2S)-6-[[[2-(cyclobutylmethylcarbamoyl)phenyl]methyl-prop-2-enyl-amino]methyl]-2-(3-hydroxy-3-oxopropyl)-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid",1216,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,GLU96,TYR99,THR125,ALA128,ALA129,TRP132",1.75,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CED,ASD01670056,9NS,B,Lig,Inhibitor,"(2S)-6-[[[2-(furan-2-ylmethylcarbamoyl)phenyl]methyl-prop-2-enyl-amino]methyl]-2-(3-hydroxy-3-oxopropyl)-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid",1215,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,GLU96,TYR99,LEU102,THR125,ALA128,ALA129",1.75,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CEE,ASD01670055,B0T,A,Lig,Inhibitor,"(2S)-6-[[[2-[[(2S)-butan-2-yl]carbamoyl]phenyl]methyl-methyl-amino]methyl]-2-(3-hydroxy-3-oxopropyl)-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid",1215,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,GLU96,TYR99,LEU102,ALA128",1.8,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CEF,ASD01670054,D0T,A,Lig,Inhibitor,"(2S)-2-(3-hydroxy-3-oxopropyl)-6-[[methyl-[[2-[(phenylmethyl)carbamoyl]phenyl]methyl]amino]methyl]-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid",1215,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,GLU96,TYR99,THR125,ALA128,ALA129,TRP132",1.7,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CEO,ASD01670053,G0T,A,Lig,Inhibitor,"(2S)-2-(3-hydroxy-3-oxopropyl)-6-[[[2-[(4-methoxyphenyl)methylcarbamoyl]phenyl]methyl-methyl-amino]methyl]-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid",1215,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,GLU96,ALA98,TYR99,LEU102,THR125,ALA128,ALA129",1.9,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CEQ,ASD01670052,QCH,A,Lig,Inhibitor,"(2S)-6-[[[2-(cyclohexylmethylcarbamoyl)phenyl]methyl-methyl-amino]methyl]-2-(3-hydroxy-3-oxopropyl)-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid",1215,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,GLU96,TYR99,ALA129,TRP132",1.7,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CER,ASD01670051,VL4,A,Lig,Inhibitor,"(2S)-6-[[[2-(cyclobutylmethylcarbamoyl)phenyl]methyl-methyl-amino]methyl]-2-(3-hydroxy-3-oxopropyl)-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid",1215,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,GLU96,TYR99,LEU102,ALA128,ALA129,TRP132",1.7,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CES,ASD01670050,NFW,A,Lig,Inhibitor,"(2S)-6-[[[2-(furan-2-ylmethylcarbamoyl)phenyl]methyl-methyl-amino]methyl]-2-(3-hydroxy-3-oxopropyl)-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid",1215,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,GLU96,TYR99,LEU102,THR125,ALA128,ALA129,TRP132",1.85,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CEZ,ASD01670049,O3N,A,Lig,Inhibitor,"(2S)-2-(2-carboxyethyl)-6-[[[2-(cyclohexylmethylcarbamoyl)phenyl]methyl-prop-2-enyl-amino]methyl]-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid",1215,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,GLU96,TYR99,THR125,TRP132",1.7,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CF0,ASD01670048,O5U,A,Lig,Inhibitor,"(2R)-6-[[(1R,2S)-2-(6-azanylhexanoylamino)-2,3-dihydro-1H-inden-1-yl]methyl]-2-(3-hydroxy-3-oxopropyl)-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid",1213,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,GLU96,TYR99,LEU102,THR125,ALA128,ALA129,TRP132",1.85,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CF1,ASD01670047,IY7,A,Lig,Inhibitor,"(2S)-6-[[(1R,2S)-2-(5-azanylpentanoylamino)-2,3-dihydro-1H-inden-1-yl]methyl]-2-(3-hydroxy-3-oxopropyl)-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid",1215,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,GLU96,TYR99,LEU102,THR125,ALA129,TRP132",1.95,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CF2,ASD01670046,3GM,A,Lig,Inhibitor,"(2S)-6-[[(1R,2S)-2-(4-azanylbutanoylamino)-2,3-dihydro-1H-inden-1-yl]methyl]-2-(3-hydroxy-3-oxopropyl)-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid",1213,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,GLU96,TYR99,LEU102,THR125,ALA129,TRP132",1.95,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CF8,ASD01670045,V7H,A,Lig,Inhibitor,"(2S)-2-(3-hydroxy-3-oxopropyl)-6-[[[2-[(phenylmethyl)carbamoyl]phenyl]methylamino]methyl]-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid",1217,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,GLU96,TYR99,THR125,ALA128,ALA129,TRP132",1.65,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CF9,ASD01670044,5EY,A,Lig,Inhibitor,"(3R)-3-(3-hydroxy-3-oxopropyl)-6-[(E)-[(2R)-2-oxidanyl-2,3-dihydroinden-1-ylidene]methyl]-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid",1214,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,TYR99,LEU102,THR125,ALA129,TRP132",2.1,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CFA,ASD01670043,WOP,A,Lig,Inhibitor,"5-[[methyl-[[(1S)-2-oxidanylidene-1-phenyl-2-[(phenylmethyl)amino]ethyl]carbamoyl]amino]methyl]-1,3-benzodioxole-4-carboxylic acid",1214,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ARG166,ASP167,GLN168,ALA169,GLU170,HIS171,THR174; Chain B:GLN95,ALA98,THR125,ALA128,ALA129",2.05,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CFB,ASD01670075,OM3,A,Lig,Inhibitor,"(R)-(4-carboxy-1,3-benzodioxol-5-yl)methyl-[[2-(cyclohexylmethylcarbamoyl)phenyl]methyl]-methyl-azanium",1217,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,TYR99,THR125,ALA128,ALA129,TRP132",1.95,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CFC,ASD01670041,7NV,A,Lig,Inhibitor,"5-[[[(1S)-2-(butylamino)-2-oxidanylidene-1-phenyl-ethyl]carbamoyl-methyl-amino]methyl]-1,3-benzodioxole-4-carboxylic acid",1216,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174; Chain B:GLN95,ALA98,TYR99,THR125,ALA128,ALA129",1.9,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CFD,ASD01670040,S8Y,A,Lig,Inhibitor,"5-[[[(1R)-2-(tert-butylamino)-2-oxidanylidene-1-phenyl-ethyl]carbamoyl-methyl-amino]methyl]-1,3-benzodioxole-4-carboxylic acid",1217,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174; Chain B:GLN95,ALA98,TYR99,THR125,ALA128,ALA129",2.15,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CGD,ASD01670039,8P3,A,Lig,Inhibitor,2-[(2-oxidanylidene-3H-indol-1-yl)methyl]benzoic acid,1216,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ALA169,GLU170,HIS171,THR174; Chain B:GLN95,LEU102,THR125,ALA128,ALA129,TRP132",2.0,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CGF,ASD01670038,UJ6,A,Lig,Inhibitor,"5-[[(3S)-2-oxidanylidene-1,3-dihydroindol-3-yl]methyl]-1,3-benzodioxole-4-carboxylic acid",1216,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,TYR99,LEU102,THR125,ALA128,ALA129,TRP132",1.7,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CGG,ASD01670037,K5Q,B,Lig,Inhibitor,"(2S)-6-[(E)-[(2E)-2-hydroxyimino-3H-inden-1-ylidene]methyl]-2-(3-hydroxy-3-oxopropyl)-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid",1218,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:GLN168,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,GLU96,TYR99,LEU102,THR125,ALA129,TRP132",1.75,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CGH,ASD01670036,LOZ,A,Lig,Inhibitor,"5-[[(1S,2R)-2-(4-azanylbutanoylamino)-2,3-dihydro-1H-inden-1-yl]methyl]-1,3-benzodioxole-4-carboxylic acid",1216,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,TYR99,LEU102,THR125,ALA129,TRP132",1.76,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CGI,ASD01670034,NZL,A,Lig,Inhibitor,"5-[[(1S,2S)-2-(6-azanylhexanoylamino)-2,3-dihydro-1H-inden-1-yl]methyl]-1,3-benzodioxole-4-carboxylic acid",1215,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,TYR99,LEU102,THR125,ALA129,TRP132",2.07,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CGJ,ASD01670034,NZL,A,Lig,Inhibitor,"5-[[(1S,2S)-2-(6-azanylhexanoylamino)-2,3-dihydro-1H-inden-1-yl]methyl]-1,3-benzodioxole-4-carboxylic acid",1216,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,TYR99,LEU102,THR125,ALA129,TRP132",2.15,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CHN,ASD01670033,ONZ,A,Lig,Inhibitor,"2-(1,3-benzodioxol-4-ylcarbonylamino)ethanoic acid",1217,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:TYR83,ASN184,HIS185,ARG187,SER195,GLY197,GLU198,VAL201; Chain B:GLY106,ARG107,TRP108,PRO109,ILE208",2.0,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CHO,ASD01670032,U2Z,B,Lig,Inhibitor,[1-[2-(aminomethyl)phenyl]-5-methyl-pyrazol-3-yl]methanol,1218,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:GLN168,THR174,MET178; Chain B:GLN95,ALA98,TYR99,LEU102,ALA128,ALA129,TRP132",1.7,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CHP,ASD01670030,IMV,A,Lig,Inhibitor,"5-[(2-oxo-3H-indol-1-yl)methyl]-1,3-benzodioxole-4-carboxylic acid",1216,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,TYR99,LEU102,THR125,ALA128,ALA129,TRP132",1.9,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CHP,ASD01670030,IMV,A,Lig,Inhibitor,"5-[(2-oxo-3H-indol-1-yl)methyl]-1,3-benzodioxole-4-carboxylic acid",1217,Inner Protein Regulator,Inner Protein,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,Yes,"Chain A:VAL77,VAL79,GLY82,ILE84,VAL150,MET154,GLU157,LEU158,HIS183",1.9,True,1
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CHQ,ASD01670029,CWU,A,Lig,Inhibitor,"5-[[(1S,2R)-2-oxidanyl-2,3-dihydro-1H-inden-1-yl]methyl]-1,3-benzodioxole-4-carboxylic acid",1217,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,TYR99,LEU102,THR125,ALA129,TRP132",1.95,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CHY,ASD01670028,C5Q,B,Lig,Inhibitor,"5-(1H-indol-3-ylmethyl)-1,3-benzodioxole-4-carboxylic acid",1214,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:GLN168,THR174,MET178; Chain B:GLN95,ALA98,TYR99,LEU102,THR125,ALA128,ALA129,TRP131,TRP132",1.7,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CHZ,ASD01670027,H75,A,Lig,Inhibitor,"2-(4-bromophenyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-3-one",1220,Inner Protein Regulator,Inner Protein,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,Yes,"Chain A:VAL77,VAL79,GLY82,ILE84,VAL150,MET154,GLU157,LEU158,HIS183",1.8,True,1
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CIE,ASD01670026,Y7N,A,Lig,Inhibitor,"5-[(E)-[(2S)-2-(6-azanylhexanoylamino)-2,3-dihydroinden-1-ylidene]methyl]-1,3-benzodioxole-4-carboxylic acid",1215,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,TYR99,LEU102,THR125,ALA129,TRP132",1.7,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CIF,ASD01670025,JDX,A,Lig,Inhibitor,2-methoxy-6-[[[2-[(4-methoxyphenyl)methylcarbamoyl]phenyl]methyl-methyl-amino]methyl]benzoic acid,1216,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,ALA98,LEU102,THR125,ALA128,ALA129",1.8,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CIG,ASD01670024,X0P,A,Lig,Inhibitor,2-methoxy-6-[[[3-[(4-methoxyphenyl)methylcarbamoyl]naphthalen-2-yl]methyl-methyl-amino]methyl]benzoic acid,1217,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,ALA98,LEU102,THR125,ALA128,ALA129",1.7,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CJ3,ASD01670023,E4F,A,Lig,Inhibitor,"5-[[(1R,2S)-2-(5-azanylpentanoylamino)-2,3-dihydro-1H-inden-1-yl]methyl]-1,3-benzodioxole-4-carboxylic acid",1214,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,TYR99,LEU102,THR125,ALA129,TRP132",1.7,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CJ4,ASD01670022,S3G,A,Lig,Inhibitor,"5-[(2S)-4-methyl-2-[(pyridin-4-ylcarbonylamino)methyl]pentyl]-1,3-benzodioxole-4-carboxylic acid",1217,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,TYR99,THR125,ALA128,ALA129,TRP132",1.8,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CJ5,ASD01670021,4VW,A,Lig,Inhibitor,"5-[(2S)-2-[[(4-aminophenyl)carbonylamino]methyl]-4-methyl-pentyl]-1,3-benzodioxole-4-carboxylic acid",1216,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,TYR99,THR125,ALA128,ALA129,TRP132",1.95,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CJE,ASD01670020,Q31,A,Lig,Inhibitor,"5-[(2S)-2-[[2-(1H-imidazol-4-yl)ethanoylamino]methyl]-4-methyl-pentyl]-1,3-benzodioxole-4-carboxylic acid",1213,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,TYR99,THR125,ALA128,ALA129,TRP132",1.9,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CJF,ASD01670019,RVN,A,Lig,Inhibitor,"5-[(E)-(2-oxidanylidene-1H-indol-3-ylidene)methyl]-1,3-benzodioxole-4-carboxylic acid",1217,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,TYR99,LEU102,THR125,ALA129,TRP132",1.9,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CJK,ASD01670018,H39,A,Lig,Inhibitor,"5-[(2S)-4-methyl-2-[[2-(1H-pyrrol-3-yl)ethanoylamino]methyl]pentyl]-1,3-benzodioxole-4-carboxylic acid",1215,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,TYR99,THR125,ALA128,ALA129,TRP132",1.75,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CJL,ASD01670017,9PA,A,Lig,Inhibitor,"5-[(2S)-2-[(5-azanylpentanoylamino)methyl]-4-methyl-pentyl]-1,3-benzodioxole-4-carboxylic acid",1216,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178",1.77,True,1
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CJP,ASD01670016,4D2,A,Lig,Inhibitor,"5-[(2S)-4-methyl-2-[(pyridin-3-ylcarbonylamino)methyl]pentyl]-1,3-benzodioxole-4-carboxylic acid",1215,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,TYR99,THR125,ALA128,ALA129,TRP132",2.0,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CJQ,ASD01670015,VXO,A,Lig,Inhibitor,"5-[(2S)-2-[[2-(1H-indol-3-yl)ethanoylamino]methyl]-4-methyl-pentyl]-1,3-benzodioxole-4-carboxylic acid",1214,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,TYR99,ALA128,ALA129,TRP132",1.7,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CJR,ASD01670014,FYM,A,Lig,Inhibitor,"2-methoxy-6-[[[6-[(4-methoxyphenyl)methylcarbamoyl]-1,3-benzodioxol-5-yl]methyl-methyl-amino]methyl]benzoic acid",1215,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,LYS173,THR174; Chain B:GLN95,ALA98,THR125,ALA128,ALA129",1.8,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CJS,ASD01670013,L0Y,A,Lig,Inhibitor,"6-[[[2-(cyclohexylmethylcarbamoyl)phenyl]methyl-methyl-amino]methyl]-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid",1217,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,TYR99,THR125,TRP132",1.8,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CJT,ASD01670012,HLR,A,Lig,Inhibitor,"1,2-benzoxazol-3-amine",1215,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:TYR83,TRP108,ASN184,HIS185,GLY197,GLU198,VAL201; Chain B:GLY106,ARG107,TRP108,PRO109,ILE204,ILE208",1.71,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CJU,ASD01670011,JNS,A,Lig,Inhibitor,"5-[(Z)-2-phenylethenyl]-1,3-benzodioxole-4-carboxylic acid",1217,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,TYR99,LEU102,THR125,ALA129,TRP132",1.7,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CJV,ASD01670010,IV2,A,Lig,Inhibitor,"5-chloranyl-4-methyl-1,3-benzothiazol-2-amine",1212,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:TYR83,ASN184,HIS185,GLY197,GLU198,VAL201; Chain B:GLY106,ARG107,TRP108,PRO109,ILE204,ILE208",1.95,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CJW,ASD01670008,CBJ,B,Lig,Inhibitor,"6-[(5-bromo-2,3-dioxo-indol-1-yl)methyl]-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid",1217,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:GLN95,LEU102,THR125,ALA129,TRP132; Chain B:GLN168,ALA169,GLU170,HIS171,THR174,MET178",1.95,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CJW,ASD01670008,CBJ,A,Lig,Inhibitor,"6-[(5-bromo-2,3-dioxo-indol-1-yl)methyl]-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid",1216,Inner Protein Regulator,Inner Protein,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,Yes,"Chain A:VAL79,ALA80,SER81,GLY82,ILE84,VAL150,MET154,GLU157,LEU158,HIS183",1.95,True,1
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CK1,ASD01670007,OM1,A,Lig,Inhibitor,"(4-carboxy-1,3-benzodioxol-5-yl)methyl-[[2-[(4-methoxyphenyl)methylcarbamoyl]phenyl]methyl]azanium",1216,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,ALA98,TYR99,LEU102,THR125,ALA128,ALA129",1.75,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CK2,ASD01670005,NVU,A,Lig,Inhibitor,"2-(1,2-benzoxazol-3-yl)ethanoic acid",1216,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:TYR99,LEU102,ALA129",1.85,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CK2,ASD01670005,NVU,A,Lig,Inhibitor,"2-(1,2-benzoxazol-3-yl)ethanoic acid",1215,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:TYR83,ASN184,HIS185,ARG187,SER195,GLY197,GLU198; Chain B:ARG107,TRP108,PRO109,ILE208",1.85,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CK3,ASD01670004,K1T,A,Lig,Inhibitor,"5-[(2S)-2-[(4-azanylbutanoylamino)methyl]-4-methyl-pentyl]-1,3-benzodioxole-4-carboxylic acid",1213,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,TYR99,THR125,ALA128,ALA129,TRP132",1.79,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4LH5,ASD01670001,LF0,A,Lig,Inhibitor,"(2S)-2-[4-(3,4-dihydro-2H-chromen-6-yl)-2-methyl-quinolin-3-yl]-2-[(2-methylpropan-2-yl)oxy]ethanoic acid",301,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24261564,Dual inhibition of HIV-1 replication by integrase-LEDGF allosteric inhibitors is predominant at the post-integration stage.,No,"Chain A:ALA169,GLU170,HIS171,THR174,MET178",2.19,True,1
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4OVL,ASD01670003,1TD,A,Lig,Inhibitor,3-[(E)-(2-oxidanylidene-1H-indol-3-ylidene)methyl]benzoic acid,308,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV integrase for compounds that bind--a SAMPL challenge.,No,"Chain A:ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,LEU102,THR125,ALA128,ALA129,TRP132",1.7,True,2
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,5KGW,ASD01670031,7SK,A,Lig,Inhibitor,"(2S)-tert-butoxy[3-(3,4-dihydro-2H-1-benzopyran-6-yl)-1-methyl-1H-indol-2-yl]acetic acid",304,Allosteric Fuction,Allosteric Position,27568085,Indole-based allosteric inhibitors of HIV-1 integrase.,No,"Chain A:LEU172,MET178,ALA169,ALA175,GLN168,LYS173,GLU170,HIS171,THR174",2.34,True,1
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,5KGX,ASD01670031,7SK,A,Lig,Inhibitor,"(2S)-tert-butoxy[3-(3,4-dihydro-2H-1-benzopyran-6-yl)-1-methyl-1H-indol-2-yl]acetic acid",301,Allosteric Fuction,Allosteric Position,27568085,Indole-based allosteric inhibitors of HIV-1 integrase.,No,"Chain A:GLU170,HIS171",2.67,True,1
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,5KRS,ASD05060085,6XI,A,Lig,Inhibitor,3-(1H-pyrrol-1-yl)-2-thiophenecarboxylic acid,302,Allosteric Fuction,Allosteric Position,27645997,A New Class of Allosteric HIV-1 Integrase Inhibitors Identified by Crystallographic Fragment Screening of the Catalytic Core Domain.,No,"Chain A:GLU92,SER123,GLY94,THR97,VAL126,THR122,ASN120,THR124,SER119,PHE121,CAF65,GLN95,THR93",1.7,True,1
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,5KRT,ASD05060099,6W6,A,Lig,Inhibitor,"3-[2,5-bis(chloranyl)pyrrol-1-yl]thiophene-2-carboxylic acid",301,Allosteric Fuction,Allosteric Position,27645997,A New Class of Allosteric HIV-1 Integrase Inhibitors Identified by Crystallographic Fragment Screening of the Catalytic Core Domain.,No,"Chain A:ILE161,ILE182,GLU157,HIS183,VAL165,GLN164,LYS186,ILE162,LYS160",1.651,True,1
ASD01760000_2,ldh,Bacillus stearothermophilus,P00344,1LDN,ASD00200001,FBP,A,Lig,Activator,"[(2R,3S,4S,5R)-2,3,4-trihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]methyl dihydrogen phosphate",353,Inner Protein Regulator,Inner Protein,1731077,Structure of a ternary complex of an allosteric lactate dehydrogenase from Bacillus stearothermophilus at 2.5 A resolution,No,"Chain A:ARG171,GLN183,ASN184,HIS186; Chain C:ARG171,GLN183,ASN184,HIS186",2.5,True,2
ASD01770000_1,lacI,Escherichia coli,P03023,1EFA,ASD01770002,NPF,A,Lig,Activator,"(2R,3R,4S,5R,6S)-2-methyl-6-(2-nitrophenoxy)oxane-3,4,5-triol",901,Protein-DNA/RNA Interaction Regulator,Inner Protein,10700279,A closer view of the conformation of the Lac repressor bound to operator.,No,"Chain A:LEU73,ALA75,PRO76,ILE79,ASN125,LEU148,ASP149,PHE161,SER193,ARG197,TRP220,ASN246,ASP274,GLN291,PHE293",2.6,True,1
ASD01770000_1,lacI,Escherichia coli,P03023,1TLF,ASD01770001,IPT,A,Lig,Inhibitor,"(2R,3R,4S,5R,6S)-2-(hydroxymethyl)-6-propan-2-ylsulfanyl-oxane-3,4,5-triol",998,Protein-DNA/RNA Interaction Regulator,Inner Protein,7792597,Crystal structure of lac repressor core tetramer and its implications for DNA looping.,No,"Chain A:SER69,LEU73,ALA75,PRO76,ILE79,ASN125,PRO127,LEU148,ASP149,SER193,ARG197,TRP220,ALA245,ASN246,ASP274,GLN291",2.6,True,1
ASD01770000_1,lacI,Escherichia coli,P03023,2P9H,ASD01770001,IPT,A,Lig,Inhibitor,"(2R,3R,4S,5R,6S)-2-(hydroxymethyl)-6-propan-2-ylsulfanyl-oxane-3,4,5-triol",998,Protein-DNA/RNA Interaction Regulator,Inner Protein,17543986,Structural analysis of lac repressor bound to allosteric effectors.,No,"Chain A:SER69,LEU73,ALA75,PRO76,ILE79,ASN125,LEU148,ASP149,SER193,ARG197,TRP220,ASN246,ASP274,GLN291",2.0,True,1
ASD01770000_1,lacI,Escherichia coli,P03023,3EDC,ASD01770014,HEZ,A,Lig,Regulator,"hexane-1,6-diol",400,Protein-DNA/RNA Interaction Regulator,Inner Protein,19004002,Crystal structure of a 1.6-hexanediol bound tetrameric form of Escherichia coli lac-repressor refined to 2.1 A resolution,No,"Chain A:SER69,LEU71,LEU73,PRO76,PRO127,ASP149,ARG197,TRP220",2.1,True,1
ASD01780000_1,ansA,Escherichia coli,P0A962,2HIM,ASD01780001,ASN,A,Lig,Activator,"(2S)-2,4-bis(azanyl)-4-oxidanylidene-butanoic acid",8001,Inner Protein Regulator,Protein-Protein Interaction,17451745,Crystal Structure and Allosteric Regulation of the Cytoplasmic Escherichia coli L-Asparaginase I.,No,"Chain A:ALA162,ARG240,THR271,GLN272,CYS273,THR301,VAL302,GLU303; Chain C:ARG240",1.82,True,2
ASD01780000_1,ansA,Escherichia coli,P0A962,2P2N,ASD01780001,ASN,A,Lig,Activator,"(2S)-2,4-bis(azanyl)-4-oxidanylidene-butanoic acid",8001,Inner Protein Regulator,Protein-Protein Interaction,17451745,Crystal Structure and Allosteric Regulation of the Cytoplasmic Escherichia colil-Asparaginase I,No,"Chain A:THR162,ARG240,THR271,GLN272,CYS273,THR301,VAL302,GLU303; Chain C:ARG240",1.9,True,2
ASD01860000_3,,Ascaris lumbricoides,P27443,1O0S,ASD01860001,TTN,A,Lig,Inhibitor,2-hydroxypropanedioate,810,Inner Protein Regulator,Protein-Protein Interaction,12853453,Crystallographic studies on Ascaris suum NAD-malic enzyme bound to reduced cofactor and identification of an effector site.,No,"Chain A:MET73,GLN78,ARG81,VAL82,ARG105,LEU109; Chain B:TYR141",2.0,True,2
ASD02000000_1,argA,Neisseria gonorrhoeae,Q5FAK7,3D2P,ASD02000001,ARG,A,Lig,Inhibitor,[amino-[[(4S)-4-amino-5-hydroxy-5-oxo-pentyl]amino]methylidene]azanium,438,Inner Protein Regulator,Inner Protein,19095660,Mechanism of allosteric inhibition of N-acetyl-L-glutamate synthase by L-arginine.,No,"Chain A:TYR17,LYS201,GLU220,THR221,GLN257,GLU270,LEU271,PHE272,THR273,ARG274,ASN275,GLY276,ILE277,GLY278,THR279,SER280,ASP334",2.56,True,1
ASD02000000_3,Mmar10_0365,Maricaulis maris,Q0ASS9,4KZT,ASD02000001,ARG,A,Lig,Inhibitor,[amino-[[(4S)-4-amino-5-hydroxy-5-oxo-pentyl]amino]methylidene]azanium,501,Inner Protein Regulator,Inner Protein,23850694,Structure of N-acetyl-L-glutamate synthase/kinase from Maricaulis maris with the allosteric inhibitor L-arginine bound.,No,"Chain A:TYR28,LYS206,SER225,SER265,GLU277,LEU278,THR280,HIS281,ALA282,GLY283,GLY285,THR286,LEU287,GLY365",2.8,True,1
ASD02030000_1,Grin1,Rattus norvegicus,P35439,5I56,ASD02032012,67P,B,Lig,Activator,N-({4-[2-(benzenecarbonyl)hydrazinecarbonyl]phenyl}methyl)-3-chloro-4-fluorobenzene-1-sulfonamide,802,Inner Protein regulator,Inner Protein,27618671,Structural Basis for Negative Allosteric Modulation of GluN2A-Containing NMDA Receptors.,No,"Chain B:PHE131,ALA217,GLU276,PRO130,MET272,THR243,PHE19,VAL132,VAL267,GLU133,VAL129,TYR245,LEU263,PHE62,LEU264,THR134,GLY244,LEU280",2.28,True,1
ASD02030000_1,Grin1,Rattus norvegicus,P35439,5I58,ASD02030551,67R,B,Lig,Activator,"5-({[(3-chloro-4-fluorophenyl)sulfonyl]amino}methyl)-N-[(2-methyl-1,3-thiazol-5-yl)methyl]pyrazine-2-carboxamide",302,Inner Protein regulator,Inner Protein,27618671,Structural Basis for Negative Allosteric Modulation of GluN2A-Containing NMDA Receptors.,No,"Chain B:ALA217,GLU276,GLU273,PRO130,PHE131,MET272,THR243,PHE19,VAL132,VAL267,GLU133,VAL129,LEU264,LEU263,PHE62,THR134,GLY244,LEU280",2.52,True,1
ASD02030000_1,Grin1,Rattus norvegicus,P35439,5I59,ASD02030766,67Q,B,Lig,Activator,"5-({[(3,4-difluorophenyl)sulfonyl]amino}methyl)-6-methyl-N-[(2-methyl-4H-1lambda~4~,3-thiazol-5-yl)methyl]pyrazine-2-carboxamide",302,Inner Protein regulator,Inner Protein,27618671,Structural Basis for Negative Allosteric Modulation of GluN2A-Containing NMDA Receptors.,No,"Chain B:ALA217,GLU276,GLU273,PRO130,PHE131,MET272,PHE19,VAL132,GLU133,VAL129,LEU264,LEU263,PHE62,VAL267,GLY244,LEU280",2.25,True,1
ASD02030000_1,Grin1,Rattus norvegicus,P35439,5JTY,ASD02030552,6ND,B,Lig,Activator,"5-({[(3,4-difluorophenyl)sulfonyl]amino}methyl)-6-methyl-N-[(2-methyl-1,3-thiazol-5-yl)methyl]pyrazine-2-carboxamide",601,Inner Protein regulator,Inner Protein,27618671,Structural Basis for Negative Allosteric Modulation of GluN2A-Containing NMDA Receptors.,No,"Chain B:ALA217,GLU276,GLU273,PRO130,PHE131,MET272,THR243,PHE19,VAL132,VAL267,GLU133,VAL129,LEU264,LEU263,PHE62,THR134,GLY244,LEU280",2.72,True,1
ASD02080000_1,cysK,Salmonella typhimurium,P0A1E3,1FCJ,ASD01630003,CL,A,Ion,Inhibitor,chloride,2006,Inner Protein Regulator,Protein-Protein Interaction,11023792,Identification of an allosteric anion-binding site on O-acetylserine sulfhydrylase: structure of the enzyme with chloride bound.,No,"Chain A:ARG34,ILE267,LEU268; Chain C:ASN7",2.0,True,2
ASD02090000_1,opd,Brevundimonas diminuta,P0A434,1QW7,ASD01030021,EBP,A,Lig,Inhibitor,1-(diethoxyphosphorylmethyl)-4-methyl-benzene,702,Inner Protein Regulator,Inner Protein,16188223,Structural and mutational studies of organophosphorus hydrolase reveal a cryptic and functional allosteric-binding site.,No,"Chain A:PHE51,THR350",1.9,True,1
ASD02160000_2,,Cyanidioschyzon merolae strain 10D,M1VAN7,3WMG,ASD02160003;ASD02160003;ASD02160003;ASD02160003;ASD02160003;ASD02160003;ASD02160003;ASD02160003;ASD02160003;ASD02160003;ASD02160003;ASD02160003;ASD02160003;ASD02160003;ASD02160003;ASD02160003;ASD02160003;ASD02160003,ACE;DTR;LEU;ASP;GLN;ILE;VAL;TRP;PHE;ASN;ALA;PRO;GLY;ASP;LEU;HIS;LEU;CYS,B;B;B;B;B;B;B;B;B;B;B;B;B;B;B;B;B,Pep,Inhibitor,"ethanal;(2R)-2-amino-3-(1H-indol-3-yl)propanoic acid;(2S)-2-amino-4-methyl-pentanoic acid;(2S)-2-azanylbutanedioic acid;(2S)-2,5-diamino-5-oxo-pentanoic acid;(2S,3S)-2-amino-3-methyl-pentanoic acid;(2S)-2-amino-3-methyl-butanoic acid;(2S)-2-amino-3-(1H-indol-3-yl)propanoic acid;(2S)-2-amino-3-phenyl-propanoic acid;(2S)-2,4-bis(azanyl)-4-oxidanylidene-butanoic acid;(2S)-2-aminopropanoic acid;(2S)-pyrrolidine-2-carboxylic acid;2-aminoethanoic acid;(2S)-2-azanylbutanedioic acid;(2S)-2-amino-4-methyl-pentanoic acid;(2S)-2-amino-3-(1H-imidazol-3-ium-4-yl)propanoic acid;(2S)-2-amino-4-methyl-pentanoic acid;(2R)-2-amino-3-sulfanyl-propanoic acid",0;1;2;3;4;5;6;7;8;9;10;11;12;13;14;15;16,Inner Protein Regulator,Inner Protein,24591620,Structural basis for gating mechanisms of a eukaryotic P-glycoprotein homolog.,No,"Chain A:ARG144,LYS162,TYR163,GLY166,ILE257,PHE258,ASN375,ASN378; Chain B:CYS17",2.4,True,2
ASD02180000_1,ipdC,Azospirillum brasilense,P51852,2Q5O,ASD02180002,PPY,A,Lig,Activator,2-oxo-3-phenyl-propanoic acid,5003,Inner Protein Regulator,Inner Protein,17905741,Molecular mechanism of allosteric substrate activation in a thiamine diphosphate-dependent decarboxylase.,No,"Chain A:ARG60,ARG214,ARG215,MET238,ARG240,GLY241,LEU242,LEU375,GLY394,LEU395,MET396,ALA397",2.15,True,1
ASD02180000_1,ipdC,Azospirillum brasilense,P51852,2Q5Q,ASD02180003,KPV,A,Lig,Activator,2-oxo-5-phenyl-pentanoic acid,5004,Inner Protein Regulator,Inner Protein,17905741,Molecular mechanism of allosteric substrate activation in a thiamine diphosphate-dependent decarboxylase.,No,"Chain A:ARG60,TYR61,ARG214,ARG215,MET238,ARG240,GLY241,LEU242,LEU375,GLY394,LEU395,MET396,ALA397",1.9,True,1
ASD02210000_1,ppc,Escherichia coli,P00864,1FIY,ASD01260006,ASP,A,Lig,Inhibitor,(2S)-2-azanylbutanedioic acid,884,Inner Protein Regulator,Inner Protein,9927652,Three-dimensional structure of phosphoenolpyruvate carboxylase: a proposed mechanism for allosteric inhibition.,No,"Chain A:ARG587,MET769,LYS773,MET819,ILE825,ARG832,ARG880,ASN881",2.8,True,1
ASD02210000_1,ppc,Escherichia coli,P00864,1JQN,ASD01260006,ASP,A,Lig,Inhibitor,(2S)-2-azanylbutanedioic acid,884,Inner Protein Regulator,Inner Protein,12467579,Crystal structures of C4 form maize and quaternary complex of E. coli phosphoenolpyruvate carboxylases.,No,"Chain A:ARG587,PRO591,MET769,LYS773,ILE825,ARG832,MET879,ARG880,ASN881",2.35,True,1
ASD02210000_1,,Escherichia coli,P00864,1QB4,ASD01260006,ASP,A,Lig,Inhibitor,ASPARTIC ACID,884,Inner Protein Regulator,Inner Protein,10481043,Plausible phosphoenolpyruvate binding site revealed by 2.6 A structure of Mn2+-bound phosphoenolpyruvate carboxylase from Escherichia coli.,No,"Chain A:GLY586,MET769,GLU86,MET819,MET766,ILE829,GLY588,ARG587,ILE825,ASN881,MET616,PRO591,ARG880,LYS773,LEU822,SER828,ARG832,MET879,GLY878",2.6,True,1
ASD02220000_1,pfkB,Escherichia coli,P06999,3CQD,ASD00150001,ATP,B,Lig,Inhibitor,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",312,Inner Protein Regulator,Protein-Protein Interaction,18762190,Crystallographic structure of phosphofructokinase-2 from Escherichia coli in complex with two ATP molecules. Implications for substrate inhibition.,Yes,"Chain A:ASN187,LYS189,GLY226,PRO227,THR251; Chain B:TYR23,PRO24,GLY26,LYS27",1.98,True,2
ASD02220000_1,pfkB,Escherichia coli,P06999,3UMO,ASD00150001,ATP,B,Lig,Inhibitor,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",312,Inner Protein Regulator,Protein-Protein Interaction,23823238,A Ribokinase Family Conserved Monovalent Cation Binding Site Enhances the MgATP-induced Inhibition in E. coli Phosphofructokinase-2,Yes,"Chain A:ASN187,LYS189,GLY226,PRO227,THR251; Chain B:TYR23,PRO24,GLY26,LYS27",1.696,True,2
ASD02230000_1,serA,Mycobacterium tuberculosis,P9WNX3,3DC2,ASD01260004,SER,A,Lig,Inhibitor,(2S)-2-amino-3-hydroxy-propanoic acid,600,Inner Protein Regulator,Inner Protein,18627175,Structural analysis of substrate and effector binding in Mycobacterium tuberculosis D-3-phosphoglycerate dehydrogenase.,No,"Chain A:TYR461,ASP463,ARG464,PRO465,GLY466,ALA467,LEU468,LEU487",2.7,True,1
ASD02230000_2,serA,Escherichia coli,P0A9T0,1PSD,ASD01260004,SER,A,Lig,Inhibitor,(2S)-2-amino-3-hydroxy-propanoic acid,451,Inner Protein Regulator,Inner Protein,7719856,The allosteric ligand site in the Vmax-type cooperative enzyme phosphoglycerate dehydrogenase.,No,"Chain A:HIS344,GLU345,ASN346,ARG347,PRO348,GLY349,VAL350,LEU351,LEU370",2.75,True,1
ASD02230000_2,serA,Escherichia coli,P0A9T0,2P9C,ASD01260004,SER,A,Lig,Inhibitor,(2S)-2-amino-3-hydroxy-propanoic acid,451,Inner Protein Regulator,Inner Protein,17459882,The effect of hinge mutations on effector binding and domain rotation in Escherichia coli D-3-phosphoglycerate dehydrogenase.,No,"Chain A:HIS344,GLU345,ASN346,ARG347,PRO348,GLY349,LEU351,LEU370,THR372",2.46,True,1
ASD02230000_2,serA,Escherichia coli,P0A9T0,2P9G,ASD01260004,SER,A,Lig,Inhibitor,(2S)-2-amino-3-hydroxy-propanoic acid,451,Inner Protein Regulator,Inner Protein,17459882,The effect of hinge mutations on effector binding and domain rotation in Escherichia coli D-3-phosphoglycerate dehydrogenase.,No,"Chain A:HIS344,ASN346,ARG347,PRO348,GLY349,VAL350,LEU351,LEU370,THR372; Chain B:ASN364,ILE365",2.8,True,2
ASD02230000_2,serA,Escherichia coli,P0A9T0,2PA3,ASD01260004,SER,A,Lig,Inhibitor,(2S)-2-amino-3-hydroxy-propanoic acid,451,Inner Protein Regulator,Inner Protein,17459882,The effect of hinge mutations on effector binding and domain rotation in Escherichia coli D-3-phosphoglycerate dehydrogenase.,No,"Chain A:HIS344,ASN346,ARG347,PRO348,GLY349,VAL350,LEU351,LEU370",2.74,True,1
ASD02280000_1,prs,Bacillus subtilis,P14193,1DKR,ASD02880002,SO4,A,Ion,Activator,sulfate,1004,Inner Protein Regulator,Protein-Protein Interaction,10742175,Structural basis for the function of Bacillus subtilis phosphoribosyl-pyrophosphate synthetase.,No,"Chain A:GLN309,SER310,VAL311,SER312; Chain B:ARG109",2.3,True,2
ASD02280000_1,prs,Bacillus subtilis,P14193,1DKU,ASD02280001,AP2,A,Lig,Inhibitor,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]methylphosphonic acid",1002,Inner Protein Regulator,Protein-Protein Interaction,10742175,Structural basis for the function of Bacillus subtilis phosphoribosyl-pyrophosphate synthetase.,No,"Chain A:GLN140,ASP148,HIS149,SER310,VAL311,SER312,PHE315; Chain B:LYS105,ALA106,ARG107,SER108,ARG109",2.2,True,2
ASD02280000_1,prs,Bacillus subtilis,P14193,1IBS,ASD02880002,SO4,A,Ion,Activator,sulfate,1004,Inner Protein Regulator,Protein-Protein Interaction,11790837,Binding of cations in Bacillus subtilis phosphoribosyldiphosphate synthetase and their role in catalysis.,No,"Chain A:SER310,VAL311,SER312; Chain B:ARG109",2.8,True,2
ASD02370000_3,pheA,Chlorobium tepidum,Q8KBW6,2QMX,ASD02170001,PHE,A,Lig,Inhibitor,(2S)-2-amino-3-phenyl-propanoic acid,303,Inner Protein Regulator,Protein-Protein Interaction,18171624,Structures of open (R) and close (T) states of prephenate dehydratase (PDT) - implication of allosteric regulation by L-phenylalanine.,No,"Chain A:ASP224,LEU225,THR226,LYS227,ILE228; Chain B:ASN206,GLU207,GLY209,SER210,LEU211,SER230,TYR240,PHE242",2.3,True,2
ASD02370000_4,pheA,Arthrobacter aurescens,A1R118,3MWB,ASD02170001,PHE,B,Lig,Inhibitor,(2S)-2-amino-3-phenyl-propanoic acid,311,Inner Protein Regulator,Protein-Protein Interaction,,The Crystal Structure of Prephenate dehydratase in complex with L-Phe from Arthrobacter aurescens to 2.0A,No,"Chain A:ASN226,LEU227,SER228,ARG229,ILE230; Chain B:LEU205,ASP208,HIS209,PRO210,GLY211,ALA212,LEU213,SER232,TYR242,PHE244",2.0,True,2
ASD02400000_9,Prkaca,Mus musculus,P05132,4DFX,ASD02400001,MYR,E,Lig,Activator,tetradecanoic acid,401,Inner Protein Regulator,Inner Protein,22617327,Role of N-terminal myristylation in the structure and regulation of cAMP-dependent protein kinase.,No,"Chain E:GLY1,ASN2,ALA3,ALA4,GLU11,SER14,PHE18,LEU19,PHE100,LEU152,GLU155,TYR156,ILE303,TYR306",1.35,True,1
ASD02400000_9,Prkaca,Mus musculus,P05132,4DFZ,ASD02400001,MYR,E,Lig,Activator,tetradecanoic acid,401,Inner Protein Regulator,Inner Protein,22617327,Role of N-terminal myristylation in the structure and regulation of cAMP-dependent protein kinase.,No,"Chain E:GLY1,ASN2,ALA3,ALA4,GLU11,SER14,PHE18,LEU19,PHE100,LEU152,GLU155,TYR156,ILE303,TYR306",2.0,True,1
ASD02470000_1,,Saccharomyces cerevisiae,P06169,2VK1,ASD00340002,PYR,A,Lig,Activator,PYRUVIC ACID,603,Inner Protein Regulator,Inner Protein,19246454,Covalently bound substrate at the regulatory site of yeast pyruvate decarboxylases triggers allosteric enzyme activation.,No,"Chain A:CYS222,ASP312,HIS313,PHE309,ALA287,SER311,HIS92,HIS310,CYS221,HIS225,VAL285,LEU288,ALA220,GLY286,MET326",1.71,True,1
ASD02470000_1,,Saccharomyces cerevisiae,P06169,2VK8,ASD02470003,2OP,A,Lig,Activator,(2S)-2-HYDROXYPROPANOIC ACID,1566,Inner Protein Regulator,Inner Protein,19246454,Covalently bound substrate at the regulatory site of yeast pyruvate decarboxylases triggers allosteric enzyme activation.,No,"Chain A:ASP312,PHE309,ALA287,SER311,HIS92,HIS310,CYS221,HIS225,VAL285,LEU288,ARG161,ALA220,GLY286,MET326",1.42,True,1
ASD02470000_3,,Kluyveromyces lactis,Q12629,2VJY,ASD02470009,ALK,A,Lig,Activator,(1R)-1-[DIHYDROXY(METHOXY)-LAMBDA^5^-PHOSPHANYL]ETHANOL,603,Inner Protein Regulator,Inner Protein,19246454,Covalently Bound Substrate at the Regulatory Site of Yeast Pyruvate Decarboxylases Triggers Allosteric Enzyme Activation.,No,"Chain A:CYS222,ASP312,TYR313,PHE309,ALA287,SER311,HIS92,HIS310,CYS221,HIS225,VAL285,LEU288,ARG161,ALA220,GLY286,MET326",2.3,True,1
ASD02500000_4,PKM,Oryctolagus cuniculus,P11974,2G50,ASD02500002,ALA,A,Lig,Regulator,L-alanine,6101,Inner Protein Regulator,Inner Protein,16634623,Differentiating a Ligand's Chemical Requirements for Allosteric Interactions from Those for Protein Binding. Phenylalanine Inhibition of Pyruvate Kinase.,No,"Chain A:GLY67,ILE46,ARG105,ARG42,PHE469,PRO470,HIS463,ASN69,THR44,TYR465,LEU464,ALA462,GLY45,ASN43,ILE468,GLY467",1.65,True,1
ASD02500000_4,PKM,Oryctolagus cuniculus,P11974,3N25,ASD03150001,PRO,A,Lig,Regulator,(2S)-pyrrolidine-2-carboxylic acid,1200,Inner Protein Regulator,Inner Protein,20629175,"The pyruvate kinase model system, a cautionary tale for the use of osmolyte perturbations to support conformational equilibria in allostery.",No,"Chain A:ARG42,ASN43,ASN69,ARG105,HIS463,TYR465,GLY467,ILE468,PHE469,PRO470",2.41,True,1
ASD02500000_8,PYK,Leishmania mexicana,Q27686,3HQP,ASD01120132,FDP,A,Lig,Activator,"[(2S,3S,4S,5R)-3,4-dihydroxy-2-(hydroxymethyl)-5-(phosphonooxymethyl)oxolan-2-yl] dihydrogen phosphate",700,Inner Protein Regulator,Inner Protein,20123988,The allosteric mechanism of pryuvate kinase from Leishmania mexicana: a rock and lock model,No,"Chain A:LEU399,SER400,ASN401,THR402,ARG404,SER405,LYS453,ARG456,HIS480,ALA481,VAL485,LYS486,GLY487,TYR488,ALA489",2.3,True,1
ASD02500000_9,PYK1,Trypanosoma brucei brucei,P30615,4HYV,ASD01120132,FDP,A,Lig,Activator,"[(2S,3S,4S,5R)-3,4-dihydroxy-2-(hydroxymethyl)-5-(phosphonooxymethyl)oxolan-2-yl] dihydrogen phosphate",1004,Inner Protein Regulator,Inner Protein,23999300,`In crystallo' substrate binding triggers major domain movements and reveals magnesium as a co-activator of Trypanosoma brucei pyruvate kinase.,No,"Chain A:LEU400,SER401,ASN402,THR403,ARG405,SER406,LYS454,ARG457,HIS481,ALA482,VAL486,LYS487,GLY488,TYR489,PRO490",2.3,True,1
ASD02500000_9,PYK1,Trypanosoma brucei brucei,P30615,4HYW,ASD01120132,FDP,A,Lig,Activator,"[(2S,3S,4S,5R)-3,4-dihydroxy-2-(hydroxymethyl)-5-(phosphonooxymethyl)oxolan-2-yl] dihydrogen phosphate",503,Inner Protein Regulator,Inner Protein,23999300,`In crystallo' substrate binding triggers major domain movements and reveals magnesium as a co-activator of Trypanosoma brucei pyruvate kinase.,No,"Chain A:LEU400,SER401,ASN402,THR403,ARG405,SER406,LYS454,ARG457,HIS481,ALA482,VAL486,LYS487,GLY488,TYR489,PRO490",2.35,True,1
ASD02510000_1,recA,Escherichia coli,P0A7G6,1XMS,ASD00498001,ANP,A,Lig,Regulator,"[[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]amino]phosphonic acid",400,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,15610008,Crystal structures of Escherichia coli RecA in complex with MgADP and MnAMP-PNP.,No,"Chain A:PRO67,GLU68,SER69,SER70,GLY71,LYS72,THR73,THR74,ASP100,TYR103,GLN194,SER240,ILE262,TYR264,GLY265",2.1,True,1
ASD02510000_1,recA,Escherichia coli,P0A7G6,1XMV,ASD01720027,ADP,A,Lig,Regulator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl phosphono hydrogen phosphate",400,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,15610008,Crystal structures of Escherichia coli RecA in complex with MgADP and MnAMP-PNP.,No,"Chain A:PRO67,GLU68,SER69,SER70,GLY71,LYS72,THR73,THR74,ASP100,TYR103,GLN194,SER240,ILE262,TYR264,GLY265",1.9,True,1
ASD02510000_1,recA,Escherichia coli,P0A7G6,3CMW,ASD01720027,ADP,A,Lig,Regulator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl phosphono hydrogen phosphate",502,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,18497818,Mechanism of homologous recombination from the RecA-ssDNA/dsDNA structures.,No,"Chain A:SER69,SER70,GLY71,LYS72,THR73,THR74,ASP100,TYR103,SER240,TYR264,ASN1249,LYS1250,ILE1251,ALA1252,ALA1253,PRO1254",2.8,True,1
ASD02520000_1,RCVRN,Bos taurus,P21457,4YI8,ASD11630001,CA,A,Ion,Activator,CALCIUM ION,301,Allosteric function,Allosteric position,26584024,Crystal Structure of Recoverin with Calcium Ions Bound to Both Functional EF Hands.,No,"Chain A:LEU81,ASP82,ALA75,GLU85,ASP74,PHE73,ASP78,ARG43,GLY79,ASN76,THR80,SER77",1.2,True,1
ASD02520000_1,RCVRN,Bos taurus,P21457,4YI8,ASD11630001,CA,A,Ion,Activator,CALCIUM ION,302,Allosteric function,Allosteric position,26584024,Crystal Structure of Recoverin with Calcium Ions Bound to Both Functional EF Hands.,No,"Chain A:GLU121,TYR109,ILE117,SER118,ASP112,VAL111,GLY113,ASN114,ASP110,THR116,GLY115",1.2,True,1
ASD02560000_1,gag-pol,Human immunodeficiency virus type 1,P04585,3AO2,ASD05062029,AVX,A,Lig,Inhibitor,"5-(7-bromo-1,3-benzodioxol-5-yl)-2-methyl-pyrazol-3-amine",1,Protein-Protein Interaction Regulator,Protein-Protein Interaction,21275048,Fragment-based design of ligands targeting a novel site on the integrase enzyme of human immunodeficiency virus 1,No,"Chain A:TYR83,TRP108,ASN184,HIS185,ARG187,SER195,GLY197,GLU198,VAL201; Chain B:GLY106,ARG107,TRP108,PRO109",1.8,True,2
ASD02560000_1,gag-pol,Human immunodeficiency virus type 1,P04585,3I0R,ASD02560079,RT3,A,Lig,Inhibitor,"S-[2-[(2-chloro-4-sulfamoyl-phenyl)amino]-2-oxo-ethyl] 6-methyl-3,4-dihydro-2H-quinoline-1-carbothioate",601,Inner Protein Regulator,Inner Protein,19631528,Substituted tetrahydroquinolines as potent allosteric inhibitors of reverse transcriptase and its key mutants.,No,"Chain A:LEU100,LYS101,LYS102,LYS103,LYS104,SER105,VAL106,VAL179,TYR181,TYR188,PRO225,TRP229,LEU234,HIS235,PRO236,TYR318",2.98,True,1
ASD02560000_1,gag-pol,Human immunodeficiency virus type 1,P04585,3I0S,ASD02560083,RT7,A,Lig,Inhibitor,"S-[2-[(2-chloro-4-sulfamoyl-phenyl)amino]-2-oxo-ethyl] 6,8-dichloro-3,4-dihydro-2H-quinoline-1-carbothioate",601,Inner Protein Regulator,Inner Protein,19631528,Substituted tetrahydroquinolines as potent allosteric inhibitors of reverse transcriptase and its key mutants.,No,"Chain A:LEU100,LYS101,LYS102,LYS103,LYS104,SER105,VAL106,VAL179,TYR181,TYR188,PRO225,PHE227,TRP229,LEU234,HIS235,PRO236,TYR318",2.7,True,1
ASD02580000_1,nrdA,Escherichia coli,P00452,5CNS,ASD00870004,DTP,A,Lig,Regulator,2'-DEOXYADENOSINE 5'-TRIPHOSPHATE,804,Allosteric function,Allosteric position,26754917,Molecular basis for allosteric specificity regulation in class Ia ribonucleotide reductase from Escherichia coli.,Yes,"Chain B:GLN250,GLY295,LYS246,GLN294,SER291,GLY296,CYS292,VAL248,SER249,SER293",2.975,True,1
ASD02580000_1,nrdA,Escherichia coli,P00452,5CNS,ASD00870004,DTP,A,Lig,Inhibitor,2'-DEOXYADENOSINE 5'-TRIPHOSPHATE,804,Allosteric Function,Allosteric Position,26754917,Molecular basis for allosteric specificity regulation in class Ia ribonucleotide reductase from Escherichia coli.,No,"Chain B:GLN250,GLY295,LYS246,GLN294,SER291,GLY296,CYS292,VAL248,SER249,SER293",2.975,True,1
ASD02580000_2,nrdJ,Thermotoga maritima,O33839,1XJE,ASD02040015,TTP,A,Lig,Regulator,"[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-pyrimidin-1-yl)oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",1005,Inner Protein Regulator,Protein-Protein Interaction,15475969,Structural mechanism of allosteric substrate specificity regulation in a ribonucleotide reductase.,No,"Chain A:ASP141,SER142,ILE143,ILE146,ARG171,VAL177,ALA178,GLY179,ALA184,SER185,PHE190; Chain B:LYS158,VAL200,VAL201,LYS202",1.9,True,2
ASD02580000_2,nrdJ,Thermotoga maritima,O33839,1XJF,ASD00870004,DTP,A,Lig,Regulator,"[[(2R,3S,5R)-5-(6-aminopurin-9-yl)-3-hydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",1002,Inner Protein Regulator,Protein-Protein Interaction,15475969,Structural mechanism of allosteric substrate specificity regulation in a ribonucleotide reductase.,No,"Chain A:ASP141,SER142,ILE143,ILE146,ARG171,VAL177,ALA178,GLY179,THR180,LYS183,ALA184,SER185,PHE190; Chain B:LYS158,VAL200,VAL201,LYS202",2.4,True,2
ASD02580000_2,nrdJ,Thermotoga maritima,O33839,1XJG,ASD00870004,DTP,A,Lig,Regulator,"[[(2R,3S,5R)-5-(6-aminopurin-9-yl)-3-hydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",1004,Inner Protein Regulator,Protein-Protein Interaction,15475969,Structural Mechanism of Allosteric Substrate Specificity Regulation in a Ribonucleotide Reductase,No,"Chain A:ASP141,SER142,ILE143,ILE146,ARG171,VAL177,ALA178,GLY179,THR180,LYS183,ALA184,SER185,PHE190; Chain B:LYS158,VAL200,VAL201,LYS202",2.5,True,2
ASD02580000_2,nrdJ,Thermotoga maritima,O33839,1XJJ,ASD09690001,DGT,A,Lig,Regulator,"[[(2R,3S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",1001,Inner Protein Regulator,Protein-Protein Interaction,15475969,Structural Mechanism of Allosteric Substrate Specificity Regulation in a Ribonucleotide Reductase,No,"Chain A:ASP141,SER142,ILE143,ILE146,ARG171,VAL177,ALA178,ALA184,SER185,PHE190; Chain B:HIS127,LYS158,VAL200,VAL201",1.86,True,2
ASD02580000_2,nrdJ,Thermotoga maritima,O33839,1XJK,ASD09690001,DGT,A,Lig,Regulator,"[[(2R,3S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",1003,Inner Protein Regulator,Protein-Protein Interaction,15475969,Structural mechanism of allosteric substrate specificity regulation in a ribonucleotide reductase.,No,"Chain A:ASP141,SER142,ILE143,ILE146,ARG171,VAL177,ALA178,ALA184,SER185,PHE190; Chain B:LYS158,VAL200,VAL201,GLN203",2.12,True,2
ASD02580000_2,nrdJ,Thermotoga maritima,O33839,1XJM,ASD02040015,TTP,A,Lig,Regulator,"[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-pyrimidin-1-yl)oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",1001,Inner Protein Regulator,Protein-Protein Interaction,15475969,Structural mechanism of allosteric substrate specificity regulation in a ribonucleotide reductase.,No,"Chain A:ASP141,SER142,ILE143,ILE146,ARG171,VAL177,ALA178,GLY179,THR180,ALA184,SER185,PHE190; Chain B:LYS158,VAL200,VAL201",2.4,True,2
ASD02580000_2,nrdJ,Thermotoga maritima,O33839,1XJN,ASD00870004,DTP,A,Lig,Regulator,"[[(2R,3S,5R)-5-(6-aminopurin-9-yl)-3-hydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",1005,Inner Protein Regulator,Protein-Protein Interaction,15475969,Structural Mechanism of Allosteric Substrate Specificity Regulation in a Ribonucleotide Reductase,No,"Chain A:ASP141,SER142,ILE143,ILE146,ARG171,VAL177,ALA178,ALA184,SER185,PHE190; Chain B:LYS158,VAL200,VAL201,LYS202",2.25,True,2
ASD02580000_2,nrdJ,Thermotoga maritima,O33839,3O0N,ASD02040015,TTP,A,Lig,Regulator,"[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-pyrimidin-1-yl)oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",1001,Inner Protein Regulator,Protein-Protein Interaction,20672854,Structural Basis for Adenosylcobalamin Activation in AdoCbl-Dependent Ribonucleotide Reductases.,No,"Chain A:ASP141,SER142,ILE143,ILE146,ARG171,VAL177,ALA178,GLY179,ALA184,SER185,PHE190; Chain B:LYS158,VAL200,VAL201,LYS202",1.95,True,2
ASD02580000_2,nrdJ,Thermotoga maritima,O33839,3O0O,ASD02040015,TTP,A,Lig,Regulator,"[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-pyrimidin-1-yl)oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",1001,Inner Protein Regulator,Protein-Protein Interaction,20672854,Structural Basis for Adenosylcobalamin Activation in AdoCbl-Dependent Ribonucleotide Reductases.,No,"Chain A:ASP141,SER142,ILE143,ILE146,LEU170,ARG171,PHE176,VAL177,ALA178,GLY179,ALA184,SER185,PHE190; Chain B:LYS158,VAL200,VAL201,LYS202",1.9,True,2
ASD02580000_2,nrdJ,Thermotoga maritima,O33839,3O0Q,ASD02040015,TTP,A,Lig,Regulator,"[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-pyrimidin-1-yl)oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",1001,Inner Protein Regulator,Protein-Protein Interaction,20672854,Structural Basis for Adenosylcobalamin Activation in AdoCbl-Dependent Ribonucleotide Reductases.,No,"Chain A:ASP141,SER142,ILE143,ILE146,ARG171,VAL177,ALA178,GLY179,ALA184,SER185,PHE190; Chain B:LYS158,VAL200,VAL201,LYS202",1.8,True,2
ASD02580000_3,nrdE,Salmonella typhimurium,Q08698,1PEQ,ASD02040015,TTP,A,Lig,Regulator,"[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-pyrimidin-1-yl)oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",716,Inner Protein Regulator,Protein-Protein Interaction,12818204,Structure of the large subunit of class Ib ribonucleotide reductase from Salmonella typhimurium and its complexes with allosteric effectors.,No,"Chain A:ASP185,ASN186,MET187,ILE190,LEU214,ARG215,ILE221,LYS222,SER228,SER229",2.8,True,1
ASD02580000_7,NRDD,Enterobacteria phage T4,P07071,1H78,ASD00900001,DCP,A,Lig,Regulator,"[(2R,3S,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3-hydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",1589,Inner Protein Regulator,Protein-Protein Interaction,11587648,Structural Basis for Allosteric Substrate Specificty Regulation in Anaerobic Ribonucleotide Reductase,No,"Chain A:GLN98,ILE99,GLU100,PRO102,LYS103,SER104,VAL107,ALA110,ILE111,GLN114,LYS146",2.5,True,1
ASD02580000_7,NRDD,Enterobacteria phage T4,P07071,1H79,ASD02040015,TTP,A,Lig,Regulator,"[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-pyrimidin-1-yl)oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",1586,Inner Protein Regulator,Protein-Protein Interaction,11587648,Structural Basis for Allosteric Substrate Specificty Regulation in Anaerobic Ribonucleotide Reductase,No,"Chain A:ILE99,GLU100,THR101,LYS103,VAL107,ALA110,ILE111,GLN114,LYS146",2.9,True,1
ASD02580000_7,NRDD,Enterobacteria phage T4,P07071,1H7A,ASD00870004,DTP,A,Lig,Regulator,"[[(2R,3S,5R)-5-(6-aminopurin-9-yl)-3-hydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",1590,Inner Protein Regulator,Protein-Protein Interaction,11587648,Structural Basis for Allosteric Substrate Specificty Regulation in Anaerobic Ribonucleotide Reductase,No,"Chain A:ILE99,GLU100,LYS103,SER104,VAL107,ILE111,GLN114,LYS146",2.75,True,1
ASD02580000_7,NRDD,Enterobacteria phage T4,P07071,1HK8,ASD09690001,DGT,A,Lig,Regulator,"[[(2R,3S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",1587,Inner Protein Regulator,Protein-Protein Interaction,12655046,A Metal-Binding Site in the Catalytic Subunit of Anaerobic Ribonucleotide Reductase.,No,"Chain A:ILE99,GLU100,THR101,PRO102,LYS103,VAL107,ALA110,ILE111,GLN114,LYS146",2.45,True,1
ASD02580000_8,RNR1,Saccharomyces cerevisiae,P21524,3RSR,ASD02580032,N5P,A,Lig,Regulator,[[5-(5-nitroindol-1-yl)-3-oxidanyl-oxolan-2-yl]methoxy-oxidanyl-phosphoryl] phosphono hydrogen phosphate,841,Inner Protein Regulator,Protein-Protein Interaction,22933704,Evaluating the therapeutic potential of a non-natural nucleotide that inhibits human ribonucleotide reductase.,No,"Chain A:ASP226,SER227,ILE228,ILE231,ILE255,ARG256,ILE262,ALA263,GLY264,THR265,SER269",2.3,True,1
ASD02580000_8,RNR1,Saccharomyces cerevisiae,P21524,3S87,ASD09690001,DGT,A,Lig,Regulator,"[[(2R,3S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",1001,Inner Protein Regulator,Protein-Protein Interaction,,Structural and biochemical basis of lethal mutant R293A of yeast ribonucleotide reductase,No,"Chain A:ASP226,SER227,ILE228,ILE231,ILE255,ARG256,ILE262,ALA263,GLY264,ASN270",2.25,True,1
ASD02580000_8,RNR1,Saccharomyces cerevisiae,P21524,3S8A,ASD09690001,DGT,A,Lig,Regulator,"[[(2R,3S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",1001,Inner Protein Regulator,Protein-Protein Interaction,,Structural and biochemical basis of lethal mutant R293A of yeast ribonucleotide reductase,No,"Chain A:ASP226,SER227,ILE228,ILE231,ARG256,ILE262,ALA263,GLY264,ASN270",2.9,True,1
ASD02580000_8,RNR1,Saccharomyces cerevisiae,P21524,3S8B,ASD00498001,ANP,A,Lig,Regulator,"[[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]amino]phosphonic acid",890,Inner Protein Regulator,Protein-Protein Interaction,,Structural and biochemical basis of lethal mutant R293A of yeast ribonucleotide reductase,No,"Chain A:ASP226,SER227,ILE228,ILE231,ARG256,ILE262,ALA263,SER269",2.8,True,1
ASD02580000_8,RNR1,Saccharomyces cerevisiae,P21524,3S8C,ASD00498001,ANP,A,Lig,Regulator,"[[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]amino]phosphonic acid",889,Inner Protein Regulator,Protein-Protein Interaction,,Structural and biochemical basis of lethal mutant R293A of yeast ribonucleotide reductase,No,"Chain A:ASP226,SER227,ILE228,ILE231,ARG256,ILE262,ALA263,ASN270",2.77,True,1
ASD02580000_8,RNR1,Saccharomyces cerevisiae,P21524,3TB9,ASD00498001,ANP,A,Lig,Regulator,"[[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]amino]phosphonic acid",890,Inner Protein Regulator,Protein-Protein Interaction,22465672,Role of Arginine 293 and Glutamine 288 in Communication between Catalytic and Allosteric Sites in Yeast Ribonucleotide Reductase.,No,"Chain A:ASP226,SER227,ILE228,ILE231,ARG256,ILE262,ALA263",2.53,True,1
ASD02580000_8,RNR1,Saccharomyces cerevisiae,P21524,3TBA,ASD09690001,DGT,A,Lig,Regulator,"[[(2R,3S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",890,Inner Protein Regulator,Protein-Protein Interaction,22465672,Role of Arginine 293 and Glutamine 288 in Communication between Catalytic and Allosteric Sites in Yeast Ribonucleotide Reductase.,No,"Chain A:ASP226,SER227,ILE228,ILE231,ARG256,ILE262,ALA263,GLY264",2.8,True,1
ASD02790000_1,,Arabidopsis thaliana,Q9S7B5,2C2B,ASD00350007;ASD00350007,SAM;SAM,A;A,Lig,Activator,S-ADENOSYLMETHIONINE;S-ADENOSYLMETHIONINE,500;501,Inner Protein Regulator,Inner Protein,16319072,Allosteric threonine synthase. Reorganization of the pyridoxal phosphate site upon asymmetric activation through S-adenosylmethionine binding to a novel site,No,"Chain B:ASP148,GLU137,LYS152,ARG426,PHE134,ASN132,SER131,GLN281,ASN147,TRP135,LEU133,PHE282,TRP150,LYS141,ASN130,ASP283",2.6,True,1
ASD02890000_3,kynA,Xanthomonas campestris pv. campestris,Q8PDA8,2NW8,ASD00320001,TRP,A,Lig,Activator,(2S)-2-amino-3-(1H-indol-3-yl)propanoic acid,308,Inner Protein Regulator,Protein-Protein Interaction,17197414,"Molecular insights into substrate recognition and catalysis by tryptophan 2,3-dioxygenase.",No,"Chain A:ARG85,LYS92,TYR220,SER221,GLU224,ASP225,ASP228",1.6,True,1
ASD02900000_1,trpA,Salmonella typhimurium,P00929,1BEU,ASD02900004,IPL,A,Lig,Regulator,3-(1H-indol-3-yl)propyl dihydrogen phosphate,273,Inner Protein Regulator,Inner Protein,9692955,Cryocrystallography and microspectrophotometry of a mutant (alpha D60N) tryptophan synthase alpha 2 beta 2 complex reveals allosteric roles of alpha Asp60.,Yes,"Chain A:PHE22,ALA59,ASN60,ILE64,LEU100,TYR102,ALA129,TYR175,GLY211,GLY213,ILE232,GLY234,SER235",1.9,True,1
ASD02900000_1,trpA,Salmonella typhimurium,P00929,1FUY,ASD02900013,FIP,A,Lig,Regulator,3-(5-fluoro-1H-indol-3-yl)propyl dihydrogen phosphate,269,Inner Protein Regulator,Inner Protein,11034989,Structural basis for the impaired channeling and allosteric inter-subunit communication in the beta A169L/beta C170W mutant of tryptophan synthase.,Yes,"Chain A:PHE22,ALA59,ASP60,ILE64,LEU100,TYR102,ALA129,ILE153,TYR175,THR183,GLY184,PHE212,GLY213,SER233,GLY234,SER235",2.25,True,1
ASD02900000_1,trpA,Salmonella typhimurium,P00929,1K3U,ASD02908006,IAD,A,Lig,Regulator,(2S)-2-[2-(1H-indol-3-yl)ethanoylamino]butanedioic acid,801,Inner Protein Regulator,Inner Protein,11756456,Crystal structures of a new class of allosteric effectors complexed to tryptophan synthase.,Yes,"Chain A:PHE22,ASP60,ILE64,LEU100,ILE153,TYR175,THR183,GLY184,GLY211,PHE212,GLY213,ILE214,ILE232,SER233,GLY234,SER235",1.7,True,1
ASD02900000_1,trpA,Salmonella typhimurium,P00929,1K7E,ASD02900001,IAG,A,Lig,Regulator,2-[2-(1H-indol-3-yl)ethanoylamino]ethanoic acid,401,Inner Protein Regulator,Inner Protein,11756456,Crystal structures of a new class of allosteric effectors complexed to tryptophan synthase.,Yes,"Chain A:PHE22,GLU49,ASP60,ILE64,LEU100,ILE153,TYR175,THR183,PHE212,GLY213,ILE232,GLY234,SER235",2.3,True,1
ASD02900000_1,trpA,Salmonella typhimurium,P00929,1K7F,ASD02908007,IAV,A,Lig,Regulator,(2S)-2-[2-(1H-indol-3-yl)ethanoylamino]-3-methyl-butanoic acid,401,Inner Protein Regulator,Inner Protein,11756456,Crystal structures of a new class of allosteric effectors complexed to tryptophan synthase.,Yes,"Chain A:PHE22,ALA59,ASP60,LEU100,TYR102,LEU127,ALA129,ILE153,TYR175,GLY211,PHE212,GLY213,GLY234,SER235",1.9,True,1
ASD02900000_1,trpA,Salmonella typhimurium,P00929,1K8Y,ASD02900028,13P,A,Lig,Regulator,(3-hydroxy-2-oxo-propyl) dihydrogen phosphate,701,Inner Protein Regulator,Inner Protein,11756454,Crystal structure of the beta Ser178--> Pro mutant of tryptophan synthase.,Yes,"Chain A:PHE22,GLU49,ILE64,LEU100,TYR175,PHE212,GLY213,SER233,GLY234,SER235",1.5,True,1
ASD02900000_1,trpA,Salmonella typhimurium,P00929,1K8Z,ASD02900001,IAG,A,Lig,Regulator,2-[2-(1H-indol-3-yl)ethanoylamino]ethanoic acid,501,Inner Protein Regulator,Inner Protein,11756454,Crystal structure of the beta Ser178--> Pro mutant of tryptophan synthase. A,Yes,"Chain A:PHE22,GLU49,ALA59,ASP60,ILE64,LEU100,ILE153,TYR175,PHE212,ILE232,GLY234,SER235",1.7,True,1
ASD02900000_1,trpA,Salmonella typhimurium,P00929,1KFB,ASD02900006,IGP,A,Lig,Regulator,"[(2R,3S)-2,3-dihydroxy-3-(1H-indol-3-yl)propyl] dihydrogen phosphate",550,Inner Protein Regulator,Inner Protein,12460570,On the Role of alphaTHR183 in the Allosteric Regulation and Catalytic Mechanism of Tryptophan Synthase,Yes,"Chain A:PHE22,GLU49,ALA59,ASP60,LEU100,TYR102,ALA129,ILE153,TYR175,PHE212,GLY213,SER233,GLY234,SER235",1.9,True,1
ASD02900000_1,trpA,Salmonella typhimurium,P00929,1KFC,ASD02900004,IPL,A,Lig,Regulator,3-(1H-indol-3-yl)propyl dihydrogen phosphate,674,Inner Protein Regulator,Inner Protein,12460570,On the Role of AlphaTHR183 in the Allosteric Regulation and Catalytic Mechanism of Tryptophan Synthase,Yes,"Chain A:PHE22,ALA59,ASP60,LEU100,ALA129,ILE153,TYR175,PHE212,GLY213,ILE232,SER233,GLY234,SER235",1.5,True,1
ASD02900000_1,trpA,Salmonella typhimurium,P00929,1TJP,ASD02900027,HPF,A,Lig,Regulator,"[(2R,3R)-2,3-dihydroxy-3-[(2-hydroxyphenyl)amino]propyl] dihydrogen phosphate",1001,Inner Protein Regulator,Inner Protein,16120446,"On the structural basis of the catalytic mechanism and the regulation of the alpha subunit of tryptophan synthase from Salmonella typhimurium and BX1 from maize, two evolutionarily related enzymes.",Yes,"Chain A:PHE22,GLU49,ALA59,ASP60,ILE64,LEU100,TYR175,THR183,GLY184,PHE212,GLY213,ILE232,SER233,GLY234,SER235",1.5,True,1
ASD02900000_1,trpA,Salmonella typhimurium,P00929,2CLE,ASD02908001,F6F,A,Lig,Regulator,2-[[4-(trifluoromethoxy)phenyl]carbonylamino]ethyl dihydrogen phosphate,1268,Inner Protein Regulator,Inner Protein,17559195,Synthesis and Characterization of Allosteric Probes of Substrate Channeling in the Tryptophan Synthase Bienzyme Complex.,Yes,"Chain A:GLU49,ALA59,ASP60,LEU100,ALA129,ILE153,TYR175,PHE212,GLY213,ILE232,GLY234,SER235; Chain B:PRO18",1.5,True,2
ASD02900000_1,trpA,Salmonella typhimurium,P00929,2CLF,ASD02908001,F6F,A,Lig,Regulator,2-[[4-(trifluoromethoxy)phenyl]carbonylamino]ethyl dihydrogen phosphate,1269,Inner Protein Regulator,Inner Protein,17559195,Synthesis and Characterization of Allosteric Probes of Substrate Channeling in the Tryptophan Synthase Bienzyme Complex.,Yes,"Chain A:GLU49,ALA59,ASP60,LEU100,LEU127,ALA129,ILE153,TYR175,PHE212,GLY213,ILE232,GLY234,SER235; Chain B:PRO18",1.7,True,2
ASD02900000_1,trpA,Salmonella typhimurium,P00929,2CLH,ASD02900010,F19,A,Lig,Regulator,2-(naphthalen-2-ylsulfonylamino)ethyl dihydrogen phosphate,1268,Inner Protein Regulator,Inner Protein,17559195,Synthesis and Characterization of Allosteric Probes of Substrate Channeling in the Tryptophan Synthase Bienzyme Complex.,Yes,"Chain A:PHE22,GLU49,ALA59,ASP60,LEU100,LEU127,ALA129,ILE153,TYR175,THR183,GLY184,PHE212,GLY213,ILE232,SER233,GLY234,SER235",1.7,True,1
ASD02900000_1,trpA,Salmonella typhimurium,P00929,2CLI,ASD02900008,F9F,A,Lig,Regulator,2-[[4-(trifluoromethoxy)phenyl]sulfonylamino]ethyl dihydrogen phosphate,1269,Inner Protein Regulator,Inner Protein,17559195,Synthesis and Characterization of Allosteric Probes of Substrate Channeling in the Tryptophan Synthase Bienzyme Complex.,Yes,"Chain A:PHE22,GLU49,ALA59,LEU100,LEU127,ALA129,ILE153,TYR175,THR183,GLY184,PHE212,GLY213,ILE232,SER233,GLY234,SER235; Chain B:PRO18",1.7,True,2
ASD02900000_1,trpA,Salmonella typhimurium,P00929,2CLK,ASD02900029,G3H,A,Lig,Regulator,[(2R)-2-hydroxy-3-oxo-propyl] dihydrogen phosphate,1268,Inner Protein Regulator,Inner Protein,17559195,Synthesis and Characterization of Allosteric Probes of Substrate Channeling in the Tryptophan Synthase Bienzyme Complex.,Yes,"Chain A:PHE22,ILE64,LEU100,TYR175,THR183,GLY184,PHE212,GLY213,ILE232,SER233,GLY234,SER235",1.5,True,1
ASD02900000_1,trpA,Salmonella typhimurium,P00929,2CLL,ASD02900008,F9F,A,Lig,Regulator,2-[[4-(trifluoromethoxy)phenyl]sulfonylamino]ethyl dihydrogen phosphate,1268,Inner Protein Regulator,Inner Protein,17559232,Allosteric Regulation of Substrate Channeling in Tryptophan Synthase: Modulation of the L-Serine Reaction in Stage I of the Beta-Reaction by Alpha-Site Ligands.,Yes,"Chain A:PHE22,GLU49,ALA59,ASP60,ILE64,LEU100,LEU127,ALA129,ILE153,TYR175,THR183,GLY184,PHE212,GLY213,ILE232,SER233,GLY234,SER235; Chain B:PRO18",1.6,True,2
ASD02900000_1,trpA,Salmonella typhimurium,P00929,2CLM,ASD02908001,F6F,A,Lig,Regulator,2-[[4-(trifluoromethoxy)phenyl]carbonylamino]ethyl dihydrogen phosphate,1268,Inner Protein Regulator,Inner Protein,17559232,Allosteric Regulation of Substrate Channeling in Tryptophan Synthase: Modulation of the L-Serine Reaction in Stage I of the Beta-Reaction by Alpha-Site Ligands.,Yes,"Chain A:GLU49,ALA59,ASP60,ILE64,LEU100,ALA129,ILE153,TYR175,PHE212,GLY213,GLY234,SER235; Chain B:PRO18",1.51,True,2
ASD02900000_1,trpA,Salmonella typhimurium,P00929,2CLO,ASD02900010,F19,A,Lig,Regulator,2-(naphthalen-2-ylsulfonylamino)ethyl dihydrogen phosphate,1268,Inner Protein Regulator,Inner Protein,17559232,Allosteric Regulation of Substrate Channeling in Tryptophan Synthase: Modulation of the L-Serine Reaction in Stage I of the Beta-Reaction by Alpha-Site Ligands.,Yes,"Chain A:PHE22,GLU49,ALA59,ASP60,LEU100,LEU127,ALA129,ILE153,TYR175,THR183,GLY184,PHE212,GLY213,ILE232,GLY234,SER235",1.5,True,1
ASD02900000_1,trpA,Salmonella typhimurium,P00929,2J9X,ASD02908005,G3P,A,Lig,Regulator,"[(2R)-2,3-dihydroxypropyl] dihydrogen phosphate",1268,Inner Protein Regulator,Inner Protein,17559232,Allosteric Regulation of Substrate Channeling in Tryptophan Synthase: Modulation of the L-Serine Reaction in Stage I of the Beta-Reaction by Alpha-Site Ligands.,Yes,"Chain A:PHE22,ILE64,LEU100,TYR175,THR183,GLY184,PHE212,GLY213,ILE232,GLY234,SER235",1.9,True,1
ASD02900000_1,trpA,Salmonella typhimurium,P00929,2RH9,ASD02900006,IGP,A,Lig,Regulator,"[(2R,3S)-2,3-dihydroxy-3-(1H-indol-3-yl)propyl] dihydrogen phosphate",269,Inner Protein Regulator,Inner Protein,,"Tryptophan synthase complexed with IGP, internal aldimine, pH 9.0.",Yes,"Chain A:PHE22,GLU49,ALA59,ASP60,ILE64,LEU100,ALA129,ILE153,TYR175,PHE212,GLY213,ILE232,SER233,GLY234,SER235",1.7,True,1
ASD02900000_1,trpA,Salmonella typhimurium,P00929,3CEP,ASD02908005,G3P,A,Lig,Regulator,"[(2R)-2,3-dihydroxypropyl] dihydrogen phosphate",269,Inner Protein Regulator,Inner Protein,18351684,Structure and mechanistic implications of a tryptophan synthase quinonoid intermediate.,Yes,"Chain A:GLU49,ILE64,TYR175,THR183,GLY184,PHE212,GLY213,ILE232,GLY234,SER235",2.1,True,1
ASD02900000_1,trpA,Salmonella typhimurium,P00929,4HN4,ASD02900008,F9F,A,Lig,Regulator,2-[[4-(trifluoromethoxy)phenyl]sulfonylamino]ethyl dihydrogen phosphate,301,Inner Protein Regulator,Inner Protein,23952479,Allostery and substrate channeling in the tryptophan synthase bienzyme complex: evidence for two subunit conformations and four quaternary states.,Yes,"Chain A:PHE22,GLU49,ALA59,ILE64,LEU100,LEU127,ALA129,ILE153,TYR175,ARG179,THR183,GLY184,PHE212,GLY213,ILE232,SER233,GLY234,SER235; Chain B:PRO18",1.64,True,2
ASD02900000_1,trpA,Salmonella typhimurium,P00929,4HPJ,ASD02900008,F9F,A,Lig,Regulator,2-[[4-(trifluoromethoxy)phenyl]sulfonylamino]ethyl dihydrogen phosphate,301,Inner Protein Regulator,Inner Protein,23952479,Allostery and substrate channeling in the tryptophan synthase bienzyme complex: evidence for two subunit conformations and four quaternary states.,Yes,"Chain A:PHE22,GLU49,ALA59,ILE64,LEU100,LEU127,ALA129,ILE153,TYR175,THR183,GLY184,PHE212,GLY213,ILE232,SER233,GLY234,SER235; Chain B:PRO18",1.45,True,2
ASD02900000_1,trpA,Salmonella typhimurium,P00929,4HPX,ASD02900008,F9F,A,Lig,Regulator,2-[[4-(trifluoromethoxy)phenyl]sulfonylamino]ethyl dihydrogen phosphate,301,Inner Protein Regulator,Inner Protein,23952479,Allostery and substrate channeling in the tryptophan synthase bienzyme complex: evidence for two subunit conformations and four quaternary states.,Yes,"Chain A:PHE22,GLU49,ALA59,ILE64,LEU100,LEU127,ALA129,ILE153,TYR175,THR183,GLY184,PHE212,GLY213,ILE232,SER233,GLY234,SER235; Chain B:PRO18",1.65,True,2
ASD02900000_1,trpA,Salmonella typhimurium,P00929,4HT3,ASD02900008,F9F,A,Lig,Regulator,2-[[4-(trifluoromethoxy)phenyl]sulfonylamino]ethyl dihydrogen phosphate,301,Inner Protein Regulator,Inner Protein,23952479,Allostery and substrate channeling in the tryptophan synthase bienzyme complex: evidence for two subunit conformations and four quaternary states.,Yes,"Chain A:PHE22,GLU49,ALA59,ILE64,LEU100,LEU127,ALA129,ILE153,TYR175,LEU177,THR183,GLY184,PHE212,GLY213,ILE232,SER233,GLY234,SER235; Chain B:PRO18",1.3,True,2
ASD02900000_1,trpA,Salmonella typhimurium,P00929,4KKX,ASD02908001,F6F,A,Lig,Regulator,2-[[4-(trifluoromethoxy)phenyl]carbonylamino]ethyl dihydrogen phosphate,301,Inner Protein Regulator,Inner Protein,23952479,Allostery and substrate channeling in the tryptophan synthase bienzyme complex: evidence for two subunit conformations and four quaternary states.,Yes,"Chain A:PHE22,GLU49,ALA59,ILE64,LEU100,LEU127,ALA129,ILE153,TYR175,THR183,GLY184,PHE212,GLY213,GLY234,SER235; Chain B:PRO18",1.77,True,2
ASD02900000_2,trpB,Salmonella typhimurium,P0A2K1,4WX2,ASD02908001,F6F,"A,B",Lig,,2-{[4-(TRIFLUOROMETHOXY)BENZOYL]AMINO}ETHYL DIHYDROGEN PHOSPHATE,"301A,302A,404B",Protein-Protein Interaction,Protein-Protein Interaction,26708480,Visualizing the tunnel in tryptophan synthase with crystallography: Insights into a selective filter for accommodating indole and rejecting water.,Yes,"Chain B:ASP176,ASN171,GLY193,SER178,CYS170,ALA192,LYS87,TYR186,TYR279,GLY281,PRO194,GLY233,GLY113,THR110,MET282,GLY303,THR190,ILE20,ALA112,GLY116,GLN19,LEU188,LEU174,ALA302,LEU21,GLU109,GLY189,GLY111,PHE306,PHE280,HIS115,PRO18,LEU166,GLN114,ARG175,VAL17",1.75,True,1
ASD02910000_1,trpS,Bacillus stearothermophilus,P00953,1I6K,ASD02910001,TYM,A,Lig,Regulator,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] (2S)-2-amino-3-(1H-indol-3-yl)propanoate",350,Protein-DNA/RNA Interaction Regulator,Inner Protein,11679724,High-resolution experimental phases for tryptophanyl-tRNA synthetase (TrpRS) complexed with tryptophanyl-5'AMP.,Yes,"Chain A:PHE5,SER6,GLY7,ILE8,GLN9,GLY17,ASN18,GLY21,ALA22,VAL40,HIS43,TYR125,ASP132,ILE133,VAL141,VAL143,GLY144,ASP146,GLN147,GLY180,ALA181,ARG182,ILE183,LYS192",1.72,True,1
ASD02910000_1,trpS,Bacillus stearothermophilus,P00953,1I6L,ASD02910001,TYM,A,Lig,Regulator,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] (2S)-2-amino-3-(1H-indol-3-yl)propanoate",350,Protein-DNA/RNA Interaction Regulator,Inner Protein,11679724,High-resolution experimental phases for tryptophanyl-tRNA synthetase (TrpRS) complexed with tryptophanyl-5'AMP.,Yes,"Chain A:PHE5,SER6,GLY7,ILE8,GLN9,GLY17,ASN18,GLY21,ALA22,VAL40,HIS43,TYR125,ASP132,ILE133,VAL141,VAL143,GLY144,ASP146,GLN147,GLY180,ALA181,ARG182,ILE183,LYS192,LYS195",1.72,True,1
ASD02910000_1,trpS,Bacillus stearothermophilus,P00953,1I6M,ASD02910001,TYM,A,Lig,Regulator,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] (2S)-2-amino-3-(1H-indol-3-yl)propanoate",350,Protein-DNA/RNA Interaction Regulator,Inner Protein,11679724,High-resolution experimental phases for tryptophanyl-tRNA synthetase (TrpRS) complexed with tryptophanyl-5'AMP.,Yes,"Chain A:PHE5,SER6,GLY7,ILE8,GLN9,GLY17,ASN18,GLY21,ALA22,VAL40,HIS43,TYR125,MET129,ASP132,ILE133,VAL141,VAL143,GLY144,ASP146,GLN147,GLY180,ALA181,ARG182,ILE183,LYS192,MET193,LYS195",1.72,True,1
ASD02910000_1,trpS,Bacillus stearothermophilus,P00953,1M83,ASD00150001,ATP,A,Lig,Regulator,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",400,Protein-DNA/RNA Interaction Regulator,Inner Protein,12473451,"Interconversion of ATP binding and conformational free energies by tryptophanyl-tRNA synthetase: structures of ATP bound to open and closed, pre-transition-state conformations.",Yes,"Chain A:GLY7,ILE8,GLN9,SER11,GLY17,ASN18,GLY21,ALA22,LYS111,VAL143,GLY144,ASP146,GLN147,GLY180,ALA181,ARG182,ILE183,LYS192,MET193,SER194,LYS195,SER196",2.2,True,1
ASD02910000_1,trpS,Bacillus stearothermophilus,P00953,1MAU,ASD00150001,ATP,A,Lig,Regulator,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",400,Protein-DNA/RNA Interaction Regulator,Inner Protein,12473451,"Interconversion of ATP binding and conformational free energies by tryptophanyl-tRNA synthetase: structures of ATP bound to open and closed, pre-transition-state conformations.",Yes,"Chain A:GLY7,ILE8,GLN9,SER11,GLY17,ASN18,GLY21,ALA22,LYS111,VAL143,GLY144,ASP146,GLN147,GLY180,ALA181,ARG182,ILE183,LYS192,MET193,SER194,LYS195,SER196",2.15,True,1
ASD02910000_1,trpS,Bacillus stearothermophilus,P00953,2OV4,ASD02910002,AQP,A,Lig,Regulator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl [hydroxy-(hydroxy-phosphonooxy-phosphoryl)oxy-phosphoryl] hydrogen phosphate",400,Protein-DNA/RNA Interaction Regulator,Inner Protein,17428498,Crystal Structure of Tryptophanyl-tRNA Synthetase Complexed with Adenosine-5' Tetraphosphate: Evidence for Distributed Use of Catalytic Binding Energy in Amino Acid Activation by Class I Aminoacyl-tRNA Synthetases.,Yes,"Chain A:GLY7,ILE8,GLN9,SER11,GLY17,ASN18,GLY21,ALA22,LYS111,VAL143,GLY144,ASP146,GLN147,GLY180,ALA181,ARG182,ILE183,LYS192,MET193,SER194,LYS195,SER196",2.5,True,1
ASD02910000_1,trpS,Bacillus stearothermophilus,P00953,3FHJ,ASD00030001,AMP,A,Lig,Regulator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",1003,Protein-DNA/RNA Interaction Regulator,Inner Protein,19174517,Independent saturation of three TrpRS subsites generates a partially assembled state similar to those observed in molecular simulations.,Yes,"Chain A:GLY17,ASN18,GLY21,ALA22,PRO142,ASP146,ILE176,ALA181,ARG182,ILE183,LYS192,MET193",2.65,True,1
ASD02910000_1,trpS,Bacillus stearothermophilus,P00953,3FI0,ASD00030001,AMP,A,Lig,Regulator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",1003,Protein-DNA/RNA Interaction Regulator,Inner Protein,19174517,Independent saturation of three TrpRS subsites generates a partially assembled state similar to those observed in molecular simulations.,Yes,"Chain A:GLY17,ASN18,GLY21,ALA22,PRO142,ASP146,ILE176,ARG182,ILE183,LYS192",2.7,True,1
ASD02980000_2,BA_5509,Bacillus anthracis,Q81K32,3BEO,ASD10298001,UD1,A,Lig,Activator,"[[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-hydroxy-phosphoryl] [(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl hydrogen phosphate",372,Inner Protein Regulator,Inner Protein,18188181,A structural basis for the allosteric regulation of non-hydrolysing UDP-GlcNAc 2-epimerases.,Yes,"Chain A:PRO15,GLN43,HIS44,ARG45,GLN46,MET47,MET66,LYS67,ASP68,ARG69,GLN70,LEU72,ILE75,THR101,THR102,PRO135,GLU136,HIS209,ARG210,ARG211,HIS242,MET243,ASN244,PRO245",1.7,True,1
ASD02980000_4,wecB,Methanocaldococcus jannaschii,Q58899,4NES,ASD10298001,UD1,A,Lig,Activator,"[[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-hydroxy-phosphoryl] [(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl hydrogen phosphate",400,Inner Protein Regulator,Inner Protein,,Crystal structures of the archaeal UDP-GlcNAc 2-epimerase from Methanocaldococcus jannaschii reveal a conformational change induced by UDP-GlcNAc.,Yes,"Chain A:THR9,PRO11,GLN37,HIS38,TYR39,SER40,SER64,HIS67,GLN70,THR96,ASN97,GLU129,HIS207,ARG208,HIS241,PRO242,ARG243,LYS246",1.42,True,1
ASD02980000_5,mnaA,Bacillus subtilis,P39131,4FKZ,ASD10298001,UD1,A,Lig,Activator,"[[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-hydroxy-phosphoryl] [(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl hydrogen phosphate",401,Inner Protein Regulator,Inner Protein,,Crystal structure of Bacillus subtilis UDP-GlcNAc 2-epimerase in complex with UDP-GlcNAc and UDP,Yes,"Chain A:PRO14,GLN41,HIS42,ARG43,GLN44,MET45,MET64,LYS65,GLU66,ARG67,GLN68,LEU70,ILE73,THR99,THR100,PRO133,GLU134,HIS207,ARG208,ARG209,HIS240,LEU241,ASN242,PRO243",1.69,True,1
ASD02990000_1,pyrH1,Bacillus anthracis,Q81S73,2JJX,ASD00150001,ATP,A,Lig,Regulator,"adenosine 5'-(tetrahydrogen triphosphate) [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",1246,Inner Protein Regulator,Protein-Protein Interaction,18625239,The Crystal Structure of Ump Kinase from Bacillus Anthracis (Ba1797) Reveals an Allosteric Nucleotide-Binding Site.,No,"Chain B:HIS120,ILE114,ARG117,ASN124,LEU116",2.82,True,1
ASD02990000_2,pyrH,Escherichia coli,P0A7E9,2V4Y,ASD00290006,GTP,A,Lig,Activator,"[[(2R,3S,4R,5R)-5-(2-azanyl-6-oxidanylidene-1H-purin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] phosphono hydrogen phosphate",1242,Inner Protein Regulator,Protein-Protein Interaction,18945668,Structural and Functional Characterization of Escherichia Coli Ump Kinase in Complex with its Allosteric Regulator GTP.,No,"Chain A:ARG92,ASP93,HIS96,ASN101,ALA102,ARG103,ARG130; Chain E:TRP119,ALA120,ILE123,SER124,ARG127; Chain F:ASN72,VAL75",2.8,True,3
ASD02990000_3,pyrH,Xanthomonas campestris pv. campestris,P59009,3EK5,ASD00290006,GTP,E,Lig,Activator,"[[(2R,3S,4R,5R)-5-(2-azanyl-6-oxidanylidene-1H-purin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] phosphono hydrogen phosphate",2006,Inner Protein Regulator,Protein-Protein Interaction,19059268,Unique GTP-Binding Pocket and Allostery of Uridylate Kinase from a Gram-Negative Phytopathogenic Bacterium,No,"Chain D:ILE115,ARG117,ARG118,ARG121,LYS125; Chain E:LYS98,ARG100,ASN108,ASP109,VAL110,CYS111,GLU112,ARG118,LYS125,ARG127",2.56,True,2
ASD02990000_4,pyrH,Mycobacterium tuberculosis,P9WHK5,3NWY,ASD00290006,GTP,A,Lig,Activator,"[[(2R,3S,4R,5R)-5-(2-azanyl-6-oxidanylidene-1H-purin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] phosphono hydrogen phosphate",262,Inner Protein Regulator,Protein-Protein Interaction,21149268,Structural and functional characterization of the Mycobacterium tuberculosis uridine monophosphate kinase: insights into the allosteric regulation.,No,"Chain A:ARG123,GLY131,GLN132,ALA134,GLU135,PRO136,ARG141,HIS145,LYS148,ARG150; Chain D:LEU138,LEU140,ARG141,ARG144",2.54,True,2
ASD02990000_5,pyrH,Helicobacter pylori,P56106,4A7W,ASD00290006,GTP,A,Lig,Activator,"[[(2R,3S,4R,5R)-5-(2-azanyl-6-oxidanylidene-1H-purin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] phosphono hydrogen phosphate",1241,Inner Protein Regulator,Protein-Protein Interaction,22751662,Structures of Helicobacter Pylori Uridylate Kinase: Insight Into Release of the Product Udp,No,"Chain A:ARG102,LYS110,GLU111,ILE112,CYS113,GLU114,LYS120,ARG123,HIS124,LYS127,ARG129",1.8,True,1
ASD03000000_1,upp,Sulfolobus solfataricus,Q980Q4,1VST,ASD00290006,GTP,A,Lig,Activator,"[[(2R,3S,4R,5R)-5-(2-azanyl-6-oxidanylidene-1H-purin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] phosphono hydrogen phosphate",301,Inner Protein Regulator,Protein-Protein Interaction,19683539,Structural and kinetic studies of the allosteric transition in Sulfolobus solfataricus uracil phosphoribosyltransferase: Permanent activation by engineering of the C-terminus.,No,"Chain A:LYS30,ARG34,ARG37",2.8,True,1
ASD03000000_1,upp,Sulfolobus solfataricus,Q980Q4,1XTU,ASD00150003;ASD00150003;ASD00150003;ASD00150003,CTP;CTP;CTP;CTP,A;D;E;H,Lig;Lig;Lig;Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",1260;4260;5260;8260,Inner Protein Regulator,Protein-Protein Interaction,15654744,Allosteric regulation and communication between subunits in uracil phosphoribosyltransferase from Sulfolobus solfataricus.,No,"Chain A:ARG29,LYS30,VAL33,ARG37,GLU87,LYS91; Chain E:ARG37,LYS91; Chain H:GLU87,LEU90,LYS91,PHE93,PRO94,ALA96",2.8,True,3
ASD03000000_1,upp,Sulfolobus solfataricus,Q980Q4,3G6W,ASD00290006;ASD00290006;ASD00290006;ASD00290006,GTP;GTP;GTP;GTP,A;B;D;D,Lig;Lig;Lig;Lig,Activator,"[[(2R,3S,4R,5R)-5-(2-azanyl-6-oxidanylidene-1H-purin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] phosphono hydrogen phosphate",301;301;217;301,Inner Protein Regulator,Protein-Protein Interaction,19683539,Structural and kinetic studies of the allosteric transition in Sulfolobus solfataricus uracil phosphoribosyltransferase: Permanent activation by engineering of the C-terminus.,No,"Chain A:LYS30,ARG34,ARG37; Chain B:ARG37,LYS91,PRO94; Chain D:ILE26,ASN27,LYS30,ARG34",2.9,True,3
ASD03000000_2,uprt,Toxoplasma gondii,Q26998,1JLR,ASD00290006,GTP,A,Lig,Activator,"[[(2R,3S,4R,5R)-5-(2-azanyl-6-oxidanylidene-1H-purin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] phosphono hydrogen phosphate",303,Inner Protein Regulator,Protein-Protein Interaction,11773618,The structural mechanism of GTP stabilized oligomerization and catalytic activation of the Toxoplasma gondii uracil phosphoribosyltransferase.,No,"Chain A:LEU78,PHE101,SER103,LYS104,ILE105,VAL124,CYS125,ARG129,ARG158; Chain C:GLN44,TYR65,ARG68; Chain D:LYS59",2.45,True,3
ASD03140000_1,bla,Escherichia coli,P62593,1PZO,ASD03140002;ASD03140002,CBT;CBT,A;A,Lig,Inhibitor,"N,N-bis[(4-chlorophenyl)methyl]-2H-1,2,3,4-tetrazol-5-amine",300;301,Inner Protein Regulator,Inner Protein,15037085,Allosteric inhibition through core disruption.,Yes,"Chain A:VAL216,ALA217,LEU220,LEU221,ALA224,SER235,GLY236,ALA237,ARG244,GLY245,ILE246,VAL261,ILE263,ASN276,ILE279,ALA280,GLY283,LEU286",1.9,True,1
ASD03140000_1,bla,Escherichia coli,P62593,1PZP,ASD03140005,FTA,A,Lig,Inhibitor,"(Z)-3-[(4-phenylazanylphenyl)amino]-2-(2H-1,2,3,4-tetrazol-5-yl)prop-2-enenitrile",300,Inner Protein Regulator,Inner Protein,15037085,Allosteric inhibition through core disruption.,Yes,"Chain A:LEU221,ALA224,LEU225,LEU250,VAL261,ILE263,ALA280,GLY283,ALA284,ILE287",1.45,True,1
ASD03160000_2,ADORA2A,Escherichia coli,P0ABE7,4EIY,ASD03160008,,A,Ion,Inhibitor,sodium(+1) cation,2402,Inner Protein Regulator,Inner Protein,22798613,Structural basis for allosteric regulation of GPCRs by sodium ions.,No,"Chain A:ASP52,SER91,ASN280",1.8,True,1
ASD03160000_2,GRM1,Escherichia coli,P0ABE7,4N6H,ASD03160008,,A,Ion,Inhibitor,sodium(+1) cation,1220,Inner Protein Regulator,Inner Protein,24413399,Molecular control of delta-opioid receptor signalling.,No,"Chain A:ASP95,ASN131,SER135",1.8,True,1
ASD03160000_2,GRM1,Escherichia coli,P0ABE7,4OR2,ASD01870242,FM9,A,Lig,Inhibitor,"4-fluoranyl-N-methyl-N-[4-[6-(propan-2-ylamino)pyrimidin-4-yl]-1,3-thiazol-2-yl]benzamide",1901,Inner Protein Regulator,Inner Protein,24603153,Structure of a class C GPCR metabotropic glutamate receptor 1 bound to an allosteric modulator,No,"Chain A:LEU648,GLN660,ARG661,VAL664,GLY665,SER668,THR748,VAL753,PRO756,LEU757,ASN760,THR794,ILE797,TRP798,PHE801,TYR805,LYS811,ILE812,THR815,ALA818,SER822",2.8,True,1
ASD03160000_2,cybC,Escherichia coli,P0ABE7,5L32,ASD01310003,ZN,A,Ion,Regulator,ZINC ION,203,Allosteric Function,Allosteric Position,27649076,De Novo Design of an Allosteric Metalloprotein Assembly with Strained Disulfide Bonds.,No,"Chain D:HIS77,LEU78,ASP74",2.1,True,1
ASD03160000_2,cybC,Escherichia coli,P0ABE7,5WIV,ASD03160008,,A,Ion,Regulator,SODIUM ION,1224,Allosteric function,Allosteric position,29051383,D4 dopamine receptor high-resolution structures enable the discovery of selective agonists.,No,"Chain A:ASP80,LEU118,PHE403,ALA79,TRP407,LEU76,LEU83,SER441,SER122,CYS119,ASN440",2.143,True,1
ASD03160000_2,cybC,Escherichia coli,P0ABE7,6C1Q,ASD03160010,9P2,B,Lig,Inhibitor,"1-(1,3-benzodioxol-5-yl)-~{N}-(1,3-benzodioxol-5-ylmethyl)-~{N}-[(3-butyl-2,5-diphenyl-imidazol-4-yl)methyl]methanamine",501,Allosteric function,Allosteric position,29867214,Orthosteric and allosteric action of the C5a receptor antagonists.,No,Chain B:PRO300,2.9,True,1
ASD03160000_2,cybC,Escherichia coli,P0ABE7,6C1R,ASD03160012,EFD,B,Lig,Inhibitor,"(2R,3S)-2-[4-(cyclopentylamino)phenyl]-1-(2-fluoro-6-methylbenzene-1-carbonyl)-N-[4-methyl-3-(trifluoromethyl)phenyl]piperidine-3-carboxamide",501,Allosteric function,Allosteric position,29867214,Orthosteric and allosteric action of the C5a receptor antagonists.,No,Chain B:TRP299,2.2,True,1
ASD03310000_1,SRN,Bos taurus,P00669,11BG,ASD03310002,U2G,A,Lig,Activator,"[(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl [(2R,3R,4R,5R)-2-(2,4-dioxopyrimidin-1-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate",131,Inner Protein Regulator,Protein-Protein Interaction,10543951,A potential allosteric subsite generated by domain swapping in bovine seminal ribonuclease.,No,"Chain A:ASP14,ASN24,ASN27,LEU28,ASN94,CYS95; Chain B:CYS32,ARG33",1.9,True,2
ASD03320000_2,Abl1,Mus musculus,P00520,3K5V,ASD03320002,STJ,A,Lig,Inhibitor,3-[6-[[4-(trifluoromethoxy)phenyl]amino]pyrimidin-4-yl]benzamide,1,Inner Protein Regulator,Inner Protein,20072125,Targeting Bcr-Abl by combining allosteric with ATP-binding-site inhibitors.,No,"Chain A:ALA356,LEU359,LEU360,ALA363,LEU448,ILE451,ALA452,TYR454,GLU481,GLY482,CYS483,PRO484,VAL487,PHE512,ILE521,VAL525,LEU529",1.74,True,1
ASD03320000_2,Abl1,Mus musculus,P00520,6HD6,ASD03320240,FYH,A,Lig,Inhibitor,3-(morpholin-4-ylmethyl)-~{N}-[4-(trifluoromethyloxy)phenyl]benzamide,602,Allosteric function,Allosteric position,30137981,"Discovery of Asciminib (ABL001), an Allosteric Inhibitor of the Tyrosine Kinase Activity of BCR-ABL1.",No,"Chain A:TYR361,ALA356,PRO484,GLU481,LEU359,VAL525,PHE512,VAL358,CYS483,THR453,MET362,SER355,ARG351,VAL357,VAL354,LEU448,THR364,PRO480,LEU360,MET456,GLY482,TYR454,LEU529,VAL487,MET515,PHE516,ALA363,MET491,ALA452,ILE521,ILE451",2.3,True,1
ASD03380000_1,degS,Escherichia coli,P0AEE3,1SOZ,ASD03380004,Chain D,D;D;D;D,Pep,Activator,VYQF,407;408;409;410,Inner Protein Regulator,Inner Protein,15137941,Crystal structure of the DegS stress sensor: How a PDZ domain recognizes misfolded protein and activates a protease,No,"Chain D:GLN409,PHE410,TYR408,VAL407",2.4,True,1
ASD03380000_1,degS,Escherichia coli,P0AEE3,2R3Y,ASD03380009,Chain D,D;D;D;D,Pep,Activator,VYWF,407;408;409;410,Inner Protein Regulator,Inner Protein,17938245,Regulation of the sigmaE stress response by DegS: how the PDZ domain keeps the protease inactive in the resting state and allows integration of different OMP-derived stress signals upon folding stress.,No,"Chain D:VAL407,PHE410,TYR408,TRP409",2.5,True,1
ASD03380000_1,degS,Escherichia coli,P0AEE3,3GCO,ASD03380004,Chain B,B;B;B;B,Pep,Activator,VYQF,407;408;409;410,Inner Protein Regulator,Inner Protein,19836340,OMP peptides activate the DegS stress-sensor protease by a relief of inhibition mechanism.,No,"Chain B:GLN409,TYR408,PHE410,VAL407",2.798,True,1
ASD03380000_1,degS,Escherichia coli,P0AEE3,3GDS,ASD03380007,Chain B,B;B;B;B,Pep,Activator,VYYF,407;408;409;410,Inner Protein Regulator,Inner Protein,19836340,OMP peptides activate the DegS stress-sensor protease by a relief of inhibition mechanism.,No,"Chain B:TYR409,TYR408,PHE410,VAL407",2.85,True,1
ASD03380000_1,degS,Escherichia coli,P0AEE3,3GDV,ASD03380005,Chain D,D;D;D,Pep,Activator,YQF,408;409;410,Inner Protein Regulator,Inner Protein,19836340,OMP peptides activate the DegS stress-sensor protease by a relief of inhibition mechanism.,No,"Chain D:GLN409,PHE410,TYR408",2.489,True,1
ASD03380000_1,degS,Escherichia coli,P0AEE3,4RQZ,ASD03380005,Chain D,D;D;D,Pep,Activator,YQF,408;409;410,Inner Protein Regulator,Inner Protein,25703375,A Conserved Activation Cluster Is Required for Allosteric Communication in HtrA-Family Proteases.,No,"Chain D:GLN409,TYR408,PHE410",2.4,True,1
ASD03430000_2,Hcn2,Mus musculus,O88703,1Q3E,ASD02408002,PCG,A,Lig,Activator,"2-amino-9-[(4R,6S,7R,8R)-4,7-dihydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-8-yl]-1H-purin-6-one",401,Inner Protein Regulator,Inner Protein,12968185,Structural basis for modulation and agonist specificity of HCN pacemaker channels.,No,"Chain A:ILE545,VAL564,THR566,MET572,PHE580,GLY581,GLU582,ILE583,CYS584,ARG591,THR592,ALA593,VAL595,ARG632",1.9,True,1
ASD03430000_2,Hcn2,Mus musculus,O88703,1Q43,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",646,Inner Protein Regulator,Inner Protein,12968185,Structural basis for modulation and agonist specificity of HCN pacemaker channels.,No,"Chain A:ILE545,VAL564,LEU574,PHE580,GLY581,GLU582,ILE583,CYS584,ARG591,THR592,ALA593,VAL595,ARG632,ARG635",2.0,True,1
ASD03430000_2,PGI,Mus musculus,P42861,1Q5O,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",201,Inner Protein Regulator,Inner Protein,12968185,Structural basis for modulation and agonist specificity of HCN pacemaker channels.,No,"Chain A:ILE545,VAL564,PHE580,GLY581,GLU582,ILE583,CYS584,ARG591,THR592,ALA593,ARG632,ARG635,ILE636",2.3,True,1
ASD03430000_2,Hcn2,Mus musculus,O88703,2Q0A,ASD02408002,PCG,A,Lig,Activator,"2-amino-9-[(4R,6S,7R,8R)-4,7-dihydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-8-yl]-1H-purin-6-one",401,Inner Protein Regulator,Inner Protein,17562314,Structure and rearrangements in the carboxy-terminal region of SpIH channels.,No,"Chain A:ILE545,VAL564,THR566,MET572,PHE580,GLY581,GLU582,ILE583,CYS584,ARG591,THR592,ALA593,VAL595,ARG632,ASP636",2.25,True,1
ASD03430000_2,Hcn2,Mus musculus,O88703,3BPZ,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",641,Inner Protein Regulator,Inner Protein,18367452,C-terminal movement during gating in cyclic nucleotide-modulated channels.,No,"Chain A:ILE545,VAL564,MET572,LEU574,PHE580,GLY581,GLU582,ILE583,CYS584,ARG591,THR592,ALA593,VAL595,ARG632,ARG635,ILE636",1.65,True,1
ASD03430000_2,Hcn2,Mus musculus,O88703,3ETQ,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",1,Inner Protein Regulator,Inner Protein,19525958,Mapping the structure and conformational movements of proteins with transition metal ion FRET.,No,"Chain A:ILE545,VAL564,MET572,LEU574,PHE580,GLY581,GLU582,ILE583,SER584,ARG591,THR592,ALA593,VAL595,ARG632,ARG635,ILE636",1.9,True,1
ASD03430000_3,Sp-Hcn1,Strongylocentrotus purpuratus,O76977,2PTM,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",401,Inner Protein Regulator,Inner Protein,17562314,Structure and rearrangements in the carboxy-terminal region of SpIH channels.,No,"Chain A:ILE573,ILE592,THR601,PHE609,GLY610,GLU611,ILE612,CYS613,ARG620,VAL621,ALA622,VAL624,ARG661",1.93,True,1
ASD03450000_1,murI,Helicobacter pylori,Q9ZLT0,2JFZ,ASD03450001,3,A,Lig,Inhibitor,"5-methyl-7-(2-methylpropyl)-2-(naphthalen-1-ylmethyl)-3-pyridin-4-yl-pyrazolo[4,3-e]pyrimidine-4,6-dione",1256,Inner Protein Regulator,Inner Protein,17568739,Exploitation of structural and regulatory diversity in glutamate racemases.,No,"Chain A:VAL10,GLY11,PHE13,SER14,ILE149,GLU150,SER152,LEU154,THR182,HIS183,LEU186,GLN248,TRP252",1.86,True,1
ASD03450000_1,murI,Helicobacter pylori,Q9ZLT0,2W4I,ASD03450005,VGA,B,Lig,Inhibitor,"1-[(3S)-5-phenyl-3-thiophen-2-yl-3H-1,4-benzodiazepin-2-yl]azetidin-3-ol",1256,Inner Protein Regulator,Protein-Protein Interaction,19097892,Potent and selective inhibitors of Helicobacter pylori glutamate racemase (MurI): pyridodiazepine amines.,No,"Chain A:PRO38,THR41,SER143,VAL146,PRO147,GLU150,GLU151; Chain B:VAL37,PRO38,THR41,LYS117,VAL146,PRO147,GLU150,GLU151",1.87,True,2
ASD03450000_1,murI,Helicobacter pylori,Q9ZLT0,4B1F,ASD03450008,KRH,A,Lig,Inhibitor,"5-methyl-3-(3-methylimidazol-4-yl)-7-(2-methylpropyl)-2-(naphthalen-1-ylmethyl)pyrazolo[3,4-d]pyrimidine-4,6-dione",1256,Inner Protein Regulator,Inner Protein,22877632,Design of Inhibitors of Helicobacter Pylori Glutamate Racemase as Selective Antibacterial Agents: Incorporation of Imidazoles Onto a Core Pyrazolopyrimidinedione Scaffold to Improve Bioavailabilty.,No,"Chain A:VAL10,GLY11,PHE13,LYS17,ILE149,GLU150,SER152,LEU154,THR182,HIS183,LEU186,GLN248,TRP252,LEU253",2.05,True,1
ASD03450000_3,murI,Escherichia coli,P22634,2JFN,ASD03450006,UMA,A,Lig,Activator,"(2S)-2-[[(2R)-2-[(2R,3R,4R,5S,6R)-3-acetamido-2-[[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxypropanoyl]amino]propanoic acid",1286,Inner Protein Regulator,Inner Protein,17568739,Exploitation of Structural and Regulatory Diversity in Glutamate Racemases,No,"Chain A:LEU100,ARG104,VAL112,GLY113,VAL114,VAL115,PRO116,ALA117,LYS119,PRO120,PHE151,SER227,ALA230,ILE231,ARG233,ARG234",1.9,True,1
ASD03450000_4,murI,Listeria monocytogenes serovar 1/2a,Q8Y7N7,3HFR,ASD03450007,6JZ,A,Lig,Inhibitor,1-ethoxy-2-[2-[2-(2-ethoxyethoxy)ethoxy]ethoxy]ethane,270,Inner Protein Regulator,Inner Protein,,Crystal structure of glutamate racemase from Listeria monocytogenes,No,"Chain A:GLY153,TYR155,LYS156,ASP246,ASP250",2.3,True,1
ASD03450000_5,murI,Enterococcus faecalis,Q836J0,2VVT,ASD03450004,I24,A,Lig,Inhibitor,"2-butoxy-9-[(2,6-difluorophenyl)methyl]-N-(2-morpholin-4-ylethyl)purin-6-amine",1269,Inner Protein Regulator,Inner Protein,18614367,Exploring 9-Benzyl Purines as Inhibitors of Glutamate Racemase (Muri) in Gram-Positive Bacteria.,No,"Chain A:VAL14,GLY15,THR38,VAL152,GLU153,ASN155,TYR157,HIS187,LEU190,MET246,ILE250,TRP254",1.65,True,1
ASD03470000_1,,Human immunodeficiency virus type 1,P12497,3AV9,ASD03470003;ASD03470003;ASD03470003;ASD03470003;ASD03470003;ASD03470003;ASD03470003;ASD03470003,SER;ALA;LYS;ILE;ASP;ASN;LEU;ASP,X;X;X;X;X;X;X;X,Pep,Inhibitor,"(2S)-2-amino-3-hydroxy-propanoic acid;(2S)-2-aminopropanoic acid;[(5S)-5-amino-6-hydroxy-6-oxo-hexyl]azanium;(2S,3S)-2-amino-3-methyl-pentanoic acid;(2S)-2-azanylbutanedioic acid;(2S)-2,4-bis(azanyl)-4-oxidanylidene-butanoic acid;(2S)-2-amino-4-methyl-pentanoic acid;(2S)-2-azanylbutanedioic acid",1;2;3;4;5;6;7;8,Protein-Protein Interaction Regulator,Protein-Protein Interaction,21850718,Crystal Structures of Novel Allosteric Peptide Inhibitors of HIV Integrase Identify New Interactions at the LEDGF Binding Site.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,THR124,THR125,ALA128,TRP132",1.7,True,2
ASD03470000_1,,Human immunodeficiency virus type 1,P12497,3AVA,ASD03470004;ASD03470004;ASD03470004;ASD03470004;ASD03470004;ASD03470004;ASD03470004;ASD03470004,ALA;LEU;LYS;ILE;ASP;ASN;LEU;ASP,X;X;X;X;X;X;X;X,Pep,Inhibitor,"(2S)-2-aminopropanoic acid;(2S)-2-amino-4-methyl-pentanoic acid;[(5S)-5-amino-6-hydroxy-6-oxo-hexyl]azanium;(2S,3S)-2-amino-3-methyl-pentanoic acid;(2S)-2-azanylbutanedioic acid;(2S)-2,4-bis(azanyl)-4-oxidanylidene-butanoic acid;(2S)-2-amino-4-methyl-pentanoic acid;(2S)-2-azanylbutanedioic acid",1;2;3;4;5;6;7;8,Protein-Protein Interaction Regulator,Protein-Protein Interaction,21850718,Crystal Structures of Novel Allosteric Peptide Inhibitors of HIV Integrase Identify New Interactions at the LEDGF Binding Site.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,THR124,THR125,ALA128,TRP132",1.7,True,2
ASD03470000_1,,Human immunodeficiency virus type 1,P12497,3AVB,ASD03470005;ASD03470005;ASD03470005;ASD03470005;ASD03470005;ASD03470005;ASD03470005;ASD03470005,SER;LEU;LYS;ILE;ASP;ASN;LEU;ASP,X;X;X;X;X;X;X;X,Pep,Inhibitor,"(2S)-2-amino-3-hydroxy-propanoic acid;(2S)-2-amino-4-methyl-pentanoic acid;[(5S)-5-amino-6-hydroxy-6-oxo-hexyl]azanium;(2S,3S)-2-amino-3-methyl-pentanoic acid;(2S)-2-azanylbutanedioic acid;(2S)-2,4-bis(azanyl)-4-oxidanylidene-butanoic acid;(2S)-2-amino-4-methyl-pentanoic acid;(2S)-2-azanylbutanedioic acid",1;2;3;4;5;6;7;8,Protein-Protein Interaction Regulator,Protein-Protein Interaction,21850718,Crystal Structures of Novel Allosteric Peptide Inhibitors of HIV Integrase Identify New Interactions at the LEDGF Binding Site.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,THR124,THR125,ALA128,TRP132",1.85,True,2
ASD03470000_1,,Human immunodeficiency virus type 1,P12497,3AVC,ASD03470006;ASD03470006;ASD03470006;ASD03470006;ASD03470006;ASD03470006,SER;ASP;LYS;ILE;ASP;ASN,F;F;F;F;F;F,Pep,Inhibitor,"(2S)-2-amino-3-hydroxy-propanoic acid;(2S)-2-azanylbutanedioic acid;[(5S)-5-amino-6-hydroxy-6-oxo-hexyl]azanium;(2S,3S)-2-amino-3-methyl-pentanoic acid;(2S)-2-azanylbutanedioic acid;(2S)-2,4-bis(azanyl)-4-oxidanylidene-butanoic acid",1;2;3;4;5;6,Protein-Protein Interaction Regulator,Protein-Protein Interaction,21850718,Crystal Structures of Novel Allosteric Peptide Inhibitors of HIV Integrase Identify New Interactions at the LEDGF Binding Site.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,THR125,ALA128; Chain F:LEU7,ASP8",1.77,True,3
ASD03470000_1,,Human immunodeficiency virus type 1,P12497,3AVF,ASD03470007;ASD03470007;ASD03470007;ASD03470007;ASD03470007;ASD03470007;ASD03470007;ASD03470007,ASP;LEU;LYS;ILE;ASP;ASN;LEU;ASP,D;D;D;D;D;D;D;D,Pep,Inhibitor,"(2S)-2-azanylbutanedioic acid;(2S)-2-amino-4-methyl-pentanoic acid;[(5S)-5-amino-6-hydroxy-6-oxo-hexyl]azanium;(2S,3S)-2-amino-3-methyl-pentanoic acid;(2S)-2-azanylbutanedioic acid;(2S)-2,4-bis(azanyl)-4-oxidanylidene-butanoic acid;(2S)-2-amino-4-methyl-pentanoic acid;(2S)-2-azanylbutanedioic acid",1;2;3;4;5;6;7;8,Protein-Protein Interaction Regulator,Protein-Protein Interaction,21850718,Crystal Structures of Novel Allosteric Peptide Inhibitors of HIV Integrase Identify New Interactions at the LEDGF Binding Site.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,THR124,THR125,ALA128,TRP131,TRP132",1.7,True,2
ASD03470000_1,,Human immunodeficiency virus type 1,P12497,3AVG,ASD03470008;ASD03470008;ASD03470008;ASD03470008;ASD03470008;ASD03470008;ASD03470008;ASD03470008,ALA;ASP;LYS;ILE;ASP;ASN;LEU;ASP,F;F;F;F;F;F;F;F,Pep,Inhibitor,"(2S)-2-aminopropanoic acid;(2S)-2-azanylbutanedioic acid;[(5S)-5-amino-6-hydroxy-6-oxo-hexyl]azanium;(2S,3S)-2-amino-3-methyl-pentanoic acid;(2S)-2-azanylbutanedioic acid;(2S)-2,4-bis(azanyl)-4-oxidanylidene-butanoic acid;(2S)-2-amino-4-methyl-pentanoic acid;(2S)-2-azanylbutanedioic acid",1;2;3;4;5;6;7;8,Protein-Protein Interaction Regulator,Protein-Protein Interaction,21850718,Crystal Structures of Novel Allosteric Peptide Inhibitors of HIV Integrase Identify New Interactions at the LEDGF Binding Site.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,THR124,THR125",1.7,True,2
ASD03470000_1,,Human immunodeficiency virus type 1,P12497,3AVH,ASD03470002;ASD03470002;ASD03470002;ASD03470002;ASD03470002;ASD03470002;ASD03470002;ASD03470002,ALA;ARG;LYS;ILE;ASP;ASN;LEU;ASP,F;F;F;F;F;F;F;F,Pep,Inhibitor,"(2S)-2-aminopropanoic acid;[amino-[[(4S)-4-amino-5-hydroxy-5-oxo-pentyl]amino]methylidene]azanium;[(5S)-5-amino-6-hydroxy-6-oxo-hexyl]azanium;(2S,3S)-2-amino-3-methyl-pentanoic acid;(2S)-2-azanylbutanedioic acid;(2S)-2,4-bis(azanyl)-4-oxidanylidene-butanoic acid;(2S)-2-amino-4-methyl-pentanoic acid;(2S)-2-azanylbutanedioic acid",1;2;3;4;5;6;7;8,Protein-Protein Interaction Regulator,Protein-Protein Interaction,21850718,Crystal Structures of Novel Allosteric Peptide Inhibitors of HIV Integrase Identify New Interactions at the LEDGF Binding Site.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,THR124,THR125,ALA128,TRP131,TRP132",1.88,True,2
ASD03470000_1,,Human immunodeficiency virus type 1,P12497,3AVI,ASD03470009;ASD03470009;ASD03470009;ASD03470009;ASD03470009;ASD03470009;ASD03470009;ASD03470009,SER;LEU;LYS;ILE;ASP;ASN;MET;ASP,F;F;F;F;F;F;F;F,Pep,Inhibitor,"(2S)-2-amino-3-hydroxy-propanoic acid;(2S)-2-amino-4-methyl-pentanoic acid;[(5S)-5-amino-6-hydroxy-6-oxo-hexyl]azanium;(2S,3S)-2-amino-3-methyl-pentanoic acid;(2S)-2-azanylbutanedioic acid;(2S)-2,4-bis(azanyl)-4-oxidanylidene-butanoic acid;(2S)-2-amino-4-methylsulfanyl-butanoic acid;(2S)-2-azanylbutanedioic acid",1;2;3;4;5;6;7;8,Protein-Protein Interaction Regulator,Protein-Protein Interaction,21850718,Crystal Structures of Novel Allosteric Peptide Inhibitors of HIV Integrase Identify New Interactions at the LEDGF Binding Site.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,THR124,THR125,ALA128,ALA129,TRP131,TRP132",1.7,True,2
ASD03470000_1,,Human immunodeficiency virus type 1,P12497,3AVJ,ASD03470010;ASD03470010;ASD03470010;ASD03470010;ASD03470010;ASD03470010;ASD03470010;ASD03470010,ALA;LEU;LYS;ILE;ASP;ASN;MET;ASP,F;F;F;F;F;F;F;F,Pep,Inhibitor,"(2S)-2-aminopropanoic acid;(2S)-2-amino-4-methyl-pentanoic acid;[(5S)-5-amino-6-hydroxy-6-oxo-hexyl]azanium;(2S,3S)-2-amino-3-methyl-pentanoic acid;(2S)-2-azanylbutanedioic acid;(2S)-2,4-bis(azanyl)-4-oxidanylidene-butanoic acid;(2S)-2-amino-4-methylsulfanyl-butanoic acid;(2S)-2-azanylbutanedioic acid",1;2;3;4;5;6;7;8,Protein-Protein Interaction Regulator,Protein-Protein Interaction,21850718,Crystal Structures of Novel Allosteric Peptide Inhibitors of HIV Integrase Identify New Interactions at the LEDGF Binding Site.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,THR124,THR125,ALA128,ALA129,TRP131,TRP132",1.7,True,2
ASD03470000_1,,Human immunodeficiency virus type 1,P12497,3AVK,ASD03470011;ASD03470011;ASD03470011;ASD03470011;ASD03470011;ASD03470011;ASD03470011;ASD03470011,SER;LEU;LYS;ILE;ASP;ASN;GLU;ASP,F;F;F;F;F;F;F;F,Pep,Inhibitor,"(2S)-2-amino-3-hydroxy-propanoic acid;(2S)-2-amino-4-methyl-pentanoic acid;[(5S)-5-amino-6-hydroxy-6-oxo-hexyl]azanium;(2S,3S)-2-amino-3-methyl-pentanoic acid;(2S)-2-azanylbutanedioic acid;(2S)-2,4-bis(azanyl)-4-oxidanylidene-butanoic acid;(2S)-2-azanylpentanedioic acid;(2S)-2-azanylbutanedioic acid",1;2;3;4;5;6;7;8,Protein-Protein Interaction Regulator,Protein-Protein Interaction,21850718,Crystal Structures of Novel Allosteric Peptide Inhibitors of HIV Integrase Identify New Interactions at the LEDGF Binding Site.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,THR124,THR125,ALA128,ALA129,TRP131,TRP132",1.75,True,2
ASD03470000_1,,Human immunodeficiency virus type 1,P12497,3AVL,ASD03470012;ASD03470012;ASD03470012;ASD03470012;ASD03470012;ASD03470012;ASD03470012;ASD03470012,ALA;THR;LYS;ILE;ASP;ASN;LEU;ASP,F;F;F;F;F;F;F;F,Pep,Inhibitor,"(2S)-2-aminopropanoic acid;(2S,3R)-2-amino-3-hydroxy-butanoic acid;[(5S)-5-amino-6-hydroxy-6-oxo-hexyl]azanium;(2S,3S)-2-amino-3-methyl-pentanoic acid;(2S)-2-azanylbutanedioic acid;(2S)-2,4-bis(azanyl)-4-oxidanylidene-butanoic acid;(2S)-2-amino-4-methyl-pentanoic acid;(2S)-2-azanylbutanedioic acid",1;2;3;4;5;6;7;8,Protein-Protein Interaction Regulator,Protein-Protein Interaction,21850718,Crystal Structures of Novel Allosteric Peptide Inhibitors of HIV Integrase Identify New Interactions at the LEDGF Binding Site.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,THR124,THR125,ALA128,TRP131,TRP132",1.88,True,2
ASD03470000_1,,Human immunodeficiency virus type 1,P12497,3AVM,ASD03470013;ASD03470013;ASD03470013;ASD03470013;ASD03470013;ASD03470013;ASD03470013;ASD03470013,SER;ARG;LYS;ILE;ASP;ASN;LEU;ASP,F;F;F;F;F;F;F;F,Pep,Inhibitor,"(2S)-2-amino-3-hydroxy-propanoic acid;[amino-[[(4S)-4-amino-5-hydroxy-5-oxo-pentyl]amino]methylidene]azanium;[(5S)-5-amino-6-hydroxy-6-oxo-hexyl]azanium;(2S,3S)-2-amino-3-methyl-pentanoic acid;(2S)-2-azanylbutanedioic acid;(2S)-2,4-bis(azanyl)-4-oxidanylidene-butanoic acid;(2S)-2-amino-4-methyl-pentanoic acid;(2S)-2-azanylbutanedioic acid",1;2;3;4;5;6;7;8,Protein-Protein Interaction Regulator,Protein-Protein Interaction,21850718,Crystal Structures of Novel Allosteric Peptide Inhibitors of HIV Integrase Identify New Interactions at the LEDGF Binding Site.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,THR124,THR125,ALA128,TRP131,TRP132",1.88,True,2
ASD03470000_1,,Human immunodeficiency virus type 1,P12497,3AVN,ASD03470014;ASD03470014;ASD03470014;ASD03470014;ASD03470014;ASD03470014;ASD03470014;ASD03470014,SER;HIS;LYS;ILE;ASP;ASN;LEU;ASP,H;H;H;H;H;H;H;H,Pep,Inhibitor,"(2S)-2-amino-3-hydroxy-propanoic acid;(2S)-2-amino-3-(1H-imidazol-3-ium-4-yl)propanoic acid;[(5S)-5-amino-6-hydroxy-6-oxo-hexyl]azanium;(2S,3S)-2-amino-3-methyl-pentanoic acid;(2S)-2-azanylbutanedioic acid;(2S)-2,4-bis(azanyl)-4-oxidanylidene-butanoic acid;(2S)-2-amino-4-methyl-pentanoic acid;(2S)-2-azanylbutanedioic acid",1;2;3;4;5;6;7;8,Protein-Protein Interaction Regulator,Protein-Protein Interaction,21850718,Crystal Structures of Novel Allosteric Peptide Inhibitors of HIV Integrase Identify New Interactions at the LEDGF Binding Site.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,THR124,THR125,ALA128,TRP131,TRP132",2.1,True,2
ASD03470000_1,gag-pol,Human immunodeficiency virus type 1,P12497,3LPU,ASD03470001,976,A,Lig,Inhibitor,(2S)-2-(6-chloro-2-methyl-4-phenyl-quinolin-3-yl)pentanoic acid,1,Protein-Protein Interaction Regulator,Protein-Protein Interaction,20473303,Rational design of small molecule inhibitors of the LEDGF/75-integrase interaction and HIV replication,No,"Chain A:GLN95,TYR99,THR124,THR125,ALA128,ALA129",1.95,True,1
ASD03470000_1,gag-pol,Human immunodeficiency virus type 1,P12497,3NF6,ASD01670030,IMV,A,Lig,Inhibitor,"5-[(2-oxo-3H-indol-1-yl)methyl]-1,3-benzodioxole-4-carboxylic acid",230,Inner Protein Regulator,Inner Protein,21602613,Structural basis for a new mechanism of inhibition of HIV-1 integrase identified by fragment screening and structure-based design,Yes,"Chain A:VAL77,VAL79,GLY82,ILE84,VAL150,MET154,GLU157,LEU158,HIS183",1.9,True,1
ASD03470000_1,gag-pol,Human immunodeficiency virus type 1,P12497,3NF7,ASD03470034,CIW,A,Lig,Inhibitor,"5-[(5-chloro-2-oxo-3H-indol-1-yl)methyl]-1,3-benzodioxole-4-carboxylic acid",221,Inner Protein Regulator,Inner Protein,21602613,Structural basis for a new mechanism of inhibition of HIV-1 integrase identified by fragment screening and structure-based design,Yes,"Chain A:GLN62,VAL77,VAL79,GLY82,ILE84,VAL150,ILE151,SER153,MET154,GLU157,LEU158,HIS183",1.8,True,1
ASD03470000_1,gag-pol,Human immunodeficiency virus type 1,P12497,3NF8,ASD03470033,CDQ,A,Lig,Inhibitor,"6-[(5-chloro-2-oxo-3H-indol-1-yl)methyl]-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid",247,Inner Protein Regulator,Inner Protein,21602613,Structural basis for a new mechanism of inhibition of HIV-1 integrase identified by fragment screening and structure-based design,Yes,"Chain A:GLN62,VAL77,VAL79,GLY82,ILE84,VAL150,MET154,GLU157,LEU158,HIS183",1.9,True,1
ASD03470000_1,gag-pol,Human immunodeficiency virus type 1,P12497,3NF9,ASD03470032,CD9,A,Lig,Inhibitor,"5-[(6-chloro-2-oxo-3H-indol-1-yl)methyl]-1,3-benzodioxole-4-carboxylic acid",220,Inner Protein Regulator,Inner Protein,21602613,Structural basis for a new mechanism of inhibition of HIV-1 integrase identified by fragment screening and structure-based design,Yes,"Chain A:VAL77,VAL79,GLY82,VAL150,ILE151,SER153,MET154,GLU157,HIS183",1.95,True,1
ASD03470000_1,gag-pol,Human immunodeficiency virus type 1,P12497,3NFA,ASD01670008,CBJ,A,Lig,Inhibitor,"6-[(5-bromo-2,3-dioxo-indol-1-yl)methyl]-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid",213,Inner Protein Regulator,Inner Protein,21602613,Structural basis for a new mechanism of inhibition of HIV-1 integrase identified by fragment screening and structure-based design,Yes,"Chain A:VAL79,ALA80,SER81,GLY82,ILE84,VAL150,MET154,GLU157,LEU158,HIS183,LYS188,ARG199",1.95,True,1
ASD03470000_1,gag-pol,Human immunodeficiency virus type 1,P12497,4AH9,ASD03470015,0MB,A,Lig,Inhibitor,"5-(1,4-diazepan-1-yl)-3-phenyl-1,2,4-thiadiazole",218,Protein-Protein Interaction Regulator,Protein-Protein Interaction,23139382,Parallel Screening of Low Molecular Weight Fragment Libraries: Do Differences in Methodology Affect Hit Identification?,No,"Chain A:GLY106,ARG107,TRP108,PRO109,ILE204,ILE208; Chain B:TYR83,ASN184,HIS185,ARG187,GLY197,GLU198",1.7,True,2
ASD03470000_1,gag-pol,Human immunodeficiency virus type 1,P12497,4AHR,ASD03470016,I2E,A,Lig,Inhibitor,"3-(1,3-benzodioxol-5-yl)propanoic acid",1218,Protein-Protein Interaction Regulator,Protein-Protein Interaction,23139382,Parallel Screening of Low Molecular Weight Fragment Libraries: Do Differences in Methodology Affect Hit Identification?,No,"Chain A:ALA105,GLY106,ARG107,TRP108,PRO109,ILE204,ILE208; Chain B:TYR83,ASN184,HIS185,GLY197,GLU198,VAL201",1.9,True,2
ASD03470000_1,gag-pol,Human immunodeficiency virus type 1,P12497,4AHS,ASD03470017,AKH,A,Lig,Inhibitor,1-benzofuran-7-carboxylic acid,1216,Protein-Protein Interaction Regulator,Protein-Protein Interaction,23139382,Parallel Screening of Low Molecular Weight Fragment Libraries: Do Differences in Methodology Affect Hit Identification?,No,"Chain A:GLY106,ARG107,TRP108,PRO109,ILE204,ILE208; Chain B:TYR83,HIS185,GLY197,GLU198,VAL201",1.75,True,2
ASD03470000_1,gag-pol,Human immunodeficiency virus type 1,P12497,4AHT,ASD03470018,Q6T,A,Lig,Inhibitor,"1,3-benzodioxole-4-carboxylic acid",1216,Protein-Protein Interaction Regulator,Protein-Protein Interaction,23139382,Parallel Screening of Low Molecular Weight Fragment Libraries: Do Differences in Methodology Affect Hit Identification?,No,"Chain A:GLY106,ARG107,TRP108,PRO109,ILE208; Chain B:TYR83,ASN184,HIS185,GLY197,GLU198,VAL201",1.8,True,2
ASD03470000_1,gag-pol,Human immunodeficiency virus type 1,P12497,4AHU,ASD06710009,ICO,A,Lig,Inhibitor,1H-indole-3-carboxylic acid,1217,Protein-Protein Interaction Regulator,Protein-Protein Interaction,23139382,Parallel Screening of Low Molecular Weight Fragment Libraries: Do Differences in Methodology Affect Hit Identification?,No,"Chain A:TYR83,ASN184,HIS185,GLY197,GLU198,VAL201; Chain B:GLY106,ARG107,TRP108,PRO109,ILE208",1.9,True,2
ASD03470000_1,gag-pol,Human immunodeficiency virus type 1,P12497,4AHV,ASD03470020,Z5P,A,Lig,Inhibitor,(2-pyrazol-1-ylphenyl)methanamine,1219,Protein-Protein Interaction Regulator,Protein-Protein Interaction,23139382,Parallel Screening of Low Molecular Weight Fragment Libraries: Do Differences in Methodology Affect Hit Identification?,No,"Chain A:TYR83,ASN184,HIS185,GLY197,GLU198,VAL201; Chain B:GLY106,ARG107,TRP108,PRO109,ILE204,ILE208",1.8,True,2
ASD03470000_1,gag-pol,Human immunodeficiency virus type 1,P12497,4DMN,ASD05062031,0L9,A,Lig,Inhibitor,(2S)-2-[6-bromanyl-4-(4-chlorophenyl)-2-methyl-quinolin-3-yl]-2-methoxy-ethanoic acid,305,Protein-Protein Interaction Regulator,Protein-Protein Interaction,22437836,"A multimode, cooperative mechanism of action of allosteric HIV-1 integrase inhibitors.",No,"Chain A:GLN95,THR124,THR125,ALA128,ALA129,TRP132",2.45,True,1
ASD03470000_1,gag-pol,Human immunodeficiency virus type 1,P12497,4E1M,ASD05068001,TQ2,A,Lig,Inhibitor,"(2S)-2-[4-(3,4-dimethylphenyl)-2-methyl-quinolin-3-yl]-2-[(2-methylpropan-2-yl)oxy]ethanoic acid",301,Protein-Protein Interaction Regulator,Protein-Protein Interaction,22535962,New Class of HIV-1 Integrase (IN) Inhibitors with a Dual Mode of Action.,No,"Chain A:GLN168,ALA169,GLU170,HIS171,THR174,MET178",1.9,True,1
ASD03470000_1,gag-pol,Human immunodeficiency virus type 1,P12497,4E1N,ASD05068002,TQX,A,Lig,Inhibitor,"(2S)-2-[4-(8-fluoranyl-5-methyl-3,4-dihydro-2H-chromen-6-yl)-2-methyl-quinolin-3-yl]-2-[(2-methylpropan-2-yl)oxy]ethanoic acid",301,Protein-Protein Interaction Regulator,Protein-Protein Interaction,22535962,New Class of HIV-1 Integrase (IN) Inhibitors with a Dual Mode of Action.,No,"Chain A:GLN168,ALA169,GLU170,HIS171,THR174,MET178",2.0,True,1
ASD03470000_1,gag-pol,Human immunodeficiency virus type 1,P12497,4GVM,ASD05060053,LF2,A,Lig,Inhibitor,(2S)-2-[6-bromanyl-4-(4-chlorophenyl)-2-methyl-quinolin-3-yl]-2-[(2-methylpropan-2-yl)oxy]ethanoic acid,303,Protein-Protein Interaction Regulator,Protein-Protein Interaction,23615903,The A128T Resistance Mutation Reveals Aberrant Protein Multimerization as the Primary Mechanism of Action of Allosteric HIV-1 Integrase Inhibitors.,No,"Chain A:GLN95,TYR99,THR124,THR125,THR128,ALA129,TRP132",2.16,True,1
ASD03470000_1,gag-pol,Human immunodeficiency virus type 1,P12497,4GW6,ASD05060053,LF2,A,Lig,Inhibitor,(2S)-2-[6-bromanyl-4-(4-chlorophenyl)-2-methyl-quinolin-3-yl]-2-[(2-methylpropan-2-yl)oxy]ethanoic acid,303,Protein-Protein Interaction Regulator,Protein-Protein Interaction,23615903,The A128T Resistance Mutation Reveals Aberrant Protein Multimerization as the Primary Mechanism of Action of Allosteric HIV-1 Integrase Inhibitors.,No,"Chain A:GLN95,LEU102,THR125,ALA128,ALA129,TRP132",2.65,True,1
ASD03470000_1,gag-pol,Human immunodeficiency virus type 1,P12497,4ID1,ASD01670001,LF0,A,Lig,Inhibitor,"(2S)-2-[4-(3,4-dihydro-2H-chromen-6-yl)-2-methyl-quinolin-3-yl]-2-[(2-methylpropan-2-yl)oxy]ethanoic acid",301,Protein-Protein Interaction Regulator,Protein-Protein Interaction,23610442,Allosteric integrase inhibitor potency is determined through the inhibition of HIV-1 particle maturation.,No,"Chain A:GLN95,LEU102,THR124,THR125,ALA128,ALA129,TRP132",1.87,True,1
ASD03470000_1,gag-pol,Human immunodeficiency virus type 1,P12497,4JLH,ASD05062031,0L9,A,Lig,Inhibitor,(2S)-2-[6-bromanyl-4-(4-chlorophenyl)-2-methyl-quinolin-3-yl]-2-methoxy-ethanoic acid,301,Protein-Protein Interaction Regulator,Protein-Protein Interaction,23615903,The A128T Resistance Mutation Reveals Aberrant Protein Multimerization as the Primary Mechanism of Action of Allosteric HIV-1 Integrase Inhibitors.,No,"Chain A:GLN95,THR124,THR125,THR128,ALA129,TRP132",2.09,True,1
ASD03470000_1,gag-pol,Human immunodeficiency virus type 1,P12497,4O0J,ASD03470025,LF8,A,Lig,Inhibitor,"(2S)-2-[4-(4-chlorophenyl)-6-(3,4-dimethylphenyl)-2,5-dimethyl-pyridin-3-yl]-2-[(2-methylpropan-2-yl)oxy]ethanoic acid",301,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24874515,A New Class of Multimerization Selective Inhibitors of HIV-1 Integrase.,No,"Chain A:GLN95,LEU102,THR124,THR125,ALA128,ALA129,TRP132",2.05,True,1
ASD03470000_1,gag-pol,Human immunodeficiency virus type 1,P12497,4O55,ASD03470026,LF9,A,Lig,Inhibitor,"(2S)-2-[6-(5-chloranyl-1H-benzimidazol-2-yl)-2,5-dimethyl-4-phenyl-pyridin-3-yl]-2-[(2-methylpropan-2-yl)oxy]ethanoic acid",301,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24874515,A New Class of Multimerization Selective Inhibitors of HIV-1 Integrase.,No,"Chain A:GLN95,THR124,THR125,ALA128,ALA129",2.24,True,1
ASD03470000_1,gag-pol,Human immunodeficiency virus type 1,P12497,4O5B,ASD03470026,LF9,A,Lig,Inhibitor,"(2S)-2-[6-(5-chloranyl-1H-benzimidazol-2-yl)-2,5-dimethyl-4-phenyl-pyridin-3-yl]-2-[(2-methylpropan-2-yl)oxy]ethanoic acid",301,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24874515,A New Class of Multimerization Selective Inhibitors of HIV-1 Integrase.,No,"Chain A:GLN95,THR124,THR125,THR128,ALA129",2.37,True,1
ASD03580000_3,pfkA,Escherichia coli,P0A796,1PFK,ASD01720027,ADP,A,Lig,Activator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl phosphono hydrogen phosphate",326,Inner Protein Regulator,Protein-Protein Interaction,2975709,Crystal structure of the complex of phosphofructokinase from Escherichia coli with its reaction products.,No,"Chain A:ARG154,SER158,GLY185,GLU187,LYS211,GLY212,LYS213,LYS214,HIS215,TYR319; Chain B:ARG21,ARG25,ARG54,TYR55,SER58,ASP59",2.4,True,2
ASD03580000_4,pfkA,Geobacillus stearothermophilus,P00512,4PFK,ASD01720027,ADP,A,Lig,Activator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl phosphono hydrogen phosphate",326,Inner Protein Regulator,Protein-Protein Interaction,6115424,1 - 4PFK : Phosphofructokinase performs the third step of glycolysis. It is an allosteric enzyme that regulates the pathway. This structure is the active form.,No,"Chain A:ARG154,GLY185,GLU187,ARG211,GLY212,LYS213,LYS214,HIS215",2.4,True,1
ASD03640000_1,purR,Escherichia coli,P0ACP7,1BDH,ASD03640003,HPA,A,Lig,Activator,"1,7-dihydropurin-6-one",599,Protein-DNA/RNA Interaction Regulator,Inner Protein,,A Positively Charged Residue Bound in the Minor Groove Does not Alter the Bending of a DNA Duplex,No,"Chain A:TYR73,PHE74,ARG190,THR192,ARG196,PHE221,ASP275",2.7,True,1
ASD03640000_1,purR,Escherichia coli,P0ACP7,1JFS,ASD03640003,HPA,A,Lig,Activator,"1,7-dihydropurin-6-one",599,Protein-DNA/RNA Interaction Regulator,Inner Protein,11781089,Role of residue 147 in the gene regulatory function of the Escherichia coli purine repressor.,No,"Chain A:TYR73,PHE74,ARG190,THR192,ARG196,PHE221,ASP275",2.9,True,1
ASD03640000_1,purR,Escherichia coli,P0ACP7,1JFT,ASD03640003,HPA,A,Lig,Activator,"1,7-dihydropurin-6-one",599,Protein-DNA/RNA Interaction Regulator,Inner Protein,11781089,Role of residue 147 in the gene regulatory function of the Escherichia coli purine repressor.,No,"Chain A:TYR73,PHE74,ARG190,THR192,ARG196,PHE221,ASP275",2.5,True,1
ASD03640000_1,purR,Escherichia coli,P0ACP7,1JH9,ASD03640003,HPA,A,Lig,Activator,"1,7-dihydropurin-6-one",599,Protein-DNA/RNA Interaction Regulator,Inner Protein,11781089,Role of residue 147 in the gene regulatory function of the Escherichia coli purine repressor.,No,"Chain A:TYR73,PHE74,SER124,ARG190,THR192,ARG196,PHE221,ASP275",2.55,True,1
ASD03640000_1,purR,Escherichia coli,P0ACP7,1PNR,ASD03640003,HPA,A,Lig,Activator,"1,7-dihydropurin-6-one",599,Protein-DNA/RNA Interaction Regulator,Inner Protein,7973627,"Crystal structure of LacI member, PurR, bound to DNA: minor groove binding by alpha helices.",No,"Chain A:TYR73,PHE74,ARG190,THR192,ARG196,PHE221,ASP275",2.7,True,1
ASD03640000_1,purR,Escherichia coli,P0ACP7,1QP7,ASD03640003,HPA,A,Lig,Activator,"1,7-dihydropurin-6-one",599,Protein-DNA/RNA Interaction Regulator,Inner Protein,10438625,The role of lysine 55 in determining the specificity of the purine repressor for its operators through minor groove interactions.,No,"Chain A:TYR73,PHE74,ARG190,THR192,ARG196,PHE221,ASP275",2.9,True,1
ASD03640000_1,purR,Escherichia coli,P0ACP7,1QPZ,ASD03640003,HPA,A,Lig,Activator,"1,7-dihydropurin-6-one",599,Protein-DNA/RNA Interaction Regulator,Inner Protein,10438625,The role of lysine 55 in determining the specificity of the purine repressor for its operators through minor groove interactions.,No,"Chain A:TYR73,PHE74,ARG190,THR192,ARG196,PHE221,ASP275",2.5,True,1
ASD03640000_1,purR,Escherichia coli,P0ACP7,1QQB,ASD03640003,HPA,A,Lig,Activator,"1,7-dihydropurin-6-one",599,Protein-DNA/RNA Interaction Regulator,Inner Protein,10438625,The role of lysine 55 in determining the specificity of the purine repressor for its operators through minor groove interactions.,No,"Chain A:TYR73,PHE74,ARG190,THR192,ARG196,PHE221,ASP275",2.7,True,1
ASD03640000_1,purR,Escherichia coli,P0ACP7,1VPW,ASD03640003,HPA,A,Lig,Activator,"1,7-dihydropurin-6-one",599,Protein-DNA/RNA Interaction Regulator,Inner Protein,9628480,The structure of PurR mutant L54M shows an alternative route to DNA kinking.,No,"Chain A:TYR73,PHE74,ARG190,THR192,ARG196,PHE221,ASP275",2.7,True,1
ASD03640000_1,purR,Escherichia coli,P0ACP7,1WET,ASD03640014,GUN,A,Lig,Activator,"2-amino-1,9-dihydropurin-6-one",599,Protein-DNA/RNA Interaction Regulator,Inner Protein,9278422,The X-ray structure of the PurR-guanine-purF operator complex reveals the contributions of complementary electrostatic surfaces and a water-mediated hydrogen bond to corepressor specificity and binding affinity.,No,"Chain A:ALA71,TYR73,PHE74,ARG190,THR192,ARG196,PHE221,ASP275",2.6,True,1
ASD03640000_1,purR,Escherichia coli,P0ACP7,1ZAY,ASD03640003,HPA,A,Lig,Activator,"1,7-dihydropurin-6-one",599,Protein-DNA/RNA Interaction Regulator,Inner Protein,,The Roles of Exocyclic Groups in the Central Base-Pair Step in Modulating the Affinity of PurR for its Operator,No,"Chain A:TYR73,PHE74,ARG190,THR192,ARG196,PHE221,ASP275",2.7,True,1
ASD03640000_1,purR,Escherichia coli,P0ACP7,2PUA,ASD03640020,6MP,A,Lig,Activator,6-methyl-7H-purine,599,Protein-DNA/RNA Interaction Regulator,Inner Protein,7973627,"Crystal structure of LacI member, PurR, bound to DNA: minor groove binding by alpha helices.",No,"Chain A:TYR73,PHE74,SER124,THR192,ARG196,PHE221,ASP275",2.9,True,1
ASD03640000_1,purR,Escherichia coli,P0ACP7,2PUB,ASD01320045,ADE,A,Lig,Activator,9H-purin-6-amine,599,Protein-DNA/RNA Interaction Regulator,Inner Protein,7973627,"Crystal structure of LacI member, PurR, bound to DNA: minor groove binding by alpha helices.",No,"Chain A:TYR73,PHE74,SER124,THR192,ARG196,PHE221,ASP275",2.7,True,1
ASD03640000_1,purR,Escherichia coli,P0ACP7,2PUC,ASD03640014,GUN,A,Lig,Activator,"2-amino-1,9-dihydropurin-6-one",599,Protein-DNA/RNA Interaction Regulator,Inner Protein,7973627,"Crystal structure of LacI member, PurR, bound to DNA: minor groove binding by alpha helices.",No,"Chain A:ALA71,TYR73,PHE74,SER124,THR192,ARG196,PHE221,ASP275",2.6,True,1
ASD03640000_1,purR,Escherichia coli,P0ACP7,2PUD,ASD03640003,HPA,A,Lig,Activator,"1,7-dihydropurin-6-one",599,Protein-DNA/RNA Interaction Regulator,Inner Protein,7973627,"Crystal structure of LacI member, PurR, bound to DNA: minor groove binding by alpha helices.",No,"Chain A:TYR73,PHE74,SER124,THR192,ARG196,PHE221,ASP275",2.6,True,1
ASD03640000_1,purR,Escherichia coli,P0ACP7,2PUE,ASD01320045,ADE,A,Lig,Activator,9H-purin-6-amine,599,Protein-DNA/RNA Interaction Regulator,Inner Protein,9454587,Structure-based redesign of corepressor specificity of the Escherichia coli purine repressor by substitution of residue 190.,No,"Chain A:TYR73,PHE74,GLN190,THR192,ARG196,PHE221,ASP275",2.7,True,1
ASD03640000_1,purR,Escherichia coli,P0ACP7,2PUG,ASD03640003,HPA,A,Lig,Activator,"1,7-dihydropurin-6-one",599,Protein-DNA/RNA Interaction Regulator,Inner Protein,9454587,Structure-based redesign of corepressor specificity of the Escherichia coli purine repressor by substitution of residue 190.,No,"Chain A:TYR73,PHE74,GLN190,THR192,ARG196,PHE221,ASP275",2.7,True,1
ASD03670000_4,rpoB,Thermus thermophilus,Q8RQE9,2A68,ASD03670006,RBT,C,Lig,Inhibitor,"(9S,12E,14S,15R,16S,17R,18R,19R,20S,21S,22E,24Z)-6,18,20-trihydroxy-14-methoxy-7,9,15,17,19,21,25-heptamethyl-1'-(2-methylpropyl)-5,10,26-trioxo-3,5,9,10-tetrahydrospiro[9,4-(epoxypentadeca[1,11,13]trienoimino)furo[2',3':7,8]naphtho[1,2-d]imidazole-2,4'-piperidin]-16-yl acetate",8001,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,16096056,Allosteric modulation of the RNA polymerase catalytic reaction is an essential component of transcription control by rifamycins.,No,"Chain C:ARG134,GLN390,SER392,GLN393,PHE394,LYS395,ASP396,HIS406,ARG409,SER411,PRO444,ILE452; Chain F:ASP323",2.5,True,2
ASD03670000_4,rpoB,Thermus thermophilus,Q8RQE9,2A69,ASD03670007,RPT,C,Lig,Inhibitor,"(2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-8-{(E)-[(4-cyclopentylpiperazin-1-yl)imino]methyl}-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate",8001,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,16096056,Allosteric modulation of the RNA polymerase catalytic reaction is an essential component of transcription control by rifamycins.,No,"Chain C:ARG134,SER389,GLN390,SER392,GLN393,PHE394,LYS395,ASP396,HIS406,ARG409,SER411,LEU413,PRO444,ILE452; Chain F:ASP323",2.5,True,2
ASD03710000_1,VC_1451,Vibrio cholerae,Q9KS12,3EEB,ASD03710003,IHP,A,Lig,Regulator,"(2,3,4,5,6-pentaphosphonooxycyclohexyl) dihydrogen phosphate",210,Inner Protein Regulator,Inner Protein,18845756,Small molecule-induced allosteric activation of the Vibrio cholerae RTX cysteine protease domain.,No,"Chain A:GLU27,THR28,ARG29,PHE30,LYS54,HIS55,ARG85,SER136,SER169,ARG171,ARG182,LYS183,LYS195,LYS200",2.1,True,1
ASD03710000_1,VC_1451,Vibrio cholerae,Q9KS12,3FZY,ASD03710003,IHP,A,Lig,Regulator,"(2,3,4,5,6-pentaphosphonooxycyclohexyl) dihydrogen phosphate",8000,Inner Protein Regulator,Inner Protein,19620709,Structural and molecular mechanism for autoprocessing of MARTX toxin of Vibrio cholerae at multiple sites.,No,"Chain A:GLU3455,THR3456,ARG3457,PHE3458,LYS3482,HIS3483,ARG3513,GLN3515,HIS3562,SER3564,SER3597,ARG3599,GLY3609,ARG3610,LYS3611,LYS3623,LYS3628",1.95,True,1
ASD03710000_1,VC_1451,Vibrio cholerae,Q9KS12,3GCD,ASD03710003,IHP,A,Lig,Regulator,"(2,3,4,5,6-pentaphosphonooxycyclohexyl) dihydrogen phosphate",214,Inner Protein Regulator,Inner Protein,19465933,Mechanistic and structural insights into the proteolytic  activation of Vibrio cholerae MARTX toxin.,No,"Chain A:GLU27,THR28,ARG29,PHE30,LYS54,HIS55,ARG85,SER136,SER169,ARG171,ARG182,LYS183,LYS195,LYS200",2.35,True,1
ASD03720000_3,vdra,Danio rerio,Q9PTN2,4Q0A,ASD03720014,4OA,C,Lig,Activator,"(4R)-4-[(3R,5R,8R,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid",502,Inner Protein Regulator,Inner Protein,24818857,Structural insights into the molecular mechanism of vitamin d receptor activation by lithocholic Acid involving a new mode of ligand recognition.,Yes,"Chain C:ASP181,ARG184,PHE185,ASP260,SER263,TYR264,GLN267",1.9,True,1
ASD03740000_2,,Hepatitis C virus,P26663,1NHU,ASD01418002,153,A,Lig,Inhibitor,"(2S)-2-[(2,4-dichlorophenyl)carbonyl-[[3-(trifluoromethyl)phenyl]methyl]amino]-3-phenyl-propanoic acid",5001,Inner Protein Regulator,Inner Protein,12509436,Non-Nucleoside Analogue Inhibitors Bind to an Allosteric Site on   HCV NS5B Polymerase: Crystal Structures and Mechanism of Inhibition,No,"Chain A:LEU419,ARG422,MET423,LEU474,HIS475,SER476,TYR477,ILE482,LEU497,ARG498,ARG501,TRP528",2.0,True,1
ASD03740000_2,,Hepatitis C virus,P26663,1NHV,ASD01410468,154,A,Lig,Inhibitor,"(2S)-2-[[5-(1-benzofuran-2-yl)thiophen-2-yl]methyl-(2,4-dichlorophenyl)carbonyl-amino]-3-phenyl-propanoic acid",5001,Inner Protein Regulator,Inner Protein,12509436,Non-Nucleoside Analogue Inhibitors Bind to an Allosteric Site on HCV NS5B Polymerase: Crystal Structures and Mechanism of Inhibition,No,"Chain A:ARG422,MET423,LEU474,HIS475,SER476,TYR477,LEU497,ARG501,TRP528",2.9,True,1
ASD03740000_2,,Hepatitis C virus,P26663,1OS5,ASD03740210,NH1,A,Lig,Inhibitor,(6S)-3-(4-amino-2-tert-butyl-5-methyl-phenyl)sulfanyl-6-cyclopentyl-4-hydroxy-6-[2-(4-hydroxyphenyl)ethyl]-5H-pyran-2-one,901,Inner Protein Regulator,Inner Protein,12805457,Crystallographic identification of a noncompetitive inhibitor binding site on the hepatitis C virus NS5B RNA polymerase enzyme.,No,"Chain A:LEU419,ARG422,MET423,SER473,LEU474,HIS475,SER476,TYR477,ILE482,LEU497,TRP528,LYS533",2.2,True,1
ASD03740000_2,,Hepatitis C virus,P26663,2AWZ,ASD01418008,5H,A,Lig,Inhibitor,"N-[(5R)-5-[(4-bromophenyl)methyl]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]benzenesulfonamide",801,Inner Protein Regulator,Inner Protein,16451069,SAR and Mode of Action of Novel Non-Nucleoside Inhibitors of Hepatitis C NS5b RNA Polymerase.,Yes,"Chain A:PHE193,PRO197,ARG200,CYS366,SER368,LEU384,GLY410,ASN411,MET414,TYR415,GLN446,ILE447,TYR448,GLY449,SER556",2.15,True,1
ASD03740000_2,,Hepatitis C virus,P26663,2AX0,ASD01418009,5X,A,Lig,Inhibitor,"N-[(5R)-5-[(E)-2-methyl-3-phenyl-prop-2-enyl]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]benzenesulfonamide",1001,Inner Protein Regulator,Inner Protein,16451069,SAR and Mode of Action of Novel Non-Nucleoside Inhibitors of Hepatitis C NS5b RNA Polymerase.,Yes,"Chain A:PHE193,PRO197,ARG200,ASN316,CYS366,SER368,LEU384,GLY410,ASN411,MET414,TYR415,GLN446,ILE447,TYR448,SER556",2.0,True,1
ASD03740000_2,,Hepatitis C virus,P26663,2AX1,ASD01418007,5EE,A,Lig,Inhibitor,"N-[(5R)-5-[(3,4-dichlorophenyl)methyl]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]thiophene-2-sulfonamide",1001,Inner Protein Regulator,Inner Protein,16451069,SAR and Mode of Action of Novel Non-Nucleoside Inhibitors of Hepatitis C NS5b RNA Polymerase.,Yes,"Chain A:PHE193,PRO197,ARG200,ASN316,CYS366,LEU384,GLY410,ASN411,MET414,TYR415,GLN446,ILE447,TYR448,GLY449,SER556",2.1,True,1
ASD03740000_2,,Hepatitis C virus,P26663,2BRK,ASD01410351,CMF,A,Lig,Inhibitor,3-cyclohexyl-1-(2-morpholin-4-yl-2-oxo-ethyl)-2-phenyl-indole-6-carboxylic acid,1534,Inner Protein Regulator,Inner Protein,15955819,Interdomain Communication in Hepatitis C Virus Polymerase Abolished by Small-Molecule Inhibitors Bound to a Novel Allosteric Site,No,"Chain A:VAL37,LEU392,ALA393,ALA395,ALA396,ILE424,LEU425,HIS428,PHE429,LEU492,GLY493,VAL494,PRO495,TRP500,ARG503",2.3,True,1
ASD03740000_2,,Hepatitis C virus,P26663,2BRL,ASD03740207,POO,A,Lig,Inhibitor,"3-cyclohexyl-1-[2-[methyl-[[(1S,3R)-1-methylpiperidin-3-yl]methyl]amino]-2-oxo-ethyl]-2-phenyl-indole-6-carboxylic acid",1534,Inner Protein Regulator,Inner Protein,15955819,Interdomain Communication in Hepatitis C Virus Polymerase Abolished by Small-Molecule Inhibitors Bound to a Novel Allosteric Site,No,"Chain A:VAL37,LEU392,ALA393,ALA395,ALA396,ILE424,LEU425,HIS428,PHE429,LEU492,GLY493,VAL494,PRO495,TRP500,ARG503",2.4,True,1
ASD03740000_2,,Hepatitis C virus,Q99AU2,2D3U,ASD01418011,CCT,A,Lig,Inhibitor,5-(4-cyanophenyl)-3-[(2-methylphenyl)sulfonylamino]thiophene-2-carboxylic acid,1001,Inner Protein Regulator,Inner Protein,16828488,Non-nucleoside Inhibitors Binding to Hepatitis C Virus NS5B Polymerase Reveal a Novel Mechanism of Inhibition,No,"Chain A:LEU419,ARG422,MET423,LEU474,HIS475,SER476,TYR477,ILE482,ALA486,LEU489,LEU497,TRP528",2.0,True,1
ASD03740000_2,,Hepatitis C virus,Q99AU2,2D3Z,ASD01418013,FIH,A,Lig,Inhibitor,5-(4-fluorophenyl)-3-[(4-methylphenyl)sulfonylamino]thiophene-2-carboxylic acid,2001,Inner Protein Regulator,Inner Protein,16828488,Non-nucleoside Inhibitors Binding to Hepatitis C Virus NS5B Polymerase Reveal a Novel Mechanism of Inhibition,No,"Chain A:LEU419,ARG422,MET423,LEU474,HIS475,SER476,TYR477,ILE482,ALA486,LEU489,LEU497,ARG501,TRP528",1.8,True,1
ASD03740000_2,,Hepatitis C virus,Q99AU2,2D41,ASD01418019,SNH,A,Lig,Inhibitor,"3-[(2,4-dimethylphenyl)sulfonylamino]-5-(5-ethanoylthiophen-2-yl)thiophene-2-carboxylic acid",1001,Inner Protein Regulator,Inner Protein,16828488,Non-nucleoside Inhibitors Binding to Hepatitis C Virus NS5B Polymerase Reveal a Novel Mechanism of Inhibition,No,"Chain A:LEU419,ARG422,MET423,LEU474,HIS475,SER476,TYR477,ILE482,ALA486,LEU489,PRO496,LEU497,ARG501,TRP528",2.1,True,1
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,2DXS,ASD03740246,JTP,A,Lig,Inhibitor,"N-[(13-cyclohexyl-6,7-dihydroindolo[1,2-d][1,4]benzoxazepin-10-yl)carbonyl]-2-methyl-D-alanine",1000,Inner Protein Regulator,Inner Protein,17125247,Discovery of Conformationally Constrained Tetracyclic Compounds as Potent Hepatitis C Virus NS5B RNA Polymerase Inhibitors,No,"Chain A:VAL37,LEU392,ALA393,ALA395,ALA396,THR399,ILE424,LEU425,HIS428,PHE429,LEU492,GLY493,VAL494,PRO495,TRP500,ARG503",2.2,True,1
ASD03740000_2,,Hepatitis C virus,Q99AU2,2FVC,ASD03740228,888,A,Lig,Inhibitor,"3-(1,1-dioxo-4H-benzo[e][1,2,4]thiadiazin-3-yl)-4-hydroxy-1-(3-methylbutyl)quinolin-2-one",901,Inner Protein Regulator,Inner Protein,16451063,"3-(1,1-dioxo-2H-(1,2,4)-benzothiadiazin-3-yl)-4-hydroxy-2(1H)-quinolinones, potent inhibitors of hepatitis C virus RNA-dependent RNA polymerase.",Yes,"Chain A:PHE193,PRO197,ARG200,ASN316,CYS366,SER368,LEU384,GLY410,ASN411,MET414,TYR415,GLN446,TYR448,GLY449,SER556",2.0,True,1
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,2GIQ,ASD03740273,NN2,A,Lig,Inhibitor,"1-(2-cyclopropylethyl)-3-(1,1-dioxo-2H-benzo[e][1,2,4]thiadiazin-3-yl)-6-fluoro-4-hydroxy-quinolin-2-one",1001,Inner Protein Regulator,Inner Protein,16731953,Selection and characterization of replicon variants dually resistant to thumb- and palm-binding nonnucleoside polymerase inhibitors of the hepatitis C virus.,No,"Chain A:PHE193,ARG200,ASN316,ASP318,CYS366,SER368,LEU384,GLY410,ASN411,MET414,TYR415,GLN446,TYR448,GLY449,SER556",1.65,True,1
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,2GIR,ASD03740241,NN3,A,Lig,Inhibitor,3-[(4-methylcyclohexyl)carbonyl-propan-2-yl-amino]-5-phenyl-thiophene-2-carboxylic acid,1001,Inner Protein Regulator,Inner Protein,16731953,Selection and characterization of replicon variants dually resistant to thumb- and palm-binding nonnucleoside polymerase inhibitors of the hepatitis C virus.,No,"Chain A:LEU419,ARG422,MET423,LEU474,HIS475,SER476,TYR477,ILE482,LEU497,TRP528",1.9,True,1
ASD03740000_2,,Hepatitis C virus,Q99AU2,2HAI,ASD01418016,PFI,A,Lig,Inhibitor,(6S)-6-cyclopentyl-6-[2-(3-fluoro-4-propan-2-yloxy-phenyl)ethyl]-4-hydroxy-5H-pyran-2-one,601,Inner Protein Regulator,Inner Protein,16824756,Identification and structure-based optimization of novel dihydropyrones as potent HCV RNA polymerase inhibitors.,No,"Chain A:LEU419,ARG422,MET423,HIS475,SER476,TYR477,ILE482,ALA486,LEU497,ARG501,TRP528",1.58,True,1
ASD03740000_2,,Hepatitis C virus,P26663,2HWH,ASD03740218,RNA,A,Lig,Inhibitor,"4-methyl-N-[5-[(5-methylfuran-2-yl)methylidene]-4-oxo-1,3-thiazol-2-yl]benzenesulfonamide",960,Inner Protein Regulator,Inner Protein,16934455,Structure-based design of a novel thiazolone scaffold as HCV NS5B polymerase allosteric inhibitors.,No,"Chain A:LEU419,ARG422,MET423,LEU474,HIS475,SER476,TYR477,ILE482,LEU497,ARG501,TRP528",2.3,True,1
ASD03740000_2,,Hepatitis C virus,P26663,2HWI,ASD03740219,VRX,A,Lig,Inhibitor,"(2S)-2-[[(5Z)-5-[(5-ethylfuran-2-yl)methylidene]-4-oxo-1,3-thiazol-2-yl]amino]-2-(4-fluorophenyl)ethanoic acid",600,Inner Protein Regulator,Inner Protein,16934455,Structure-based design of a novel thiazolone scaffold as HCV NS5B polymerase allosteric inhibitors.,No,"Chain A:LEU419,ARG422,MET423,LEU474,HIS475,SER476,TYR477,ILE482,VAL485,ALA486,LEU489,LEU497,ARG501,TRP528,LYS533",2.0,True,1
ASD03740000_2,,Hepatitis C virus,P26663,2I1R,ASD01418022,VXR,A,Lig,Inhibitor,"(5Z)-5-[(5-ethylfuran-2-yl)methylidene]-2-[[(S)-(4-fluorophenyl)-(1H-1,2,3,4-tetrazol-5-yl)methyl]amino]-1,3-thiazol-4-one",600,Inner Protein Regulator,Inner Protein,17049849,"Novel thiazolones as HCV NS5B polymerase allosteric inhibitors: Further designs, SAR, and X-ray complex structure.",No,"Chain A:LEU419,ARG422,MET423,LEU474,SER476,TYR477,ILE482,VAL485,LEU497,ARG501,TRP528,LYS533",2.2,True,1
ASD03740000_2,,Hepatitis C virus,P26663,2JC0,ASD03740225,699,A,Lig,Inhibitor,"(2S,4S,5R)-2-(2-methylpropyl)-5-thiophen-2-yl-1-[4-(trifluoromethyl)phenyl]carbonyl-pyrrolidine-2,4-dicarboxylic acid",1564,Inner Protein Regulator,Inner Protein,17269759,Optimization of Novel Acyl Pyrrolidine Inhibitors of Hepatitis C Virus RNA-Dependent RNA Polymerase Leading to a Development Candidate.,No,"Chain A:LEU419,ARG422,MET423,LEU474,HIS475,SER476,TYR477,ARG501,TRP528,LYS533",2.2,True,1
ASD03740000_2,,Hepatitis C virus,P26663,2JC0,ASD03740225,699,A,Lig,Inhibitor,"(2S,4S,5R)-2-(2-methylpropyl)-5-thiophen-2-yl-1-[4-(trifluoromethyl)phenyl]carbonyl-pyrrolidine-2,4-dicarboxylic acid",1563,Inner Protein Regulator,Inner Protein,17269759,Optimization of Novel Acyl Pyrrolidine Inhibitors of Hepatitis C Virus RNA-Dependent RNA Polymerase Leading to a Development Candidate.,Yes,"Chain A:ARG200,ASN316,SER365,CYS366,SER368,LEU384,ARG386,GLY410,ASN411,MET414,TYR415,GLN446,ILE447,TYR448,GLY449",2.2,True,1
ASD03740000_2,,Hepatitis C virus,P26663,2JC1,ASD03740227,698,A,Lig,Inhibitor,"(2S,4S,5R)-1-(4-tert-butylphenyl)carbonyl-2-(2-methylpropyl)-5-(1,3-thiazol-2-yl)pyrrolidine-2,4-dicarboxylic acid",600,Inner Protein Regulator,Inner Protein,17269759,Optimization of Novel Acyl Pyrrolidine Inhibitors of Hepatitis C Virus RNA-Dependent RNA Polymerase Leading to a Development Candidate.,Yes,"Chain A:PRO197,ARG200,CYS366,SER368,LEU384,ARG386,SER407,GLY410,ASN411,MET414,TYR415,GLN446,ILE447,TYR448,GLY449",2.0,True,1
ASD03740000_2,,Hepatitis C virus,P26663,2O5D,ASD03740220,VR1,A,Lig,Inhibitor,"(2S)-2-[[(5Z)-5-[(5-ethylfuran-2-yl)methylidene]-4-oxo-1,3-thiazol-2-yl]amino]-2-(4-fluorophenyl)-N-(4-nitrophenyl)sulfonyl-ethanamide",600,Inner Protein Regulator,Inner Protein,17276060,Thiazolone-acylsulfonamides as novel HCV NS5B polymerase allosteric inhibitors: Convergence of structure-based drug design and X-ray crystallographic study.,No,"Chain A:LEU419,ARG422,MET423,LEU474,HIS475,SER476,TYR477,ILE482,VAL485,ALA486,LEU497,ARG501,TRP528,VAL530,LYS533",2.2,True,1
ASD03740000_2,,Hepatitis C virus,Q99AU2,2QE2,ASD01410051,452,A,Lig,Inhibitor,2-[2-[(5-chloro-2-ethanoyl-4-fluoro-phenyl)amino]ethanoylamino]benzoic acid,579,Inner Protein Regulator,Inner Protein,17402724,Identification of Anthranilic Acid Derivatives as a Novel Class of Allosteric Inhibitors of Hepatitis C NS5B Polymerase,Yes,"Chain A:PHE193,PRO197,ARG200,CYS366,SER368,ARG386,GLY410,ASN411,MET414,TYR415,GLN446,ILE447,TYR448",2.9,True,1
ASD03740000_2,,Hepatitis C virus,Q99AU2,2QE5,ASD01410015,617,A,Lig,Inhibitor,2-[2-(4-chlorophenoxy)ethanoylamino]benzoic acid,579,Inner Protein Regulator,Inner Protein,17402724,Identification of Anthranilic Acid Derivatives as a Novel Class of Allosteric Inhibitors of Hepatitis C NS5B Polymerase,Yes,"Chain A:PRO197,ARG200,CYS366,LEU384,ARG386,GLY410,ASN411,MET414,TYR415,GLN446,ILE447,TYR448",2.6,True,1
ASD03740000_2,,Hepatitis C virus,P26663,2WCX,ASD01418020,VGC,A,Lig,Inhibitor,"6-cyclohexyl-4-methyl-5-phenyl-thieno[4,5-b]pyrrole-2-carboxylic acid",1534,Inner Protein Regulator,Inner Protein,19672916,Optimization of Thienopyrrole-Based Finger-Loop Inhibitors of the Hepatitis C Virus Ns5B Polymerase.,No,"Chain A:VAL37,LEU392,ALA393,ALA395,ALA396,THR399,ILE424,HIS428,LEU492,GLY493,VAL494,PRO495,TRP500,ARG503",2.0,True,1
ASD03740000_2,,Hepatitis C virus,P26663,2WHO,ASD01411053,VGI,A,Lig,Inhibitor,"2-(3-BROMOPHENYL)-6-[(2-HYDROXYETHYL)AMINO]- 1H-BENZO[DE]ISOQUINOLINE-1,3(2H)-DIONE",1534,Inner Protein Regulator,Inner Protein,19877603,"Identification and Biological Evaluation of a Series of 1H-Benzo[De]Isoquinoline-1,3(2H)-Diones as Hepatitis C Virus Ns5B Polymerase Inhibitors",No,"Chain A:ARG422,MET423,LEU474,HIS475,ILE482,ALA486,ARG498,ARG501,TRP528",2.0,True,1
ASD03740000_2,,Hepatitis C virus,P26663,2WRM,ASD01410467,QQ3,A,Lig,Inhibitor,"(3R)-3-(4-methyl-1,3-dioxo-pyrrolo[3,4-c]quinolin-2-yl)hexanoic acid",1532,Inner Protein Regulator,Inner Protein,,Identification of Novel Allosteric Inhibitors of Hepatitis C Virus Ns5B Polymerase Thumb Domain (Site II) by Structure-Based Design,No,"Chain A:ARG422,MET423,TYR477,LEU497,ARG498,ARG501,TRP528",1.95,True,1
ASD03740000_2,,Hepatitis C virus,P26663,2XWY,ASD01418014,IB8,A,Lig,Inhibitor,"(7R)-14-cyclohexyl-7-{[2-(dimethylamino)ethyl](methyl)amino}- 7,8-dihydro-6H-indolo[1,2-e][1,5]benzoxazocine- 11-carboxylic acid",1532,Inner Protein Regulator,Inner Protein,21141896,"Discovery of (7R)-14-Cyclohexyl-7-{[2-(Dimethylamino)Ethyl] (Methyl)Amino}-7,8-Dihydro-6H-Indolo[1,2-E][1,5] Benzoxazocine -11-Carboxylic Acid (Mk-3281), a Potent and Orally Bioavailable Finger-Loop Inhibitor of the Hepatitis C Virus Ns5B Polymerase",No,"Chain A:VAL37,LEU392,ALA395,ALA396,ILE424,HIS428,PHE429,LEU492,GLY493,VAL494,PRO495,ARG503",2.53,True,1
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,3BR9,ASD03740260,DEY,A,Lig,Inhibitor,"(2R)-2-[[3-[5-hydroxy-2-(3-methylbutyl)-3-oxo-6-thiophen-2-yl-pyridazin-4-yl]-1,1-dioxo-2H-benzo[e][1,2,4]thiadiazin-7-yl]oxy]propanamide",579,Inner Protein Regulator,Inner Protein,18242088,"Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda6-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 1: exploration of 7'-substitution of benzothiadiazine.",No,"Chain A:PHE193,PRO197,ARG200,ASP225,THR287,SER288,ASN291,ASN316,GLY317,ASP318,CYS366,SER368,LEU384,GLY410,ASN411,MET414,TYR415,GLN446,ILE447,TYR448,GLY449,SER556",2.3,True,1
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,3BSA,ASD03740270,1PD,A,Lig,Inhibitor,"2-[[3-[5-hydroxy-2-(3-methylbutyl)-3-oxo-6-(1,3-thiazol-5-yl)pyridazin-4-yl]-1,1-dioxo-2H-benzo[e][1,2,4]thiadiazin-7-yl]oxy]ethanamide",579,Inner Protein Regulator,Inner Protein,18242088,"Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda6-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 1: exploration of 7'-substitution of benzothiadiazine.",No,"Chain A:PHE193,PRO197,ARG200,THR287,ASN291,ASN316,GLY317,ASP318,CYS366,SER368,LEU384,GLY410,ASN411,MET414,TYR415,GLN446,ILE447,TYR448,GLY449,SER556",2.3,True,1
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,3BSC,ASD03740259,2PD,A,Lig,Inhibitor,"5-hydroxy-4-(7-methoxy-1,1-dioxo-2H-benzo[e][1,2,4]thiadiazin-3-yl)-2-(3-methylbutyl)-6-phenyl-pyridazin-3-one",579,Inner Protein Regulator,Inner Protein,18242088,"Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda6-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 1: exploration of 7'-substitution of benzothiadiazine.",No,"Chain A:PHE193,PRO197,ARG200,ASN316,GLY317,ASP318,CYS366,SER368,LEU384,GLY410,ASN411,MET414,TYR415,GLN446,TYR448,GLY449,SER556",2.65,True,1
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,3CDE,ASD03740248,N3H,A,Lig,Inhibitor,"N-[3-[5-hydroxy-2-(3-methylbutyl)-3-oxo-6-thiophen-2-yl-pyridazin-4-yl]-1,1-dioxo-2H-benzo[e][1,2,4]thiadiazin-7-yl]methanesulfonamide",579,Inner Protein Regulator,Inner Protein,18457949,"Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda(6)-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 3: Further optimization of the 2-, 6-, and 7'-substituents and initial pharmacokinetic assessments.",No,"Chain A:PHE193,PRO197,ARG200,SER288,ASN291,ASN316,GLY317,ASP318,CYS366,SER368,LEU384,GLY410,ASN411,MET414,TYR415,GLN446,ILE447,TYR448,GLY449,SER556",2.1,True,1
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,3CIZ,ASD03740243,SX1,B,Lig,Inhibitor,2-amino-5-bromo-benzoic acid,572,Inner Protein Regulator,Inner Protein,18400495,Fragment-based discovery of hepatitis C virus NS5b RNA polymerase inhibitors.,No,"Chain B:LEU419,ARG422,MET423,LEU474,HIS475,ARG501,TRP528,LYS533",1.87,True,1
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,3CJ0,ASD03740236,SX2,A,Lig,Inhibitor,4-[(5-bromopyridin-2-yl)amino]-4-oxo-butanoic acid,571,Inner Protein Regulator,Inner Protein,18400495,Fragment-based discovery of hepatitis C virus NS5b RNA polymerase inhibitors.,No,"Chain A:LEU419,ARG422,MET423,LEU474,HIS475,SER476,TYR477,ARG501,TRP528",1.9,True,1
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,3CJ2,ASD03740235,SX3,A,Lig,Inhibitor,"(2-amino-5-bromo-phenyl)-[(3R,5S)-3,5-dimethylpiperidin-1-yl]methanone",571,Inner Protein Regulator,Inner Protein,18400495,Fragment-based discovery of hepatitis C virus NS5b RNA polymerase inhibitors.,No,"Chain A:ARG422,MET423,LEU474,HIS475,TYR477,ILE482,LEU497,ARG498,ARG501,TRP528",1.75,True,1
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,3CJ3,ASD03740244,SX4,A,Lig,Inhibitor,(2-amino-5-bromo-phenyl)-[(2R)-2-[(2-chlorophenyl)methyl]pyrrolidin-1-yl]methanone,572,Inner Protein Regulator,Inner Protein,18400495,Fragment-based discovery of hepatitis C virus NS5b RNA polymerase inhibitors.,No,"Chain A:LEU419,ARG422,MET423,LEU474,HIS475,SER476,TYR477,ILE482,LEU497,ARG498,ARG501,TRP528",1.87,True,1
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,3CJ4,ASD03740237,SX5,A,Lig,Inhibitor,"4-[[4-bromo-2-[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl-phenyl]amino]-4-oxo-butanoic acid",571,Inner Protein Regulator,Inner Protein,18400495,Fragment-based discovery of hepatitis C virus NS5b RNA polymerase inhibitors.,No,"Chain A:LEU419,ARG422,MET423,LEU474,HIS475,SER476,TYR477,ILE482,LEU497,ARG498,ARG501,TRP528",2.07,True,1
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,3CJ5,ASD03740234,SX6,A,Lig,Inhibitor,"N-[4-bromo-2-[(3S,5R)-3,5-dimethylpiperidin-1-yl]carbonyl-phenyl]-4-morpholin-4-yl-4-oxo-butanamide",571,Inner Protein Regulator,Inner Protein,18400495,Fragment-based discovery of hepatitis C virus NS5b RNA polymerase inhibitors.,No,"Chain A:LEU419,ARG422,MET423,LEU474,HIS475,SER476,TYR477,ILE482,LEU497,ARG498,ARG501,TRP528",1.92,True,1
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,3CO9,ASD03740261,3MS,A,Lig,Inhibitor,"N-[3-[4-hydroxy-1-(3-methylbutyl)-2-oxo-pyrrolo[2,1-f]pyridazin-3-yl]-1,1-dioxo-2H-benzo[e][1,2,4]thiadiazin-7-yl]methanesulfonamide",579,Inner Protein Regulator,Inner Protein,18487044,"Pyrrolo[1,2-b]pyridazin-2-ones as potent inhibitors of HCV NS5B polymerase.",No,"Chain A:PHE193,PRO197,ARG200,SER288,ASN291,ASN316,GLY317,ASP318,CYS366,SER368,LEU384,ASN411,MET414,TYR415,ILE447,TYR448,GLY449,SER556",2.1,True,1
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,3CVK,ASD03740267,N34,A,Lig,Inhibitor,"N-[3-[(4aS,8S)-1-(3,3-dimethylbutyl)-4-hydroxy-2-oxo-4a,5,6,7-tetrahydropyrrolo[2,1-f]pyridazin-3-yl]-1,1-dioxo-2H-benzo[e][1,2,4]thiadiazin-7-yl]methanesulfonamide",579,Inner Protein Regulator,Inner Protein,18722768,"Hexahydro-pyrrolo- and hexahydro-1H-pyrido[1,2-b]pyridazin-2-ones as potent inhibitors of HCV NS5B polymerase.",No,"Chain A:PHE193,PRO197,ARG200,SER288,ASN291,ASN316,GLY317,ASP318,CYS366,SER368,ASN411,MET414,TYR415,ILE447,TYR448,GLY449,SER556",2.31,True,1
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,3CWJ,ASD03740265,321,A,Lig,Inhibitor,"N-[3-[5-hydroxy-2-(3-methylbutyl)-3-oxo-6-thiophen-2-yl-pyridazin-4-yl]-1,1-dioxo-2H-benzo[b][1,4]thiazin-7-yl]methanesulfonamide",1001,Inner Protein Regulator,Inner Protein,18662878,"4-(1,1-Dioxo-1,4-dihydro-1lambda6-benzo[1,4]thiazin-3-yl)-5-hydroxy-2H-pyridazin-3-ones as potent inhibitors of HCV NS5B polymerase",No,"Chain A:PHE193,PRO197,ARG200,SER288,ASN291,ASN316,GLY317,ASP318,CYS366,SER368,LEU384,GLY410,ASN411,MET414,TYR415,GLN446,ILE447,TYR448,GLY449,SER556",2.4,True,1
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,3D28,ASD03740268,B34,A,Lig,Inhibitor,"(5S)-3-(1,1-dioxo-1,2-benzothiazol-3-yl)-4-hydroxy-1-(phenylmethyl)-5-propan-2-yl-5H-pyrrol-2-one",579,Inner Protein Regulator,Inner Protein,18554907,"Structure-based design, synthesis, and biological evaluation of 1,1-dioxoisothiazole and benzo[b]thiophene-1,1-dioxide derivatives as novel inhibitors of hepatitis C virus NS5B polymerase.",No,"Chain A:PHE193,PRO197,ARG200,ASN316,CYS366,SER368,LEU384,GLY410,MET414,TYR415,GLN446,ILE447,TYR448,GLY449,SER556",2.3,True,1
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,3D5M,ASD03740275,4MS,A,Lig,Inhibitor,"N-[[3-[(5S)-5-tert-butyl-1-[(3-chloro-4-fluoro-phenyl)methyl]-4-hydroxy-2-oxo-5H-pyrrol-3-yl]-1,1-dioxo-1,2-benzothiazol-7-yl]methyl]methanesulfonamide",579,Inner Protein Regulator,Inner Protein,18554907,"Structure-based design, synthesis, and biological evaluation of 1,1-dioxoisothiazole and benzo[b]thiophene-1,1-dioxide derivatives as novel inhibitors of hepatitis C virus NS5B polymerase.",No,"Chain A:PHE193,PRO197,ARG200,SER288,ASN291,ASN316,GLY317,ASP318,ASP319,CYS366,SER368,LEU384,ASN411,MET414,TYR415,GLN446,ILE447,TYR448,GLY449,SER556",2.2,True,1
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,3FQK,ASD03740266,79Z,A,Lig,Inhibitor,5-cyclopropyl-2-(4-fluorophenyl)-6-(2-hydroxyethyl-methylsulfonyl-amino)-N-methyl-1-benzofuran-3-carboxamide,571,Inner Protein Regulator,Inner Protein,19246450,Slow binding inhibition and mechanism of resistance of non-nucleoside polymerase inhibitors of hepatitis C virus.,No,"Chain A:PHE193,PRO197,ARG200,LEU204,LEU314,ASN316,ASP319,VAL321,LEU360,ILE363,SER365,CYS366,SER368,ASN369,LEU384,MET414,TYR415,TYR448",2.2,True,1
ASD03740000_2,,Hepatitis C virus,P26663,3FRZ,ASD09990001,AG0,A,Lig,Inhibitor,"(6R)-6-cyclopentyl-6-[2-(2,6-diethylpyridin-4-yl)ethyl]-3-[(5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl]-4-hydroxy-5H-pyran-2-one",577,Inner Protein Regulator,Inner Protein,19209845,"Discovery of (R)-6-cyclopentyl-6-(2-(2,6-diethylpyridin-4-yl)ethyl)-3-((5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl)-4-hydroxy-5,6-dihydropyran-2-one (PF-00868554) as a potent and orally available hepatitis C virus polymerase inhibitor.",No,"Chain A:LEU419,ARG422,MET423,SER473,HIS475,SER476,TYR477,ILE482,VAL485,LEU497,ARG501,TRP528",1.86,True,1
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,3G86,ASD03740278,T18,A,Lig,Inhibitor,"N-[3-[6-fluoro-1-[(4-fluorophenyl)methyl]-4-hydroxy-2-oxo-quinolin-3-yl]-1,1-dioxo-4H-benzo[b][1,4]thiazin-7-yl]methanesulfonamide",571,Inner Protein Regulator,Inner Protein,19457662,Non-nucleoside inhibitors of HCV polymerase NS5B. Part 2: Synthesis and structure-activity relationships of benzothiazine-substituted quinolinediones,No,"Chain A:PHE193,PRO197,ARG200,SER288,ASN291,ASN316,GLY317,ASP318,CYS366,SER368,LEU384,GLY410,ASN411,MET414,TYR415,GLN446,ILE447,TYR448,GLY449,SER556",2.2,True,1
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,3GYN,ASD03740280,B42,A,Lig,Inhibitor,"N-[3-[(5R)-1-cyclopentyl-4-hydroxy-5-methyl-5-(3-methylbutyl)-2-oxo-6H-pyridin-3-yl]-1,1-dioxo-4H-benzo[e][1,2,4]thiadiazin-7-yl]methanesulfonamide",579,Inner Protein Regulator,Inner Protein,19796938,"5,5'- and 6,6'-dialkyl-5,6-dihydro-1H-pyridin-2-ones as potent inhibitors of HCV NS5B polymerase.",No,"Chain A:PHE193,ARG200,SER288,ASN291,ASN316,GLY317,ASP318,CYS366,SER367,LEU384,ARG386,GLY410,ASN411,MET414,TYR415,GLN446,ILE447,TYR448,GLY449,SER556",2.15,True,1
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,3H2L,ASD03740262,YAK,A,Lig,Inhibitor,"N-[3-[(4aR,7aS)-1-[(4-fluorophenyl)methyl]-4-hydroxy-2-oxo-5,6,7,7a-tetrahydro-4aH-cyclopenta[e]pyridin-3-yl]-1,1-dioxo-2H-benzo[e][1,2,4]thiadiazin-7-yl]methanesulfonamide",601,Inner Protein Regulator,Inner Protein,19818610,"Discovery of tricyclic 5,6-dihydro-1H-pyridin-2-ones as novel, potent, and orally bioavailable inhibitors of HCV NS5B polymerase.",No,"Chain A:PHE193,PRO197,ARG200,SER288,ASN291,ASN316,GLY317,ASP318,ASP319,CYS366,SER368,LEU384,MET414,TYR415,GLN446,ILE447,TYR448,GLY449,SER556",1.9,True,1
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,3H59,ASD03740279,H59,A,Lig,Inhibitor,"N-[3-[(5S)-1-[(4-fluoro-3-methyl-phenyl)methyl]-4-hydroxy-5-(2-methylbutan-2-yl)-2-oxo-5H-pyrrol-3-yl]-1,1-dioxo-4H-benzo[b][1,4]thiazin-7-yl]methanesulfonamide",571,Inner Protein Regulator,Inner Protein,19700319,Non-nucleoside inhibitors of HCV polymerase NS5B. Part 3: synthesis and optimization studies of benzothiazine-substituted tetramic acids,No,"Chain A:PHE193,PRO197,ARG200,SER288,ASN291,ASN316,GLY317,ASP318,CYS366,SER368,LEU384,GLY410,ASN411,MET414,TYR415,GLN446,ILE447,TYR448,GLY449,SER556",2.1,True,1
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,3H5S,ASD03740277,H5S,A,Lig,Inhibitor,"(5S)-5-tert-butyl-1-[(4-fluoro-3-methyl-phenyl)methyl]-4-hydroxy-3-(8-methylsulfonyl-1,1-dioxo-7,9-dihydro-6H-[1,2]thiazolo[4,5-h]isoquinolin-3-yl)-5H-pyrrol-2-one",571,Inner Protein Regulator,Inner Protein,19709881,"Non-nucleoside inhibitors of HCV polymerase NS5B. Part 4: structure-based design, synthesis, and biological evaluation of benzo[d]isothiazole-1,1-dioxides",No,"Chain A:PHE193,PRO197,ARG200,SER288,ASN291,ASN316,GLY317,ASP318,ASP319,CYS366,SER368,LEU384,ASN411,MET414,TYR415,GLN446,ILE447,TYR448,GLY449,SER556",2.0,True,1
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,3H5U,ASD03740276,H5U,A,Lig,Inhibitor,"N-[[3-[(5S)-5-tert-butyl-1-[(4-fluorophenyl)methyl]-4-hydroxy-2-oxo-5H-pyrrol-3-yl]-1,1-dioxo-1,2-benzothiazol-7-yl]methyl]methanesulfonamide",571,Inner Protein Regulator,Inner Protein,19709881,"Non-nucleoside inhibitors of HCV polymerase NS5B. Part 4: structure-based design, synthesis, and biological evaluation of benzo[d]isothiazole-1,1-dioxides",No,"Chain A:PHE193,PRO197,ARG200,SER288,ASN291,ASN316,GLY317,ASP318,ASP319,CYS366,LEU384,GLY410,ASN411,MET414,TYR415,GLN446,ILE447,TYR448,GLY449,SER556",1.95,True,1
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,3H98,ASD03740258,B5P,A,Lig,Inhibitor,"N-[3-[5-hydroxy-8-(3-methylbutyl)-7-oxo-imidazo[2,1-b]pyrimidin-6-yl]-1,1-dioxo-4H-benzo[e][1,2,4]thiadiazin-7-yl]methanesulfonamide",571,Inner Protein Regulator,Inner Protein,19500983,"HCV NS5B polymerase inhibitors 2: Synthesis and in vitro activity of (1,1-dioxo-2H-[1,2,4]benzothiadiazin-3-yl) azolo[1,5-a]pyridine and azolo[1,5-a]pyrimidine derivatives.",No,"Chain A:PHE193,SER288,ASN291,ASN316,GLY317,ASP318,CYS366,SER368,LEU384,MET414,TYR415,ILE447,TYR448,GLY449,SER556",1.9,True,1
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,3IGV,ASD03740271,B80,A,Lig,Inhibitor,"N-[3-[(2S)-2-ethyl-1-[(4-fluorophenyl)methyl]-4-hydroxy-6-oxo-2,3-dihydropyridin-5-yl]-1,1-dioxo-2H-benzo[e][1,2,4]thiadiazin-7-yl]methanesulfonamide",579,Inner Protein Regulator,Inner Protein,19796938,"5,5'- and 6,6'-dialkyl-5,6-dihydro-1H-pyridin-2-ones as potent inhibitors of HCV NS5B polymerase.",No,"Chain A:PHE193,PRO197,ARG200,SER288,ASN291,ASN316,GLY317,ASP318,CYS366,SER368,LEU384,ASN411,MET414,TYR415,ILE447,TYR448,GLY449,SER556",2.6,True,1
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,3MF5,ASD03740239,HJZ,A,Lig,Inhibitor,3-[2-(4-methylcyclohexyl)phenyl]-5-phenyl-thiophene-2-carboxylic acid,571,Inner Protein Regulator,Inner Protein,20584604,Cyclic amide bioisosterism: Strategic application to the design and synthesis of HCV NS5B polymerase inhibitors.,No,"Chain A:LEU419,ARG422,MET423,LEU474,HIS475,SER476,TYR477,ILE482,ALA486,LEU497,ARG501,TRP528",2.0,True,1
ASD03740000_2,,Hepatitis C virus,P26663,3UDL,ASD01418015,KLI,A,Lig,Inhibitor,"6-fluoranyl-1-[[2-fluoranyl-4-(trifluoromethyl)phenyl]methyl]-7-(4-methylpiperazin-1-yl)-3-[5-(phenylmethyl)-1,2,4-oxadiazol-3-yl]quinolin-4-one",571,Inner Protein Regulator,Inner Protein,21145235,Quinolones as HCV NS5B polymerase inhibitors.,No,"Chain A:LEU419,ARG422,MET423,LEU474,HIS475,SER476,TYR477,SER478,PRO479,ILE482,ASN483,VAL485,ALA486,LEU489,LEU497,TRP528",2.174,True,1
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,3VQS,ASD03740281,JT1,A,Lig,Inhibitor,"(2R)-4-(5-cyclopropyl-[1,3]thiazolo[4,5-d]pyrimidin-2-yl)-N-[[3-fluoranyl-4-(trifluoromethyloxy)phenyl]methyl]-1-[4-(trifluoromethyl)phenyl]sulfonyl-piperazine-2-carboxamide",1000,Inner Protein Regulator,Inner Protein,22615294,"Preclinical Characterization of JTK-853, a Novel Nonnucleoside Inhibitor of the Hepatitis C Virus RNA-Dependent RNA Polymerase.",No,"Chain A:VAL179,TYR191,GLY192,PHE193,TYR195,SER196,PRO197,ARG200,SER288,CYS289,ASN316,CYS366,SER368,LEU384,ILE413,MET414,TYR415,ILE447,TYR448,ALA450,TYR452,ILE454,ILE462,LEU466,LEU547,PHE551",1.9,True,1
ASD03740000_2,,Hepatitis C virus,P26663,4B6E,ASD03740034,10L,B,Lig,Inhibitor,1H-indazol-7-amine,1722,Inner Protein Regulator,Inner Protein,23023261,Discovery of an Allosteric Mechanism for the Regulation of Hcv Ns3 Protein Function.,Yes,"Chain B:TYR56,HIS57,VAL78,ASP79,ASP81,MET485,VAL524,CYS525,GLN526",2.46,True,1
ASD03740000_2,,Hepatitis C virus,P26663,4B6F,ASD03740193,20L,A,Lig,Inhibitor,(4-phenoxyphenyl)methylazanium,1722,Inner Protein Regulator,Inner Protein,23023261,Discovery of an Allosteric Mechanism for the Regulation of Hcv Ns3 Protein Function.,Yes,"Chain A:HIS57,VAL78,ASP79,GLN80,ASP81,ARG155,MET485,PHE486,VAL524,CYS525,GLN526,GLU628,VAL630",2.89,True,1
ASD03740000_2,,Hepatitis C virus,P26663,4B71,ASD03740195,DJL,A,Lig,Inhibitor,[(1R)-1-(4-chloranyl-2-fluoranyl-3-phenoxy-phenyl)propyl]azanium,1721,Inner Protein Regulator,Inner Protein,23023261,Discovery of an Allosteric Mechanism for the Regulation of Hcv Ns3 Protein Function.,Yes,"Chain A:TYR56,HIS57,VAL78,ASP79,GLN80,ASP81,ARG155,MET485,PHE486,VAL524,CYS525,GLN526,ASP527,GLU628,VAL630",2.5,True,1
ASD03740000_2,,Hepatitis C virus,P26663,4B73,ASD03740202,4VA,A,Lig,Inhibitor,[(2S)-4-azanyl-4-oxidanylidene-butan-2-yl]-[(1R)-1-(4-chloranyl-2-fluoranyl-3-phenoxy-phenyl)propyl]azanium,1721,Inner Protein Regulator,Inner Protein,23023261,Discovery of an Allosteric Mechanism for the Regulation of Hcv Ns3 Protein Function.,Yes,"Chain A:HIS57,VAL78,ASP79,GLN80,ASP81,ARG155,MET485,PHE486,LEU517,ASN518,PRO523,VAL524,CYS525,GLN526,ASP527,GLU628,VAL630",2.5,True,1
ASD03740000_2,,Hepatitis C virus,P26663,4B74,ASD03740203,1LH,A,Lig,Inhibitor,[(2S)-4-(2-azaniumylethylamino)-4-oxidanylidene-butan-2-yl]-[(1R)-1-(4-chloranyl-2-fluoranyl-3-phenoxy-phenyl)propyl]azanium,1721,Inner Protein Regulator,Inner Protein,23023261,Discovery of an Allosteric Mechanism for the Regulation of Hcv Ns3 Protein Function,Yes,"Chain A:HIS57,VAL78,ASP79,GLN80,ASP81,ARG155,MET485,PHE486,TYR516,LEU517,THR519,PRO520,GLY521,LEU522,PRO523,VAL524,CYS525,GLN526,ASP527,GLU628,VAL630",2.18,True,1
ASD03740000_2,,Hepatitis C virus,P26663,4B75,ASD03740202,4VA,A,Lig,Inhibitor,[(2S)-4-azanyl-4-oxidanylidene-butan-2-yl]-[(1R)-1-(4-chloranyl-2-fluoranyl-3-phenoxy-phenyl)propyl]azanium,1721,Inner Protein Regulator,Inner Protein,23023261,Discovery of an Allosteric Mechanism for the Regulation of Hcv Ns3 Protein Function.,Yes,"Chain A:HIS57,VAL78,ASP79,GLN80,ASP81,ARG155,MET485,PHE486,LEU517,PRO523,VAL524,CYS525,GLN526,ASP527,GLU628,LEU630",2.53,True,1
ASD03740000_2,,Hepatitis C virus,P26663,4B76,ASD03740205,PW1,A,Lig,Inhibitor,"[2,4-bis(fluoranyl)-3-phenoxy-phenyl]methylazanium",1721,Inner Protein Regulator,Inner Protein,23023261,Discovery of an Allosteric Mechanism for the Regulation of Hcv Ns3 Protein Function.,Yes,"Chain A:TYR56,HIS57,VAL78,ASP79,ASP81,ARG155,MET485,PHE486,VAL524,CYS525,GLN526,GLU628,VAL630",2.14,True,1
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,4EO6,ASD03740242,0S2,A,Lig,Inhibitor,"5-(3,3-dimethylbut-1-ynyl)-3-[(4-methylcyclohexyl)carbonyl-propan-2-yl-amino]thiophene-2-carboxylic acid",600,Inner Protein Regulator,Inner Protein,22664130,Tri-substituted acylhydrazines as tertiary amide bioisosteres: HCV NS5B polymerase inhibitors.,No,"Chain A:LEU419,ARG422,MET423,LEU474,HIS475,SER476,TYR477,ILE482,VAL485,ALA486,LEU497,TRP528",1.791,True,1
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,4EO8,ASD03740238,0S3,A,Lig,Inhibitor,"3-[dimethylamino-(4-methylcyclohexyl)carbonyl-amino]-5-(3,3-dimethylbut-1-ynyl)thiophene-2-carboxylic acid",600,Inner Protein Regulator,Inner Protein,22664130,Tri-substituted acylhydrazines as tertiary amide bioisosteres: HCV NS5B polymerase inhibitors.,No,"Chain A:LEU419,ARG422,MET423,LEU474,HIS475,SER476,TYR477,ILE482,VAL485,ALA486,LEU497,TRP528",1.798,True,1
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,4IH5,ASD03740254,12R,A,Lig,Inhibitor,"1-phenyl-2-(1H-pyrazolo[3,4-d]pyrimidin-4-yl)diazane",601,Inner Protein Regulator,Inner Protein,23509929,De novo fragment design: a medicinal chemistry approach to fragment-based lead generation.,No,"Chain A:ARG200,CYS366,LEU384,GLY410,ASN411,MET414,TYR415,GLN446,ILE447,TYR448",1.9,True,1
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,4IH6,ASD03740249,1EP,A,Lig,Inhibitor,"(5S)-3-[(4-tert-butylphenyl)methyl]-5-propan-2-yl-imidazolidine-2,4-dione",601,Inner Protein Regulator,Inner Protein,23509929,De novo fragment design: a medicinal chemistry approach to fragment-based lead generation.,No,"Chain A:PRO197,ARG200,CYS366,SER368,LEU384,SER407,GLY410,ASN411,MET414,TYR415,GLN446,ILE447,TYR448",2.2,True,1
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,4IH7,ASD03740255,1ER,A,Lig,Inhibitor,3-(3-tert-butylphenyl)-1H-pyridin-2-one,602,Inner Protein Regulator,Inner Protein,23509929,De novo fragment design: a medicinal chemistry approach to fragment-based lead generation.,No,"Chain A:ARG200,CYS366,SER368,LEU384,GLY410,ASN411,MET414,TYR415,GLN446,ILE447,TYR448",2.3,True,1
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,4KAI,ASD03740240,1PV,A,Lig,Inhibitor,[4-[[[5-cyclopropyl-2-(4-fluorophenyl)-3-(methylcarbamoyl)-1-benzofuran-6-yl]-methylsulfonyl-amino]methyl]-2-fluoranyl-phenyl]boronic acid,602,Inner Protein Regulator,Inner Protein,23672667,Discovery of a Potent Boronic Acid Derived Inhibitor of the HCV RNA-Dependent RNA Polymerase.,No,"Chain A:LEU419,MET423,LEU474,HIS475,SER476,TYR477,ILE482,LEU497,ARG498,ARG501,TRP528,LYS533",2.3,True,1
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,4KAI,ASD03740240,1PV,A,Lig,Inhibitor,[4-[[[5-cyclopropyl-2-(4-fluorophenyl)-3-(methylcarbamoyl)-1-benzofuran-6-yl]-methylsulfonyl-amino]methyl]-2-fluoranyl-phenyl]boronic acid,601,Inner Protein Regulator,Inner Protein,23672667,Discovery of a Potent Boronic Acid Derived Inhibitor of the HCV RNA-Dependent RNA Polymerase.,No,"Chain A:PHE193,PRO197,ARG200,LEU204,LEU314,ASN316,ASP319,VAL321,LEU360,ILE363,SER365,CYS366,SER368,LEU384,MET414,TYR415,TYR448,GLY449",2.3,True,1
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,4KB7,ASD03740274,690,A,Lig,Inhibitor,"5-cyclopropyl-2-(4-fluorophenyl)-N-methyl-6-[methylsulfonyl-[2-[(3R)-1-oxidanyl-3H-2,1-benzoxaborol-3-yl]ethyl]amino]-1-benzofuran-3-carboxamide",601,Inner Protein Regulator,Inner Protein,23672667,Discovery of a Potent Boronic Acid Derived Inhibitor of the HCV RNA-Dependent RNA Polymerase.,No,"Chain A:PHE193,PRO197,ARG200,LEU204,LEU314,TYR316,ASP319,VAL321,ILE363,SER365,CYS366,SER368,LEU384,ASN411,MET414,TYR415,GLN446,TYR448",1.85,True,1
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,4KBI,ASD03740269,1C0,A,Lig,Inhibitor,"5-cyclopropyl-6-[(7-fluoranyl-1-oxidanyl-3H-2,1-benzoxaborol-5-yl)methyl-methylsulfonyl-amino]-2-(4-fluorophenyl)-N-methyl-1-benzofuran-3-carboxamide",601,Inner Protein Regulator,Inner Protein,23672667,Discovery of a Potent Boronic Acid Derived Inhibitor of the HCV RNA-Dependent RNA Polymerase.,No,"Chain A:PRO197,ARG200,LEU204,LEU314,TYR316,VAL321,LEU360,ILE363,SER365,CYS366,SER368,LEU384,MET414,TYR415,GLN446,ILE447,TYR448,GLY449",2.06,True,1
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,4KE5,ASD03740240,1PV,A,Lig,Inhibitor,[4-[[[5-cyclopropyl-2-(4-fluorophenyl)-3-(methylcarbamoyl)-1-benzofuran-6-yl]-methylsulfonyl-amino]methyl]-2-fluoranyl-phenyl]boronic acid,602,Inner Protein Regulator,Inner Protein,23672667,Discovery of a Potent Boronic Acid Derived Inhibitor of the HCV RNA-Dependent RNA Polymerase.,No,"Chain A:LEU419,MET423,LEU474,HIS475,SER476,TYR477,ILE482,LEU497,ARG498,ARG501,TRP528,ALA529,VAL530,LYS531",2.11,True,1
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,4KE5,ASD03740240,1PV,A,Lig,Inhibitor,[4-[[[5-cyclopropyl-2-(4-fluorophenyl)-3-(methylcarbamoyl)-1-benzofuran-6-yl]-methylsulfonyl-amino]methyl]-2-fluoranyl-phenyl]boronic acid,601,Inner Protein Regulator,Inner Protein,23672667,Discovery of a Potent Boronic Acid Derived Inhibitor of the HCV RNA-Dependent RNA Polymerase.,No,"Chain A:PRO197,ARG200,LEU204,LEU314,TYR316,ASP319,VAL321,ILE363,SER365,CYS366,SER368,LEU384,MET414,TYR415,TYR448",2.11,True,1
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,4MIA,ASD03740247,28L,A,Lig,Inhibitor,N-[4-[6-tert-butyl-5-methoxy-8-(2-methoxy-6-oxidanylidene-3H-pyridin-5-yl)quinolin-3-yl]phenyl]methanesulfonamide,602,Inner Protein Regulator,Inner Protein,24195700,"Discovery of N-[4-[6-tert-butyl-5-methoxy-8-(6-methoxy-2-oxo-1H-pyridin-3-yl)-3-quinolyl]phenyl]methanesulfonamide (RG7109), a potent inhibitor of the hepatitis C virus NS5B polymerase.",No,"Chain A:PHE193,PRO197,ARG200,ASN291,ASN316,GLY317,ASP318,CYS366,SER368,SER407,GLY410,ASN411,MET414,TYR415,GLN446,ILE447,TYR448,SER556",2.8,True,1
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,4MIB,ASD03740264,28M,A,Lig,Inhibitor,N-[[(3S)-1-[6-tert-butyl-5-methoxy-8-(2-oxidanylidene-1H-pyridin-3-yl)quinolin-3-yl]pyrrolidin-3-yl]methyl]methanesulfonamide,602,Inner Protein Regulator,Inner Protein,24195700,"Discovery of N-[4-[6-tert-butyl-5-methoxy-8-(6-methoxy-2-oxo-1H-pyridin-3-yl)-3-quinolyl]phenyl]methanesulfonamide (RG7109), a potent inhibitor of the hepatitis C virus NS5B polymerase.",No,"Chain A:PHE193,ARG200,SER288,ASN291,ASN316,GLY317,ASP318,CYS366,SER368,LEU384,GLY410,ASN411,MET414,TYR415,GLN446,ILE447,TYR448,SER556",2.3,True,1
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,4MK7,ASD03740256,28O,A,Lig,Inhibitor,3-(3-tert-butyl-4-methoxy-phenyl)-1H-pyridin-2-one,603,Inner Protein Regulator,Inner Protein,24069953,Discovery of a Novel Series of Potent Non-Nucleoside Inhibitors of Hepatitis C Virus NS5B.,No,"Chain A:PHE193,ARG200,ASN316,CYS366,GLY410,ASN411,MET414,TYR415,GLN446,ILE447,TYR448",2.8,True,1
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,4MK8,ASD03740257,28Q,A,Lig,Inhibitor,N-[4-[2-[3-tert-butyl-2-methoxy-5-(2-oxidanylidene-1H-pyridin-3-yl)phenyl]ethyl]phenyl]methanesulfonamide,602,Inner Protein Regulator,Inner Protein,24069953,Discovery of a Novel Series of Potent Non-Nucleoside Inhibitors of Hepatitis C Virus NS5B.,No,"Chain A:PHE193,ARG200,SER288,ASN291,ASN316,GLY317,ASP318,ASP319,SER368,LEU384,GLY410,ASN411,MET414,TYR415,GLN446,ILE447,TYR448,SER556",2.09,True,1
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,4MK9,ASD03740272,28R,A,Lig,Inhibitor,"N-[2-[3-tert-butyl-2-methoxy-5-(2-oxidanylidene-1H-pyridin-3-yl)phenyl]-1,3-benzoxazol-5-yl]methanesulfonamide",601,Inner Protein Regulator,Inner Protein,24069953,Discovery of a Novel Series of Potent Non-Nucleoside Inhibitors of Hepatitis C Virus NS5B.,No,"Chain A:PHE193,ARG200,SER288,ASN291,ASN316,GLY317,ASP318,ASP319,CYS366,SER368,GLY410,ASN411,MET414,TYR415,GLN446,ILE447,TYR448,SER556",2.05,True,1
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,4MKA,ASD03740250,2AY,A,Lig,Inhibitor,N-[3-[3-tert-butyl-2-methoxy-5-(2-oxidanylidene-1H-pyridin-3-yl)phenyl]-1-oxidanylidene-isochromen-7-yl]methanesulfonamide,602,Inner Protein Regulator,Inner Protein,24069953,Discovery of a Novel Series of Potent Non-Nucleoside Inhibitors of Hepatitis C Virus NS5B.,No,"Chain A:PHE193,ARG200,SER288,ASN291,ASN316,GLY317,ASP318,ASP319,CYS366,SER368,LEU384,GLY410,ASN411,MET414,TYR415,GLN446,ILE447,TYR448,GLY449,SER556",2.05,True,1
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,4MKB,ASD03740263,28V,A,Lig,Inhibitor,N-[4-[(E)-2-[3-tert-butyl-2-methoxy-5-(6-oxidanylidene-1H-pyridazin-5-yl)phenyl]ethenyl]phenyl]methanesulfonamide,601,Inner Protein Regulator,Inner Protein,24069953,Discovery of a Novel Series of Potent Non-Nucleoside Inhibitors of Hepatitis C Virus NS5B.,No,"Chain A:PHE193,ARG200,SER288,ASN291,ASN316,GLY317,ASP318,CYS366,SER368,LEU384,GLY410,ASN411,MET414,TYR415,GLN446,ILE447,TYR448,SER556",1.9,True,1
ASD03750000_6,F2,Bos taurus,P00735,3PMA,ASD03750006,SCR,B,Lig,Inhibitor,"[(2R,3R,4S,5R,6R)-2-[(2S,3S,4R,5R)-3,4-disulfooxy-2,5-bis(sulfooxymethyl)oxolan-2-yl]oxy-4,5-disulfooxy-6-(sulfooxymethyl)oxan-3-yl] hydrogen sulfate",248,Inner Protein Regulator,Protein-Protein Interaction,21736375,Interaction of thrombin with sucrose octasulfate.,No,"Chain B:ASP125,LYS126,PHE232,LYS235,GLN239; Chain D:LYS87,TYR89,TRP237,LYS240,VAL241,ARG244,LEU245",2.2,True,2
ASD03910000_3,HBA,Equus caballus,P01958,1IWH,ASD03910090,PEM,A,Lig,Regulator,2-[4-[2-[(4-chlorophenyl)carbonylamino]ethyl]phenoxy]-2-methyl-propanoic acid,501,Inner Protein Regulator,Inner Protein,12122004,Crystal Structure of Horse Carbonmonoxyhemoglobin-Bezafibrate Complex at 1.55A Resolution. A Novel Allosteric Binding Site in R-State Hemoglobin,No,"Chain A:ALA57,LYS60,LYS61,ASP64,ALA65,LEU83",1.55,True,1
ASD03910000_3,HBA,Equus caballus,P01958,2D5X,ASD03910091,L35,A,Lig,Regulator,"2-[4-[(3,5-dichlorophenyl)carbamoylamino]phenoxy]-2-methyl-propanoic acid",1200,Inner Protein Regulator,Inner Protein,16403522,R-state haemoglobin with low oxygen affinity: crystal structures of deoxy human and carbonmonoxy horse haemoglobin bound to the effector molecule L35,No,"Chain A:LYS61,ASP64,ALA65,LEU68,ASN82,LEU83,LEU86,LYS90",1.45,True,1
ASD03910000_4,HBB,Equus caballus,P02062,2D5X,ASD03910091,L35,B,Lig,Regulator,"2-[4-[(3,5-dichlorophenyl)carbamoylamino]phenoxy]-2-methyl-propanoic acid",1201,Inner Protein Regulator,Protein-Protein Interaction,16403522,R-state haemoglobin with low oxygen affinity: crystal structures of deoxy human and carbonmonoxy horse haemoglobin bound to the effector molecule L35,No,"Chain A:PHE36,LYS99,LEU100,HIS103,ASP126,SER130; Chain B:TYR35,TRP37,LEU105,ASN108",1.45,True,2
ASD03940000_2,clpX,Helicobacter pylori,O25926,1UM8,ASD01720027,ADP,A,Lig,Regulator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl phosphono hydrogen phosphate",487,Protein-Protein Interaction Regulator,Inner Protein,14514695,Crystal Structure of ClpX Molecular Chaperone from Helicobacter pylori,No,"Chain A:TYR92,VAL93,ILE94,THR151,GLY152,SER153,GLY154,LYS155,THR156,LEU157,ILE343,ILE351,ALA395,ARG396",2.6,True,1
ASD04010000_1,ISPD,Arabidopsis thaliana,P69834,2YC3,ASD04010001,MW5,A,Lig,Inhibitor,"5-chloro-6-(phenylmethyl)-3H-[1,2,4]triazolo[1,5-a]pyrimidin-7-one",1301,Inner Protein Regulator,Inner Protein,21766403,Inhibitors of the Herbicidal Target Ispd: Allosteric Site Binding.,Yes,"Chain A:ARG157,ILE177,ALA203,VAL204,GLN238,VAL239,ILE240,LEU245,VAL259,ASP261,ASP262,VAL263,SER264,ILE265,VAL266,VAL273",1.4,True,1
ASD04010000_1,ISPD,Arabidopsis thaliana,P69834,2YC5,ASD04010002,6BC,A,Lig,Inhibitor,"5-chloro-7-hydroxy-6-(phenylmethyl)pyrazolo[1,5-a]pyrimidine-3-carbonitrile",1300,Inner Protein Regulator,Inner Protein,21766403,Inhibitors of the Herbicidal Target Ispd: Allosteric Site Binding.,Yes,"Chain A:ARG157,GLN158,ILE177,ALA203,VAL204,GLN238,VAL239,ILE240,LEU245,VAL259,ASP261,ASP262,VAL263,SER264,ILE265,VAL266,VAL273",1.6,True,1
ASD04010000_1,ISPD,Arabidopsis thaliana,P69834,2YCM,ASD04010003,30A,A,Lig,Inhibitor,"5-chloro-7-hydroxy-6-(phenylmethyl)pyrazolo[1,5-a]pyrimidine-3-carboxylic acid",1306,Inner Protein Regulator,Inner Protein,21766403,Inhibitors of the Herbicidal Target Ispd: Allosteric Site Binding.,Yes,"Chain A:ARG157,GLN158,ILE177,ALA203,VAL204,GLN238,VAL239,ILE240,VAL259,ASP261,ASP262,VAL263,SER264,ILE265,VAL266,VAL273",1.8,True,1
ASD04010000_1,ISPD,Arabidopsis thaliana,P69834,4NAK,ASD05233003,PBQ,A,Lig,Inhibitor,"2,4-dibromo-6-(3,4,5-tribromo-1H-pyrrol-2-yl)phenol",401,Inner Protein Regulator,Inner Protein,24446431,"Pseudilins: Halogenated, Allosteric Inhibitors of the Non-Mevalonate Pathway Enzyme IspD.",Yes,"Chain A:ARG157,VAL161,ALA202,ALA203,GLN238,VAL239,LEU245,PHE249,SER264,ILE265,VAL266",1.8,True,1
ASD04010000_1,ISPD,Arabidopsis thaliana,P69834,4NAL,ASD05233007,H70,A,Lig,Inhibitor,"2,4-dichloro-6-(3,4,5-tribromo-1H-pyrrol-2-yl)phenol",401,Inner Protein Regulator,Inner Protein,24446431,"Pseudilins: Halogenated, Allosteric Inhibitors of the Non-Mevalonate Pathway Enzyme IspD.",Yes,"Chain A:ARG157,VAL161,ALA202,ALA203,VAL204,GLN238,VAL239,LEU245,PHE249,SER264,ILE265,VAL266,VAL273",1.8,True,1
ASD04010000_1,ISPD,Arabidopsis thaliana,P69834,4NAN,ASD04010006,2JM,A,Lig,Inhibitor,"2-bromanyl-6-[3,4,5-tris(bromanyl)-1H-pyrrol-2-yl]phenol",401,Inner Protein Regulator,Inner Protein,24446431,"Pseudilins: Halogenated, Allosteric Inhibitors of the Non-Mevalonate Pathway Enzyme IspD.",Yes,"Chain A:GLN158,VAL161,ILE177,ALA203,VAL204,GLN238,VAL239,LEU245,PHE249,SER264,ILE265,VAL266,VAL273",1.8,True,1
ASD04010000_1,ISPD,Arabidopsis thaliana,P69834,5MRM,ASD04010011,Q9T,A,Lig,Inhibitor,"2,4-bis(bromanyl)-6-[3-(trifluoromethyl)- 1,2-oxazol-5-yl]phenol",401,Inner Protein Regulator,Inner Protein,28686408,Mechanism of Allosteric Inhibition of the Enzyme IspD by Three Different Classes of Ligands.,Yes,"Chain A:LEU245,GLN238,ILE177,TYR162,VAL239,VAL273,PHE249,ASP159,ARG157,VAL266,GLU267,LEU84,GLN158,ALA203,VAL161,ALA202,ILE265,VAL204,SER264,ILE240,VAL259",1.8,True,1
ASD04010000_1,ISPD,Arabidopsis thaliana,P69834,5MRO,ASD04012001,Q9P,A,Lig,Inhibitor,Azolopyrimidine,401,Inner Protein Regulator,Inner Protein,28686408,Mechanism of Allosteric Inhibition of the Enzyme IspD by Three Different Classes of Ligands.,Yes,"Chain A:ILE177,ASP261,LEU245,ASP262,TYR274,PHE249,VAL204,ARG157,GLN158,VAL161,GLN238,VAL273,ALA203,VAL266,GLU267,VAL263,ALA202,VAL239,ILE265,SER264,ILE240,VAL259",1.8,True,1
ASD04010000_1,ISPD,Arabidopsis thaliana,P69834,5MRP,ASD04010002,6BC,A,Lig,Inhibitor,"5-chloro-7-hydroxy-6-(phenylmethyl)pyrazolo[1,5- a]pyrimidine-3-carbonitrile",401,Inner Protein Regulator,Inner Protein,28686408,Mechanism of Allosteric Inhibition of the Enzyme IspD by Three Different Classes of Ligands.,Yes,"Chain A:ASP159,ASP261,LEU245,ASP262,TYR274,PHE249,VAL204,ARG157,GLN158,GLU156,VAL161,GLN238,ILE177,VAL273,ALA203,VAL266,GLU267,VAL263,ALA202,VAL239,ILE265,SER264,ILE240,VAL259",1.9,True,1
ASD04020000_2,kgd,Mycobacterium smegmatis,A0R2B1,2XTA,ASD05550001,ACO,A,Lig,Activator,"S-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]oxy-2-hydroxy-3,3-dimethyl-butanoyl]amino]propanoylamino]ethyl] ethanethioate",2004,Inner Protein Regulator,Inner Protein,21867916,Functional Plasticity and Allosteric Regulation of Alpha-Ketoglutarate Decarboxylase in Central Mycobacterial Metabolism.,No,"Chain A:THR1038,ARG1054,ASP1058,ILE1060,LYS1089,SER1092,GLN1142,PRO1145,PRO1147,ARG1148,ARG1149,ARG1150",2.2,True,1
ASD04020000_2,kgd,Mycobacterium smegmatis,A0R2B1,2Y0P,ASD05550001,ACO,A,Lig,Activator,"S-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]oxy-2-hydroxy-3,3-dimethyl-butanoyl]amino]propanoylamino]ethyl] ethanethioate",2228,Inner Protein Regulator,Inner Protein,21867916,Functional Plasticity and Allosteric Regulation of Alpha-Ketoglutarate Decarboxylase in Central Mycobacterial Metabolism.,No,"Chain A:GLU822,ILE827,LYS830,GLY1035,MET1037,THR1038,ARG1054,ASP1058,ILE1060,ARG1062,SER1092,GLN1142,PRO1145,LEU1146,PRO1147,ARG1148,ARG1149,ARG1150",2.4,True,1
ASD04030000_2,,Hepatitis C virus genotype 1b,Q9WMX2,3Q0Z,ASD04030003,23E,A,Lig,Inhibitor,"(E)-3-[4-[[1-[(13-cyclohexyl-6-oxo-5,7-dihydroindolo[1,2-d][1,4]benzodiazepin-10-yl)carbonylamino]cyclopentyl]carbonylamino]phenyl]prop-2-enoic acid",601,Inner Protein Regulator,Inner Protein,21486696,Syntheses and initial evaluation of a series of indolo-fused heterocyclic inhibitors of the polymerase enzyme (NS5B) of the hepatitis C virus.,No,"Chain A:LEU392,ALA393,ALA395,ALA396,THR399,ILE424,HIS428,PHE429,LEU492,GLY493,VAL494,PRO495,PRO496,ARG498,VAL499,TRP500,ARG503",2.29,True,1
ASD04030000_2,,Hepatitis C virus genotype 1b,Q9WMX2,4NLD,ASD01410478,2N7,A,Lig,Inhibitor,"(1aR,12bS)-8-cyclohexyl-N-(dimethylsulfamoyl)- 11-methoxy-1a-{[(1R,5S)-3-methyl-3,8-diazabicyclo[3.2.1]oct- 8-yl]carbonyl}-1,1a,2,12b-tetrahydrocyclopropa[d]indolo[2,1- a][2]benzazepine-5-carboxamide",601,Inner Protein Regulator,Inner Protein,24397558,"Discovery and Preclinical Characterization of the Cyclopropylindolobenzazepine BMS-791325, A Potent Allosteric Inhibitor of the Hepatitis C Virus NS5B Polymerase.",No,"Chain A:LEU392,ALA393,ALA395,ALA396,THR399,ALA400,ILE424,LEU425,HIS428,PHE429,LEU492,GLY493,VAL494,PRO495,TRP500,ARG503",2.75,True,1
ASD04030000_2,,Hepatitis C virus genotype 1b,Q9WMX2,5PZK,ASD04030002,2N5,A,Lig,Inhibitor,2-(4-fluorophenyl)-N-methyl-6-[(methylsulfonyl)amino]- 5-(propan-2-yloxy)-1-benzofuran-3-carboxamide,602,Inner Protein Regulator,Inner Protein,28430437,Discovery of a Hepatitis C Virus NS5B Replicase Palm Site Allosteric Inhibitor (BMS-929075) Advanced to Phase 1 Clinical Studies.,No,"Chain A:SER368,LEU204,CYS316,ASN369,SER365,VAL370,CYS366,LEU320,ASP319,TYR448,PRO197,TYR415,MET414,ARG200,ILE363,THR364,LEU360,LEU314,SER196,VAL315,TYR195,THR385,VAL321,GLY192,PHE193,LEU384,HIS467,ILE323",2.2,True,1
ASD04030000_2,,Hepatitis C virus genotype 1b,Q9WMX2,5PZL,ASD04030012,8XV,A,Lig,Inhibitor,"2-({3-[1-(2-cyclopropylethyl)-6-fluoro-4- hydroxy-2-oxo-1,2-dihydroquinolin-3-yl]-1,1- dioxo-1,4-dihydro-1lambda~6~,2,4-benzothiadiazin- 7-yl}oxy)acetamide",602,Inner Protein Regulator,Inner Protein,28430437,Discovery of a Hepatitis C Virus NS5B Replicase Palm Site Allosteric Inhibitor (BMS-929075) Advanced to Phase 1 Clinical Studies.,No,"Chain A:SER368,CYS316,SER288,TYR555,GLY317,SER365,ILE447,CYS366,GLY449,ASP319,SER556,TYR448,TYR415,ASN291,MET414,ALA450,ASP318,PHE224,ARG200,SER407,ASN411,GLN446,SER196,SER367,GLY410,THR287,PRO197,TYR195,LEU409,ASP225,GLY554,PHE193,LEU384",2.06,True,1
ASD04030000_2,,Hepatitis C virus genotype 1b,Q9WMX2,5PZM,ASD04030011,8XS,B,Lig,Inhibitor,3-[2-(4-fluorophenyl)-3-(methylcarbamoyl)- 1-benzofuran-5-yl]benzoic acid,602,Inner Protein Regulator,Inner Protein,28430437,Discovery of a Hepatitis C Virus NS5B Replicase Palm Site Allosteric Inhibitor (BMS-929075) Advanced to Phase 1 Clinical Studies.,No,"Chain B:LEU204,ASN369,LEU384,GLY449,GLY192,SER367,GLN446,ILE447,LEU360,PHE193,VAL321,TYR415,ASP319,MET414,THR364,ARG200,ILE363,SER368,VAL370,SER365,TYR448,LEU320,CYS366,ILE323,VAL315,LEU314,CYS316",2.54,True,1
ASD04030000_2,,Hepatitis C virus genotype 1b,Q9WMX2,5PZN,ASD04030010,8XP,A,Lig,Inhibitor,5-[3-(tert-butylcarbamoyl)phenyl]-2-(4-fluorophenyl)- N-methyl-1-benzofuran-3-carboxamide,602,Inner Protein Regulator,Inner Protein,28430437,Discovery of a Hepatitis C Virus NS5B Replicase Palm Site Allosteric Inhibitor (BMS-929075) Advanced to Phase 1 Clinical Studies.,No,"Chain A:ILE413,SER368,LEU204,CYS316,ASN369,SER365,VAL370,ILE447,CYS366,LEU320,ASP319,TYR448,PRO197,TYR415,MET414,TYR452,TRP550,ARG200,ILE363,THR364,PHE551,LEU360,LEU314,SER196,GLY410,GLY449,VAL315,TYR195,VAL321,LEU466,GLY192,PHE193,LEU384,ILE323",2.25,True,1
ASD04030000_2,,Hepatitis C virus genotype 1b,Q9WMX2,5PZO,ASD04030009,8XM,A,Lig,Inhibitor,"2-(4-fluorophenyl)-N-methyl-5-[3-({2-methyl- 1-oxo-1-[(1,3,4-thiadiazol-2-yl)amino]propan- 2-yl}carbamoyl)phenyl]-1-benzofuran-3-carboxamide",602,Inner Protein Regulator,Inner Protein,28430437,Discovery of a Hepatitis C Virus NS5B Replicase Palm Site Allosteric Inhibitor (BMS-929075) Advanced to Phase 1 Clinical Studies.,No,"Chain A:ILE413,SER549,TYR415,SER368,LEU204,ASN369,VAL552,SER365,VAL370,ILE447,CYS366,LEU320,ASP319,TYR448,PRO197,GLN194,GLN199,ASN316,MET414,TYR452,TRP550,ARG200,ILE363,THR364,LEU360,LEU314,SER196,SER367,GLY410,GLY449,VAL315,TYR195,ALA553,VAL321,LEU466,GLY192,PHE193,LEU384,LEU547",2.8,True,1
ASD04030000_2,,Hepatitis C virus genotype 1b,Q9WMX2,5PZP,ASD14560001,8XJ,A,Lig,Inhibitor,"2-(4-fluorophenyl)-N-methyl-5-[3-({2-methyl- 1-oxo-1-[(1,3,4-thiadiazol-2-yl)amino]propan- 2-yl}carbamoyl)phenyl]-1-benzofuran-3-carboxamide",602,Inner Protein Regulator,Inner Protein,28430437,Discovery of a Hepatitis C Virus NS5B Replicase Palm Site Allosteric Inhibitor (BMS-929075) Advanced to Phase 1 Clinical Studies.,No,"Chain A:ILE413,TYR415,SER368,LEU204,CYS316,ASN369,SER365,VAL370,ILE447,CYS366,LEU320,ASP319,SER556,TYR448,PRO197,GLN194,GLN199,MET414,TYR452,TRP550,ARG200,ILE363,THR364,PHE551,LEU360,LEU314,SER196,SER367,LEU362,VAL315,TYR195,GLY554,VAL321,LEU466,GLY192,PHE193,LEU384,LEU547",2.95,True,1
ASD04030000_2,,Hepatitis C virus genotype 1b,Q9WMX2,5TRH,ASD01411144,7HL,A,Lig,Inhibitor,2-[(benzenecarbonyl)amino]-3-[(4-chlorophenyl)methoxy]benzoic acid,602,Inner Protein Regulator,Inner Protein,27908764,Discovery and initial optimization of alkoxyanthranilic acid derivatives as inhibitors of HCV NS5B polymerase.,No,"Chain A:SER368,CYS316,SER288,SER365,ILE447,CYS366,SER556,MET414,TYR415,TYR448,ALA450,ARG200,SER407,ASN411,SER196,SER367,GLY410,GLY449,PRO197,TYR195,GLN446,PHE193,LEU384",2.7,True,1
ASD04030000_2,,Hepatitis C virus genotype 1b,Q9WMX2,5TRI,ASD01411149,7HM,A,Lig,Inhibitor,"3-[(4-chlorophenyl)methoxy]-2-(1-oxo-1,3- dihydro-2H-isoindol-2-yl)benzoic acid",602,Inner Protein Regulator,Inner Protein,27908764,Discovery and initial optimization of alkoxyanthranilic acid derivatives as inhibitors of HCV NS5B polymerase.,No,"Chain A:SER368,CYS316,GLY317,SER365,ILE447,CYS366,ASP319,SER556,MET414,TYR415,TYR448,ARG200,SER407,ASN411,SER196,GLY410,GLY449,PRO197,TYR195,THR385,GLN446,PHE193,LEU384,HIS467",2.3,True,1
ASD04030000_2,,Hepatitis C virus genotype 1b,Q9WMX2,5TRJ,ASD01411153,7HO,A,Lig,Inhibitor,2-{[2-(carboxymethoxy)benzene-1-carbonyl]amino}- 3-[(4-chlorophenyl)methoxy]benzoic acid,602,Inner Protein Regulator,Inner Protein,27908764,Discovery and initial optimization of alkoxyanthranilic acid derivatives as inhibitors of HCV NS5B polymerase.,No,"Chain A:SER368,CYS316,GLY317,PRO391,SER365,ILE447,CYS366,ASP319,SER556,TYR448,ARG386,TYR415,MET414,ALA450,ARG200,SER407,ASN411,SER196,SER367,GLY410,GLY449,PRO197,TYR195,THR385,GLN446,PHE193,LEU384,HIS467",2.57,True,1
ASD04030000_2,,Hepatitis C virus genotype 1b,Q9WMX2,5TRK,ASD04030004,7HH,A,Lig,Inhibitor,N-{3-[(benzenecarbonyl)amino]-4-[(4-chlorophenyl)methoxy]benzene- 1-carbonyl}glycine,602,Inner Protein Regulator,Inner Protein,27908764,Discovery and initial optimization of alkoxyanthranilic acid derivatives as inhibitors of HCV NS5B polymerase.,No,"Chain A:GLY198,SER368,CYS316,SER288,TYR555,GLY317,SER365,ILE447,CYS366,GLY449,ASP319,SER556,TYR448,TYR415,ASN291,MET414,ASP318,ARG200,SER407,THR292,ASN411,SER196,GLY410,THR287,PRO197,TYR195,THR385,GLN446,ASP225,GLY554,PHE193,LEU384,CYS289,HIS467",2.06,True,1
ASD04090000_1,argB,Thermotoga maritima,Q9X2A4,2BTY,ASD02000001,ARG,A,Lig,Inhibitor,[amino-[[(4S)-4-amino-5-hydroxy-5-oxo-pentyl]amino]methylidene]azanium,1283,Inner Protein Regulator,Inner Protein,16376937,"Structural Bases of Feed-Back Control of Arginine Biosynthesis, Revealed by the Structure of Two Hexameric N-Acetylglutamate Kinases, from Thermotoga Maritima and Pseudomonas Aeruginosa",No,"Chain A:TYR15,PHE19,LYS196,SER214,HIS253,GLU266,ILE267,SER269,ARG270,LYS271,GLY272,GLY274,THR275,MET276",2.75,True,1
ASD04090000_2,NAGK,Arabidopsis thaliana,Q9SCL7,2RD5,ASD02000001,ARG,A,Lig,Inhibitor,[amino-[[(4S)-4-amino-5-hydroxy-5-oxo-pentyl]amino]methylidene]azanium,1000,Inner Protein Regulator,Inner Protein,17913711,Structural Basis for the Regulation of N-Acetylglutamate Kinase by PII in Arabidopsis thaliana.,No,"Chain A:PHE33,LYS210,LYS232,GLU284,ILE285,SER287,ASP288,GLU289,GLY290,ALA291,GLY292,MET294",2.51,True,1
ASD04090000_3,"ARG5,6",Saccharomyces cerevisiae,Q01217,3ZZH,ASD02000001,ARG,C,Lig,Inhibitor,[amino-[[(4S)-4-amino-5-hydroxy-5-oxo-pentyl]amino]methylidene]azanium,1362,Inner Protein Regulator,Inner Protein,22529931,Insight on an Arginine Synthesis Metabolon from the Tetrameric Structure of Yeast Acetylglutamate Kinase,No,"Chain C:TYR87,LYS265,SER285,MET286,GLU337,LEU338,PHE339,THR340,ASP341,SER342,GLY343,GLY345,MET347",2.1,True,1
ASD04250000_1,argR,Escherichia coli,P0A6D0,1XXA,ASD02000001,ARG,A,Lig,Activator,[amino-[[(4S)-4-amino-5-hydroxy-5-oxo-pentyl]amino]methylidene]azanium,1,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,8594204,Structure of the oligomerization and L-arginine binding domain of the arginine repressor of Escherichia coli.,No,"Chain A:GLN106,ALA109,ARG110,ASP113,THR124,ILE125,ALA126; Chain C:GLY127,ASP128,ASP129,THR130; Chain D:GLY103,ASP128",2.2,True,3
ASD04250000_1,argR,Escherichia coli,P0A6D0,1XXB,ASD02000001,ARG,A,Lig,Activator,[amino-[[(4S)-4-amino-5-hydroxy-5-oxo-pentyl]amino]methylidene]azanium,1,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,8594204,Structure of the oligomerization and L-arginine binding domain of the arginine repressor of Escherichia coli.,No,"Chain A:GLN106,ALA109,ARG110,ASP113,THR124,ILE125,ALA126; Chain C:GLY127,ASP128,ASP129,THR130; Chain D:PRO102,GLY103,ASP128",2.6,True,3
ASD04250000_3,argR,Mycobacterium tuberculosis,P9WPY9,2ZFZ,ASD02000001,ARG,A,Lig,Activator,[amino-[[(4S)-4-amino-5-hydroxy-5-oxo-pentyl]amino]methylidene]azanium,300,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,18703843,Structure of the C-terminal domain of the arginine repressor protein from Mycobacterium tuberculosis.,No,"Chain A:HIS125,ALA128,SER129,ASP132,THR142,ILE143,ALA144; Chain C:GLY145,ASP146,ASP147,THR148; Chain F:PRO121,GLY122,ASP146",1.85,True,3
ASD04250000_3,argR,Mycobacterium tuberculosis,P9WPY9,3CAG,ASD02000001,ARG,A,Lig,Activator,[amino-[[(4S)-4-amino-5-hydroxy-5-oxo-pentyl]amino]methylidene]azanium,300,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,18703843,Structure of the C-terminal domain of the arginine repressor protein from Mycobacterium tuberculosis.,No,"Chain A:HIS125,ALA128,SER129,ASP132,THR142,ILE143,ALA144; Chain C:GLY145,ASP146,ASP147,THR148; Chain F:PRO121,GLY122,ASP146",1.9,True,3
ASD04250000_3,argR,Mycobacterium tuberculosis,P9WPY8,3LAJ,ASD02000001,ARG,A,Lig,Activator,[amino-[[(4S)-4-amino-5-hydroxy-5-oxo-pentyl]amino]methylidene]azanium,200,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,20382162,crystal structure of the intermediate complex of the arginine repressor from Mycobacterium tuberculosis bound with its DNA operator reveals detailed mechanism of arginine repression.,No,"Chain A:HIS125,ALA128,SER129,ASP132,THR142,ILE143,ALA144; Chain C:GLY145,ASP146,ASP147,THR148; Chain F:ASP146",2.306,True,3
ASD04250000_3,argR,Mycobacterium tuberculosis,P9WPY8,3LAP,ASD04250001,GGB,A,Lig,Activator,(2S)-2-amino-4-carbamimidamidooxy-butanoic acid,200,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,20382162,crystal structure of the intermediate complex of the arginine repressor from Mycobacterium tuberculosis bound with its DNA operator reveals detailed mechanism of arginine repression.,No,"Chain A:HIS125,ALA128,SER129,ASP132,THR142,ILE143,ALA144; Chain C:GLY145,ASP146,ASP147,THR148; Chain F:PRO121,GLY122,ASP146",2.15,True,3
ASD04250000_4,argR,Bacillus subtilis,P17893,2P5M,ASD02000001,ARG,B,Lig,Activator,[amino-[[(4S)-4-amino-5-hydroxy-5-oxo-pentyl]amino]methylidene]azanium,201,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,18007040,Structure of the C-terminal effector-binding domain of AhrC bound to its corepressor L-arginine.,No,"Chain A:GLY124,ASP125,ASP126,THR127; Chain B:GLN104,GLY107,ALA108,ASP111,THR121,ILE122,CYS123",1.95,True,2
ASD04250000_5,argR,Geobacillus stearothermophilus,O31408,1B4B,ASD02000001,ARG,A,Lig,Activator,[amino-[[(4S)-4-amino-5-hydroxy-5-oxo-pentyl]amino]methylidene]azanium,1,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,10331868,Structure of the arginine repressor from Bacillus stearothermophilus.,No,"Chain A:HIS104,GLY107,VAL108,ASP111,THR121,ILE122,CYS123; Chain C:GLY124,ASP125,ASP126,THR127",2.2,True,2
ASD04270000_2,Ptgs2,Mus musculus,Q05769,3QH0,ASD09270001,PLM,A,Lig,Activator,hexadecanoic acid,625,Inner Protein Regulator,Inner Protein,21467029,Human cyclooxygenase-2 is a sequence homodimer that functions as a conformational heterodimer.,No,"Chain A:VAL116,ARG120,PHE205,TYR348,VAL349,SER353,TYR355,TYR385,TRP387,VAL523,GLY526,ALA527,SER530,LEU531",2.1,True,1
ASD04270000_2,Ptgs2,Mus musculus,Q05769,4OTJ,ASD04270003,IXP,"A,B,C,D",Lig,Inhibitor,"(5S,5aS,8aS,9S)-8-oxo-9-(3,4,5-trimethoxyphenyl)- 5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3- d][1,3]dioxol-5-yl 4-{[4-({[1-(4-chlorobenzoyl)- 5-methoxy-2-methyl-1H-indol-3-yl]acetyl}amino)butyl]amino}- 4-oxobutanoate",706,Inner Protein Regulator,Allosteric Position,27588346,Antitumor Activity of Cytotoxic Cyclooxygenase-2 Inhibitors.,No,"Chain D:LYS180,LEU183,MET487,ILE442,ARG438,GLU486,GLU490,GLU179,ARG185,ARG184,VAL181",2.11,True,1
ASD04270000_2,Ptgs2,Mus musculus,Q05769,4RUT,ASD05450001,LM8,A,Lig,Activator,"(5Z,8Z,11Z,13S,14Z)-13-methylicosa-5,8,11,14- tetraenoic acid",706,Inner Protein Regulator,Inner Protein,25648895,13-methylarachidonic Acid is a positive allosteric modulator of endocannabinoid oxygenation by cyclooxygenase.,No,"Chain A:LEU534,TYR355,ILE345,LEU359,LEU117,PHE209,SER353,VAL116,TYR348,LEU525,TRP387,ARG120,MET113,VAL349,PHE529,PHE205,MET522,VAL344,LEU352,GLY526,ALA527,LYS360,THR206,PHE518,SER530,LEU531,GLU524,PRO528,TYR385,LEU384,PHE381,VAL523,MET535",2.16,True,1
ASD04420000_1,CDC4,Saccharomyces cerevisiae,P07834,3MKS,ASD04420001,C1C,D,Lig,Inhibitor,1-(2-carboxynaphthalen-1-yl)naphthalene-2-carboxylic acid,1,Inner Protein Regulator,Inner Protein,20581844,An allosteric inhibitor of substrate recognition by the SCF(Cdc4) ubiquitin ligase.,No,"Chain D:LEU628,GLN629,GLY630,THR632,LEU634,ALA649,ARG655,GLY656,TRP657,ARG664,PHE666,SER667",2.6,True,1
ASD04430000_2,Pde2a,Mus musculus,Q922S4,1MC0,ASD02408002,PCG,A,Lig,Activator,CYCLIC GUANOSINE MONOPHOSPHATE,160,Inner Protein Regulator,Inner Protein,12271124,The two GAF domains in phosphodiesterase 2A have distinct roles in dimerization and in cGMP binding.,No,"Chain A:CYS423,GLY440,PHE426,PHE490,ILE458,PHE438,THR492,GLY460,VAL484,ASP439,GLY483,ARG482,GLU512,SER424,LEU479,ILE422,PHE480,GLY457,VAL514,ASP485,THR488,GLN456,TYR481,VAL437,ALA459,ILE452,ILE495",2.86,True,1
ASD04460000_1,leuA,Leptospira interrogans,Q8F3Q1,3F6G,ASD02780002,ILE,B,Lig,Inhibitor,"(2S,3S)-2-amino-3-methyl-pentanoic acid",1,Inner Protein Regulator,Protein-Protein Interaction,19351325,Molecular basis of the inhibitor selectivity and insights into the feedback inhibition mechanism of citramalate synthase from Leptospira interrogans,No,"Chain A:GLY428,GLY429,TYR430,ASP431,TYR454; Chain B:ILE458,LYS463,THR464,ASP465,ALA466,VAL468,PRO493,ASP494,GLN495",2.0,True,2
ASD04460000_1,leuA,Leptospira interrogans,Q8F3Q1,3F6H,ASD02780002,ILE,A,Lig,Inhibitor,"(2S,3S)-2-amino-3-methyl-pentanoic acid",1,Inner Protein Regulator,Protein-Protein Interaction,19351325,Molecular basis of the inhibitor selectivity and insights into the feedback inhibition mechanism of citramalate synthase from Leptospira interrogans,No,"Chain A:GLY428,GLY429,TYR430,ASP431,TYR454",2.7,True,1
ASD04630000_1,rzcA,Staphylococcus aureus,O85142,1R1V,ASD01310003,ZN,A,Ion,Regulator,zinc(+2) cation,501,Protein-DNA/RNA Interaction Regulator,Inner Protein,14568530,A metal-ligand-mediated intersubunit allosteric switch in related SmtB/ArsR zinc sensor proteins.,No,"Chain A:ASP84,HIS86",2.3,True,1
ASD04660000_1,hemB,Pseudomonas aeruginosa,Q59643,1B4K,ASD00330030,MG,A,Ion,Activator,magnesium(+2) cation,402,Inner Protein Regulator,Inner Protein,10356331,High resolution crystal structure of a Mg2+-dependent porphobilinogen synthase.,No,"Chain A:ARG181,GLU245,ASP249",1.67,True,1
ASD04660000_1,hemB,Pseudomonas aeruginosa,Q59643,1GZG,ASD00330030,MG,A,Ion,Activator,magnesium(+2) cation,1338,Inner Protein Regulator,Inner Protein,12079382,Structure of Porphobilinogen Synthase from Pseudomonas Aeruginosa in Complex with 5-Fluorolevulinic Acid Suggests a Double Schiff Base Mechanism,No,"Chain A:ARG181,GLU245,ASP249",1.66,True,1
ASD04660000_1,hemB,Pseudomonas aeruginosa,Q59643,1W54,ASD00330030,MG,A,Ion,Activator,magnesium(+2) cation,1339,Inner Protein Regulator,Inner Protein,15644204,Tracking the Evolution of Porphobilinogen Synthase Metal Dependence in Vitro,No,"Chain A:ARG181,GLU245,ASP249",2.2,True,1
ASD04660000_1,hemB,Pseudomonas aeruginosa,Q59643,1W56,ASD00330030,MG,A,Ion,Activator,magnesium(+2) cation,1338,Inner Protein Regulator,Inner Protein,15644204,Tracking the Evolution of Porphobilinogen Synthase Metal Dependence in Vitro,No,"Chain A:ARG181,GLU245,ASP249",1.7,True,1
ASD04660000_1,hemB,Pseudomonas aeruginosa,Q59643,1W5M,ASD00330030,MG,A,Ion,Activator,magnesium(+2) cation,1343,Inner Protein Regulator,Inner Protein,15644204,Tracking the Evolution of Porphobilinogen Synthase Metal Dependence in Vitro,No,"Chain A:LYS273,LYS314,GLY317,ALA318,ASP319",1.6,True,1
ASD04660000_1,hemB,Pseudomonas aeruginosa,Q59643,1W5N,ASD00330030,MG,A,Ion,Activator,magnesium(+2) cation,1339,Inner Protein Regulator,Inner Protein,15644204,Tracking the Evolution of Porphobilinogen Synthase Metal Dependence in Vitro,No,"Chain A:ARG181,GLU245,ASP249",1.65,True,1
ASD04660000_1,hemB,Pseudomonas aeruginosa,Q59643,1W5O,ASD00330030,MG,A,Ion,Activator,magnesium(+2) cation,1338,Inner Protein Regulator,Inner Protein,15644204,Tracking the Evolution of Porphobilinogen Synthase Metal Dependence in Vitro,No,"Chain A:ARG181,GLU245,ASP249",1.85,True,1
ASD04660000_1,hemB,Pseudomonas aeruginosa,Q59643,1W5P,ASD00330030,MG,A,Ion,Activator,magnesium(+2) cation,1342,Inner Protein Regulator,Inner Protein,15644204,Tracking the Evolution of Porphobilinogen Synthase Metal Dependence in Vitro,No,"Chain A:ARG181,GLU245,ASP249",1.55,True,1
ASD04660000_1,hemB,Pseudomonas aeruginosa,Q59643,1W5Q,ASD00330030,MG,A,Ion,Activator,magnesium(+2) cation,1338,Inner Protein Regulator,Inner Protein,15644204,Tracking the Evolution of Porphobilinogen Synthase Metal Dependence in Vitro,No,"Chain A:ARG181,GLU245,ASP249",1.4,True,1
ASD04660000_1,hemB,Pseudomonas aeruginosa,Q59643,2C13,ASD00330030,MG,A,Ion,Activator,magnesium(+2) cation,1336,Inner Protein Regulator,Inner Protein,16819823,Probing the Active Site of Pseudomonas Aeruginosa Porphobilinogen Synthase Using Newly Developed Inhibitors.,No,"Chain A:ARG181,GLU245,ASP249",2.15,True,1
ASD04660000_1,hemB,Pseudomonas aeruginosa,Q59643,2C14,ASD00330030,MG,A,Ion,Activator,magnesium(+2) cation,1336,Inner Protein Regulator,Inner Protein,16819823,Probing the Active Site of Pseudomonas Aeruginosa Porphobilinogen Synthase Using Newly Developed Inhibitors.,No,"Chain A:ARG181,GLU245,ASP249",1.9,True,1
ASD04660000_1,hemB,Pseudomonas aeruginosa,Q59643,2C15,ASD00330030,MG,A,Ion,Activator,magnesium(+2) cation,345,Inner Protein Regulator,Inner Protein,16819823,Probing the Active Site of Pseudomonas Aeruginosa Porphobilinogen Synthase Using Newly Developed Inhibitors.,No,"Chain A:ARG181,GLU245,ASP249",1.48,True,1
ASD04660000_1,hemB,Pseudomonas aeruginosa,Q59643,2C16,ASD00330030,MG,A,Ion,Activator,magnesium(+2) cation,1336,Inner Protein Regulator,Inner Protein,16819823,Probing the Active Site of Pseudomonas Aeruginosa Porphobilinogen Synthase Using Newly Developed Inhibitors.,No,"Chain A:ARG181,GLU245,ASP249",2.02,True,1
ASD04660000_1,hemB,Pseudomonas aeruginosa,Q59643,2C18,ASD00330030,MG,A,Ion,Activator,magnesium(+2) cation,347,Inner Protein Regulator,Inner Protein,16819823,Probing the Active Site of Pseudomonas Aeruginosa Porphobilinogen Synthase Using Newly Developed Inhibitors.,No,"Chain B:ASN31,LYS273,LYS314,GLY317,ALA318,ASP319",1.93,True,1
ASD04660000_1,hemB,Pseudomonas aeruginosa,Q59643,2C19,ASD00330030,MG,A,Ion,Activator,magnesium(+2) cation,1336,Inner Protein Regulator,Inner Protein,16819823,Probing the Active Site of Pseudomonas Aeruginosa Porphobilinogen Synthase Using Newly Developed Inhibitors.,No,"Chain A:ARG181,GLU245,ASP249",2.05,True,1
ASD04660000_1,hemB,Pseudomonas aeruginosa,Q59643,2WOQ,ASD00330030,MG,A,Ion,Activator,magnesium(+2) cation,1335,Inner Protein Regulator,Inner Protein,19822707,Structure of the Heme Biosynthetic Pseudomonas Aeruginosa Porphobilinogen Synthase in Complex with the Antibiotic Alaremycin.,No,"Chain A:ARG181,GLU245,ASP249",1.75,True,1
ASD04660000_2,PBGS,Toxoplasma gondii,S8F7E9,3OBK,ASD00330030,MG,A,Ion,Activator,magnesium(+2) cation,365,Inner Protein Regulator,Inner Protein,21383008,Crystal Structure of Toxoplasma gondii Porphobilinogen Synthase: INSIGHTS ON OCTAMERIC STRUCTURE AND PORPHOBILINOGEN FORMATION.,No,"Chain A:ARG189,GLU252,ASP256",2.5,True,1
ASD04670000_2,folA,Escherichia coli,P0ABQ4,5CC9,ASD04670003,NAP,A,Lig,Regulator,NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE,201,Allosteric Function,Allosteric Position,26147643,Cofactor-Mediated Conformational Dynamics Promote Product Release From Escherichia coli Dihydrofolate Reductase via an Allosteric Pathway.,No,"Chain A:ILE14,GLY95,VAL99,TRP74,LEU62,MET42,VAL75,GLY15,SER49,THR46,LYS76,THR123,GLY97,HIS45,SER77,MET16,GLY96,ILE61,ALA19,ASN18,PHE103,GLN102,ASP122,SER64,SER63,ARG44,TYR100,TRP47,GLY121,GLN65,GLY43,VAL78,ARG98",1.199,True,1
ASD04670000_2,folA,Escherichia coli,P0ABQ4,5w3Q,ASD13040013,NDP,A,Lig,Regulator,NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE,201,Inner Protein Regulator,Inner Protein,28737940,Defining the Structural Basis for Allosteric Product Release from E. coli Dihydrofolate Reductase Using NMR Relaxation Dispersion.,No,"Chain A:GLU17,SER49,ILE5,ILE14,GLY95,VAL99,TRP74,LEU62,ASP27,MET42,MET20,VAL75,GLY15,ALA6,THR46,LYS76,THR123,TYR100,GLY97,HIS45,SER77,MET16,GLY96,ILE61,ALA7,ASN18,ALA19,PHE103,GLN102,ASP122,PRO21,SER64,SER63,TRP22,ARG44,VAL13,ARG98,TRP47,GLN65,ILE94,GLY43,VAL78,LEU8",1.401,True,1
ASD04920000_1,,Rattus norvegicus,Q9Z2W9,3LSW,ASD01230001,4MP,A,Lig,Activator,1-(4-methoxyphenyl)carbonylpyrrolidin-2-one,801,Inner Protein Regulator,Protein-Protein Interaction,20163115,Piracetam Defines a New Binding Site for Allosteric Modulators of alpha-Amino-3-hydroxy-5-methyl-4-isoxazole-propionic Acid (AMPA) Receptors.,No,"Chain A:PRO105,PHE106,MET107,SER108,SER217,LYS218,GLY219",1.752,True,1
ASD04920000_1,,Rattus norvegicus,Q9Z2W9,3LSX,ASD04920002,PZI,A,Lig,Activator,2-(2-oxopyrrolidin-1-yl)ethanamide,802,Inner Protein Regulator,Protein-Protein Interaction,20163115,Piracetam Defines a New Binding Site for Allosteric Modulators of alpha-Amino-3-hydroxy-5-methyl-4-isoxazole-propionic Acid (AMPA) Receptors.,No,"Chain A:ASP248,ASN252",2.006,True,1
ASD04920000_1,Gria3,Rattus norvegicus,P19492,3M3F,ASD04920003,P99,A,Lig,Activator,"2-[2,6-difluoro-4-[2-(phenylsulfonylamino)ethylsulfanyl]phenoxy]ethanamide",800,Inner Protein Regulator,Protein-Protein Interaction,20199107,Molecular mechanism of flop selectivity and subsite recognition for an AMPA receptor allosteric modulator: structures of GluA2 and GluA3 in complexes with PEPA.,No,"Chain A:ILE92,LYS104,PRO105,PHE106,MET107,SER108,SER217,LYS218,GLY219,LEU239,ASN242,LEU247",2.5,True,1
ASD04970000_2,HRAS,Rattus norvegicus,P20171,3V4F,ASD04400004,DTT,A,Lig,Regulator,"(2R,3R)-1,4-bis-sulfanylbutane-2,3-diol",201,Inner Protein Regulator,Inner Protein,22845804,Shift in the Equilibrium between On and Off States of the Allosteric Switch in Ras-GppNHp Affected by Small Molecules and Bulk Solvent Composition.,No,"Chain A:HIS94,ASP92,GLU91,TYR96,GLN99,ARG68,GLN95,ARG102,LYS88",1.391,True,1
ASD04990000_1,,Human herpesvirus 8,O36607,2PBK,ASD04990003,chain C,C;C;C;C;C;C;C,Pep,Inhibitor,peptide,1;2;3;4;5;6;7,Inner Protein Regulator,Inner Protein,17870089,Substrate modulation of enzyme activity in the herpesvirus protease family.,No,"Chain B:GLU22,LEU23,HIS46,SER114,LEU115,SER116,SER117,ILE118,HIS119,ARG121,GLU122,SER128,GLY129,PRO130,GLN133,GLY141,ARG142,ARG143",1.73,True,1
ASD04990000_1,,Human herpesvirus 8,O36607,4P3H,ASD04990001,25G,A,Lig,Inhibitor,4-[[6-(cyclohexylmethyl)pyridin-2-yl]carbonylamino]-3-(phenylmethyl)benzoic acid,201,Protein-Protein Interaction Regulator,Inner Protein,24977643,Broad-spectrum allosteric inhibition of herpesvirus proteases.,No,"Chain A:ILE44,PHE76,LEU79,ALA80,LEU83,ALA90,ILE105,LEU106,TRP109,LEU110,ALA139,PHE189,PRO192,LEU193",1.45,True,1
ASD05060000_1,pol,Human immunodeficiency virus type 1,Q72498,3AO1,ASD05062025,BZX,A,Lig,Inhibitor,"1,3-benzodioxol-5-ol",213,Protein-Protein Interaction Regulator,Protein-Protein Interaction,21275048,Fragment-based design of ligands targeting a novel site on the integrase enzyme of human immunodeficiency virus 1,No,"Chain A:TYR83,ASN184,HIS185,GLY197,VAL201; Chain B:GLY106,ARG107,TRP108,PRO109,ILE204",1.9,True,2
ASD05060000_1,pol,Human immunodeficiency virus type 1,Q72498,3AO3,ASD05060095,BMC,B,Lig,Inhibitor,"5-(1,3-benzodioxol-5-yl)-2-methyl-pyrazole-3-carboxylic acid",1,Protein-Protein Interaction Regulator,Protein-Protein Interaction,21275048,Fragment-based design of ligands targeting a novel site on the integrase enzyme of human immunodeficiency virus 1,No,"Chain A:GLY106,ARG107,TRP108,PRO109,ASP207,ILE208; Chain B:TYR83,TRP108,ASN184,HIS185,ARG187,SER195,GLY197,GLU198,VAL201",1.9,True,2
ASD05060000_1,pol,Human immunodeficiency virus type 1,Q72498,3AO4,ASD05062026,833,B,Lig,Inhibitor,"5-(1,3-benzodioxol-5-yl)-2-methyl-pyrazol-3-amine",1,Protein-Protein Interaction Regulator,Protein-Protein Interaction,21275048,Fragment-based design of ligands targeting a novel site on the integrase enzyme of human immunodeficiency virus 1,No,"Chain A:ALA105,GLY106,ARG107,TRP108,PRO109,ILE204,ASP207; Chain B:TYR83,ASN184,HIS185,GLY197,GLU198,VAL201",1.95,True,2
ASD05060000_1,pol,Human immunodeficiency virus type 1,Q72498,3AO5,ASD05062030,BBY,B,Lig,Inhibitor,"5-(7-bromo-1,3-benzodioxol-5-yl)-1-methyl-pyrazol-3-amine",1,Protein-Protein Interaction Regulator,Protein-Protein Interaction,21275048,Fragment-based design of ligands targeting a novel site on the integrase enzyme of human immunodeficiency virus 1,No,"Chain A:GLY106,ARG107,TRP108,PRO109; Chain B:TYR83,TRP108,ASN184,HIS185,ARG187,SER195,GLY197,GLU198,VAL201",1.8,True,2
ASD05060000_1,pol,Human immunodeficiency virus type 1,Q72498,3L3V,ASD05060082,SUC,A,Lig,Inhibitor,"(2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol",1,Protein-Protein Interaction Regulator,Protein-Protein Interaction,20227411,Crystal structure of the HIV-1 integrase core domain in complex with sucrose reveals details of an allosteric inhibitory binding site,No,"Chain A:GLU87,VAL88,GLU96,TYR99,LYS103,LYS173; Chain B:GLU87,VAL88,GLU96,TYR99,LYS103,LYS173",2.0,True,2
ASD05060000_1,pol,Human immunodeficiency virus type 1,Q72498,3OVN,ASD05062028,MPV,B,Lig,Inhibitor,2-methyl-5-thiophen-2-yl-pyrazol-3-amine,213,Protein-Protein Interaction Regulator,Protein-Protein Interaction,21275048,Fragment-based design of ligands targeting a novel site on the integrase enzyme of human immunodeficiency virus 1,No,"Chain A:ARG107,TRP108,PRO109,ILE204,THR206; Chain B:TYR83,HIS185,GLY197,GLU198,VAL201",1.95,True,2
ASD05060000_1,pol,Human immunodeficiency virus type 1,Q72498,3VQ4,ASD05060075,0NX,A,Lig,Inhibitor,"(5-phenyl-1,2-oxazol-3-yl)methanol",305,Protein-Protein Interaction Regulator,Protein-Protein Interaction,23139382,Parallel screening of low molecular weight fragment libraries: do differences in methodology affect hit identification?,No,"Chain A:GLN95,ALA98,TYR99,LEU102,THR125,ALA128,ALA129,TRP132; Chain B:GLU170,THR174",1.9,True,2
ASD05060000_1,pol,Human immunodeficiency virus type 1,Q72498,3VQ4,ASD05060075,0NX,B,Lig,Inhibitor,"(5-phenyl-1,2-oxazol-3-yl)methanol",303,Protein-Protein Interaction Regulator,Protein-Protein Interaction,23139382,Parallel screening of low molecular weight fragment libraries: do differences in methodology affect hit identification?,No,"Chain A:TYR83,ASN184,HIS185,GLY197,GLU198; Chain B:GLY106,ARG107,PRO109,ILE204,ILE208",1.9,True,2
ASD05060000_1,pol,Human immunodeficiency virus type 1,Q72498,3VQ5,ASD05060079,MMJ,A,Lig,Inhibitor,"N-methyl-1-(4-methyl-2-phenyl-1,3-thiazol-5-yl)methanamine",1007,Protein-Protein Interaction Regulator,Protein-Protein Interaction,23139382,Parallel screening of low molecular weight fragment libraries: do differences in methodology affect hit identification?,No,"Chain A:GLY106,ARG107,TRP108,PRO109,ILE204,ASP207; Chain B:TYR83,ASN184,HIS185,GLY197,GLU198,VAL201",1.7,True,2
ASD05060000_1,pol,Human immunodeficiency virus type 1,Q72498,3VQ7,ASD05060080,SNU,B,Lig,Inhibitor,4-pyrrol-1-ylaniline,304,Protein-Protein Interaction Regulator,Protein-Protein Interaction,23139382,Parallel screening of low molecular weight fragment libraries: do differences in methodology affect hit identification?,No,"Chain A:GLN95,ALA98,TYR99,THR125,ALA128,ALA129,TRP132; Chain B:THR174,MET178",1.63,True,2
ASD05060000_1,pol,Human immunodeficiency virus type 1,Q72498,3VQ7,ASD05060080,SNU,A,Lig,Inhibitor,4-pyrrol-1-ylaniline,1004,Protein-Protein Interaction Regulator,Protein-Protein Interaction,23139382,Parallel screening of low molecular weight fragment libraries: do differences in methodology affect hit identification?,No,"Chain A:GLY106,ARG107,TRP108,PRO109,ILE204,THR206; Chain B:ASN184,HIS185,GLY197,GLU198,VAL201",1.63,True,2
ASD05060000_1,pol,Human immunodeficiency virus type 1,Q72498,3VQ7,ASD05060082,SUC,B,Lig,Inhibitor,"(2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol",305,Protein-Protein Interaction Regulator,Protein-Protein Interaction,23139382,Parallel screening of low molecular weight fragment libraries: do differences in methodology affect hit identification?,No,"Chain A:GLU87,VAL88,GLU96,TYR99,LYS103,LYS173; Chain B:GLU87,VAL88,ILE89,GLU96,TYR99,LYS103,LYS173",1.63,True,2
ASD05060000_1,pol,Human immunodeficiency virus type 1,Q72498,3VQ8,ASD05060083,BCU,A,Lig,Inhibitor,"[(3R)-3,4-dihydro-2H-chromen-3-yl]methanol",1006,Protein-Protein Interaction Regulator,Protein-Protein Interaction,23139382,Parallel screening of low molecular weight fragment libraries: do differences in methodology affect hit identification?,No,"Chain A:GLN95,ALA98,TYR99,LEU102,THR125,ALA128,ALA129; Chain B:GLN168,THR174",1.6,True,2
ASD05060000_1,pol,Human immunodeficiency virus type 1,Q72498,3VQA,ASD05060084,MWP,B,Lig,Inhibitor,"1,1-bis(oxidanylidene)-1-benzothiophen-6-amine",303,Protein-Protein Interaction Regulator,Protein-Protein Interaction,23139382,Parallel screening of low molecular weight fragment libraries: do differences in methodology affect hit identification?,No,"Chain A:ARG107,TRP108,PRO109,ILE204; Chain B:ASN184,HIS185,GLY197,GLU198,VAL201",1.9,True,2
ASD05060000_1,pol,Human immunodeficiency virus type 1,Q72498,3VQA,ASD05060082,SUC,B,Lig,Inhibitor,"(2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol",304,Protein-Protein Interaction Regulator,Protein-Protein Interaction,23139382,Parallel screening of low molecular weight fragment libraries: do differences in methodology affect hit identification?,No,"Chain A:GLU87,VAL88,GLU96,TYR99,LYS103,LYS173; Chain B:GLU87,VAL88,GLU96,TYR99,LYS103,LYS173",1.9,True,2
ASD05060000_1,pol,Human immunodeficiency virus type 1,Q72498,3VQB,ASD05060086,FBG,A,Lig,Inhibitor,"[(2R,3S,4S,5R)-2,3,4-trihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]methyl dihydrogen phosphate",304,Protein-Protein Interaction Regulator,Protein-Protein Interaction,23139382,Parallel screening of low molecular weight fragment libraries: do differences in methodology affect hit identification?,No,"Chain A:TYR83,ASN184,HIS185,SER195,GLY197,GLU198,VAL201; Chain B:GLY106,ARG107,TRP108,PRO109,ILE204,ILE208",2.1,True,2
ASD05060000_1,pol,Human immunodeficiency virus type 1,Q72498,3VQC,ASD05060087,MPK,A,Lig,Inhibitor,"(5-methyl-3-phenyl-1,2-oxazol-4-yl)methanol",304,Protein-Protein Interaction Regulator,Protein-Protein Interaction,23139382,Parallel screening of low molecular weight fragment libraries: do differences in methodology affect hit identification?,No,"Chain A:ASN184,HIS185,SER195,GLY197,GLU198; Chain B:ARG107,PRO109",2.3,True,2
ASD05060000_1,pol,Human immunodeficiency virus type 1,Q72498,3VQD,ASD05060088,MOK,A,Lig,Inhibitor,"5-methyl-3-phenyl-1,2-oxazole-4-carboxylic acid",304,Protein-Protein Interaction Regulator,Protein-Protein Interaction,23139382,Parallel screening of low molecular weight fragment libraries: do differences in methodology affect hit identification?,No,"Chain A:TYR83,ASN184,HIS185,SER195,GLY197,GLU198; Chain B:ARG107,TRP108,PRO109,ILE204,ILE208",2.0,True,2
ASD05060000_1,pol,Human immunodeficiency virus type 1,Q72498,3VQE,ASD05060089,FMQ,A,Lig,Inhibitor,[1-(4-fluorophenyl)-5-methyl-pyrazol-4-yl]methanol,1006,Protein-Protein Interaction Regulator,Protein-Protein Interaction,23139382,Parallel screening of low molecular weight fragment libraries: do differences in methodology affect hit identification?,No,"Chain A:HIS185,ARG187,SER195,GLY197,GLU198,VAL201; Chain B:PRO109,ILE204",1.7,True,2
ASD05060000_1,pol,Human immunodeficiency virus type 1,Q72498,3VQP,ASD05060090,DBJ,A,Lig,Inhibitor,"2,3-dihydro-1,4-benzodioxin-5-ylmethanol",306,Protein-Protein Interaction Regulator,Protein-Protein Interaction,23139382,Parallel screening of low molecular weight fragment libraries: do differences in methodology affect hit identification?,No,"Chain A:TYR83,TRP108,ASN184,HIS185,GLY197,GLU198,VAL201; Chain B:GLY106,ARG107,TRP108,PRO109,ILE204",2.1,True,2
ASD05060000_1,pol,Human immunodeficiency virus type 1,Q72498,3VQQ,ASD05060091,BTE,A,Lig,Inhibitor,"2,1,3-benzothiadiazol-4-amine",306,Protein-Protein Interaction Regulator,Protein-Protein Interaction,23139382,Parallel screening of low molecular weight fragment libraries: do differences in methodology affect hit identification?,No,"Chain A:ASN184,HIS185,GLY197,GLU198,VAL201; Chain B:ARG107,TRP108,PRO109,ILE204,ILE208",2.0,True,2
ASD05060000_1,pol,Human immunodeficiency virus type 1,Q72498,3VQQ,ASD05060082,SUC,A,Lig,Inhibitor,"(2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol",304,Protein-Protein Interaction Regulator,Protein-Protein Interaction,23139382,Parallel screening of low molecular weight fragment libraries: do differences in methodology affect hit identification?,No,"Chain A:GLU87,VAL88,ILE89,GLU96,TYR99,LYS103,LYS173; Chain B:GLU87,VAL88,ILE89,GLU96,TYR99,LYS103,LYS173",2.0,True,2
ASD05100000_1,lysC,Escherichia coli,P08660,2J0X,ASD00910001,LYS,A,Lig,Inhibitor,[(5S)-5-amino-6-hydroxy-6-oxo-hexyl]azanium,1451,Protein-Protein Interaction Regulator,Protein-Protein Interaction,16905770,Structures of R- and T-State Escherichia Coli Aspartokinase III: Mechanisms of the Allosteric Transition and Inhibition by Lysine.,No,"Chain A:MET318,SER321,GLY323,PHE324,LEU325,THR344,SER345,GLU346; Chain B:SER338,VAL339,ASP340",2.8,True,2
ASD05230000_1,mhcA,Dictyostelium discoideum,P08799,1YV3,ASD05238001,BIT,A,Lig,Inhibitor,"(3aS)-3a-hydroxy-6-methyl-1-phenyl-2,3-dihydropyrrolo[2,3-b]quinolin-4-one",800,Inner Protein Regulator,Inner Protein,15750603,The structural basis of blebbistatin inhibition and specificity for myosin II.,No,"Chain A:ARG238,PHE239,GLY240,TYR261,LEU262,LEU263,GLU264,ILE455,SER456,GLU467,CYS470,ILE471,THR474,TYR634,GLN637,LEU641",2.0,True,1
ASD05230000_1,mhcA,Dictyostelium discoideum,P08799,2JHR,ASD05233003,PBQ,A,Lig,Inhibitor,"2,4-dibromo-6-(3,4,5-tribromo-1H-pyrrol-2-yl)phenol",1780,Inner Protein Regulator,Inner Protein,19122661,The Mechanism of Pentabromopseudilin Inhibition of Myosin Motor Activity.,No,"Chain A:LYS265,ALA420,LYS423,ALA424,GLY427,ARG428,LEU431,ASP590,LEU592,ILE617,ALA618,SER619,ARG620",2.8,True,1
ASD05230000_1,mhcA,Dictyostelium discoideum,P08799,2XEL,ASD05233008,IA2,A,Lig,Inhibitor,"2,4-dichloro-6-(3,4,5-trichloro-1H-pyrrol-2-yl)phenol",999,Inner Protein Regulator,Inner Protein,21680745,Mechanism and Specificity of Pentachloropseudilin-Mediated Inhibition of Myosin Motor Activity.,No,"Chain A:LYS265,ALA424,GLY427,ARG428,LEU431,ASP590,LEU592,ASN616,ILE617,SER619,ARG620",2.5,True,1
ASD05230000_1,mhcA,Dictyostelium discoideum,P08799,2XO8,ASD05233007,H70,A,Lig,Inhibitor,"2,4-dichloro-6-(3,4,5-tribromo-1H-pyrrol-2-yl)phenol",1778,Inner Protein Regulator,Inner Protein,,Inhibition of Myosin ATPase Activity by Halogenated Pseudilins: A Structure-Activity Study.,No,"Chain A:LEU263,LYS265,LYS423,ALA424,GLY427,ARG428,LEU431,ASP590,LEU592,ILE617",2.4,True,1
ASD05230000_1,mhcA,Dictyostelium discoideum,P08799,3BZ7,ASD05230005,BL4,A,Lig,Inhibitor,"(3aS)-3a-hydroxy-5-methyl-1-phenyl-2,3-dihydropyrrolo[2,3-b]quinolin-4-one",800,Inner Protein Regulator,Inner Protein,18528569,The small molecule tool (S)-(-)-blebbistatin: novel insights of relevance to myosin inhibitor design.,No,"Chain A:ARG238,PHE239,GLY240,TYR261,LEU262,LEU263,GLU264,ILE455,SER456,GLU467,CYS470,ILE471,THR474,TYR634,GLN637,LEU638",2.0,True,1
ASD05230000_1,mhcA,Dictyostelium discoideum,P08799,3BZ8,ASD05230006,BL6,A,Lig,Inhibitor,"(3aS)-3a-hydroxy-7-methyl-1-phenyl-2,3-dihydropyrrolo[2,3-b]quinolin-4-one",800,Inner Protein Regulator,Inner Protein,18528569,The small molecule tool (S)-(-)-blebbistatin: novel insights of relevance to myosin inhibitor design.,No,"Chain A:ARG238,PHE239,GLY240,TYR261,LEU262,LEU263,ILE455,SER456,GLU467,CYS470,ILE471,THR474,TYR634,GLN637,LEU638",2.2,True,1
ASD05230000_1,mhcA,Dictyostelium discoideum,P08799,3BZ9,ASD05230007,BL7,A,Lig,Inhibitor,"(3aS)-3a-hydroxy-1-phenyl-2,3-dihydropyrrolo[2,3-b]quinolin-4-one",800,Inner Protein Regulator,Inner Protein,18528569,The small molecule tool (S)-(-)-blebbistatin: novel insights of relevance to myosin inhibitor design.,No,"Chain A:ARG238,PHE239,GLY240,TYR261,LEU262,LEU263,ILE455,SER456,GLU467,CYS470,ILE471,THR474,TYR634,GLN637,LEU638",2.1,True,1
ASD05230000_1,mhcA,Dictyostelium discoideum,P08799,3MJX,ASD05238001,BIT,A,Lig,Inhibitor,"(3aS)-3a-hydroxy-6-methyl-1-phenyl-2,3-dihydropyrrolo[2,3-b]quinolin-4-one",902,Inner Protein Regulator,Inner Protein,19122661,The mechanism of pentabromopseudilin inhibition of myosin motor activity.,No,"Chain A:ARG238,PHE239,GLY240,TYR261,LEU262,ILE455,SER456,GLU467,ILE471,THR474,VAL630,TYR634,LEU638,LEU641",2.2,True,1
ASD05270000_2,,Alcaligenes faecalis,P38501,1ZDQ,ASD05273001,MSM,A,Lig,Regulator,(METHYLSULFANYL)METHANE,1507,Inner Protein Regulator,Inner Protein,16574144,A rearranging ligand enables allosteric control of catalytic activity in copper-containing nitrite reductase.,No,"Chain A:ALA61,TRP144,LEU93,HIS60,PRO199,HIS95,SER148,HIS145,MET62,GLU47",1.8,True,1
ASD05270000_2,nirK,Alcaligenes faecalis,P38501,1ZDS,ASD05273004,ACM,A,Lig,Regulator,ethanamide,2500,Inner Protein Regulator,Inner Protein,16574144,A rearranging ligand enables allosteric control of catalytic activity in copper-containing nitrite reductase.,No,"Chain A:GLU47,HIS60,MET62,LEU93,HIS95,TRP144,HIS145,SER148,PRO199",1.55,True,1
ASD05270000_2,nirK,Alcaligenes faecalis,P38501,2B08,ASD05273004,ACM,A,Lig,Regulator,ethanamide,1503,Inner Protein Regulator,Inner Protein,17227014,Effect of the methionine ligand on the reorganization energy of the type-1 copper site of nitrite reductase.,No,"Chain A:GLU47,HIS60,MET62,LEU93,HIS95,TRP144,HIS145,SER148,PRO199",1.9,True,1
ASD05550000_3,pycA,Staphylococcus aureus,Q99UY8,3HO8,ASD05550003,COA,A,Lig,Activator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxy-oxolan-2-yl]methyl [hydroxy-[(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-[[3-oxo-3-(2-sulfanylethylamino)propyl]amino]butoxy]phosphoryl] hydrogen phosphate",2001,Inner Protein Regulator,Protein-Protein Interaction,19523900,A Symmetrical Tetramer for S. aureus Pyruvate Carboxylase in Complex with Coenzyme A.,No,"Chain A:ARG398,ARG448,GLU449,ARG451,ARG453,SER493,LEU494,ARG496,GLY497,GLY1055,LYS1056,ARG1057,MET1080,ASN1081,ARG1085; Chain C:ALA57,ARG77,TYR78,LYS79,ALA80,ASP81,GLU82,SER83",2.9,True,2
ASD05550000_5,,Listeria monocytogenes R479a,L8DYY9,4QSH,ASD05550002,2BA,A,Lig,Regulator,"(2R,3R,3aS,5R,7aR,9R,10R,10aS,12R,14aR)-2,9- bis(6-amino-9H-purin-9-yl)octahydro-2H,7H- difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine- 3,5,10,12-tetrol 5,12-dioxide",2004,Inner Protein Regulator,Inner Protein,25215494,The Cyclic Dinucleotide c-di-AMP Is an Allosteric Regulator of Metabolic Enzyme Function.,No,Chain D:SER756,2.51,True,1
ASD05550000_5,,Listeria monocytogenes R479a,L8DYY9,4QSK,ASD05550002,2BA,A,Lig,Regulator,"(2R,3R,3aS,5R,7aR,9R,10R,10aS,12R,14aR)-2,9- bis(6-amino-9H-purin-9-yl)octahydro-2H,7H- difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine- 3,5,10,12-tetrol 5,12-dioxide",2000,Inner Protein Regulator,Inner Protein,25215494,The Cyclic Dinucleotide c-di-AMP Is an Allosteric Regulator of Metabolic Enzyme Function.,No,"Chain A:TYR722,TYR749,LEU785,GLN719,PRO718,ALA754,ASN789,ALA752,ALA753,SER756,ALA757",2.7,True,1
ASD05860000_2,,Escherichia coli,P04483,2NS8,ASD05860010;ASD05860010;ASD05860010;ASD05860010;ASD05860010;ASD05860010;ASD05860010;ASD05860010;ASD05860010;ASD05860010;ASD05860010;ASD05860010,ACE;TRP;THR;TRP;ASN;ALA;TYR;ALA;PHE;ALA;ALA;PRO,E;E;E;E;E;E;E;E;E;E;E;E,Pep,Inhibitor,,0;1;2;3;4;5;6;7;8;9;10;11,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,17374541,How an agonist peptide mimics the antibiotic tetracycline to induce Tet-repressor,No,"Chain E:ASN4,ALA10,PHE8,THR2,TRP3,TYR6,ALA9,PRO11,ALA5,ALA7,TRP1",2.55,True,1
ASD05860000_2,,Escherichia coli,P04483,3ZQF,ASD05860006;ASD05860006;ASD05860006;ASD05860006;ASD05860006;ASD05860006;ASD05860006;ASD05860006;ASD05860006;ASD05860006;ASD05860006;ASD05860006;ASD05860006,GLU;GLY;LEU;ALA;ARG;VAL;ALA;ALA;LEU;ALA;ARG;SER;ARG,C;C;C;C;C;C;C;C;C;C;C;C;C,Pep,Inhibitor,,4;5;6;7;8;9;10;11;12;13;14;15;16,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,22178479,An Exclusive Alpha/Beta Code Directs Allostery in Tetr-Peptide Complexes.,No,"Chain C:ALA13,GLY5,ARG14,LEU6,LEU12,SER15,ALA10,VAL9,GLU4,ALA11,ARG16,ALA7,ARG8",2.56,True,1
ASD05860000_2,,Escherichia coli,P04483,3ZQG,ASD05860007;ASD05860007;ASD05860007;ASD05860007;ASD05860007;ASD05860007;ASD05860007;ASD05860007;ASD05860007;ASD05860007;ASD05860007;ASD05860007;ASD05860007,ARG;GLY;ARG;TRP;GLN;VAL;TRP;GLY;LEU;ALA;LYS;ARG;CYS,C;C;C;C;C;C;C;C;C;C;C;C;C,Pep,Inhibitor,,4;5;6;7;8;9;10;11;12;13;14;15;16,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,22178479,An Exclusive Alpha/Beta Code Directs Allostery in Tetr-Peptide Complexes.,No,"Chain C:TRP10,ALA13,ARG4,GLY5,LEU12,VAL9,GLY11,GLN8,CYS16,LYS14,ARG15,TRP7,ARG6",2.45,True,1
ASD05860000_2,,Escherichia coli,P04483,3ZQH,ASD05860008;ASD05860008;ASD05860008;ASD05860008;ASD05860008;ASD05860008;ASD05860008;ASD05860008;ASD05860008;ASD05860008;ASD05860008;ASD05860008,SER;ARG;VAL;VAL;VAL;TRP;ARG;LEU;PRO;PRO;LEU;HIS,C;C;C;C;C;C;C;C;C;C;C;C,Pep,Inhibitor,,4;5;6;7;8;9;10;11;12;13;14;15,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,22178479,An Exclusive Alpha/Beta Code Directs Allostery in Tetr-Peptide Complexes.,No,"Chain C:PRO13,HIS15,VAL7,ARG5,SER4,VAL8,LEU14,LEU11,VAL6,TRP9,PRO12,ARG10",1.6,True,1
ASD05860000_2,,Escherichia coli,P04483,3ZQI,ASD05860009;ASD05860009;ASD05860009;ASD05860009;ASD05860009;ASD05860009;ASD05860009;ASD05860009;ASD05860009;ASD05860009;ASD05860009;ASD05860009;ASD05860009;ASD05860009,SER;VAL;LEU;ALA;ALA;ARG;ALA;ARG;MET;TRP;MET;TRP;HIS;TRP,C;C;C;C;C;C;C;C;C;C;C;C;C;C,Pep,Inhibitor,,3;4;5;6;7;8;9;10;11;12;13;14;15;16,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,22178479,An Exclusive Alpha/Beta Code Directs Allostery in Tetr-Peptide Complexes.,No,"Chain B:HIS151,ASP148,PRO161,GLU156,PHE177,MET166,THR163,SER165,LEU169,LYS155,THR160,ASP164,ASP178,GLU159,ALA173,ARG171,LEU170,GLU147,THR162,ILE174,GLU175,ARG158",1.5,True,1
ASD05860000_3,tetR,Escherichia coli,P0ACT4,2XPU,ASD05860005,TDC,A,Lig,Activator,"5A,6-ANHYDROTETRACYCLINE",1209,Allosteric function,Allosteric position,,The Role of the Metal Ion for Induction of Tetr(D) with Anhydrotetracycline.,No,"Chain A:HIS100,SER138,GLN109,THR112,LEU60,ARG104,LEU117,PHE78,ILE134,SER135,LEU79,LEU131,PRO105,VAL113,VAL137,SER67,HIS64,PHE86,GLN116,THR103,TYR66,ASN82,ALA83",1.55,True,1
ASD05860000_4,tetR,Pasteurella multocida,P51561,2VPR,ASD05860005,TDC,A,Lig,Regulator,"(4S,4aS,12aS)-4-dimethylamino-3,10,11,12a-tetrahydroxy-6-methyl-1,12-dioxo-4a,5-dihydro-4H-tetracene-2-carboxamide",1206,Protein-DNA/RNA Interaction Regulator,Inner Protein,18395746,"Tet Repressor Induction by Tetracycline: A Molecular Dynamics, Continuum Electrostatics, and Crystallographic Study",No,"Chain A:LEU60,HIS64,VAL67,ASN82,PHE86,HIS100,THR103,ARG104,PRO105,GLN109,SER113,GLN116,LEU134,SER135",2.49,True,1
ASD05950000_1,tcdB,Clostridium difficile,Q189K3,3PA8,ASD03710003,IHP,A,Lig,Activator,"(2,3,4,5,6-pentaphosphonooxycyclohexyl) dihydrogen phosphate",257,Inner Protein Regulator,Inner Protein,21095570,Rational design of inhibitors and activity-based probes targeting Clostridium difficile virulence factor TcdB.,No,"Chain A:ARG28,ARG32,TYR34,LEU54,LYS57,LYS104,GLY207,ARG208,ARG209,LYS221,LYS232,TYR234,LYS249",2.0,True,1
ASD05950000_1,tcdB,Clostridium difficile,Q189K3,3PEE,ASD03710003,IHP,A,Lig,Activator,"(2,3,4,5,6-pentaphosphonooxycyclohexyl) dihydrogen phosphate",255,Inner Protein Regulator,Inner Protein,21317893,Defining an allosteric circuit in the cysteine protease domain of Clostridium difficile toxins.,No,"Chain A:ARG28,ARG32,TYR34,LEU54,LYS57,LYS104,GLY207,ARG208,ARG209,LYS221,LYS232,TYR234,LYS249",2.1,True,1
ASD06120000_2,ugd,Klebsiella pneumoniae,C4XAX5,3PJG,ASD06120002,UGA,A,Lig,Inhibitor,"(2S,3S,4S,5R,6R)-6-[[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]oxy-3,4,5-trihydroxy-oxane-2-carboxylic acid",902,Inner Protein Regulator,Inner Protein,21536136,Conformational change upon product binding to Klebsiella pneumoniae UDP-glucose dehydrogenase: a possible inhibition mechanism for the key enzyme in polymyxin resistance.,No,"Chain A:LYS256,ASP257,LYS259,LYS284,GLN319,GLY320,MET322,LYS323,ARG324,LYS326,PHE345",2.7,True,1
ASD06430000_1,csoR,Mycobacterium tuberculosis,P9WP49,2HH7,ASD06432001,CU1,A,Ion,Inhibitor,copper(+1) cation,120,Protein-DNA/RNA Interaction Regulator,Inner Protein,17143269,CsoR is a novel Mycobacterium tuberculosis copper-sensing transcriptional regulator.,No,"Chain A:TYR35,CYS36",2.55,True,1
ASD06640000_2,sbcB,Escherichia coli,P04995,3HL8,ASD06640001,BBP,A,Lig,Inhibitor,"5-tert-butyl-2-(6-chloro-1,3-benzothiazol-2-yl)-3,4-dihydropyrazol-3-ol",501,Protein-Protein Interaction Regulator,Inner Protein,20018747,Small-molecule tools for dissecting the roles of SSB/protein interactions in genome maintenance,Yes,"Chain A:PRO228,TRP245,LEU264,ALA312,ASN313,ARG316,PRO317,ARG327,CYS330,LEU331,LEU334",1.55,True,1
ASD06680000_2,Rv0998,Mycobacterium tuberculosis,O05581,4AVB,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",400,Inner Protein Regulator,Inner Protein,22773105,Cyclic AMP Regulation of Protein Lysine Acetylation in Mycobacterium Tuberculosis.,No,"Chain A:LEU48,VAL67,ALA79,ARG80,ILE86,VAL87,GLY88,GLU89,ILE90,ALA91,ARG98,SER99,ALA100,VAL102,ARG138,PHE142",1.8,True,1
ASD06680000_2,Rv0998,Mycobacterium tuberculosis,O05581,4AVC,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",400,Inner Protein Regulator,Inner Protein,22773105,Cyclic AMP Regulation of Protein Lysine Acetylation in Mycobacterium Tuberculosis.,No,"Chain A:VAL67,ALA79,ARG80,VAL87,GLY88,GLU89,ILE90,ALA91,ARG98,SER99,ALA100,VAL102,ARG138,PHE142",2.806,True,1
ASD06680000_3,Dhaf_0733,Desulfitobacterium hafniense,B8FW11,3E5U,ASD06680001,3C4,A,Lig,Activator,2-(3-chloro-4-hydroxy-phenyl)ethanoic acid,501,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,18717788,"Molecular basis of halorespiration control by CprK, a CRP-FNR type transcriptional regulator",No,"Chain A:LEU63,TYR76,LEU83,ILE84,GLY85,LYS86,THR90,ASN92,ILE94,TYR130,LYS133; Chain B:LEU131,VAL134,ALA135",1.83,True,2
ASD06680000_3,Dhaf_0733,Desulfitobacterium hafniense,B8FW11,3E5X,ASD06680001,3C4,A,Lig,Activator,2-(3-chloro-4-hydroxy-phenyl)ethanoic acid,501,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,18717788,"Molecular basis of halorespiration control by CprK, a CRP-FNR type transcriptional regulator",No,"Chain A:LEU63,TYR76,LEU83,ILE84,GLY85,LYS86,THR90,ASN92,ILE94,TYR130,LYS133; Chain B:LEU131,VAL134,ALA135",1.999,True,2
ASD06680000_3,Dhaf_0733,Desulfitobacterium hafniense,B8FW11,3E6B,ASD06680001,3C4,A,Lig,Activator,2-(3-chloro-4-hydroxy-phenyl)ethanoic acid,301,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,18717788,"Molecular basis of halorespiration control by CprK, a CRP-FNR type transcriptional regulator",No,"Chain A:LEU63,LEU75,TYR76,LEU83,ILE84,GLY85,LYS86,THR90,ASN92,ILE94,TYR130,LYS133; Chain B:LEU131,VAL134,ALA135",2.01,True,2
ASD06680000_3,Dhaf_0733,Desulfitobacterium hafniense,B8FW11,3E6C,ASD06680001,3C4,C,Lig,Activator,2-(3-chloro-4-hydroxy-phenyl)ethanoic acid,604,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,18717788,"Molecular basis of halorespiration control by CprK, a CRP-FNR type transcriptional regulator",No,"Chain C:LEU63,TYR76,LEU83,ILE84,GLY85,LYS86,THR90,ASN92,ILE94,TYR130,LYS133",1.8,True,1
ASD06820000_1,EF_1143,Enterococcus faecalis,Q836G9,3IRH,ASD09690001,DGT,A,Lig,Activator,"[[(2R,3S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",458,Inner Protein Regulator,Protein-Protein Interaction,21757692,Characterization of the deoxynucleotide triphosphate triphosphohydrolase (dNTPase) activity of the EF1143 protein from Enterococcus faecalis and crystal structure of the activator-substrate complex.,No,"Chain A:PHE54,THR55,VAL247,ARG326,LYS330,LYS422; Chain B:LYS14,VAL15,PHE16,ILE35,ASN36,GLN41,ARG44,PHE64",2.4,True,2
ASD06820000_1,EF_1143,Enterococcus faecalis,Q836G9,4LRL,ASD09690001,DGT,B,Lig,Activator,"[[(2R,3S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",502,Inner Protein Regulator,Protein-Protein Interaction,24338016,Mechanisms of Allosteric Activation and Inhibition of the Deoxyribonucleoside Triphosphate Triphosphohydrolase from Enterococcus faecalis.,No,"Chain A:PHE54,THR55,VAL247,ARG326,LYS330; Chain B:LYS14,VAL15,PHE16,LEU32,ILE35,ASN36,GLN41,ARG44,PHE64",2.35,True,2
ASD06820000_1,EF_1143,Enterococcus faecalis,Q836G9,4LRL,ASD02040015,TTP,B,Lig,Inhibitor,"[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-pyrimidin-1-yl)oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",503,Inner Protein Regulator,Protein-Protein Interaction,24338016,Mechanisms of Allosteric Activation and Inhibition of the Deoxyribonucleoside Triphosphate Triphosphohydrolase from Enterococcus faecalis.,No,"Chain A:THR55,PHE56,THR197,GLN241,HIS245; Chain B:VAL15,PHE16,ARG17; Chain D:ARG206,ARG209,ASN223",2.35,True,3
ASD06980000_1,fimX,Pseudomonas aeruginosa,Q9HUK6,3HV8,ASD06980001,C2E,A,Lig,Inhibitor,"9,9'-[(2R,3R,3aS,5S,7aR,9R,10R,10aS,12S,14aR)- 3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro- 2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine- 2,9-diyl]bis(2-amino-1,9-dihydro-6H-purin- 6-one)",900,Inner Protein Regulator,Inner Protein,19679088,Structural analysis of the GGDEF-EAL domain-containing c-di-GMP receptor FimX.,No,"Chain A:GLN461,LEU477,LEU478,ARG479,PRO490,LEU494,ASP507,VAL510,HIS533,LEU534,SER535,GLN596,PHE652,VAL653,GLU654,GLY672,TYR673,PRO678",1.445,True,1
ASD06990000_1,mhkA,Dictyostelium discoideum,P42527,3LLA,ASD06990001,PO4,A,Ion,Regulator,PHOSPHATE ION,5954,Inner Protein Regulator,Inner Protein,20197546,Crystal Structure of the {alpha}-Kinase Domain of Dictyostelium Myosin Heavy Chain Kinase A.,No,"Chain A:PRO683,LYS684,ARG734,ASP762,PRO737,THR736,VAL799,ASN733,SER735",2.11,True,1
ASD06990000_1,mhkA,Dictyostelium discoideum,P42527,3LMH,ASD06990001,PO4,A,Ion,Regulator,PHOSPHATE ION,842,Inner Protein Regulator,Inner Protein,20197546,Crystal Structure of the {alpha}-Kinase Domain of Dictyostelium Myosin Heavy Chain Kinase A.,No,"Chain A:PRO683,LYS684,ARG734,ASP762,PRO737,THR736,VAL799,ASN733,SER735",2.0,True,1
ASD06990000_1,mhkA,Dictyostelium discoideum,P42527,3LMI,ASD06990001,PO4,B,Ion,Regulator,PHOSPHATE ION,5956,Inner Protein Regulator,Inner Protein,20197546,Crystal Structure of the {alpha}-Kinase Domain of Dictyostelium Myosin Heavy Chain Kinase A.,No,"Chain B:SER735,ASN733,ARG734,PRO737,ASP762,VAL799,THR736,PRO683,LYS684",2.2,True,1
ASD06990000_1,mhkA,Dictyostelium discoideum,P42527,3PDT,ASD06990001,PO4,A,Ion,Regulator,PHOSPHATE ION,810,Inner Protein Regulator,Inner Protein,21071445,Autophosphorylation Activates Dictyostelium Myosin II Heavy Chain Kinase A by Providing a Ligand for an Allosteric Binding Site in the {alpha}-Kinase Domain.,No,"Chain A:PRO683,LYS684,ARG734,ASP762,PRO737,THR736,VAL799,ASN733,SER735",1.8,True,1
ASD07020000_1,Nos2,Mus musculus,P29477,1DD7,ASD07020002,13:00,A,Lig,Inhibitor,"methyl (3S)-3-[2-(1,3-benzodioxol-5-ylmethylamino)-2-oxo-ethyl]-4-(2-imidazol-1-ylpyrimidin-4-yl)piperazine-1-carboxylate",601,Protein-Protein Interaction Regulator,Inner Protein,10677491,Allosteric inhibitors of inducible nitric oxide synthase dimerization discovered via combinatorial chemistry.,Yes,"Chain A:ARG193,GLN257,PRO344,ALA345,VAL346,PHE363,ASN364,GLY365,TRP366,TYR367,MET368,TYR485",2.25,True,1
ASD07020000_1,Nos2,Mus musculus,P29477,2ORO,ASD07020004,228,A,Lig,Inhibitor,"methyl (3S)-3-[2-(1,3-benzodioxol-5-ylmethylamino)-2-oxo-ethyl]-4-(2-imidazol-1-ylpyrimidin-4-yl)piperazine-1-carboxylate",601,Protein-Protein Interaction Regulator,Inner Protein,17315988,"Design, Synthesis, and Activity of 2-Imidazol-1-ylpyrimidine Derived Inducible Nitric Oxide Synthase Dimerization Inhibitors",Yes,"Chain A:ASN364,GLY365,ALA345,GLN257,TYR485,PRO344,TYR341,ILE259,TRP366,TYR367,VAL346,MET368,LEU343,PHE363,GLY369,ARG260,CYS194",2.0,True,1
ASD07020000_1,Nos2,Mus musculus,P29477,2ORP,ASD07020009,R86,A,Lig,Inhibitor,"methyl (3S)-3-[2-(1,3-benzodioxol-5-ylmethylamino)-2-oxo-ethyl]-4-(2-imidazol-1-ylpyrimidin-4-yl)piperazine-1-carboxylate",601,Protein-Protein Interaction Regulator,Inner Protein,17315988,"Design, Synthesis, and Activity of 2-Imidazol-1-ylpyrimidine Derived Inducible Nitric Oxide Synthase Dimerization Inhibitors",Yes,"Chain A:ASN364,TYR367,GLY365,PHE363,ILE372,ARG260,GLU371,MET368,GLN257,GLY373,ILE259,CYS194,VAL346,PRO344,TYR341,ARG193,TRP366,THR370,LEU343,GLY369,ALA345,TYR485",1.97,True,1
ASD07020000_1,Nos2,Mus musculus,P29477,2ORQ,ASD07020008,MSR,A,Lig,Inhibitor,"methyl (3S)-3-[2-(1,3-benzodioxol-5-ylmethylamino)-2-oxo-ethyl]-4-(2-imidazol-1-ylpyrimidin-4-yl)piperazine-1-carboxylate",601,Protein-Protein Interaction Regulator,Inner Protein,17315988,"Design, Synthesis, and Activity of 2-Imidazol-1-ylpyrimidine Derived Inducible Nitric Oxide Synthase Dimerization Inhibitors",Yes,"Chain A:ASN364,ALA345,GLN257,PRO344,TRP366,GLU371,TYR367,VAL346,GLY365,PHE363,ARG260,CYS194",2.1,True,1
ASD07020000_1,Nos2,Mus musculus,P29477,2ORR,ASD07020007,333,A,Lig,Inhibitor,"methyl (3S)-3-[2-(1,3-benzodioxol-5-ylmethylamino)-2-oxo-ethyl]-4-(2-imidazol-1-ylpyrimidin-4-yl)piperazine-1-carboxylate",601,Protein-Protein Interaction Regulator,Inner Protein,17315988,"Design, Synthesis, and Activity of 2-Imidazol-1-ylpyrimidine Derived Inducible Nitric Oxide Synthase Dimerization Inhibitors",Yes,"Chain A:ASN364,ALA345,GLN257,PRO344,TYR341,TRP366,TYR367,VAL346,TRP340,GLY365,PHE363,MET368,ARG260,CYS194",2.0,True,1
ASD07020000_1,Nos2,Mus musculus,P29477,2ORS,ASD07020006,391,A,Lig,Inhibitor,"methyl (3S)-3-[2-(1,3-benzodioxol-5-ylmethylamino)-2-oxo-ethyl]-4-(2-imidazol-1-ylpyrimidin-4-yl)piperazine-1-carboxylate",601,Protein-Protein Interaction Regulator,Inner Protein,17315988,"Design, Synthesis, and Activity of 2-Imidazol-1-ylpyrimidine Derived Inducible Nitric Oxide Synthase Dimerization Inhibitors",Yes,"Chain A:ASN364,ALA345,GLN257,PRO344,TYR341,TRP366,TYR367,VAL346,TRP340,GLY365,PHE363,MET368,ARG260,CYS194",2.0,True,1
ASD07020000_1,Nos2,Mus musculus,P29477,2ORT,ASD07020005,342,A,Lig,Inhibitor,"methyl (3S)-3-[2-(1,3-benzodioxol-5-ylmethylamino)-2-oxo-ethyl]-4-(2-imidazol-1-ylpyrimidin-4-yl)piperazine-1-carboxylate",601,Protein-Protein Interaction Regulator,Inner Protein,17315988,"Design, Synthesis, and Activity of 2-Imidazol-1-ylpyrimidine Derived Inducible Nitric Oxide Synthase Dimerization Inhibitors",Yes,"Chain A:ASN364,ALA345,GLN257,PRO344,TYR341,TRP366,TYR367,VAL346,TRP340,GLY365,PHE363,MET368,GLY369,ASP274,ARG260,CYS194",1.87,True,1
ASD07020000_1,Nos2,Mus musculus,P29477,3NQS,ASD07020010,AT2,A,Lig,Inhibitor,"methyl (3S)-3-[2-(1,3-benzodioxol-5-ylmethylamino)-2-oxo-ethyl]-4-(2-imidazol-1-ylpyrimidin-4-yl)piperazine-1-carboxylate",906,Protein-Protein Interaction Regulator,Inner Protein,20659888,"Nitric-oxide synthase forms N-NO-pterin and S-NO-cys: implications for activity, allostery, and regulation.",Yes,"Chain A:ASN364,GLY365,ALA345,GLN257,ASP376,PRO344,TYR341,ILE259,TRP366,ARG382,TYR367,VAL346,TRP340,LEU343,PHE363,MET368,ASP274,ARG260,GLU371",2.2,True,1
ASD07130000_1,,Trypanosoma brucei brucei,Q9TZZ6,1NJJ,ASD07130013,GET,A,Lig,Inhibitor,"(2R,3S,4R,5R,6S)-5-amino-6-[(1R,2S,3S,4R,6S)-4,6-diamino-3-[(2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-methylamino-oxan-2-yl]oxy-2-hydroxy-cyclohexyl]oxy-2-(1-hydroxyethyl)oxane-3,4-diol",601,Inner Protein Regulator,Protein-Protein Interaction,12672797,X-ray Structure Determination of Trypanosoma brucei Ornithine Decarboxylase Bound to D-Ornithine and to G418: INSIGHTS INTO SUBSTRATE BINDING AND ODC CONFORMATIONAL FLEXIBILITY.,No,"Chain A:ARG22,ASP243,LEU339,PRO340,GLN341,LEU382,GLU384,ASP385",2.45,True,1
ASD07400000_1,,Thermotoga maritima,Q9WZ31,2BBH,ASD00330030,MG,A,Ion,Regulator,MAGNESIUM ION,302,Inner Protein Regulator,Inner Protein,16598263,Crystal structure of the CorA Mg2+ transporter.,No,"Chain A:GLU88,ARG96,LYS98,GLN95,LEU85,ASP89",1.85,True,1
ASD07400000_1,,Thermotoga maritima,Q9WZ31,2IUB,ASD00330030,MG,A,Ion,Regulator,MAGNESIUM ION,1351,Inner Protein Regulator,Inner Protein,16857941,Crystal Structure of a Divalent Metal Ion Transporter Cora at 2.9 Angstrom Resolution.,No,"Chain B:GLU88,ASN92,LYS98,GLN95,LEU85,ASP89",2.9,True,1
ASD07400000_1,,Thermotoga maritima,Q9WZ31,4I0U,ASD00330030,MG,A,Ion,Regulator,MAGNESIUM ION,401,Inner Protein Regulator,Inner Protein,23425532,Exploring the structure and function of Thermotoga maritima CorA reveals the mechanism of gating and ion selectivity in Co2+/Mg2+ transport.,No,"Chain D:ASP253,ASP179,ASP175,TYR171,HIS257",2.7,True,1
ASD07450000_1,pleD,Caulobacter crescentus,B8GZM2,1W25,ASD06980001;ASD06980001,C2E;C2E,A;A,Lig;Lig,Inhibitor,"9,9'-[(2R,3R,3aS,5S,7aR,9R,10R,10aS,12S,14aR)- 3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro- 2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine- 2,9-diyl]bis(2-amino-1,9-dihydro-6H-purin- 6-one)",503;505,Inner Protein Regulator,Inner Protein,15569936,Structural Basis of Activity and Allosteric Control of Diguanylate Cyclase,No,"Chain A:ARG148,GLY153,GLY174,VAL175,HIS177,ARG178,SER356,ASN357,VAL358,ARG359,ALA360,ASP362,PRO377,THR379,ASP383,ILE387,ARG390",2.7,True,1
ASD07450000_1,pleD,Caulobacter crescentus,B8GZM2,2V0N,ASD06980001;ASD06980001,C2E;C2E,A;A,Lig;Lig,Inhibitor,"9,9'-[(2R,3R,3aS,5S,7aR,9R,10R,10aS,12S,14aR)- 3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro- 2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine- 2,9-diyl]bis(2-amino-1,9-dihydro-6H-purin- 6-one)",503;505,Inner Protein Regulator,Protein-Protein Interaction,17697997,"Structure of Bef3--Modified Response Regulator Pled: Implications for Diguanylate Cyclase Activation, Catalysis, and Feedback Inhibition",No,"Chain A:SER356,ASN357,VAL358,ARG359,ALA360,ASP362,THR379,ASP383,ARG386,ILE387,ARG390; Chain B:SER309,LYS312,ARG313,LEU316,GLY318",2.71,True,2
ASD07500000_2,RSP_0333,Rhodobacter sphaeroides,Q3J125,4P02,ASD06980001;ASD06980001,C2E;C2E,A;A,Lig,Activator,"9,9'-[(2R,3R,3aS,5S,7aR,9R,10R,10aS,12S,14aR)-3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro-2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine-2,9-diyl]bis(2-amino-1,9-dihydro-6H-purin-6-one)",918;919,Inner Protein Regulator,Inner Protein,24704788,Mechanism of activation of bacterial cellulose synthase by cyclic di-GMP.,No,"Chain A:VAL615,GLY614,ILE672,GLN577,VAL671,ARG584,GLY670,ALA582,VAL669,ARG658,PHE673,GLN578,SER611,LEU512,SER659,ASP609,ARG580,ARG656,ARG579,ALA581,ALA610,ARG616,SER613,ARG661",2.65,True,1
ASD07670000_1,prfA,Listeria monocytogenes,P22262,5LRS,ASD07770001,GSH,A,Lig,Activator,GLUTATHIONE,301,Allosteric function,Allosteric position,27930316,Structural basis for glutathione-mediated activation of the virulence regulatory protein PrfA in Listeria.,No,"Chain A:ILE149,TYR154,LEU60,GLN123,TYR115,LYS130,ALA66,TYR62,GLN146,LEU150,PHE67,VAL153,PHE225,LYS122,THR232,ASN2,GLN61,TRP224,THR119,LYS64,CYS229,SER127,ALA228,LEU41,TYR63,TYR126,GLY65",2.9,True,1
ASD07730000_2,fabG,Pseudomonas aeruginosa,O54438,4BNT,ASD07730030,36E,B,Lig,Inhibitor,2-(trifluoromethyl)-1H-benzimidazole,1248,Inner Protein Regulator,Protein-Protein Interaction,24015914,Discovery of an Allosteric Inhibitor Binding Site in 3-Oxo-Acyl-Acp Reductase from Pseudomonas Aeruginosa,No,"Chain A:VAL110,ASN111,LEU114,ALA156,GLY160; Chain B:TRP106,PHE107,VAL110,ASN111,LEU114,GLY160,PHE164",2.3,True,2
ASD07730000_2,fabG,Pseudomonas aeruginosa,O54438,4BNU,ASD07730031,9KQ,B,Lig,Inhibitor,"2-phenyl-4-(1,2,4-triazol-4-yl)quinazoline",1248,Inner Protein Regulator,Protein-Protein Interaction,24015914,Discovery of an Allosteric Inhibitor Binding Site in 3-Oxo-Acyl-Acp Reductase from Pseudomonas Aeruginosa,No,"Chain A:TRP106,PHE107,VAL110,ASN111,LEU114,ALA156,ALA159,GLY160,GLY163,PHE164; Chain B:TRP106,PHE107,VAL110,ASN111,LEU114,ALA156,GLY160,GLY163,PHE164",2.0,True,2
ASD07730000_2,fabG,Pseudomonas aeruginosa,O54438,4BNV,ASD07730032,Q7U,B,Lig,Inhibitor,1-(2-chlorophenyl)-3-(1-methylbenzimidazol-2-yl)urea,1247,Inner Protein Regulator,Protein-Protein Interaction,24015914,Discovery of an Allosteric Inhibitor Binding Site in Resolution,No,"Chain A:TRP106,PHE107,VAL110,ASN111,LEU114,ALA156,ALA159,GLY160,GLY163,PHE164; Chain B:TRP106,PHE107,VAL110,ASN111,LEU114,ALA156,ALA159,GLY160,GLY163,PHE164",2.5,True,2
ASD07730000_2,fabG,Pseudomonas aeruginosa,O54438,4BNX,ASD07730029,O74,A,Lig,Inhibitor,"(6E)-6-[4-[(2-chlorophenyl)amino]-1H-quinazolin-2-ylidene]cyclohexa-2,4-dien-1-one",1247,Inner Protein Regulator,Protein-Protein Interaction,24015914,Discovery of an Allosteric Inhibitor Binding Site in 3-Oxo-Acyl-Acp Reductase from Pseudomonas Aeruginosa,No,"Chain A:TRP106,PHE107,VAL110,ASN111,LEU114,ALA156,ALA159,GLY160,GLY163,PHE164; Chain B:TRP106,PHE107,VAL110,ASN111,LEU114,ALA156,GLY160,GLY163,PHE164",2.3,True,2
ASD07730000_2,fabG,Pseudomonas aeruginosa,O54438,4BNY,ASD07730028,36I,B,Lig,Inhibitor,"4-(2-phenylthieno[3,2-d]pyrimidin-4-yl)morpholine",1248,Inner Protein Regulator,Protein-Protein Interaction,24015914,Discovery of an Allosteric Inhibitor Binding Site in 3-Oxo-Acyl-Acp Reductase from Pseudomonas Aeruginosa,No,"Chain A:TRP106,PHE107,VAL110,ASN111,LEU114,ALA156,GLY160,GLY163,PHE164; Chain B:TRP106,PHE107,VAL110,ASN111,LEU114,ALA156,ALA159,GLY160,GLY163,PHE164",1.8,True,2
ASD07730000_2,fabG,Pseudomonas aeruginosa,O54438,4BNZ,ASD07730009,8M5,A,Lig,Inhibitor,1-methyl-N-phenyl-indole-3-carboxamide,1248,Inner Protein Regulator,Protein-Protein Interaction,24015914,Discovery of an Allosteric Inhibitor Binding Site in 3-Oxo-Acyl-Acp Reductase from Pseudomonas Aeruginosa,No,"Chain A:PHE107,VAL110,LEU114,ALA156,GLY160,GLY163,PHE164; Chain B:TRP106,VAL110,LEU114,ALA156,GLY160,GLY163,PHE164",2.5,True,2
ASD07730000_2,fabG,Pseudomonas aeruginosa,O54438,4BO0,ASD07730001,FXE,A,Lig,Inhibitor,1-(4-methoxy-1-methyl-indazol-3-yl)-3-(2-methoxyphenyl)urea,1248,Inner Protein Regulator,Protein-Protein Interaction,24015914,Discovery of an Allosteric Inhibitor Binding Site in 3-Oxo-Acyl-Acp Reductase from Pseudomonas Aeruginosa,No,"Chain A:TRP106,PHE107,VAL110,LEU114,ALA156,ALA159,GLY160,GLY163,PHE164; Chain B:PHE107,VAL110,ASN111,LEU114,ALA156,ALA159,GLY160,GLY163,PHE164",2.4,True,2
ASD07730000_2,fabG,Pseudomonas aeruginosa,O54438,4BO1,ASD07730003,NKH,B,Lig,Inhibitor,"N-(4-chloranyl-2,5-dimethoxy-phenyl)quinoline-8-carboxamide",1248,Inner Protein Regulator,Protein-Protein Interaction,24015914,Discovery of an Allosteric Inhibitor Binding Site in 3-Oxo-Acyl-Acp Reductase from Pseudomonas Aeruginosa,No,"Chain A:TRP106,PHE107,VAL110,ASN111,LEU114,ALA156,ALA159,GLY160,GLY163,PHE164; Chain B:TRP106,PHE107,VAL110,ASN111,LEU114,ALA156,GLY160,GLY163,PHE164",2.2,True,2
ASD07730000_2,fabG,Pseudomonas aeruginosa,O54438,4BO2,ASD07730004,36K,A,Lig,Inhibitor,1-(1-ethylbenzimidazol-2-yl)-3-(2-methoxyphenyl)urea,1248,Inner Protein Regulator,Protein-Protein Interaction,24015914,Discovery of an Allosteric Inhibitor Binding Site in 3-Oxo-Acyl-Acp Reductase from Pseudomonas Aeruginosa,No,"Chain A:TRP106,PHE107,VAL110,ASN111,LEU114,ALA156,ALA159,GLY160,GLY163,PHE164; Chain B:TRP106,PHE107,VAL110,ASN111,LEU114,ALA156,GLY160,GLY163,PHE164",1.9,True,2
ASD07730000_2,fabG,Pseudomonas aeruginosa,O54438,4BO3,ASD07730013,U98,A,Lig,Inhibitor,2-[[3-(trifluoromethyl)phenyl]amino]pyridine-3-sulfonamide,1248,Inner Protein Regulator,Protein-Protein Interaction,24015914,Discovery of an Allosteric Inhibitor Binding Site in 3-Oxo-Acyl-Acp Reductase from Pseudomonas Aeruginosa,No,"Chain A:TRP106,PHE107,VAL110,ASN111,LEU114,ALA156,ALA159,GLY160,GLY163,PHE164; Chain B:TRP106,VAL110,LEU114,ALA156,GLY163,PHE164",2.5,True,2
ASD07730000_2,fabG,Pseudomonas aeruginosa,O54438,4BO4,ASD07730016,36G,A,Lig,Inhibitor,"N-(2-methoxyphenyl)-3,4-dihydro-2H-quinoline-1-carboxamide",1248,Inner Protein Regulator,Protein-Protein Interaction,24015914,Discovery of an Allosteric Inhibitor Binding Site in 3-Oxo-Acyl-Acp Reductase from Pseudomonas Aeruginosa,No,"Chain A:TRP106,PHE107,ASN111,LEU114,ALA159,GLY160,GLY163,PHE164; Chain B:PHE107,VAL110,ASN111,LEU114,ALA156,ALA159,GLY160,GLY163",2.7,True,2
ASD07730000_2,fabG,Pseudomonas aeruginosa,O54438,4BO5,ASD07730022,WI4,B,Lig,Inhibitor,"N-(2-chlorophenyl)-4-pyrrol-1-yl-1,3,5-triazin-2-amine",1248,Inner Protein Regulator,Protein-Protein Interaction,24015914,Discovery of an Allosteric Inhibitor Binding Site in 3-Oxo-Acyl-Acp Reductase from Pseudomonas Aeruginosa,No,"Chain A:TRP106,PHE107,VAL110,LEU114,ALA156,ALA159,GLY160,GLY163,PHE164; Chain B:TRP106,VAL110,LEU114,ALA156,ALA159,GLY160,GLY163,PHE164",2.6,True,2
ASD07730000_2,fabG,Pseudomonas aeruginosa,O54438,4BO6,ASD07730023,36P,A,Lig,Inhibitor,"2,3-dihydroindol-1-yl-(2-thiophen-3-yl-1,3-thiazol-4-yl)methanone",1248,Inner Protein Regulator,Protein-Protein Interaction,24015914,Discovery of an Allosteric Inhibitor Binding Site in 3-Oxo-Acyl-Acp Reductase from Pseudomonas Aeruginosa,No,"Chain A:TRP106,PHE107,VAL110,ASN111,LEU114,GLY160,GLY163,PHE164; Chain B:PHE107,VAL110,ASN111,LEU114,ALA156,GLY160,GLY163,PHE164",2.8,True,2
ASD07730000_2,fabG,Pseudomonas aeruginosa,O54438,4BO7,ASD07730024,J2T,A,Lig,Inhibitor,"N-(2,3-dihydro-1H-inden-5-yl)-[1,2,3,4]tetrazolo[1,5-b]pyridazin-6-amine",1248,Inner Protein Regulator,Protein-Protein Interaction,24015914,Discovery of an Allosteric Inhibitor Binding Site in 3-Oxo-Acyl-Acp Reductase from Pseudomonas Aeruginosa,No,"Chain A:TRP106,PHE107,VAL110,ASN111,LEU114,ALA156,GLY160,GLY163,PHE164; Chain B:TRP106,PHE107,VAL110,ASN111,LEU114,ALA156,GLY160",2.6,True,2
ASD07730000_2,fabG,Pseudomonas aeruginosa,O54438,4BO8,ASD07730018,34X,B,Lig,Inhibitor,1-(2-azanyl-4-phenyl-imidazol-1-yl)-3-(2-fluorophenyl)urea,1248,Inner Protein Regulator,Protein-Protein Interaction,24015914,Discovery of an Allosteric Inhibitor Binding Site in 3-Oxo-Acyl-Acp Reductase from Pseudomonas Aeruginosa,No,"Chain A:TRP106,PHE107,VAL110,ASN111,LEU114,ALA156,GLY163,PHE164; Chain B:TRP106,PHE107,VAL110,ASN111,LEU114,ALA156,GLY160,GLY163,PHE164",2.7,True,2
ASD07730000_2,fabG,Pseudomonas aeruginosa,O54438,4BO9,ASD07730019,3X3,A,Lig,Inhibitor,"5-[2-(furan-2-ylmethoxy)phenyl]-2-phenyl-1,2,3,4-tetrazole",1248,Inner Protein Regulator,Protein-Protein Interaction,24015914,Discovery of an Allosteric Inhibitor Binding Site in 3-Oxo-Acyl-Acp Reductase from Pseudomonas Aeruginosa,No,"Chain A:TRP106,VAL110,ASN111,LEU114,ALA156,ALA159,GLY160,GLY163,PHE164; Chain B:TRP106,VAL110,ASN111,LEU114,ALA156,ALA159,GLY160,GLY163,PHE164",2.9,True,2
ASD07760000_2,,Streptomyces griseus,P00775,3BEU,ASD03160008,,A,Ion,Activator,SODIUM ION,248,Inner Protein Regulator,Inner Protein,18377928,Engineering protein allostery: 1.05 A resolution structure and enzymatic properties of a Na+-activated trypsin.,No,"Chain A:THR185,LYS223,LYS186,TYR225,LYS224,GLN187,ASP185,ALA221,GLY184,ARG222,GLY223,TYR185",1.05,True,1
ASD07820000_2,hisG,Mycobacterium tuberculosis,P9WMN1,1NH8,ASD01580014,HIS,A,Lig,Inhibitor,histidine,289,Inner Protein Regulator,Inner Protein,12511575,Crystal structure of ATP phosphoribosyltransferase from Mycobacterium tuberculosis,No,"Chain A:ASP216,TYR217,ASP218,LEU242,ALA273,LEU275",1.8,True,1
ASD07820000_2,hisG,Mycobacterium tuberculosis,P9WMN1,5LHT,ASD07820002,TIH,A,Lig,Activator,BETA(2-THIENYL)ALANINE,301,Allosteric Fuction,Allosteric Position,28781362,Uncoupling conformational states from activity in an allosteric enzyme.,No,"Chain A:ASP218,ASP216,LEU242,LEU275,ALA273,ILE274,TYR217,ILE250,ALA249,LYS272",2.0601,True,1
ASD07820000_2,hisG,Mycobacterium tuberculosis,P9WMN1,5LHU,ASD01580014,HIS,A,Lig,Inhibitor,L-HISTIDINE,301,Allosteric Fuction,Allosteric Position,28781362,Uncoupling conformational states from activity in an allosteric enzyme.,No,"Chain A:ASP218,ASP216,LEU242,LEU275,ALA273,ILE274,TYR217,ILE250,ALA249,LYS272",2.02,True,1
ASD07820000_3,hisG,Methanothermobacter thermautotrophicus,O27550,2VD3,ASD01580014,HIS,A,Lig,Inhibitor,histidine,1290,Inner Protein Regulator,Inner Protein,,The Structure of Histidine Inhibited Hisg from Methanobacterium Thermoautotrophicum,No,"Chain A:GLY235,MET236,THR237,GLY238,THR240,HIS254,ALA255,VAL256",2.45,True,1
ASD07980000_1,glvI,Gloeobacter violaceus,Q7NDN8,4F8H,ASD07980005,RKE,A,Lig,Inhibitor,(2R)-2-(2-chlorophenyl)-2-(methylamino)cyclohexan-1-one,401,Inner Protein Regulator,Protein-Protein Interaction,22958642,Structure of the Pentameric Ligand-Gated Ion Channel GLIC Bound with Anesthetic Ketamine.,No,"Chain A:TYR23,ASN152,ASP153,ASP154; Chain B:VAL79,PHE174,LEU176,LYS183",2.99,True,2
ASD07980000_1,glvI,Gloeobacter violaceus,Q7NDN8,5HCJ,ASD01630001,MBR,E,Lig,Regulator,tribromomethane,402,Inner Protein Regulator,Allosteric Position,27021161,Sites of Anesthetic Inhibitory Action on a Cationic Ligand-Gated Ion Channel.,No,"Chain D:ILE233,SER230",2.95,True,1
ASD07980000_1,glvI,Gloeobacter violaceus,Q7NDN8,5MZQ,ASD01630001,MBR,A,Lig,Regulator,TRIBROMOMETHANE,411,Allosteric function,Allosteric position,29694907,Structural Basis for a Bimodal Allosteric Mechanism of General Anesthetic Modulation in Pentameric Ligand-Gated Ion Channels.,No,"Chain A:ILE201,ILE258,ILE262,ILE259,TYR254,TRP205,PRO120,VAL242,TYR197,TYR119,PHE121,ILE202,THR255",2.8,True,1
ASD07990000_1,snf,Aquifex aeolicus,O67854,2Q6H,ASD07990004,CXX,A,Lig,Inhibitor,"3-(9-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethyl-propan-1-amine",801,Inner Protein Regulator,Inner Protein,17687333,Antidepressant binding site in a bacterial homologue of neurotransmitter transporters.,Yes,"Chain A:LEU25,LEU29,ARG30,VAL33,GLN34,TYR107,ILE111,PHE253,ALA319,PHE320,LEU400,ASP401,ASP404",1.85,True,1
ASD07990000_1,snf,Aquifex aeolicus,O67854,2Q72,ASD07990005,IXX,A,Lig,Inhibitor,"3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethyl-propan-1-amine",801,Inner Protein Regulator,Inner Protein,17687333,Antidepressant binding site in a bacterial homologue of neurotransmitter transporters.,Yes,"Chain A:LEU25,LEU29,ARG30,VAL33,GLN34,TYR107,ILE111,PHE253,ALA319,PHE320,LEU400,ASP401,ASP404",1.7,True,1
ASD07990000_1,snf,Aquifex aeolicus,O67854,2QB4,ASD07998004,DSM,A,Lig,Inhibitor,"3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N-methyl-propan-1-amine",801,Inner Protein Regulator,Inner Protein,17687333,Antidepressant binding site in a bacterial homologue of neurotransmitter transporters.,Yes,"Chain A:LEU25,LEU29,ARG30,VAL33,GLN34,TYR107,ILE111,PHE253,ALA319,PHE320,LEU400,ASP401,ASP404",1.9,True,1
ASD07990000_1,snf,Aquifex aeolicus,O67854,2QEI,ASD07990004,CXX,A,Lig,Inhibitor,"3-(9-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethyl-propan-1-amine",801,Inner Protein Regulator,Inner Protein,17687333,Antidepressant binding site in a bacterial homologue of neurotransmitter transporters.,Yes,"Chain A:LEU25,LEU29,ARG30,VAL33,GLN34,TYR107,ILE111,PHE253,ALA319,PHE320,LEU400,ASP401,ASP404",1.85,True,1
ASD07990000_1,snf,Aquifex aeolicus,O67854,3F48,ASD07990006,BOG,A,Lig,Inhibitor,"(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-octoxy-oxane-3,4,5-triol",706,Inner Protein Regulator,Inner Protein,19074341,A competitive inhibitor traps LeuT in an open-to-out conformation.,Yes,"Chain A:LEU25,GLY26,TYR108,ILE111,PHE253,GLY318,ALA319,PHE320,ASP401,ASP404",1.9,True,1
ASD08000000_1,aceK,Escherichia coli,Q8X607,3EPS,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",1604,Inner Protein Regulator,Inner Protein,20505668,Structure of the bifunctional isocitrate dehydrogenase kinase/phosphatase.,No,"Chain A:SER101,ASN104,SER105,HIS113,LEU116,LYS291,LYS294,THR295,TYR298,PHE375,GLU376,ASN377,PHE378",2.8,True,1
ASD08000000_1,aceK,Escherichia coli,Q8X607,3LCB,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",1604,Inner Protein Regulator,Inner Protein,20505668,Structure of the bifunctional isocitrate dehydrogenase kinase/phosphatase.,No,"Chain A:ASN104,SER105,CYS108,HIS113,LEU116,LEU121,LYS291,LYS294,THR295,TYR298,PHE375,GLU376,ASN377,PHE378",2.9,True,1
ASD08170000_2,Gls,Mus musculus,D3Z7P3,4JKT,ASD08170001,04A,D,Lig,Inhibitor,"2-phenyl-N-[5-[2-[2-[5-(2-phenylethanoylamino)-1,3,4-thiadiazol-2-yl]ethylsulfanyl]ethyl]-1,3,4-thiadiazol-2-yl]ethanamide",701,Inner Protein Regulator,Protein-Protein Interaction,23935106,Active Glutaminase C Self-assembles into a Supratetrameric Oligomer That Can Be Disrupted by an Allosteric Inhibitor.,No,"Chain A:ARG322,LYS325,LEU326,PHE327,LEU328,ASN329,GLU330,TYR399; Chain C:ARG322; Chain D:ARG322,LYS325,LEU326,PHE327,LEU328,ASN329,GLU330,TYR399",2.77,True,3
ASD08310000_1,SSE1,Saccharomyces cerevisiae,P32589,2QXL,ASD00150001,ATP,A,Lig,Regulator,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",1002,Protein-Protein Interaction Regulator,Inner Protein,17923091,Insights into hsp70 chaperone activity from a crystal structure of the yeast hsp110 Sse1.,No,"Chain A:GLY10,ASN11,ASN12,ASN13,LYS69,GLY205,HIS206,SER207,SER208,GLY234,GLU272,LYS275,LYS276,SER279,GLY342,GLY343,THR344,ARG346,ILE347",2.41,True,1
ASD08310000_1,SSE1,Saccharomyces cerevisiae,P32589,3D2E,ASD00150001,ATP,A,Lig,Regulator,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",1001,Protein-Protein Interaction Regulator,Inner Protein,,Structural Basis for the Cooperation of Hsp70 and Hsp110 Chaperones in Protein Folding,No,"Chain A:GLY10,ASN11,ASN12,ASN13,LYS69,ILE204,GLY205,HIS206,SER207,SER208,GLY234,GLU272,LYS275,LYS276,SER279,GLY342,GLY343,THR344,ARG346,ILE347; Chain B:GLN33",2.35,True,2
ASD08310000_1,SSE1,Saccharomyces cerevisiae,P32589,3D2F,ASD00150001,ATP,A,Lig,Regulator,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",1001,Protein-Protein Interaction Regulator,Inner Protein,,Structural Basis for the Cooperation of Hsp70 and Hsp110 Chaperones in Protein Folding,No,"Chain A:GLY10,ASN11,ASN12,ASN13,LYS69,GLY205,HIS206,SER207,SER208,GLY234,GLU272,LYS275,LYS276,SER279,GLY342,GLY343,THR344,ARG346,ILE347; Chain B:GLN33",2.3,True,2
ASD08370000_1,rad50,Pyrococcus furiosus,P58301,1F2U,ASD00150001,ATP,A,Lig,Activator,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",901,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,10892749,Structural biology of Rad50 ATPase: ATP-driven conformational control in DNA double-strand break repair and the ABC-ATPase superfamily.,No,"Chain A:ARG12,SER13,GLN31,ASN32,GLY33,SER34,GLY35,LYS36,SER37,SER38,GLU60,THR62,LYS63,VAL64,GLN140; Chain B:GLU823; Chain D:LYS763,TYR764,PHE791,SER793,GLY794,GLY795,GLU796",1.6,True,3
ASD08370000_1,rad50,Pyrococcus furiosus,P58301,4NCJ,ASD01720027,ADP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl phosphono hydrogen phosphate",901,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,24493214,"ATP-driven Rad50 conformations regulate DNA tethering, end resection, and ATM checkpoint signaling.",No,"Chain A:ARG12,SER13,GLN31,ASN32,GLY33,SER34,GLY35,LYS36,SER37,SER38,GLU60,PHE61,THR62,LYS63,VAL64,LEU871; Chain C:LYS763,TYR764,TRP782,PHE791,LEU792,SER793,GLU796",2.0,True,2
ASD08370000_2,rad50,Methanocaldococcus jannaschii,Q58718,3AUX,ASD01720027,ADP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl phosphono hydrogen phosphate",1006,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,,Crystal Structure of the Mre11-Rad50-ATP S Complex:Understanding the Interplay between Mre11 and Rad50,No,"Chain A:LYS14,SER15,ASN34,GLY35,SER36,GLY37,LYS38,SER39,SER40,ASP59,THR60,ILE62,THR63,LYS64,LYS994",2.8,True,1
ASD08370000_2,rad50,Methanocaldococcus jannaschii,Q58718,3AUY,ASD01720027,ADP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl phosphono hydrogen phosphate",1006,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,,Crystal Structure of the Mre11-Rad50-ATP S Complex: Understanding the Interplay between Mre11 and Rad50,No,"Chain A:LYS14,SER15,GLU33,ASN34,GLY35,SER36,GLY37,LYS38,SER39,SER40,ASP59,THR60,ILE62,THR63,LYS64,LYS994,ASN997",2.7,True,1
ASD08370000_3,rad50,Thermotoga maritima,Q9X1X1,3THO,ASD01720027,ADP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl phosphono hydrogen phosphate",1452,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,21937514,ATP driven structural changes of the bacterial Mre11:Rad50 catalytic head complex.,No,"Chain A:LEU12,GLY13,PRO31,ASN32,GLY33,ALA34,GLY35,LYS36,SER37,SER38,ARG53,TYR54,ASP59,VAL61,ASN62,ARG63,GLU798",2.6081,True,1
ASD08770000_2,AMY2,Sus scrofa,P00690,1BVN,ASD01630003,CL,P,Ion,Activator,chloride,2002,Inner Protein Regulator,Inner Protein,7897663,The crystal structure of porcine pancreatic alpha-amylase in complex with the microbial inhibitor Tendamistat.,Yes,"Chain P:ARG195,THR254,PHE256,ASN298,ARG337",2.5,True,1
ASD08770000_2,AMY2,Sus scrofa,P00690,1DHK,ASD01630003,CL,A,Ion,Activator,chloride,498,Inner Protein Regulator,Inner Protein,8994970,Substrate mimicry in the active center of a mammalian alpha-amylase: structural analysis of an enzyme-inhibitor complex.,Yes,"Chain A:ARG195,ASN298,ARG337",1.85,True,1
ASD08770000_2,AMY2,Sus scrofa,P00690,1HX0,ASD01630003,CL,A,Ion,Activator,chloride,498,Inner Protein Regulator,Inner Protein,11412124,Enzyme-catalyzed condensation reaction in a mammalian alpha-amylase. High-resolution structural analysis of an enzyme-inhibitor complex,Yes,"Chain A:ARG195,THR254,ASN298,ARG337",1.38,True,1
ASD08770000_2,AMY2,Sus scrofa,P00690,1JFH,ASD01630003,CL,A,Ion,Activator,chloride,498,Inner Protein Regulator,Inner Protein,9385631,Structure of a pancreatic alpha-amylase bound to a substrate analogue at 2.03 A resolution.,Yes,"Chain A:ARG195,GLU233,THR254,ASN298,ARG337",2.03,True,1
ASD08770000_2,AMY2,Sus scrofa,P00690,1KXQ,ASD01630003,CL,A,Ion,Activator,chloride,4002,Inner Protein Regulator,Inner Protein,11960990,Three camelid VHH domains in complex with porcine pancreatic alpha-amylase. Inhibition and versatility of binding topology.,Yes,"Chain A:ARG195,THR254,PHE256,ASN298,ARG337",1.6,True,1
ASD08770000_2,AMY2,Sus scrofa,P00690,1KXT,ASD01630003,CL,A,Ion,Activator,chloride,4002,Inner Protein Regulator,Inner Protein,11960990,Three camelid VHH domains in complex with porcine pancreatic alpha-amylase. Inhibition and versatility of binding topology.,Yes,"Chain A:ARG195,GLU233,THR254,ARG337",2.0,True,1
ASD08770000_2,AMY2,Sus scrofa,P00690,1OSE,ASD01630003,CL,A,Ion,Activator,chloride,498,Inner Protein Regulator,Inner Protein,8681972,"Crystal structure of pig pancreatic alpha-amylase isoenzyme II, in complex with the carbohydrate inhibitor acarbose.",Yes,"Chain A:ARG195,THR254,ASN298,ARG337",2.3,True,1
ASD08770000_2,AMY2,Sus scrofa,P00690,1PIF,ASD01630003,CL,A,Ion,Activator,chloride,600,Inner Protein Regulator,Inner Protein,8757803,Carbohydrate and protein-based inhibitors of porcine pancreatic alpha-amylase: structure analysis and comparison of their binding characteristics.,Yes,"Chain A:ARG195,THR254,ASN298,ARG337",2.3,True,1
ASD08770000_2,AMY2,Sus scrofa,P00690,1PIG,ASD01630003,CL,A,Ion,Activator,chloride,600,Inner Protein Regulator,Inner Protein,8757803,Carbohydrate and protein-based inhibitors of porcine pancreatic alpha-amylase: structure analysis and comparison of their binding characteristics.,Yes,"Chain A:ARG195,ASN298,ARG337",2.2,True,1
ASD08770000_2,AMY2,Sus scrofa,P00690,1PPI,ASD01630003,CL,A,Ion,Activator,chloride,498,Inner Protein Regulator,Inner Protein,8193143,1 - 1PPI : Amylase is an enzyme that breaks down starch. This structure includes the enzyme and a small starch chain.,Yes,"Chain A:ARG195,GLU233,THR254,ASN298,ARG337",2.2,True,1
ASD08770000_2,AMY2,Sus scrofa,P00690,1UA3,ASD01630003,CL,A,Ion,Activator,chloride,498,Inner Protein Regulator,Inner Protein,12962327,Crystal Structure of the Pig Pancreatic alpha-Amylase Complexed with Malto-Oligosaccharides,Yes,"Chain A:ARG195,GLU233,THR254,ASN298,ARG337",2.01,True,1
ASD08770000_2,AMY2,Sus scrofa,P00690,1VAH,ASD01630003,CL,A,Ion,Activator,chloride,498,Inner Protein Regulator,Inner Protein,15517985,Crystal structure of the pig pancreatic alpha-amylase complexed with rho-nitrophenyl-alpha-D-maltoside-flexibility in the active site,Yes,"Chain A:ARG195,GLU233,THR254,ASN298,ARG337",2.4,True,1
ASD08770000_2,AMY2,Sus scrofa,P00690,1WO2,ASD01630003,CL,A,Ion,Activator,chloride,498,Inner Protein Regulator,Inner Protein,15736930,Molecular Basis of the Effects of Chloride Ion on the Acid-Base Catalyst in the Mechanism of Pancreatic alpha-Amylase,Yes,"Chain A:ARG195,GLU233,PHE256,ASN298,ARG337",2.01,True,1
ASD08770000_2,AMY2,Sus scrofa,P00690,3L2L,ASD01630003,CL,A,Ion,Activator,chloride,502,Inner Protein Regulator,Inner Protein,20222716,"X-ray crystallographic analyses of pig pancreatic alpha-amylase with limit dextrin, oligosaccharide, and alpha-cyclodextrin.",Yes,"Chain A:ARG195,GLU233,THR254,PHE256,ASN298,ARG337",2.11,True,1
ASD08770000_2,AMY2,Sus scrofa,P00690,3L2M,ASD01630003,CL,A,Ion,Activator,chloride,502,Inner Protein Regulator,Inner Protein,20222716,"X-ray crystallographic analyses of pig pancreatic alpha-amylase with limit dextrin, oligosaccharide, and alpha-cyclodextrin.",Yes,"Chain A:ARG195,GLU233,THR254,PHE256,ASN298,ARG337",1.97,True,1
ASD08840000_1,radA,Methanococcus voltae,O73948,1T4G,ASD00498001,ANP,A,Lig,Regulator,"[[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]amino]phosphonic acid",401,Protein-DNA/RNA Interaction Regulator,Inner Protein,15304222,Crystal Structure of Archaeal Recombinase RadA; A Snapshot of Its Extended Conformation.,No,"Chain A:VAL106,PHE107,GLY108,SER109,GLY110,LYS111,THR112,GLN113,ARG158,GLN161,GLN257,ARG296,ILE315,THR316,GLU317",2.0,True,1
ASD08840000_1,radA,Methanococcus voltae,O73948,2FPK,ASD01720027,ADP,A,Lig,Regulator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl phosphono hydrogen phosphate",401,Protein-DNA/RNA Interaction Regulator,Inner Protein,16229465,Crystal Structure of Methanococcus Voltae Rada in Complex with Adp: hydrolysis-induced conformational change,No,"Chain A:VAL106,PHE107,GLY108,SER109,GLY110,LYS111,THR112,GLN113,ARG158,GLN161,ARG296,ILE315,THR316,GLU317",2.1,True,1
ASD08840000_1,radA,Methanococcus voltae,O73948,2FPL,ASD00498001,ANP,A,Lig,Regulator,"[[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]amino]phosphonic acid",401,Protein-DNA/RNA Interaction Regulator,Inner Protein,16229465,Crystal Structure of Methanococcus Voltae Rada in Complex with Adp: hydrolysis-induced conformational change,No,"Chain A:VAL106,PHE107,GLY108,SER109,GLY110,LYS111,THR112,GLN113,ARG158,GLN161,GLN257,ARG296,THR316,GLU317",2.3,True,1
ASD08840000_1,radA,Methanococcus voltae,O73948,2FPM,ASD00498001,ANP,A,Lig,Regulator,"[[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]amino]phosphonic acid",401,Protein-DNA/RNA Interaction Regulator,Inner Protein,16229465,Crystal Structure of Methanoccocus Voltae Rada in Complex with Adp: hydrolysis-induced conformational change,No,"Chain A:VAL106,PHE107,GLY108,SER109,GLY110,LYS111,THR112,GLN113,GLU151,ARG158,GLN161,ILE315,THR316,GLU317",2.0,True,1
ASD08840000_1,radA,Methanococcus voltae,O73948,2GDJ,ASD00498001,ANP,A,Lig,Regulator,"[[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]amino]phosphonic acid",401,Protein-DNA/RNA Interaction Regulator,Inner Protein,16765891,The Rad51/RadA N-Terminal Domain Activates Nucleoprotein Filament ATPase Activity.,No,"Chain A:VAL106,PHE107,GLY108,SER109,GLY110,LYS111,THR112,GLN113,ARG158,GLN161,GLN257,ARG296,ILE315,THR316,GLU317",2.5,True,1
ASD08840000_1,radA,Methanococcus voltae,O73948,3FYH,ASD01720027,ADP,A,Lig,Regulator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl phosphono hydrogen phosphate",401,Protein-DNA/RNA Interaction Regulator,Inner Protein,19555119,Crystal structure of an archaeal Rad51 homologue in complex with a metatungstate inhibitor.,No,"Chain A:VAL106,PHE107,GLY108,SER109,GLY110,LYS111,THR112,GLN113,ARG158,GLN161,ILE315,THR316,GLU317",1.9,True,1
ASD08840000_1,radA,Methanococcus voltae,O73948,3FYH,ASD08840007;ASD08840007;ASD08840007;ASD08840007;ASD08840007;ASD08840007;ASD08840007;ASD08840007;ASD08840007;ASD08840007;ASD08840007;ASD08840007;ASD08840007;ASD08840007;ASD08840007;ASD08840007;ASD08840007;ASD08840007;ASD08840007;ASD08840007;ASD08840007;ASD08840007;ASD08840007;ASD08840007,W;W;W;W;W;W;W;W;W;W;W;W;W;W;W;W;W;W;W;W;W;W;W;W,A;A;A;A;A;A;A;A;A;A;A;A;A;A;A;A;A;A;A;A;A;A;A;A,Ion,Regulator,tungsten(6+),534;511;512;513;514;515;516;517;518;519;520;521;522;523;524;525;526;527;528;529;530;531;532;533,Protein-DNA/RNA Interaction Regulator,Inner Protein,19555119,Crystal structure of an archaeal Rad51 homologue in complex with a metatungstate inhibitor.,No,"Chain A:ARG218,ARG230",1.9,True,1
ASD08840000_1,radA,Methanococcus voltae,O73948,3NTU,ASD00498001,ANP,A,Lig,Regulator,"[[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]amino]phosphonic acid",401,Protein-DNA/RNA Interaction Regulator,Inner Protein,,The RAD51 ATP cap regulates nucleoprotein filament stability.,No,"Chain A:VAL106,PHE107,GLY108,SER109,GLY110,LYS111,THR112,GLN113,GLU151,ARG158,GLN161,ARG296,THR316,GLU317",1.9,True,1
ASD08840000_2,radA,Methanococcus maripaludis,P0CW58,3ETL,ASD00498001,ANP,A,Lig,Regulator,"[[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]amino]phosphonic acid",401,Protein-DNA/RNA Interaction Regulator,Inner Protein,19465774,Conservation of a conformational switch in RadA recombinase from Methanococcus maripaludis.,No,"Chain A:PHE107,GLY108,SER109,GLY110,LYS111,THR112,GLN113,ARG158,GLN161,GLN257,ILE315,THR316,GLU317",2.4,True,1
ASD08890000_1,cnrR,Ralstonia metallidurans,P37975,2Y39,ASD08890001,NI,A,Ion,Activator,nickel(+2) cation,150,Inner Protein Regulator,Inner Protein,21414325,Structural Basis for Metal Sensing by Cnrx.,No,"Chain A:HIS42,HIS46,GLU63,HIS119,MET123",1.41,True,1
ASD08890000_1,cnrR,Ralstonia metallidurans,P37975,2Y3B,ASD08890003,CO,A,Ion,Activator,cobalt(+2) cation,1149,Inner Protein Regulator,Inner Protein,21414325,Structural Basis for Metal Sensing by Cnrx.,No,"Chain A:HIS42,HIS46,GLU63,HIS119,MET123",1.554,True,1
ASD08890000_1,cnrR,Ralstonia metallidurans,P37975,3EPV,ASD06430001,CU,A,Ion,Activator,copper(+2) cation,1,Inner Protein Regulator,Inner Protein,18992246,X-ray structure of the metal-sensor CnrX in both the apo- and copper-bound forms.,No,"Chain A:HIS12,HIS16,GLU33,HIS89",1.742,True,1
ASD08890000_1,cnrR,Ralstonia metallidurans,P37975,3ZG1,ASD08890001,NI,A,Ion,Activator,nickel(+2) cation,150,Inner Protein Regulator,Inner Protein,24154823,"Metal Sensing and Signal Transduction by Cnrx from Cupriavidus Metallidurans Ch34: Role of the Only Methionine Assessed by a Functional, Spectroscopic, and Theoretical Study",No,"Chain A:HIS42,GLU63,HIS119",1.85,True,1
ASD09090000_4,PDE6C,Gallus gallus,P52731,3DBA,ASD09090001,35G,A,Lig,Activator,"GUANOSINE-3',5'-MONOPHOSPHATE",1,Inner Protein Regulator,Inner Protein,18614542,"The Structure of the GAF A Domain from Phosphodiesterase 6C Reveals Determinants of cGMP Binding, a Conserved Binding Surface, and a Large cGMP-dependent Conformational Change.",No,"Chain A:ARG95,SER97,PHE99,LEU115,ASN116,PHE136,GLY141,ILE142,ALA143,HIS163,PHE164,SER165,LEU168,ASP169,THR172,TYR174,THR176,MET195,LEU197",2.57,True,1
ASD09330000_1,dasR,Streptomyces coelicolor,Q9K492,4ZSI,ASD80050001,GLP,A,Lig,Regulator,GLUCOSAMINE 6-PHOSPHATE,301,Allosteric Function,Allosteric Position,27337024,Crystal Structures of the Global Regulator DasR from Streptomyces coelicolor: Implications for the Allosteric Regulation of GntR/HutC Repressors.,No,"Chain A:THR178,THR174,THR96,VAL234,GLU193,SER236,LEU176,LEU219,TYR98,THR99,TYR177,ARG142,GLU154,THR156,SER223,GLN91,TYR238,GLU100,SER175,ARG144,ASP101,SER97,ARG221,GLU232",1.652,True,1
ASD09330000_1,dasR,Streptomyces coelicolor,Q9K492,4ZSI,ASD09330003,4R1,B,Lig,Regulator,beta-glucosamine-6-phosphate,301,Allosteric Function,Allosteric Position,27337024,Crystal Structures of the Global Regulator DasR from Streptomyces coelicolor: Implications for the Allosteric Regulation of GntR/HutC Repressors.,No,"Chain B:ARG144,ARG142,VAL234,GLN91,LEU176,TYR238,GLU193,ASP101,TYR98,LEU219,SER111,SER175,THR156,THR178,LEU170,GLU232,TYR177,ARG221,THR174,GLU100,THR96,SER223,SER236,SER97,THR99,GLU154",1.652,True,1
ASD09330000_1,dasR,Streptomyces coelicolor,Q9K492,4ZSK,ASD01218001,16G,A,Lig,Regulator,N-ACETYL-D-GLUCOSAMINE-6-PHOSPHATE,301,Allosteric Function,Allosteric Position,27337024,Crystal Structures of the Global Regulator DasR from Streptomyces coelicolor: Implications for the Allosteric Regulation of GntR/HutC Repressors.,No,"Chain A:THR178,THR174,THR96,VAL234,GLU193,SER236,SER220,LEU176,LEU219,TYR98,THR99,TYR177,ARG142,GLU154,THR156,SER223,TYR238,ARG235,GLU100,SER175,ARG144,ASP101,SER97,ARG221,GLU232",1.85,True,1
ASD09330000_1,dasR,Streptomyces coelicolor,Q9K492,4ZSK,ASD09330002,4QY,B,Lig,Regulator,beta-N-acetylglucosamine-6-phosphate,301,Allosteric Function,Allosteric Position,27337024,Crystal Structures of the Global Regulator DasR from Streptomyces coelicolor: Implications for the Allosteric Regulation of GntR/HutC Repressors.,No,"Chain B:ARG144,ARG142,GLN91,LEU176,TYR238,GLU193,ASP101,TYR98,LEU219,SER175,THR156,THR178,SER220,LEU170,GLU232,TYR177,ARG221,VAL234,THR174,GLU100,THR96,ARG235,SER223,SER236,SER97,THR99,GLU154",1.85,True,1
ASD09460000_1,pelD,Pseudomonas aeruginosa,Q02PM6,4DN0,ASD06980001;ASD06980001,C2E;C2E,A;A,Lig,Inhibitor,"9,9'-[(2R,3R,3aS,5S,7aR,9R,10R,10aS,12S,14aR)- 3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro- 2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine- 2,9-diyl]bis(2-amino-1,9-dihydro-6H-purin- 6-one)",501;502,Inner Protein Regulator,Inner Protein,22605337,"Structure of the Cytoplasmic Region of PelD, a Degenerate Diguanylate Cyclase Receptor That Regulates Exopolysaccharide Production in Pseudomonas aeruginosa.",No,"Chain A:ARG161,LEU165,GLN366,ARG367,GLY368,ASP370,LEU388,THR391,GLY395,GLY398,TYR399,ARG402",2.3,True,1
ASD09460000_1,pelD,Pseudomonas aeruginosa,Q9HZE7,4ETZ,ASD06980001,C2E,A,Lig,Inhibitor,"9,9'-[(2R,3R,3aS,5S,7aR,9R,10R,10aS,12S,14aR)- 3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro- 2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine- 2,9-diyl]bis(2-amino-1,9-dihydro-6H-purin- 6-one)",501,Inner Protein Regulator,Inner Protein,22810222,Structures of the PelD Cyclic Diguanylate Effector Involved in Pellicle Formation in Pseudomonas aeruginosa PAO1.,No,"Chain A:GLN158,ARG161,ARG367,ASP370,LEU388,THR391,GLY395,GLY398,TYR399,ARG402",2.05,True,1
ASD09460000_1,pelD,Pseudomonas aeruginosa,Q9HZE7,4EU0,ASD06980001,C2E,A,Lig,Inhibitor,"9,9'-[(2R,3R,3aS,5S,7aR,9R,10R,10aS,12S,14aR)- 3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro- 2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine- 2,9-diyl]bis(2-amino-1,9-dihydro-6H-purin- 6-one)",501,Inner Protein Regulator,Inner Protein,22810222,Structures of the PelD Cyclic Diguanylate Effector Involved in Pellicle Formation in Pseudomonas aeruginosa PAO1.,No,"Chain A:ARG161,ARG367,ASP370,LEU388,THR391,GLY395,GLY398,TYR399,ARG402",1.7,True,1
ASD09460000_1,pelD,Pseudomonas aeruginosa,Q9HZE7,4EUV,ASD06980001,C2E,A,Lig,Inhibitor,"9,9'-[(2R,3R,3aS,5S,7aR,9R,10R,10aS,12S,14aR)- 3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro- 2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine- 2,9-diyl]bis(2-amino-1,9-dihydro-6H-purin- 6-one)",501,Inner Protein Regulator,Inner Protein,22810222,Structures of the PelD Cyclic Diguanylate Effector Involved in Pellicle Formation in Pseudomonas aeruginosa PAO1.,No,"Chain A:ARG161,ARG367,ASP370,LEU388,THR391,GLY395,GLY398,TYR399,ARG402",2.0,True,1
ASD09970000_1,aroG,Mycobacterium tuberculosis,O53512,2YPO,ASD02170001,PHE,A,Lig,Inhibitor,(2S)-2-amino-3-phenyl-propanoic acid,900,Inner Protein Regulator,Protein-Protein Interaction,,Three Sites and You are Out: Ternary Synergistic Allostery Controls Aromatic Aminoacid Biosynthesis in Mycobacterium Tuberculosis.,No,"Chain A:PHE91,MET92,ARG171,ALA174,ASN175,ALA178; Chain B:TRP3,VAL5,ASP6,VAL55,TYR173",2.0,True,2
ASD09970000_1,aroG,Mycobacterium tuberculosis,O53512,2YPO,ASD02170001,PHE,B,Lig,Inhibitor,(2S)-2-amino-3-phenyl-propanoic acid,900,Inner Protein Regulator,Protein-Protein Interaction,,Three Sites and You are Out: Ternary Synergistic Allostery Controls Aromatic Aminoacid Biosynthesis in Mycobacterium Tuberculosis.,No,Chain B:ARG171,2.0,True,1
ASD09970000_1,aroG,Mycobacterium tuberculosis,O53512,3KGF,ASD00320001,TRP,B,Lig,Inhibitor,(2S)-2-amino-3-(1H-indol-3-yl)propanoic acid,9004,Inner Protein Regulator,Inner Protein,20667835,"Synergistic allostery, a sophisticated regulatory network for the control of aromatic amino acid biosynthesis in Mycobacterium tuberculosis",No,"Chain A:PHE91,MET92,ARG171,ALA174,ASN175,ALA178; Chain B:TRP3,VAL5,ASP6,VAL55,TYR173",2.0,True,2
ASD09970000_1,aroG,Mycobacterium tuberculosis,O53512,3KGF,ASD02170001,PHE,B,Lig,Inhibitor,(2S)-2-amino-3-phenyl-propanoic acid,9001,Inner Protein Regulator,Protein-Protein Interaction,20667835,"Synergistic allostery, a sophisticated regulatory network for the control of aromatic amino acid biosynthesis in Mycobacterium tuberculosis",No,"Chain A:LEU107,ALA110,VAL111,LYS123,ALA192,LEU194,ASN237,LEU238,THR240,ALA241",2.0,True,1
ASD09970000_1,aroG,Mycobacterium tuberculosis,O53512,3KGF,ASD02170001,PHE,B,Lig,Inhibitor,(2S)-2-amino-3-phenyl-propanoic acid,4188,Inner Protein Regulator,Inner Protein,20667835,"Synergistic allostery, a sophisticated regulatory network for the control of aromatic amino acid biosynthesis in Mycobacterium tuberculosis",No,Chain B:ARG256,2.0,True,1
ASD09970000_1,aroG,Mycobacterium tuberculosis,O53512,3NUE,ASD00320001,TRP,B,Lig,Inhibitor,(2S)-2-amino-3-(1H-indol-3-yl)propanoic acid,9004,Inner Protein Regulator,Inner Protein,20667835,"Synergistic allostery, a sophisticated regulatory network for the control of aromatic amino acid biosynthesis in Mycobacterium tuberculosis",No,"Chain A:LEU107,VAL111,LYS123,ALA192,LEU194,ASN237,LEU238,THR240,ALA241",2.5,True,1
ASD09970000_1,aroG,Mycobacterium tuberculosis,O53512,3NUE,ASD00320001,TRP,A,Lig,Inhibitor,(2S)-2-amino-3-(1H-indol-3-yl)propanoic acid,9004,Inner Protein Regulator,Inner Protein,20667835,"Synergistic allostery, a sophisticated regulatory network for the control of aromatic amino acid biosynthesis in Mycobacterium tuberculosis",No,Chain A:ASN237,2.5,True,1
ASD09970000_1,aroG,Mycobacterium tuberculosis,O53512,3RZI,ASD00320001,TRP,B,Lig,Inhibitor,(2S)-2-amino-3-phenyl-propanoic acid,466,Inner Protein Regulator,Inner Protein,,Dynamic Cross-Talk among Remote Binding Sites: The Molecular Basis for Unusual Synergistic Allostery.,No,"Chain A:PHE91,MET92,ARG171,ALA174,ASN175,ALA178; Chain B:VAL5,ASP6,VAL55,TYR173",1.95,True,2
ASD09970000_1,aroG,Mycobacterium tuberculosis,O53512,3RZI,ASD02170001,PHE,B,Lig,Inhibitor,(2S)-2-amino-3-(1H-indol-3-yl)propanoic acid,465,Inner Protein Regulator,Protein-Protein Interaction,,Dynamic Cross-Talk among Remote Binding Sites: The Molecular Basis for Unusual Synergistic Allostery.,No,"Chain A:LEU107,ALA110,VAL111,LYS123,ALA192,LEU194,ASN237,LEU238,THR240,ALA241",1.95,True,1
ASD09970000_1,aroG,Mycobacterium tuberculosis,O53512,5E7Z,ASD05860010,TRP,"A,B",Lig,Regulator,TRYPTOPHAN,505,Inner Protein Regulator,Allosteric Position,27128682,Probing the Sophisticated Synergistic Allosteric Regulation of Aromatic Amino Acid Biosynthesis in Mycobacterium tuberculosis Using -Amino Acids.,No,"Chain B:THR240,ALA192,ALA110,LEU238,ALA241,LEU194,SER193,VAL197,VAL111,THR114,VAL121,ASN237,GLN239,PRO120,GLN108,GLU242,LEU107,LYS123",2.4,True,1
ASD09970000_1,aroG,Mycobacterium tuberculosis,O53512,5EX4,ASD05860010,TRP,A,Lig,Regulator,TRYPTOPHAN,502,Allosteric Function,Allosteric Position,,3-deoxy-d-arabino-heptulosonate 7-phosphate synthase from Mycobacterium tuberculosis complexed with tryptophan in all three allosteric binding sites,No,"Chain A:LEU107,GLU242,ALA192,ALA110,LEU194,GLN239,LEU238,PRO120,VAL197,THR240,VAL111,ALA241,LYS123,ASN237,THR114,VAL121,GLN108,SER193",2.25,True,1
ASD09970000_1,aroG,Mycobacterium tuberculosis,O53512,5EX4,ASD05860010,TRP,A,Lig,Regulator,TRYPTOPHAN,504,Allosteric Function,Allosteric Position,,3-deoxy-d-arabino-heptulosonate 7-phosphate synthase from Mycobacterium tuberculosis complexed with tryptophan in all three allosteric binding sites,No,"Chain B:ALA174,SER54,PRO8,VAL51,VAL170,PRO56,TYR173,SER177,ILE7,ASP6,VAL55",2.25,True,1
ASD09970000_1,aroG,Mycobacterium tuberculosis,O53512,5EX4,ASD05860010,TRP,B,Lig,Regulator,TRYPTOPHAN,508,Allosteric Function,Allosteric Position,,3-deoxy-d-arabino-heptulosonate 7-phosphate synthase from Mycobacterium tuberculosis complexed with tryptophan in all three allosteric binding sites,No,"Chain B:ASP27,ALA257,ARG260,LEU261,ARG49,MET258,PRO16,LEU259,ARG256,LEU15,LEU18,LEU26,PRO17,GLU53,LEU271,ARG23,LEU30",2.25,True,1
ASD10100000_1,rmlA,Pseudomonas aeruginosa,Q9HU22,1FXO,ASD10100014,TMP,A,Lig,Inhibitor,"[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-pyrimidin-1-yl)oxolan-2-yl]methyl dihydrogen phosphate",9507,Inner Protein Regulator,Protein-Protein Interaction,11118200,The structural basis of the catalytic mechanism and regulation of glucose-1-phosphate thymidylyltransferase (RmlA).,No,"Chain A:LEU45,TYR114,GLY115,HIS116,ASP117,PHE118,VAL250,ALA251,GLU255,ILE256,ARG259; Chain C:GLY218,ARG219,GLY220",1.66,True,2
ASD10100000_1,,Pseudomonas aeruginosa,Q9HU22,1G0R,ASD01320159,THM,A,Lig,Inhibitor,THYMIDINE,2538,Inner Protein Regulator,Protein-Protein Interaction,11118200,The structural basis of the catalytic mechanism and regulation of glucose-1-phosphate thymidylyltransferase (RmlA).,No,"Chain C:GLY220,TYR221,GLY218,ARG219",1.87,True,1
ASD10100000_1,,Pseudomonas aeruginosa,Q9HU22,1G1L,ASD10100039,DAU,A,Lig,Inhibitor,2'DEOXY-THYMIDINE-5'-DIPHOSPHO-ALPHA-D-GLUCOSE,3501,Inner Protein Regulator,Protein-Protein Interaction,11118200,The structural basis of the catalytic mechanism and regulation of glucose-1-phosphate thymidylyltransferase (RmlA).,No,"Chain C:GLY220,MET217,ILE216,GLY218,ARG219,TYR221",1.77,True,1
ASD10100000_1,rmlA,Pseudomonas aeruginosa,Q9HU22,1G2V,ASD02040015,TTP,A,Lig,Inhibitor,"[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-pyrimidin-1-yl)oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",3501,Inner Protein Regulator,Protein-Protein Interaction,11118200,The structural basis of the catalytic mechanism and regulation of glucose-1-phosphate thymidylyltransferase (RmlA).,No,"Chain A:LEU45,TYR114,GLY115,HIS116,ASP117,PHE118,HIS119,VAL250,ALA251,GLU255,ILE256,ARG259,TYR293; Chain C:GLY218,ARG219,GLY220",2.6,True,2
ASD10100000_1,rmlA,Pseudomonas aeruginosa,Q9HU22,1G3L,ASD10100031,TRH,A,Lig,Inhibitor,"[hydroxy-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-pyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl] [(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-oxan-2-yl] hydrogen phosphate",501,Inner Protein Regulator,Protein-Protein Interaction,11118200,The structural basis of the catalytic mechanism and regulation of glucose-1-phosphate thymidylyltransferase (RmlA).,No,"Chain A:LEU45,TYR114,GLY115,HIS116,ASP117,PHE118,HIS119,GLU120,VAL250,ALA251,GLU255,ILE256,ARG259,TYR293; Chain C:ILE216,GLY218,ARG219,GLY220",2.7,True,2
ASD10100000_1,rmlA,Pseudomonas aeruginosa,Q9HU22,3ZLK,ASD10100004,Y46,A,Lig,Inhibitor,"N-[6-azanyl-2,4-bis(oxidanylidene)-1-(phenylmethyl)pyrimidin-5-yl]benzenesulfonamide",400,Inner Protein Regulator,Protein-Protein Interaction,23138692,Allosteric Competitive Inhibitors of the Glucose-1-Phosphate Thymidylyltransferase (Rmla) from Pseudomonas Aeruginosa.,No,"Chain A:TYR38,SER41,THR42,LEU45,TYR113,TYR114,GLY115,PHE118,HIS119,LYS249,VAL250,ALA251,GLU255,ILE256,ARG259",1.952,True,1
ASD10100000_1,rmlA,Pseudomonas aeruginosa,Q9HU22,3ZLL,ASD10100019,4WF,A,Lig,Inhibitor,"5-azanyl-6-oxidanyl-1-(phenylmethyl)pyrimidine-2,4-dione",400,Inner Protein Regulator,Protein-Protein Interaction,23138692,Allosteric Competitive Inhibitors of the Glucose-1-Phosphate Thymidylyltransferase (Rmla) from Pseudomonas Aeruginosa.,No,"Chain A:LEU45,VAL250,ALA251,GLU255,ILE256,ARG259",2.0,True,1
ASD10100000_1,rmlA,Pseudomonas aeruginosa,Q9HU22,4ARW,ASD10100001,HNR,A,Lig,Inhibitor,"N-[6-azanyl-1-butyl-2,4-bis(oxidanylidene)pyrimidin-5-yl]-N-methyl-benzenesulfonamide",400,Inner Protein Regulator,Protein-Protein Interaction,23138692,Allosteric Competitive Inhibitors of the Glucose-1-Phosphate Thymidylyltransferase (Rmla) from Pseudomonas Aeruginosa.,No,"Chain A:TYR38,SER41,THR42,LEU45,TYR113,TYR114,GLY115,PHE118,LYS249,VAL250,ALA251,GLU255,ILE256,ARG259",2.204,True,1
ASD10100000_1,rmlA,Pseudomonas aeruginosa,Q9HU22,4ASJ,ASD10100003,N6A,A,Lig,Inhibitor,"N-[6-azanyl-2,4-bis(oxidanylidene)-1-(phenylmethyl)pyrimidin-5-yl]-N-methyl-benzenesulfonamide",1294,Inner Protein Regulator,Protein-Protein Interaction,23138692,Allosteric Competitive Inhibitors of the Glucose-1-Phosphate Thymidylyltransferase (Rmla) from Pseudomonas Aeruginosa.,No,"Chain A:TYR38,SER41,THR42,LEU45,TYR113,TYR114,GLY115,PHE118,HIS119,LYS249,VAL250,ALA251,GLU255,ILE256,ARG259",2.25,True,1
ASD10100000_1,rmlA,Pseudomonas aeruginosa,Q9HU22,4ASY,ASD10100005,N5Y,A,Lig,Inhibitor,"N-[6-azanyl-2,4-bis(oxidanylidene)-1-(phenylmethyl)pyrimidin-5-yl]-N-methyl-benzamide",1294,Inner Protein Regulator,Protein-Protein Interaction,23138692,Allosteric Competitive Inhibitors of the Glucose-1-Phosphate Thymidylyltransferase (Rmla) from Pseudomonas Aeruginosa.,No,"Chain A:SER41,THR42,LEU45,TYR113,TYR114,GLY115,LYS249,VAL250,ALA251,GLU255,ILE256,ARG259; Chain B:ARG219",2.3,True,2
ASD10100000_1,rmlA,Pseudomonas aeruginosa,Q9HU22,4B2W,ASD10100013,BZ0,A,Lig,Inhibitor,"N-[6-azanyl-2,4-bis(oxidanylidene)-1-(phenylmethyl)pyrimidin-5-yl]benzamide",1294,Inner Protein Regulator,Protein-Protein Interaction,23138692,Allosteric Competitive Inhibitors of the Glucose-1-Phosphate Thymidylyltransferase (Rmla) from Pseudomonas Aeruginosa.,No,"Chain A:SER41,THR42,LEU45,TYR113,PHE118,LYS249,VAL250,ALA251,GLU255,ILE256,ARG259,GLN260",2.36,True,1
ASD10100000_1,rmlA,Pseudomonas aeruginosa,Q9HU22,4B2X,ASD10100023,NIQ,A,Lig,Inhibitor,"6-azanyl-1-butyl-5-(cyclopentylamino)pyrimidine-2,4-dione",400,Inner Protein Regulator,Protein-Protein Interaction,23138692,Allosteric Competitive Inhibitors of the Glucose-1-Phosphate Thymidylyltransferase (Rmla) from Pseudomonas Aeruginosa.,No,"Chain A:THR42,LEU45,TYR113,TYR114,GLY115,LYS249,VAL250,ALA251,GLU255,ILE256,ARG259,GLN260",1.7,True,1
ASD10100000_1,rmlA,Pseudomonas aeruginosa,Q9HU22,4B3U,ASD10100007,NWL,A,Lig,Inhibitor,"6-azanyl-5-(ethylamino)-1-(phenylmethyl)pyrimidine-2,4-dione",400,Inner Protein Regulator,Protein-Protein Interaction,23138692,Allosteric Competitive Inhibitors of the Glucose-1-Phosphate Thymidylyltransferase (Rmla) from Pseudomonas Aeruginosa.,No,"Chain A:LEU45,GLY115,HIS119,LYS249,VAL250,ALA251,GLU255,ILE256,ARG259,GLN260",1.8,True,1
ASD10100000_1,rmlA,Pseudomonas aeruginosa,Q9HU22,4B42,ASD10108001,942,A,Lig,Inhibitor,"N-[6-azanyl-1-butyl-2,4-bis(oxidanylidene)pyrimidin-5-yl]-N-methyl-benzamide",1294,Inner Protein Regulator,Protein-Protein Interaction,23138692,Allosteric Competitive Inhibitors of the Glucose-1-Phosphate Thymidylyltransferase (Rmla) from Pseudomonas Aeruginosa.,No,"Chain A:SER41,THR42,TYR113,TYR114,GLY115,PHE118,LYS249,VAL250,ALA251,GLU255,ILE256,ARG259",2.505,True,1
ASD10100000_1,rmlA,Pseudomonas aeruginosa,Q9HU22,4B4B,ASD10100009,GJB,A,Lig,Inhibitor,"1-(2-phenylethyl)-1,3-diazinane-2,4,6-trione",400,Inner Protein Regulator,Protein-Protein Interaction,23138692,Allosteric Competitive Inhibitors of the Glucose-1-Phosphate Thymidylyltransferase (Rmla) from Pseudomonas Aeruginosa.,No,"Chain A:LEU45,VAL250,ALA251,GLU255,ILE256,ARG259",2.1,True,1
ASD10100000_1,rmlA,Pseudomonas aeruginosa,Q9HU22,4B4G,ASD10100027,KKT,A,Lig,Inhibitor,"N-[6-azanyl-2,4-bis(oxidanylidene)-1-(phenylmethyl)pyrimidin-5-yl]-N-methyl-butane-1-sulfonamide",400,Inner Protein Regulator,Protein-Protein Interaction,23138692,Allosteric Competitive Inhibitors of the Glucose-1-Phosphate Thymidylyltransferase (Rmla) from Pseudomonas Aeruginosa.,No,"Chain A:SER41,THR42,LEU45,TYR113,TYR114,GLY115,PHE118,LYS249,VAL250,ALA251,GLU255,ILE256,ARG259",2.5,True,1
ASD10100000_1,rmlA,Pseudomonas aeruginosa,Q9HU22,4B4M,ASD10100011,JWT,A,Lig,Inhibitor,"N-[6-azanyl-2,4-bis(oxidanylidene)-1-(phenylmethyl)pyrimidin-5-yl]-4-fluoranyl-N-methyl-benzenesulfonamide",400,Inner Protein Regulator,Protein-Protein Interaction,23138692,Allosteric Competitive Inhibitors of the Glucose-1-Phosphate Thymidylyltransferase (Rmla) from Pseudomonas Aeruginosa.,No,"Chain A:TYR38,SER41,THR42,LEU45,TYR113,TYR114,GLY115,PHE118,HIS119,LYS249,VAL250,ALA251,GLU255,ILE256,ARG259",2.35,True,1
ASD10100000_1,rmlA,Pseudomonas aeruginosa,Q9HU22,4B5B,ASD10100043,BBE,A,Lig,Inhibitor,"N-[6-azanyl-2,4-bis(oxidanylidene)-1-(phenylmethyl)pyrimidin-5-yl]-N,3-dimethyl-benzenesulfonamide",400,Inner Protein Regulator,Protein-Protein Interaction,23138692,Allosteric Competitive Inhibitors of the Glucose-1-Phosphate Thymidylyltransferase (Rmla) from Pseudomonas Aeruginosa.,No,"Chain A:TYR38,SER41,THR42,LEU45,TYR113,TYR114,GLY115,PHE118,HIS119,LYS249,VAL250,ALA251,GLU255,ILE256,ARG259",2.055,True,1
ASD10100000_1,rmlA,Pseudomonas aeruginosa,Q9HU22,5FTV,ASD10100021,KDT,A,Lig,Inhibitor,"N-(6-AMINO-1-(4-BROMOBENZYL)-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-5-YL)-N-METHYLBENZENESULFONAMIDE",1294,Allosteric Function,Allosteric Position,,Allosteric Competitive Inhibitors of the Glucose-1-Phosphate Thymidylyltransferase (Rmla) from Pseudomonas Aeruginosa.,No,"Chain A:HIS116,GLN260,ILE256,LYS249,ASP117,HIS119,TYR37,TYR283,TYR114,ARG259,TYR38,LEU45,ALA251,CYS252,SER41,GLU255,PHE118,VAL250,THR42,TYR113,GLY115",2.213,True,1
ASD10100000_1,rmlA,Pseudomonas aeruginosa,Q9HU22,5FU0,ASD10100018,FKH,A,Lig,Inhibitor,"N-(6-AMINO-1-(3-METHYLBENZYL)-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-5-YL)-N-METHYLBENZENESULFONAMIDE",1294,Allosteric Function,Allosteric Position,,Allosteric Competitive Inhibitors of the Glucose-1-Phosphate Thymidylyltransferase (Rmla) from Pseudomonas Aeruginosa.,No,Chain A:GLU115,1.9,True,1
ASD10100000_1,rmlA,Pseudomonas aeruginosa,Q9HU22,5FU8,ASD10100017,DHS,A,Lig,Inhibitor,"N-(6-amino-1-(4-bromo-3-methylbenzyl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-N-methylbenzenesulfonamide",500,Allosteric Function,Allosteric Position,,Allosteric Competitive Inhibitors of the Glucose-1-Phosphate Thymidylyltransferase (Rmla) from Pseudomonas Aeruginosa.,No,"Chain A:HIS116,GLN260,ILE256,LYS249,ASP117,HIS119,TYR37,GLU120,TYR114,ARG259,TYR38,LEU45,ALA251,CYS252,SER41,GLU255,PHE118,VAL250,THR42,TYR113,GLY115",2.2,True,1
ASD10100000_1,rmlA,Pseudomonas aeruginosa,Q9HU22,5FUH,ASD10100020,HKX,A,Lig,Inhibitor,"N-[6-amino-1-(3-bromobenzyl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl]-N-methylbenzenesulfonamide",400,Allosteric Function,Allosteric Position,,Allosteric Competitive Inhibitors of the Glucose-1-Phosphate Thymidylyltransferase (Rmla) from Pseudomonas Aeruginosa.,No,"Chain A:HIS116,GLN260,ASP117,GLU255,GLU120,LYS249,THR42,LEU112,TYR38,CYS252,PHE118,VAL250,ILE256,TYR113,MET44,ALA251,ARG259,SER41,HIS119,GLN246,TYR114,LEU45,GLY115",1.6,True,1
ASD10100000_2,rmlA1,Escherichia coli,P37744,1H5R,ASD01320159,THM,A,Lig,Inhibitor,"1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-pyrimidine-2,4-dione",1292,Inner Protein Regulator,Protein-Protein Interaction,11697907,Kinetic and Crystallographic Analyses Support a Sequential-Ordered Bi Bi Catalytic Mechanism for Escherichia Coli Glucose-1-Phosphate Thymidylyltransferase,No,"Chain A:LEU46,TYR115,GLY116,LEU119,LYS250,VAL251,SER252,GLU256,ILE257,ARG260; Chain D:ARG220,GLY221",1.9,True,2
ASD10100000_2,rmlA1,Escherichia coli,P37744,1H5S,ASD10100014,TMP,A,Lig,Inhibitor,"[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-pyrimidin-1-yl)oxolan-2-yl]methyl dihydrogen phosphate",1292,Inner Protein Regulator,Protein-Protein Interaction,11697907,Kinetic and Crystallographic Analyses Support a Sequential-Ordered Bi Bi Catalytic Mechanism for Escherichia Coli Glucose-1-Phosphate Thymidylyltransferase,No,"Chain A:LEU46,TYR115,GLY116,HIS117,ASP118,LYS250,VAL251,SER252,GLU256,ILE257,ARG260; Chain D:GLY219,ARG220,GLY221",2.3,True,2
ASD10100000_3,MTH_1791,Methanothermobacter thermautotrophicus,O27819,1LVW,ASD10100015,TYD,A,Lig,Inhibitor,"[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-pyrimidin-1-yl)oxolan-2-yl]methyl phosphono hydrogen phosphate",3002,Inner Protein Regulator,Protein-Protein Interaction,,"Crystal structure of glucose-1-phosphate thymidylyltransferase, RmlA, complex with dTDP",No,"Chain A:LEU43,TYR112,GLY113,HIS114,ARG115,PHE116,SER117,TYR247,ILE248,ALA249,GLU253,ILE254; Chain C:ARG217",1.7,True,2
ASD10100000_4,SPAB_00935,Salmonella paratyphi B,A9N7P9,1MP3,ASD02040015,TTP,A,Lig,Inhibitor,"[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-pyrimidin-1-yl)oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",504,Inner Protein Regulator,Protein-Protein Interaction,12374866,Expanding pyrimidine diphosphosugar libraries via structure-based nucleotidylyltransferase engineering,No,"Chain A:LEU46,TYR115,GLY116,HIS117,ASP118,LEU119,PRO120,SER252,GLU256,ILE257,ARG260; Chain B:GLY219,ARG220,GLY221",2.2,True,2
ASD10100000_5,rmlA,Aneurinibacillus thermoaerophilus,Q9AGY4,4HO2,ASD01320159,THM,A,Lig,Inhibitor,"1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-pyrimidine-2,4-dione",301,Inner Protein Regulator,Protein-Protein Interaction,,Crystal structure of glucose 1-phosphate thymidylyltransferase from Aneurinibacillus thermoaerophilus complexed with thymidine,No,"Chain A:LEU43,TYR112,GLY113,PHE116,THR117,VAL248,ALA249,GLU253,ILE254,ARG257",1.84,True,1
ASD10100000_5,rmlA,Aneurinibacillus thermoaerophilus,Q9AGY4,4HO3,ASD02040015,TTP,A,Lig,Inhibitor,"[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-pyrimidin-1-yl)oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",301,Inner Protein Regulator,Protein-Protein Interaction,,Crystal structure of glucose 1-phosphate thymidylyltransferase from Aneurinibacillus thermoaerophilus complexed with thymidine triphosphate,No,"Chain A:LEU43,TYR112,GLY113,HIS114,GLY115,PHE116,THR117,VAL248,ALA249,GLU253,ILE254,ARG257",1.8,True,1
ASD10100000_5,rmlA,Aneurinibacillus thermoaerophilus,Q9AGY4,4HO4,ASD01320159,THM,A,Lig,Inhibitor,"1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-pyrimidine-2,4-dione",303,Inner Protein Regulator,Protein-Protein Interaction,,Crystal structure of glucose 1-phosphate thymidylyltransferase from Aneurinibacillus thermoaerophilus complexed with thymidine and glucose-1-phosphate,No,"Chain A:LEU43,TYR112,GLY113,PHE116,THR117,VAL248,ALA249,GLU253,ILE254,ARG257; Chain B:ARG217,GLY218",1.64,True,2
ASD10100000_5,rmlA,Aneurinibacillus thermoaerophilus,Q9AGY4,4HO5,ASD10100039,DAU,A,Lig,Inhibitor,"[(2R,3R,4S,5S,6R)-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl] [[(2R,3S,5R)-5-[5-methyl-2,4-bis(oxidanylidene)pyrimidin-1-yl]-3-oxidanyl-oxolan-2-yl]methoxy-oxidanyl-phosphoryl] hydrogen phosphate",301,Inner Protein Regulator,Protein-Protein Interaction,,Crystal structure of glucose 1-phosphate thymidylyltransferase from Aneurinibacillus thermoaerophilus complexed with TDP-glucose,No,"Chain A:LEU43,TYR112,GLY113,HIS114,GLY115,PHE116,THR117,VAL248,ALA249,GLU253,ILE254,ARG257; Chain B:GLY216,ARG217,GLY218",1.7,True,2
ASD10100000_5,rmlA,Aneurinibacillus thermoaerophilus,Q9AGY4,4HO6,ASD00150002,UTP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",301,Inner Protein Regulator,Protein-Protein Interaction,,Crystal structure of glucose 1-phosphate thymidylyltransferase from Aneurinibacillus thermoaerophilus complexed with UDP-glucose and UTP,No,"Chain A:LEU43,TYR112,GLY113,HIS114,GLY115,PHE116,THR117,VAL248,ALA249,GLU253,ILE254,ARG257",1.92,True,1
ASD10100000_5,rmlA,Aneurinibacillus thermoaerophilus,Q9AGY4,4HO8,ASD01320159,THM,A,Lig,Inhibitor,"1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-pyrimidine-2,4-dione",301,Inner Protein Regulator,Protein-Protein Interaction,,Crystal structure of glucose 1-phosphate thymidylyltransferase from Aneurinibacillus thermoaerophilus complexed with UDP-glucose and thymidine,No,"Chain A:LEU43,TYR112,GLY113,PHE116,THR117,VAL248,ALA249,GLU253,ILE254,ARG257; Chain B:ARG217,GLY218",2.6,True,2
ASD10100000_5,rmlA,Aneurinibacillus thermoaerophilus,Q9AGY4,4HO9,ASD00150002,UTP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",301,Inner Protein Regulator,Protein-Protein Interaction,,Crystal structure of glucose 1-phosphate thymidylyltransferase from Aneurinibacillus thermoaerophilus complexed with UDP-galactose and UTP,No,"Chain A:LEU43,TYR112,GLY113,HIS114,GLY115,PHE116,THR117,GLU118,VAL248,ALA249,GLU253,ILE254,ARG257; Chain B:GLY216,ARG217,GLY218",1.8,True,2
ASD10250000_1,allC,Escherichia coli,P77425,1Z2L,ASD02880002,SO4,A,Ion,Regulator,sulfate,513,Inner Protein Regulator,Inner Protein,17362992,Structural analysis of a ternary complex of allantoate amidohydrolase from Escherichia coli reveals its mechanics.,Yes,"Chain A:GLN215,ARG217,ARG290,ALA358,GLY359; Chain B:HIS228",2.25,True,2
ASD10290000_1,GFA1,Candida albicans,P53704,2POC,ASD10298001,UD1,A,Lig,Inhibitor,"[[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-hydroxy-phosphoryl] [(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl hydrogen phosphate",5002,Inner Protein Regulator,Inner Protein,17681543,The Crystal and Solution Studies of Glucosamine-6-phosphate Synthase from Candida albicans,No,"Chain A:ARG372,GLY383,GLY384,GLY474,VAL476,VAL479,SER484,THR487,HIS488,CYS489,GLY490,VAL491,HIS492",1.8,True,1
ASD10290000_1,GFA1,Candida albicans,P53704,2PUT,ASD10298001,UD1,B,Lig,Inhibitor,"[[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-hydroxy-phosphoryl] [(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl hydrogen phosphate",5003,Inner Protein Regulator,Inner Protein,17681543,The Crystal and Solution Studies of Glucosamine-6-phosphate Synthase from Candida albicans,No,"Chain B:ARG372,GLY383,GLY384,GLY474,VAL476,VAL479,SER484,THR487,HIS488,CYS489,GLY490,VAL491,HIS492",1.9,True,1
ASD10290000_1,GFA1,Candida albicans,P53704,2PUV,ASD10298001,UD1,B,Lig,Inhibitor,"[[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-hydroxy-phosphoryl] [(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl hydrogen phosphate",5003,Inner Protein Regulator,Inner Protein,17681543,The Crystal and Solution Studies of Glucosamine-6-phosphate Synthase from Candida albicans,No,"Chain B:ARG372,GLY383,GLY384,GLY474,VAL476,VAL479,SER484,THR487,HIS488,CYS489,GLY490,VAL491,HIS492",1.9,True,1
ASD10420000_2,Ttr,Rattus norvegicus,P02767,1IE4,ASD06898001,T44,A,Lig,Inhibitor,"(2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]propanoic acid",128,Inner Protein Regulator,Protein-Protein Interaction,11468389,Structure of rat transthyretin (rTTR) complex with thyroxine at 2.5 A resolution: first non-biased insight into thyroxine binding reveals different hormone orientation in two binding sites.,No,"Chain A:LYS15,LEU17,GLU54,ALA108,ALA109,LEU110; Chain C:LYS15,LEU17,GLU54,ALA108,LEU110",2.5,True,2
ASD10470000_1,GRESAG,Trypanosoma brucei brucei,Q99279,1FX2,ASD04400004,DTT,A,Lig,Regulator,"(2R,3R)-1,4-bis-sulfanylbutane-2,3-diol",1124,Inner Protein Regulator,Inner Protein,11157750,Structural analysis of adenylate cyclases from Trypanosoma brucei in their monomeric state.,No,"Chain A:GLN969,PHE972,LEU973,TRP1016,ASN1017,GLY1018,LEU1019,ARG1020,VAL1021,GLY1061,ARG1109",1.46,True,1
ASD10710000_1,GSU0527,Geobacter sulfurreducens,Q74FS9,4GX0,ASD11630001,CA,A,Ion,Inhibitor,calcium(+2) cation,607,Inner Protein Regulator,Protein-Protein Interaction,23240087,Distinct gating mechanisms revealed by the structures of a multi-ligand gated K(+) channel.,No,"Chain A:GLU449,ASN450,GLN453; Chain B:THR183,ASN210,THR214",2.601,True,2
ASD10710000_1,GSU0527,Geobacter sulfurreducens,Q74FS9,4GX1,ASD11630001,CA,A,Ion,Inhibitor,calcium(+2) cation,605,Inner Protein Regulator,Protein-Protein Interaction,23240087,Distinct gating mechanisms revealed by the structures of a multi-ligand gated K(+) channel.,No,"Chain A:GLU449,ASN450,GLN453; Chain B:THR183,ASN210,THR214",2.8,True,2
ASD11000000_2,Grin2b,Rattus norvegicus,Q00960,3QEL,ASD11000034,QEL,B,Lig,Inhibitor,4-[(2S)-1-hydroxy-2-[4-(phenylmethyl)piperidin-1-yl]propyl]phenol,1,Inner Protein Regulator,Protein-Protein Interaction,21677647,Subunit arrangement and phenylethanolamine binding in GluN1/GluN2B NMDA receptors.,No,"Chain A:TYR109,THR110,ARG115,SER132,ILE133,LEU135; Chain B:ALA107,GLN110,ILE111,PHE114,THR174,TYR175,PHE176,PRO177,GLU236",2.6,True,2
ASD11510000_1,S100G,Bos taurus,P02633,1IG5,ASD00330030,MG,A,Ion,Inhibitor,magnesium(+2) cation,78,Inner Protein Regulator,Inner Protein,9194174,Structural basis for the negative allostery between Ca(2+)- and Mg(2+)-binding in the intracellular Ca(2+)-receptor calbindin D9k.,No,"Chain A:ASP54,ASN56,ASP58,GLU60",1.5,True,1
ASD11510000_1,S100G,Bos taurus,P02633,1IGV,ASD00890024,MN,A,Ion,Inhibitor,manganese(+2) cation,76,Inner Protein Regulator,Inner Protein,9194174,Structural basis for the negative allostery between Ca(2+)- and Mg(2+)-binding in the intracellular Ca(2+)-receptor calbindin D9k.,No,"Chain A:ASP54,ASN56,ASP58,GLU60",1.85,True,1
ASD11510000_1,S100G,Bos taurus,P02633,3ICB,ASD11630001,CA,A,Ion,Inhibitor,calcium(+2) cation,77,Inner Protein Regulator,Inner Protein,3722173,"The refined structure of vitamin D-dependent calcium-binding protein from bovine intestine. Molecular details, ion binding, and implications for the structure of other calcium-binding proteins.",No,"Chain A:ASP54,ASN56,ASP58,GLU60,GLU65",2.3,True,1
ASD11520000_1,fadR,Escherichia coli,P0A8V6,1H9G,ASD11520001;ASD03320088,COA;MYR,A;A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxy-oxolan-2-yl]methyl [hydroxy-[(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-[[3-oxo-3-(2-sulfanylethylamino)propyl]amino]butoxy]phosphoryl] hydrogen phosphate;tetradecanoic acid",1228;1229,Protein-DNA/RNA Interaction Regulator,Inner Protein,11296236,The Structural Basis of Acyl Coenzyme A-Dependent Regulation of the Transcription Factor Fadr,No,"Chain A:ASP99,LEU101,LEU102,SER103,VAL104,ARG105,THR106,ASN107,ILE108,ASP145,ILE164,LEU165,MET168,TYR172,ILE175,GLY176,TYR179,PHE180,ARG213,GLY216,HIS217,SER219,GLY220,TRP223,HIS224",2.1,True,1
ASD11760000_1,,Bacillus caldovelox,P53608,2CEV,ASD11760001,GAI,A,Lig,Activator,GUANIDINE,1001,Inner Protein Regulator,Protein-Protein Interaction,10196128,"Crystal structures of Bacillus caldovelox arginase in complex with substrate and inhibitors reveal new insights into activation, inhibition and catalysis in the arginase superfamily.",No,"Chain B:HIS196,MET195,ASP199,GLU197,GLY244",2.15,True,1
ASD11760000_1,,Bacillus caldovelox,P53608,3CEV,ASD02000001,ARG,B,Lig,Activator,ARGININE,402,Inner Protein Regulator,Protein-Protein Interaction,10196128,"Crystal structures of Bacillus caldovelox arginase in complex with substrate and inhibitors reveal new insights into activation, inhibition and catalysis in the arginase superfamily.",No,"Chain B:GLU250,GLY291,LEU298,HIS252,GLU296,LEU253,GLU256,ARG35,ARG249,TYR248,LYS297,SER292,ALA288",2.4,True,1
ASD11760000_1,,Bacillus caldovelox,P53608,4CEV,ASD11760001,GAI,A,Lig,Activator,GUANIDINE,407,Inner Protein Regulator,Protein-Protein Interaction,10196128,"Crystal structures of Bacillus caldovelox arginase in complex with substrate and inhibitors reveal new insights into activation, inhibition and catalysis in the arginase superfamily.",No,"Chain B:HIS196,MET195,ASP199,GLU197,GLY244",2.7,True,1
ASD11790000_1,cg0350,Corynebacterium glutamicum,Q79VI7,3R6S,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",301,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,,Crystal structure of GlxR transcription factor from Corynebacterium glutamicum with cAMP,No,"Chain A:PHE41,LEU60,LEU72,MET75,PHE81,GLY82,GLU83,LEU84,SER85,ARG92,THR93,SER94,ARG133,THR137; Chain C:LEU134,ASN138",2.38,True,2
ASD11860000_1,ntcA,Nostoc sp.,P0A4U6,3LA2,ASD00710001,AKG,A,Lig,Activator,2-OXOGLUTARIC ACID,224,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,20616047,Structural basis for the allosteric control of the global transcription factor NtcA by the nitrogen starvation signal 2-oxoglutarate.,No,"Chain B:GLU134,LEU131,ILE130",2.6,True,1
ASD11860000_1,ntcA,Nostoc sp.,P0A4U6,3LA3,ASD11860001,2FT,A,Lig,Activator,"2,2-difluoropentanedioic acid",224,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,20616047,Structural basis for the allosteric control of the global transcription factor NtcA by the nitrogen starvation signal 2-oxoglutarate.,No,"Chain B:GLU134,LEU131,ILE130",2.4,True,1
ASD11870000_1,mecA,Staphylococcus aureus,Q54113,3ZFZ,ASD11870002,1W8,A,Lig,Activator,"4-(2-{[(6R,7R)-7-{[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(ethoxyimino)acetyl]amino}-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]sulfanyl}-1,3-thiazol-4-yl)-1-methylpyridinium (6R,7R)-7-[[(2Z)-2-(5-azanyl-1,2,4-thiadiazol-3-yl)-2-ethoxyimino-ethanoyl]amino]-3-[[4-(1-methylpyridin-1-ium-4-yl)-1,3-thiazol-2-yl]sulfanyl]-8-oxidanylidene-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",1669,Inner Protein Regulator,Protein-Protein Interaction,24085846,How Allosteric Control of Staphylococcus Aureus Penicillin Binding Protein 2A Enables Methicillin Resistance and Physiological Function,No,"Chain B:ILE309,ASN305,LEU147,ASN146,ASN307,ARG298,THR308,SER306,GLU145",2.25,True,1
ASD11870000_1,mecA,Staphylococcus aureus,Q54113,3ZFZ,ASD11870001,MUR,A,Lig,Activator,"2-amino-3-O-[(1R)-1-carboxyethyl]-2-deoxy-beta-D-glucopyranose (2R)-2-[(2R,3R,4R,5S,6R)-3-amino-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxypropanoic acid",1670,Inner Protein Regulator,Inner Protein,24085846,How Allosteric Control of Staphylococcus Aureus Penicillin Binding Protein 2A Enables Methicillin Resistance and Physiological Function,No,"Chain A:THR165,GLU239,VAL256,GLY257,TYR373,THR238,ARG241,PRO258,VAL277,GLY166,GLU150,HIS293,ARG151,SER240,MET372,ASN164,SER149",2.25,True,1
ASD11870000_1,mecA,Staphylococcus aureus,Q54113,3ZG0,ASD11870002,1W8,A,Lig,Activator,"4-(2-{[(6R,7R)-7-{[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(ethoxyimino)acetyl]amino}-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]sulfanyl}-1,3-thiazol-4-yl)-1-methylpyridinium (6R,7R)-7-[[(2Z)-2-(5-azanyl-1,2,4-thiadiazol-3-yl)-2-ethoxyimino-ethanoyl]amino]-3-[[4-(1-methylpyridin-1-ium-4-yl)-1,3-thiazol-2-yl]sulfanyl]-8-oxidanylidene-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",1676,Inner Protein Regulator,Protein-Protein Interaction,24085846,How Allosteric Control of Staphylococcus Aureus Penicillin Binding Protein 2A Enables Methicillin Resistance and Physiological Function,No,"Chain B:ILE309,LEU147,THR308,ASN307,ARG298,GLU315,THR300,SER306,GLU145",2.6,True,1
ASD11870000_1,mecA,Staphylococcus aureus,Q54113,3ZG0,ASD11870001,MUR,A,Lig,Activator,"2-amino-3-O-[(1R)-1-carboxyethyl]-2-deoxy-beta-D-glucopyranose (2R)-2-[(2R,3R,4R,5S,6R)-3-amino-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxypropanoic acid",1677,Inner Protein Regulator,Inner Protein,24085846,How Allosteric Control of Staphylococcus Aureus Penicillin Binding Protein 2A Enables Methicillin Resistance and Physiological Function,No,"Chain A:THR165,GLU239,VAL256,ILE278,ALA163,LYS153,ARG241,VAL277,GLN292,GLY166,GLU150,LYS148,HIS293,ARG151,SER240,GLY152,ALA276,ASN242,ASN164,SER149",2.6,True,1
ASD11890000_1,NLn,Rattus norvegicus,P42676,4FXY,ASD11890002,0W2,P,Lig,Inhibitor,"1-{(2S)-1-[(3R)-3-(2-chlorophenyl)-2-(2-fluorophenyl)pyrazolidin- 1-yl]-1-oxopropan-2-yl}-3-[(1R,3S,5R,7R)- tricyclo[3.3.1.1~3,7~]dec-2-yl]urea",701,Inner Protein Regulator,Inner Protein,25378390,Allosteric inhibition of the neuropeptidase neurolysin.,No,"Chain P:TYR142,MET113,GLU73,LEU69,VAL74,ARG491,MET149,PHE109,SER114,ILE77,ARG80,ILE72,MET115,TYR49,THR45,ASP110,GLU117,PHE120,ILE123,ILE147,GLY150,VAL119,LEU155,ARG116,LYS145,ASN153,LEU106,TYR76,ALA70,SER146,ILE111",2.8,True,1
ASD11900000_1,,Geobacillus thermodenitrificans,A4INJ9,4M1P,ASD06432001,CU1,A,Ion,Regulator,COPPER (I) ION,201,Inner Protein Regulator,Inner Protein,24831014,Cu(I)-mediated allosteric switching in a copper-sensing operon repressor (CsoR).,No,"Chain A:ARG18,HIS75,ALA76,CYS79,THR14,MET15,LEU71,ILE16,ARG74,VAL80",2.564,True,1
ASD11910000_1,folP,Bacillus anthracis,Q81VW8,4NHV,ASD11910004,2O6,A,Lig,Inhibitor,"5-(trifluoromethyl)-1,2-benzoxazol-3-amine",308,Inner Protein Regulator,Protein-Protein Interaction,24650357,Identification and characterization of an allosteric inhibitory site on dihydropteroate synthase.,No,"Chain A:GLU233,LEU235,MET264,MET261,GLY237,GLY239,GLU260,GLU236",1.992,True,1
ASD11910000_1,folP,Bacillus anthracis,Q81VW8,4NIL,ASD11910003,208,A,Lig,Inhibitor,"(2S)-3-[1-[[2-(2-chlorophenyl)-5-methyl-1,3-oxazol-4-yl]methyl]indol-5-yl]-2-ethoxy-propanoic acid",306,Inner Protein Regulator,Protein-Protein Interaction,24650357,Identification and characterization of an allosteric inhibitory site on dihydropteroate synthase.,No,"Chain A:LEU235,MET264,MET261,GLU260,GLY239,GLU236",2.18,True,1
ASD11910000_1,folP,Bacillus anthracis,Q81VW8,4NIR,ASD11910007,6DH,A,Lig,Inhibitor,3-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]propan-1-ol,308,Inner Protein Regulator,Protein-Protein Interaction,24650357,Identification and characterization of an allosteric inhibitory site on dihydropteroate synthase.,No,"Chain A:ARG263,LYS259,MET264,MET261,LEU235,GLY237,GLY239,GLU260,GLU236",1.772,True,1
ASD11910000_1,folP,Bacillus anthracis,Q81VW8,4NL1,ASD11910008,Z13,A,Lig,Inhibitor,1-[4-(trifluoromethyl)phenyl]-N-[[4-(trifluoromethyl)phenyl]methyl]methanimine,301,Inner Protein Regulator,Protein-Protein Interaction,24650357,Identification and characterization of an allosteric inhibitory site on dihydropteroate synthase.,No,"Chain A:LEU235,MET264,MET261,GLY237,GLY239,GLU260,GLU236",2.3,True,1
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,1EET,ASD11920021,BFU,A,Lig,Inhibitor,"1-(5-bromopyridin-2-yl)-3-[(1S,2S)-2-(6-fluoro-2-hydroxy-3-propanoyl-phenyl)cyclopropyl]urea",2000,Inner Protein Regulator,Inner Protein,10514285,Urea-PETT compounds as a new class of HIV-1 reverse transcriptase inhibitors. 3. Synthesis and further structure-activity relationship studies of PETT analogues.,No,"Chain A:PRO95,LEU100,LYS101,LYS103,VAL106,VAL179,TYR181,TYR188,PRO225,PHE227,TRP229,LEU234,HIS235,PRO236,TYR318; Chain B:GLU1138",2.73,True,2
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,1HNI,ASD11920022,AAA,A,Lig,Inhibitor,"(2S)-2-(2,6-dibromophenyl)-2-[(2-ethanoyl-5-methyl-phenyl)amino]ethanamide",559,Inner Protein Regulator,Inner Protein,7542140,Structure of HIV-1 reverse transcriptase in a complex with the non-nucleoside inhibitor alpha-APA R 95845 at 2.8 A resolution.,No,"Chain A:LEU100,LYS101,LYS103,VAL106,THR107,VAL179,TYR181,TYR188,VAL189,GLY190,TRP229,LEU234,HIS235,TYR318; Chain B:GLU138",2.8,True,2
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,1HQU,ASD11920019,HBY,A,Lig,Inhibitor,"propan-2-yl (2S)-7-methoxy-2-(methylsulfanylmethyl)-3-sulfanylidene-2,4-dihydroquinoxaline-1-carboxylate",561,Inner Protein Regulator,Inner Protein,11371163,The Lys103Asn mutation of HIV-1 RT: a novel mechanism of drug resistance.,No,"Chain A:LEU100,LYS101,ASN103,VAL106,VAL179,ILE180,TYR181,TYR188,VAL189,GLY190,PHE227,TRP229,LEU234,HIS235,TYR318",2.7,True,1
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,1IKX,ASD11920028,PNU,A,Lig,Inhibitor,"6-chloro-2-[(1S)-1-furo[3,2-d]pyridin-5-ylethyl]sulfanyl-pyrimidin-4-amine",2000,Inner Protein Regulator,Inner Protein,11895437,"Structural basis for the inhibitory efficacy of efavirenz (DMP-266), MSC194 and PNU142721 towards the HIV-1 RT K103N mutant.",No,"Chain A:PRO95,LEU100,LYS101,LYS102,ASN103,VAL106,VAL179,TYR181,TYR188,GLY190,PHE227,TRP229,LEU234,HIS235,PRO236,TYR318",2.8,True,1
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,1S6P,ASD11920030,IET,A,Lig,Inhibitor,"3-(4-cyanophenyl)-1-[2-(2,6-dichlorophenyl)ethanimidoyl]thiourea",701,Inner Protein Regulator,Inner Protein,15115397,Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 variants.,No,"Chain A:LEU100,LYS101,LYS103,VAL106,VAL179,TYR181,TYR188,GLY190,PHE227,LEU234,HIS235,PRO236,TYR318",2.9,True,1
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,1S9E,ASD11920032,ADB,A,Lig,Inhibitor,"4-[[4-amino-6-(2,6-dichlorophenoxy)-1,3,5-triazin-2-yl]amino]benzonitrile",701,Inner Protein Regulator,Inner Protein,15115397,Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 variants.,No,"Chain A:PRO95,LEU100,LYS101,LYS103,VAL106,VAL179,TYR181,TYR188,PHE227,TRP229,LEU234,HIS235,PRO236,TYR318; Chain B:GLU138",2.6,True,2
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,1S9G,ASD02560059,ABZ,A,Lig,Inhibitor,"4-[[4-amino-6-[(5-chloro-1H-indol-4-yl)methyl]-1,3,5-triazin-2-yl]amino]benzonitrile",701,Inner Protein Regulator,Inner Protein,15115397,Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 variants.,No,"Chain A:PRO95,GLY99,LEU100,LYS101,LYS103,VAL106,TYR181,TYR188,PHE227,TRP229,LEU234,TYR318; Chain B:GLU138",2.8,True,2
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,1SV5,ASD02560064,65B,A,Lig,Inhibitor,"4-[6-azanyl-5-bromanyl-2-[(4-cyanophenyl)amino]pyrimidin-4-yl]oxy-3,5-dimethyl-benzenecarbonitrile",600,Inner Protein Regulator,Inner Protein,15115397,Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 variants.,No,"Chain A:LEU100,LYS101,LYS102,ASN103,VAL106,VAL179,TYR181,TYR188,PRO225,PHE227,TRP229,LEU234,HIS235,TYR318",2.9,True,1
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,1TV6,ASD02560169,CP9,A,Lig,Inhibitor,"3-[[4-(2-methylimidazo[4,5-c]pyridin-1-yl)phenyl]methyl]-1,3-benzothiazol-2-one",561,Inner Protein Regulator,Inner Protein,15249669,Structure of HIV-1 reverse transcriptase bound to an inhibitor active against mutant reverse transcriptases resistant to other nonnucleoside inhibitors.,No,"Chain A:PRO95,LEU100,LYS101,LYS103,VAL106,VAL108,TYR181,TYR183,ASP186,TYR188,PRO225,TRP229,LEU234,HIS235,PRO236,TYR318",2.8,True,1
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,2B5J,ASD11920039,3AC,A,Lig,Inhibitor,3-[3-[(3-ethyl-5-iodo-2-methyl-6-oxo-1H-pyridin-4-yl)oxy]phenyl]prop-2-enenitrile,562,Inner Protein Regulator,Inner Protein,16302798,Crystal structures for HIV-1 reverse transcriptase in complexes with three pyridinone derivatives: a new class of non-nucleoside inhibitors effective against a broad range of drug-resistant strains.,No,"Chain A:LEU100,LYS101,LYS103,VAL106,VAL108,TYR188,VAL189,GLY190,PHE227,TRP229,LEU234,HIS235,TYR318",2.9,True,1
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,2B6A,ASD11920040,T50,A,Lig,Inhibitor,"2-(2,6-difluorophenyl)-1-[(2,6-difluorophenyl)methyl]-4-methyl-benzimidazole",561,Inner Protein Regulator,Inner Protein,,Crystal structure of HIV-1 reverse transcriptase (RT) in complex with THR-50,No,"Chain A:LEU100,LYS101,LYS103,VAL106,VAL179,ILE180,TYR181,TYR188,VAL189,GLY190,TRP229,LEU234,HIS235,TYR318; Chain B:GLU138",2.65,True,2
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,2BAN,ASD11920041,357,A,Lig,Inhibitor,5-ethyl-3-(2-methoxyethyl-methyl-amino)-6-methyl-4-[(3-methylphenyl)methyl]-1H-pyridin-2-one,562,Inner Protein Regulator,Inner Protein,16302798,Crystal structures for HIV-1 reverse transcriptase in complexes with three pyridinone derivatives: a new class of non-nucleoside inhibitors effective against a broad range of drug-resistant strains.,No,"Chain A:PRO95,LEU100,LYS101,LYS103,VAL179,TYR181,TYR188,VAL189,GLY190,TRP229,LEU234,TYR318; Chain B:GLU138",2.95,True,2
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,2BE2,ASD02560073,R22,A,Lig,Inhibitor,"4-(3,5-dimethylphenoxy)-5-(furan-2-ylmethylsulfanylmethyl)-3-iodo-6-methyl-1H-pyridin-2-one",4002,Inner Protein Regulator,Inner Protein,16302798,Crystal structures for HIV-1 reverse transcriptase in complexes with three pyridinone derivatives: a new class of non-nucleoside inhibitors effective against a broad range of drug-resistant strains.,No,"Chain A:PRO95,LEU100,LYS101,LYS103,VAL106,VAL179,TYR181,TYR188,GLY190,PHE227,TRP229,LEU234,HIS235,PRO236,TYR318",2.43,True,1
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,2VG5,ASD11920044,NNC,A,Lig,Inhibitor,"O-[2-(1,3-dioxoisoindol-2-yl)ethyl] [(4-chlorophenyl)amino]methanethioate",1551,Inner Protein Regulator,Inner Protein,18035053,Crystal structures of HIV-1 reverse transcriptase complexes with thiocarbamate non-nucleoside inhibitors.,No,"Chain A:PRO95,LEU100,LYS101,LYS103,VAL106,VAL179,TYR181,TYR188,PHE227,TRP229,LEU234,HIS235,PRO236,TYR318; Chain B:GLU1138",2.8,True,2
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,2VG7,ASD11920046,NNI,A,Lig,Inhibitor,"O-[2-(1,3-dioxoisoindol-2-yl)ethyl] [(4-iodophenyl)amino]methanethioate",1551,Inner Protein Regulator,Inner Protein,18035053,Crystal structures of HIV-1 reverse transcriptase complexes with thiocarbamate non-nucleoside inhibitors.,No,"Chain A:PRO95,LEU100,LYS101,LYS103,VAL106,VAL179,TYR181,TYR188,PHE227,TRP229,LEU234,HIS235,PRO236,TYR318; Chain B:GLU1138",2.82,True,2
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,2YKM,ASD11920047,YKN,A,Lig,Inhibitor,"2-[bis(fluoranyl)-(4-methylpyrimidin-2-yl)sulfanyl-methyl]-1,3-benzoxazole",1559,Inner Protein Regulator,Inner Protein,22017513,Difluoromethylbenzoxazole Pyrimidine Thioether Derivatives: A Novel Class of Potent Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors.,No,"Chain A:PRO95,LEU100,LYS101,LYS103,VAL106,VAL179,TYR181,TYR188,VAL189,GLY190,TRP229,LEU234,HIS235,PRO236,TYR318",2.9,True,1
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,2YKN,ASD11920047,YKN,A,Lig,Inhibitor,"2-[bis(fluoranyl)-(4-methylpyrimidin-2-yl)sulfanyl-methyl]-1,3-benzoxazole",1559,Inner Protein Regulator,Inner Protein,22017513,Difluoromethylbenzoxazole Pyrimidine Thioether Derivatives: A Novel Class of Potent Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors.,No,"Chain A:PRO95,LEU100,LYS101,LYS103,VAL106,VAL179,TYR181,TYR188,VAL189,GLY190,TRP229,LEU234,HIS235,TYR318",2.12,True,1
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,2ZD1,ASD02560066,T27,A,Lig,Inhibitor,"4-[[4-[[4-[(E)-2-cyanoethenyl]-2,6-dimethyl-phenyl]amino]pyrimidin-2-yl]amino]benzenecarbonitrile",557,Inner Protein Regulator,Inner Protein,18230722,High-resolution structures of HIV-1 reverse transcriptase/TMC278 complexes: strategic flexibility explains potency against resistance mutations.,No,"Chain A:PRO95,LEU100,LYS101,LYS103,VAL106,VAL179,TYR181,TYR188,PRO225,PHE227,TRP229,LEU234,HIS235,PRO236,TYR318; Chain B:GLU138",1.8,True,2
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,2ZE2,ASD02560066,T27,A,Lig,Inhibitor,"4-[[4-[[4-[(E)-2-cyanoethenyl]-2,6-dimethyl-phenyl]amino]pyrimidin-2-yl]amino]benzenecarbonitrile",556,Inner Protein Regulator,Inner Protein,18230722,High-resolution structures of HIV-1 reverse transcriptase/TMC278 complexes: strategic flexibility explains potency against resistance mutations.,No,"Chain A:PRO95,ILE100,LYS101,ASN103,VAL179,TYR181,TYR188,PRO225,PHE227,LEU228,TRP229,LEU234,HIS235,PRO236,TYR318",2.9,True,1
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,3BGR,ASD02560066,T27,A,Lig,Inhibitor,"4-[[4-[[4-[(E)-2-cyanoethenyl]-2,6-dimethyl-phenyl]amino]pyrimidin-2-yl]amino]benzenecarbonitrile",556,Inner Protein Regulator,Inner Protein,18230722,High-resolution structures of HIV-1 reverse transcriptase/TMC278 complexes: strategic flexibility explains potency against resistance mutations.,No,"Chain A:LEU100,LYS101,ASN103,VAL179,CYS181,TYR183,TYR188,GLY190,PHE227,LEU228,TRP229,LEU234,HIS235,PRO236,TYR318; Chain B:GLU138",2.1,True,2
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,3HVT,ASD02560019,NVP,A,Lig,Inhibitor,"11-cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one",557,Inner Protein Regulator,Inner Protein,7513427,Structure of the binding site for nonnucleoside inhibitors of the reverse transcriptase of human immunodeficiency virus type 1.,No,"Chain A:LEU100,LYS101,LYS103,VAL106,TYR181,TYR188,GLY190,PHE227,TRP229,LEU234,PRO236,TYR319",2.9,True,1
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,3IRX,ASD11920053,UDR,A,Lig,Inhibitor,"S-methyl 5-[(E)-1-(3,7-dimethyl-2-oxo-1,3-benzoxazol-5-yl)-5-(5-methyl-1,3,4-oxadiazol-2-yl)pent-1-enyl]-2-methoxy-3-methyl-benzenecarbothioate",556,Inner Protein Regulator,Inner Protein,19775161,Crystallographic study of a novel subnanomolar inhibitor provides insight on the binding interactions of alkenyldiarylmethanes with human immunodeficiency virus-1 reverse transcriptase.,No,"Chain A:PRO95,LEU100,LYS101,LYS103,VAL106,VAL108,TYR181,TYR188,VAL189,GLY190,PHE227,LEU228,TRP229,LEU234,HIS235,TYR318",2.8,True,1
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,3IS9,ASD11920054,AC7,A,Lig,Inhibitor,"dimethyl 5,5'-(6-methoxy-6-oxohex-1-ene-1,1-diyl)bis(3-cyano-2-methoxybenzoate)",556,Inner Protein Regulator,Inner Protein,19775161,Crystallographic study of a novel subnanomolar inhibitor provides insight on the binding interactions of alkenyldiarylmethanes with human immunodeficiency virus-1 reverse transcriptase.,No,"Chain A:PRO95,LEU100,LYS101,VAL106,VAL108,VAL179,TYR181,TYR188,VAL189,GLY190,LYS223,PHE227,LEU228,TRP229,LEU234,HIS235,PRO236,TYR318; Chain B:GLU138",2.55,True,2
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P12499,3KF0,ASD11920008,4DX,A,Lig,Inhibitor,"(1S,2S)-2-methylcyclohexan-1-ol",201,Inner Protein Regulator,Inner Protein,Not in PubMed,Fragment-Based Screen against HIV Protease,No,"Chain A:LYS14,ILE15,GLY16,GLY17,LEU63,ILE64,GLU65",1.8,True,1
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P12499,3KFN,ASD11920008,4DX,A,Lig,Inhibitor,"(1S,2S)-2-methylcyclohexan-1-ol",201,Inner Protein Regulator,Inner Protein,Not in PubMed,Fragment-Based Screen against HIV Protease,No,"Chain A:LYS14,ILE15,GLY16,GLY17,LEU63,ILE64,GLU65",1.77,True,1
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P12499,3KFR,ASD11920004,1F1,B,Lig,Inhibitor,1H-indole-6-carboxylic acid,201,Inner Protein Regulator,Inner Protein,Not in PubMed,Fragment-Based Screen against HIV Protease,No,"Chain B:TRP42,PRO44,LYS45,MET46,LYS55,VAL56,ARG57",1.3,True,1
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P12499,3KFS,ASD11920006,2FX,B,Lig,Inhibitor,2-(1-benzothiophen-2-yl)ethanoic acid,201,Inner Protein Regulator,Inner Protein,Not in PubMed,Fragment-Based Screen against HIV Protease,No,"Chain B:TRP42,PRO44,LYS45,LYS55,VAL56,ARG57",1.8,True,1
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,3QLH,ASD02560066,T27,A,Lig,Inhibitor,"4-[[4-[[4-[(E)-2-cyanoethenyl]-2,6-dimethyl-phenyl]amino]pyrimidin-2-yl]amino]benzenecarbonitrile",555,Inner Protein Regulator,Inner Protein,21568335,"Synthesis, activity, and structural analysis of novel alpha-hydroxytropolone inhibitors of human immunodeficiency virus reverse transcriptase-associated ribonuclease H.",No,"Chain A:PRO95,LEU100,LYS101,LYS103,VAL179,TYR181,TYR188,PRO225,PHE227,TRP229,LEU234,HIS235,PRO236,TYR318",2.7,True,1
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,3QO9,ASD11920056,QO9,A,Lig,Inhibitor,"1-[(5R,6R,8R,9R)-4-azanyl-9-[tert-butyl(dimethyl)silyl]oxy-6-[[tert-butyl(dimethyl)silyl]oxymethyl]-2,2-dioxo-1,7-dioxa-2$l^{6}-thiaspiro[4.4]non-3-en-8-yl]-5-methyl-pyrimidine-2,4-dione",556,Inner Protein Regulator,Inner Protein,21446702,Crystal Structure of tert-Butyldimethylsilyl-spiroaminooxathioledioxide-thymine (TSAO-T) in Complex with HIV-1 Reverse Transcriptase (RT) Redefines the Elastic Limits of the Non-nucleoside Inhibitor-Binding Pocket.,No,"Chain A:PRO95,LEU100,LYS101,LYS102,LYS103,VAL106,VAL179,TYR181,TYR183,TYR188,GLY190,LYS220,PHE227,TRP229,LEU234,HIS235,PRO236,TYR318; Chain B:GLU138",2.6,True,2
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,3V81,ASD02560019,NVP,A,Lig,Inhibitor,"11-cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one",901,Inner Protein Regulator,Inner Protein,22266819,HIV-1 reverse transcriptase complex with DNA and nevirapine reveals non-nucleoside inhibition mechanism.,No,"Chain A:LEU100,LYS101,LYS103,VAL179,TYR181,TYR188,GLY190,TRP229,LEU234,TYR318",2.8503,True,1
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P12499,4EJ8,ASD11920004,1F1,A,Lig,Inhibitor,1H-indole-6-carboxylic acid,106,Inner Protein Regulator,Inner Protein,23540839,Small molecule regulation of protein conformation by binding in the Flap of HIV protease.,No,"Chain A:TRP42,PRO44,LYS45,LYS55,VAL56,ARG57",2.347,True,1
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P12499,4EJD,ASD11920004,1F1,A,Lig,Inhibitor,1H-indole-6-carboxylic acid,102,Inner Protein Regulator,Inner Protein,23540839,Small molecule regulation of protein conformation by binding in the Flap of HIV protease.,No,"Chain A:TRP42,PRO44,LYS45,MET46,LYS55,VAL56,ARG57",1.103,True,1
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P12499,4EJK,ASD11920002,IOP,A,Lig,Inhibitor,3-(1H-indol-3-yl)propanoic acid,101,Inner Protein Regulator,Inner Protein,23540839,Small molecule regulation of protein conformation by binding in the Flap of HIV protease.,No,"Chain A:TRP42,PRO44,LYS45,MET46,LYS55,VAL56,ARG57",1.794,True,1
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P12499,4EJL,ASD11920002,IOP,A,Lig,Inhibitor,3-(1H-indol-3-yl)propanoic acid,106,Inner Protein Regulator,Inner Protein,23540839,Small molecule regulation of protein conformation by binding in the Flap of HIV protease.,No,"Chain A:TRP42,PRO44,LYS45,LYS55,VAL56,ARG57",2.445,True,1
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,4G1Q,ASD02560066,T27,A,Lig,Inhibitor,"4-[[4-[[4-[(E)-2-cyanoethenyl]-2,6-dimethyl-phenyl]amino]pyrimidin-2-yl]amino]benzenecarbonitrile",601,Inner Protein Regulator,Inner Protein,23422558,Snapshot of the equilibrium dynamics of a drug bound to HIV-1 reverse transcriptase.,No,"Chain A:PRO95,LEU100,LYS101,LYS102,LYS103,VAL106,VAL179,TYR181,TYR188,GLY190,PRO225,PHE227,TRP229,LEU234,HIS235,PRO236,TYR318; Chain B:GLU138",1.51,True,2
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,4H4M,ASD02560102,494,A,Lig,Inhibitor,"(E)-3-[3-[2-[2-[2,4-bis(oxidanylidene)pyrimidin-1-yl]ethoxy]-4-chloranyl-phenoxy]-5-chloranyl-phenyl]prop-2-enenitrile",601,Inner Protein Regulator,Inner Protein,23163887,Crystal Structures of HIV-1 Reverse Transcriptase with Picomolar Inhibitors Reveal Key Interactions for Drug Design.,No,"Chain A:PRO95,LEU100,LYS101,LYS102,LYS103,VAL106,VAL108,VAL179,TYR181,TYR188,LYS223,PHE227,TRP229,LEU234,PRO236,TYR318",2.85,True,1
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,4H4O,ASD02560175,506,A,Lig,Inhibitor,"(E)-3-[3-[2-[2-[2,4-bis(oxidanylidene)pyrimidin-1-yl]ethoxy]-4-fluoranyl-phenoxy]-5-fluoranyl-phenyl]prop-2-enenitrile",601,Inner Protein Regulator,Inner Protein,23163887,Crystal Structures of HIV-1 Reverse Transcriptase with Picomolar Inhibitors Reveal Key Interactions for Drug Design.,No,"Chain A:PRO95,LEU100,LYS101,LYS102,LYS103,VAL106,VAL108,VAL179,TYR181,TYR188,GLY190,TRP229,LEU234,HIS235,PRO236,TYR318",2.9,True,1
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,4I2P,ASD11920061,G73,A,Lig,Inhibitor,"(E)-3-[4-[[6-[(4-methoxyphenyl)amino]-7H-purin-2-yl]amino]-3,5-dimethyl-phenyl]prop-2-enenitrile",601,Inner Protein Regulator,Inner Protein,23217210,A comparison of the ability of rilpivirine (TMC278) and selected analogues to inhibit clinically relevant HIV-1 reverse transcriptase mutants.,No,"Chain A:PRO95,LEU100,LYS101,LYS103,VAL179,TYR181,TYR188,PHE227,TRP229,LEU234,HIS235,PRO236,TYR318; Chain B:GLU138",2.2964,True,2
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,4I2Q,ASD02562101,1BT,A,Lig,Inhibitor,"(E)-3-[4-[[6-(1,3-benzothiazol-5-ylamino)-9H-purin-2-yl]amino]-3,5-dimethyl-phenyl]prop-2-enenitrile",601,Inner Protein Regulator,Inner Protein,23217210,A comparison of the ability of rilpivirine (TMC278) and selected analogues to inhibit clinically relevant HIV-1 reverse transcriptase mutants.,No,"Chain A:PRO95,LEU100,LYS101,ASN103,VAL106,VAL179,CYS181,TYR183,TYR188,PHE227,LEU228,TRP229,LEU234,HIS235,PRO236,TYR318; Chain B:GLU138",2.7004,True,2
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,4ICL,ASD02560066,T27,A,Lig,Inhibitor,"4-[[4-[[4-[(E)-2-cyanoethenyl]-2,6-dimethyl-phenyl]amino]pyrimidin-2-yl]amino]benzenecarbonitrile",601,Inner Protein Regulator,Inner Protein,23342998,Detecting Allosteric Sites of HIV-1 Reverse Transcriptase by X-ray Crystallographic Fragment Screening.,No,"Chain A:PRO95,LEU100,LYS101,LYS102,LYS103,VAL106,VAL179,TYR181,TYR188,GLY190,PRO225,PHE227,TRP229,LEU234,HIS235,PRO236,TYR318; Chain B:GLU138",1.8,True,2
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,4ID5,ASD02560066,T27,A,Lig,Inhibitor,"4-[[4-[[4-[(E)-2-cyanoethenyl]-2,6-dimethyl-phenyl]amino]pyrimidin-2-yl]amino]benzenecarbonitrile",601,Inner Protein Regulator,Inner Protein,23342998,Detecting Allosteric Sites of HIV-1 Reverse Transcriptase by X-ray Crystallographic Fragment Screening.,No,"Chain A:PRO95,LEU100,LYS101,LYS103,VAL106,VAL179,TYR181,TYR188,PRO225,PHE227,TRP229,LEU234,HIS235,PRO236,TYR318; Chain B:GLU138",1.95,True,2
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,4IDK,ASD02560066,T27,A,Lig,Inhibitor,"4-[[4-[[4-[(E)-2-cyanoethenyl]-2,6-dimethyl-phenyl]amino]pyrimidin-2-yl]amino]benzenecarbonitrile",601,Inner Protein Regulator,Inner Protein,23342998,Detecting Allosteric Sites of HIV-1 Reverse Transcriptase by X-ray Crystallographic Fragment Screening.,No,"Chain A:PRO95,LEU100,LYS101,LYS103,VAL106,VAL179,TYR181,TYR188,PRO225,PHE227,TRP229,LEU234,HIS235,PRO236,TYR318; Chain B:GLU138",2.1,True,2
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,4IFY,ASD02560066,T27,A,Lig,Inhibitor,"4-[[4-[[4-[(E)-2-cyanoethenyl]-2,6-dimethyl-phenyl]amino]pyrimidin-2-yl]amino]benzenecarbonitrile",601,Inner Protein Regulator,Inner Protein,23342998,Detecting Allosteric Sites of HIV-1 Reverse Transcriptase by X-ray Crystallographic Fragment Screening.,No,"Chain A:PRO95,LEU100,LYS101,LYS103,VAL106,VAL179,TYR181,TYR188,PRO225,PHE227,TRP229,LEU234,HIS235,PRO236,TYR318; Chain B:GLU138",2.1,True,2
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,4IG3,ASD02560066,T27,A,Lig,Inhibitor,"4-[[4-[[4-[(E)-2-cyanoethenyl]-2,6-dimethyl-phenyl]amino]pyrimidin-2-yl]amino]benzenecarbonitrile",601,Inner Protein Regulator,Inner Protein,23342998,Detecting Allosteric Sites of HIV-1 Reverse Transcriptase by X-ray Crystallographic Fragment Screening.,No,"Chain A:PRO95,LEU100,LYS101,LYS103,VAL106,VAL179,TYR181,TYR188,PRO225,PHE227,LEU228,TRP229,LEU234,HIS235,PRO236,TYR318; Chain B:GLU138",1.95,True,2
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,4IG3,ASD11920073,J94,A,Lig,Inhibitor,"(6R)-6-[(5S)-6,6-dimethyl-7,8-dihydro-5H-[1,3]dioxolo[4,5-g]isoquinolin-6-ium-5-yl]-6H-furo[3,4-g][1,3]benzodioxol-8-one",609,Inner Protein Regulator,Protein-Protein Interaction,23342998,Detecting Allosteric Sites of HIV-1 Reverse Transcriptase by X-ray Crystallographic Fragment Screening.,No,"Chain A:ILE5,GLU6,VAL8,SER162,SER163,LYS166; Chain B:LYS49,ILE50,GLY51,PRO52",1.95,True,2
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P12499,4K4Q,ASD01470057,06B,B,Lig,Inhibitor,"3-bromanyl-2,6-dimethoxy-benzoic acid",102,Inner Protein Regulator,Inner Protein,23998903,Crystallographic Fragment-Based Drug Discovery: Use of a Brominated Fragment Library Targeting HIV Protease.,No,"Chain B:PRO44,LYS45,LYS55,VAL56,ARG57",1.8,True,1
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P12499,4K4R,ASD01470058,27B,A,Lig,Inhibitor,1-bromanylnaphthalene-2-carboxylic acid,102,Inner Protein Regulator,Inner Protein,23998903,Crystallographic Fragment-Based Drug Discovery: Use of a Brominated Fragment Library Targeting HIV Protease.,No,"Chain A:LYS14,LEU63,ILE64,GLU65,LYS70,ALA71",1.8,True,1
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,4KFB,ASD02560066,T27,A,Lig,Inhibitor,"4-[[4-[[4-[(E)-2-cyanoethenyl]-2,6-dimethyl-phenyl]amino]pyrimidin-2-yl]amino]benzenecarbonitrile",607,Inner Protein Regulator,Inner Protein,23342998,Detecting Allosteric Sites of HIV-1 Reverse Transcriptase by X-Ray Crystallographic Fragment Screening.,No,"Chain A:PRO95,LEU100,LYS101,LYS103,VAL106,VAL179,TYR181,TYR188,PRO225,PHE227,TRP229,LEU234,HIS235,PRO236,TYR318; Chain B:GLU138",1.854,True,2
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,4KFB,ASD11920014,1QP,A,Lig,Inhibitor,"ethyl pyrazolo[1,5-a]pyridine-3-carboxylate",601,Inner Protein Regulator,Inner Protein,23342998,Detecting Allosteric Sites of HIV-1 Reverse Transcriptase by X-Ray Crystallographic Fragment Screening.,No,"Chain A:GLN91,GLN161,MET164,THR165,LEU168,GLU169,ALA172,ILE180,TYR181,GLN182; Chain B:GLU138,THR139,PRO140",1.854,True,2
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,4KKO,ASD11920063,1RE,A,Lig,Inhibitor,"4-[[4-methoxy-6-(2-morpholin-4-ylethoxy)-1,3,5-triazin-2-yl]amino]-2-(3-methylbutoxy)benzenecarbonitrile",601,Inner Protein Regulator,Inner Protein,23899617,Extension into the entrance channel of HIV-1 reverse transcriptase-Crystallography and enhanced solubility.,No,"Chain A:LEU100,LYS101,LYS102,LYS103,VAL106,VAL179,ILE180,TYR181,TYR188,PHE227,LEU234,HIS235,PRO236,TYR318; Chain B:GLU28,ILE135,GLU138",2.89,True,2
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,4KO0,ASD11920064,JLJ,A,Lig,Inhibitor,4-[(4-methoxypyrimidin-2-yl)amino]-2-(3-methylbut-2-enoxy)benzenecarbonitrile,601,Inner Protein Regulator,Inner Protein,23899617,Extension into the entrance channel of HIV-1 reverse transcriptase-Crystallography and enhanced solubility.,No,"Chain A:LEU100,LYS101,LYS103,VAL106,VAL179,TYR181,TYR188,PHE227,TRP229,LEU234,HIS235,PRO236,TYR318; Chain B:GLU138",1.95,True,2
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,4LSL,ASD11920065,1YQ,A,Lig,Inhibitor,"(E)-3-[3-[2-[2-[2,4-bis(oxidanylidene)pyrimidin-1-yl]ethoxy]-4-chloranyl-phenoxy]phenyl]prop-2-enenitrile",601,Inner Protein Regulator,Inner Protein,24289305,Structure-Based Evaluation of C5 Derivatives in the Catechol Diether Series Targeting HIV-1 Reverse Transcriptase.,No,"Chain A:LEU100,LYS101,LYS102,LYS103,VAL106,VAL108,VAL179,TYR181,TYR188,LYS223,PHE227,TRP229,LEU234,PRO236,TYR318",2.69,True,1
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,4MFB,ASD11920067,29T,A,Lig,Inhibitor,"8-[2-[2-[2,4-bis(oxidanylidene)pyrimidin-1-yl]ethoxy]phenoxy]indolizine-2-carbonitrile",601,Inner Protein Regulator,Inner Protein,24151856,Picomolar Inhibitors of HIV Reverse Transcriptase Featuring Bicyclic Replacement of a Cyanovinylphenyl Group.,No,"Chain A:LEU100,LYS101,LYS102,LYS103,VAL106,VAL108,VAL179,TYR181,TYR188,VAL189,GLY190,PHE227,TRP229,HIS235,PRO236,TYR318",2.88,True,1
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P0C6F2,4NYF,ASD11920001,4BI,A,Lig,Inhibitor,(2S)-tert-butoxy[4-(4-chlorophenyl)-2-methylquinolin- 3-yl]ethanoic acid,301,Inner Protein Regulator,Inner Protein,24900852,"Discovery of BI 224436, a Noncatalytic Site Integrase Inhibitor (NCINI) of HIV-1.",No,"Chain B:GLU96,ALA129,GLY94,ALA124,GLN95,TYR99,THR125,ALA133,ALA128,LEU102,ALA98,TRP132",1.9,True,1
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,4O44,ASD11920068,2RS,A,Lig,Inhibitor,"4-[[4-(3-morpholin-4-ylpropoxy)-6-[(2,4,6-trimethylphenyl)amino]-1,3,5-triazin-2-yl]amino]benzenecarbonitrile",601,Inner Protein Regulator,Inner Protein,24726448,A mechanistic and structural investigation of modified derivatives of the diaryltriazine class of NNRTIs targeting HIV-1 reverse transcriptase.,No,"Chain A:LEU100,LYS101,LYS103,VAL106,THR107,VAL108,VAL179,TYR181,TYR188,PRO225,PHE227,TRP229,LEU234,HIS235,PRO236,TYR318; Chain B:GLU138",2.889,True,2
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,4OJR,ASD05060022,2SQ,A,Lig,Inhibitor,"(2S)-2-[4-(8-fluoranyl-5-methyl-3,4-dihydro-2H-chromen-6-yl)-2-methyl-1-oxidanylidene-isoquinolin-3-yl]-2-[(2-methylpropan-2-yl)oxy]ethanoic acid",301,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24904063,Allosteric Inhibition of Human Immunodeficiency Virus Integrase: LATE BLOCK DURING VIRAL REPLICATION AND ABNORMAL MULTIMERIZATION INVOLVING SPECIFIC PROTEIN DOMAINS.,No,"Chain A:GLN168,ALA169,GLU170,HIS171,THR174,MET178",1.82,True,1
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,4PUO,ASD02560019,NVP,A,Lig,Inhibitor,"11-cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one",901,Inner Protein Regulator,Inner Protein,24880687,Structures of HIV-1 RT-RNA/DNA ternary complexes with dATP and nevirapine reveal conformational flexibility of RNA/DNA: insights into requirements for RNase H cleavage.,No,"Chain A:PRO95,LEU100,LYS101,VAL106,VAL179,TYR181,TYR188,PHE227,TRP229,LEU234,PRO236,TYR318",2.901,True,1
ASD11920000_1,,Human immunodeficiency virus type 1 group M subtype B,Q90EA1,4TVG,ASD11920074,K97,A,Lig,Inhibitor,3-(morpholin-4-ylmethyl)-1H-indole-6-carboxylic acid,101,Inner Protein Regulator,Inner Protein,25189630,Distinguishing Binders from False Positives by Free Energy Calculations: Fragment Screening Against the Flap Site of HIV Protease.,No,"Chain A:ILE54,LYS45,ARG57,TRP42,MET46,LYS43,LYS55,VAL56,PRO44",2.18,True,1
ASD11930000_1,lpg0095,Legionella pneumophila subsp. pneumophila,Q5ZZB6,4OHF,ASD00860008,5GP,A,Lig,Activator,"5'-guanylic acid [(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl dihydrogen phosphate",501,Inner Protein Regulator,Protein-Protein Interaction,24456211,Allosteric regulation and substrate activation in cytosolic nucleotidase II from Legionella pneumophila.,No,"Chain B:TYR421,ASP308,TYR418,LEU116,TYR87,LEU310,ARG425,ARG86",2.53,True,1
ASD11950000_1,CM1,Arabidopsis thaliana,P42738,4PPU,ASD00690002,TYR,A,Lig,Activator,TYROSINE,401,Inner Protein Regulator,Inner Protein,25160622,Structural evolution of differential amino Acid effector regulation in plant chorismate mutases.,No,"Chain A:LEU172,ASP81,VAL148,SER153,ASP155,HIS145,GLU156,ARG150,TYR174,LEU169,PHE151,ARG79,GLY149",2.3,True,1
ASD11950000_1,CM1,Arabidopsis thaliana,P42738,4PPV,ASD02170001,PHE,A,Lig,Inhibitor,PHENYLALANINE,401,Inner Protein Regulator,Inner Protein,25160622,Structural evolution of differential amino Acid effector regulation in plant chorismate mutases.,No,"Chain A:LEU172,VAL148,SER153,HIS145,GLU156,ARG150,TYR174,LEU169,PHE151,ARG79,GLY149",2.45,True,1
ASD11960000_1,uppS,Streptococcus pneumoniae,Q8DRB3,4Q9M,ASD08550002,2ZW,A,Lig,Inhibitor,"3-(2-chlorophenyl)-5-methyl-N-(4-propan-2-ylphenyl)-1,2-oxazole-4-carboxamide",301,Inner Protein Regulator,Inner Protein,25287857,Discovery and structural characterization of an allosteric inhibitor of bacterial cis-prenyltransferase.,Yes,"Chain A:VAL99,LEU102,GLN53,THR122,LEU141,TYR95,LEU52,PHE72,ILE87,ILE109,ASP96,GLY48,ALA125,ASN89,VAL92,ALA129,LEU90,MET88,LEU118,GLU50,PHE143,PRO91,ALA71,PHE94,LEU145,TYR98,MET49,LEU126",2.06,True,1
ASD11960000_1,uppS,Streptococcus pneumoniae,Q8DRB3,4Q9O,ASD08550002,2ZW,A,Lig,Inhibitor,"3-(2-chlorophenyl)-5-methyl-N-(4-propan-2-ylphenyl)-1,2-oxazole-4-carboxamide",301,Inner Protein Regulator,Inner Protein,25287857,Discovery and structural characterization of an allosteric inhibitor of bacterial cis-prenyltransferase.,Yes,"Chain A:VAL99,LEU102,GLN53,THR122,LEU141,THR56,LEU52,PHE72,ILE87,ILE109,ASP96,GLY48,ALA125,ASN89,VAL92,ALA129,LEU90,MET88,LEU118,GLU50,PHE143,PRO91,ALA71,PHE94,LEU145,TYR98,MET49,TYR95,LEU126",2.2,True,1
ASD11990000_1,ADORA2A,Enterobacteria phage T4,P00720,3QAK,ASD11990002,UKA,A,Lig,Activator,"6-(2,2-diphenylethylamino)-9-[(2R,3R,4S,5S)-5-(ethylcarbamoyl)-3,4-dihydroxy-oxolan-2-yl]-N-[2-[(1-pyridin-2-ylpiperidin-4-yl)carbamoylamino]ethyl]purine-2-carboxamide",1200,Inner Protein Regulator,Inner Protein,21393508,Structure of an agonist-bound human A2A adenosine receptor.,Yes,"Chain A:ILE66,VAL84,LEU85,THR88,GLN89,ILE92,LEU167,PHE168,GLU169,MET177,ASN181,TRP246,LEU249,HIS250,ASN253,THR256,HIS264,LEU267,MET270,TYR271,ILE274,SER277,HIS278",2.71,True,1
ASD11990000_1,GRM5,Enterobacteria phage T4,P00720,4OO9,ASD01916286,2U8,A,Lig,Inhibitor,"methyl (3aR,4S,7aR)-4-[2-(3-methylphenyl)ethynyl]-4-oxidanyl-3,3a,5,6,7,7a-hexahydro-2H-indole-1-carboxylate",4005,Inner Protein Regulator,Inner Protein,25042998,Structure of class C GPCR metabotropic glutamate receptor 5 transmembrane domain.,No,"Chain A:GLY624,ILE625,ILE651,SER654,PRO655,SER658,TYR659,VAL740,PRO743,LEU744,ASN747,ILE751,TRP785,PHE788,MET802,SER805,VAL806,SER809,ALA810,ALA813",2.6,True,1
ASD11990000_1,GPR40 E,Enterobacteria phage T4,P00720,4PHU,ASD09380007,2YB,A,Lig,Activator,"[(3S)-6-({2',6'-dimethyl-4'-[3-(methylsulfonyl)propoxy]biphenyl- 3-yl}methoxy)-2,3-dihydro-1-benzofuran-3- yl]acetic acid",2401,Inner Protein Regulator,Inner Protein,25043059,High-resolution structure of the human GPR40 receptor bound to allosteric agonist TAK-875.,No,"Chain A:VAL81,VAL84,LEU171,PHE142,TYR2240,LEU158,PRO80,ALA179,TYR91,PHE87,LEU135,ARG183,HIS137,VAL141,ASN2244,TRP174,ALA182,GLY139,VAL134,LEU90,LEU140,GLY143,ARG2258,CYS136,GLU172,LEU138,ALA83",2.332,True,1
ASD11990000_1,E,Enterobacteria phage T4,P00720,5NDD,ASD11990004,8TZ,A,Lig,Inhibitor,(~{S})-(4-fluoranyl-2-propyl-phenyl)-(1~{H}- imidazol-2-yl)methanol,2201,Inner Protein Regulator,Inner Protein,28445455,Structural insight into allosteric modulation of protease-activated receptor 2.,No,"Chain A:VAL328,TYR156,LEU130,TRP141,CYS148,TYR82,LYS131,TYR134,LEU330,ASP228,ILE327,HIS227,CYS331,LEU151,LEU78,TYR326,GLY153,ILE152,HIS135,PHE155,CYS226",2.801,True,1
ASD12070000_1,bla,Klebsiella pneumoniae,P0AD64,1VM1,ASD12070001,MA4,A,Lig,Inhibitor,"(2R,3R,4S,5S,6R)-2-[(2R,3S,4R,5R,6R)-6-(6-cyclohexylhexoxy)-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol",300,Inner Protein Regulator,Inner Protein,11327849,Inhibition of the SHV-1 beta-lactamase by sulfones: crystallographic observation of two reaction intermediates with tazobactam.,Yes,"Chain A:SER26,VAL224,PRO226,ILE231,ILE246,ALA248,LEU250,VAL261,ILE263,ALA280,GLY283,ALA284,ILE287,GLU288",2.02,True,1
ASD12110000_1,ldh2,Bifidobacterium longum subsp. longum,E8ME30,1LTH,ASD00200001,FBP,R,Lig,Activator,"[(2R,3S,4S,5R)-2,3,4-trihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]methyl dihydrogen phosphate",320,Inner Protein Regulator,Inner Protein,7656036,"1 - 1LTH : Lactate dehydrogenase creates lactic acid as part of anaerobic respiration. This structure includes two molecules of a bacterial LDH, one in the active state and one in the inactive state.",No,"Chain R:ARG158,LYS170,ASN171,HIS173,TYR175",2.5,True,1
ASD12130000_1,ORF17,Human herpesvirus 8 type P,Q2HRB6,4P2T,ASD12130001,24Q,A,Lig,Inhibitor,4-[[6-(cyclohexylmethyl)pyridin-2-yl]carbonylamino]-3-(phenylmethyl)benzoic acid,201,Protein-Protein Interaction Regulator,Inner Protein,24977643,Broad-spectrum allosteric inhibition of herpesvirus proteases.,No,"Chain A:ILE44,PHE76,LEU79,ALA80,LEU83,ALA90,ILE105,LEU106,TRP109,LEU110,ALA139,PHE189,PRO192,LEU193,LEU196",2.15,True,1
ASD12140000_1,,Human herpesvirus 8 type M,P88911,3NJQ,ASD04992001,NJQ,A,Lig,Inhibitor,4-[[6-(cyclohexylmethyl)pyridin-2-yl]carbonylamino]-3-(phenylmethyl)benzoic acid,197,Protein-Protein Interaction Regulator,Inner Protein,21723875,Enzyme inhibition by allosteric capture of an inactive conformation.,No,"Chain A:ILE44,PHE76,LEU79,ALA80,LEU83,ILE105,TRP109,LEU110,ALA139,PHE189,PRO192,LEU193",2.0,True,1
ASD12150000_1,amy,Pseudoalteromonas haloplanktis,P29957,1AQM,ASD01630003,CL,A,Ion,Activator,chloride,900,Inner Protein Regulator,Inner Protein,9541387,Crystal structures of the psychrophilic alpha-amylase from Alteromonas haloplanctis in its native form and complexed with an inhibitor.,Yes,"Chain A:ARG172,THR221,ASN262,LYS300",1.85,True,1
ASD12150000_1,amy,Pseudoalteromonas haloplanktis,P29957,1JD7,ASD01630003,CL,A,Ion,Activator,chloride,900,Inner Protein Regulator,Inner Protein,12021442,Structural basis of alpha-amylase activation by chloride,Yes,"Chain A:ARG172,THR221,ASN262,ARG300",2.25,True,1
ASD12150000_1,amy,Pseudoalteromonas haloplanktis,P29957,1L0P,ASD08770047,NO3,A,Ion,Activator,nitrate,901,Inner Protein Regulator,Inner Protein,12021442,Structural basis of alpha-amylase activation by chloride.,Yes,"Chain A:ARG172,PHE198,GLU200,THR221,PHE223,PHE259,ASN262,LYS300",2.1,True,1
ASD12150000_2,,Tenebrio molitor,P56634,1JAE,ASD01630003,CL,A,Ion,Activator,chloride,501,Inner Protein Regulator,Inner Protein,9600843,Crystal structure of yellow meal worm alpha-amylase at 1.64 A resolution.,Yes,"Chain A:ARG183,LEU243,ASN285,ARG321",1.65,True,1
ASD12200000_1,toxA,Peptoclostridium difficile,P16154,3HO6,ASD03710003,IHP,A,Lig,Activator,"(2,3,4,5,6-pentaphosphonooxycyclohexyl) dihydrogen phosphate",270,Inner Protein Regulator,Inner Protein,19553670,Structure-function analysis of inositol hexakisphosphate-induced autoprocessing in Clostridium difficile toxin A.,No,"Chain A:LYS35,TYR37,LEU57,LYS60,ASN61,LYS105,LYS107,ASN154,ARG211,LYS212,LYS224,LYS235,LYS252,ASN253",1.6,True,1
ASD12210000_1,crp,Escherichia coli,C3SQJ7,4N9I,ASD02408002,PCG,A,Lig,Activator,"2-amino-9-[(4R,6S,7R,8R)-4,7-dihydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-8-yl]-1H-purin-6-one",301,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,24914983,Structures of inactive CRP species reveal the atomic details of the allosteric transition that discriminates cyclic nucleotide second messengers.,No,"Chain A:VAL49,LEU61,SER62,ILE70,GLY71,GLU72,ARG82,SER83,ALA84,VAL86,ARG123; Chain B:GLN125,THR127,LYS130",2.19,True,2
ASD12220000_1,VC0395_0091,Vibrio cholerae serotype O1,A5F1K1,2RDE,ASD06980001,C2E,A,Lig,Activator,"9,9'-[(2R,3R,3aS,5S,7aR,9R,10R,10aS,12S,14aR)- 3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro- 2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine- 2,9-diyl]bis(2-amino-1,9-dihydro-6H-purin- 6-one)",301,Protein-Protein Interaction Regulator,Inner Protein,18034161,The structural basis of cyclic diguanylate signal transduction by PilZ domains.,No,"Chain A:ILE96,LEU135,ARG136,LYS137,ARG140,ASP162,LEU163,SER164,SER166,GLY167,CYS168,ARG169,CYS207,ASN208,GLY219,LEU220,GLU221",1.92,True,1
ASD12230000_1,nadC,Mycobacterium tuberculosis,P9WJJ7,1QP0,ASD03640003,HPA,A,Lig,Activator,"1,7-dihydropurin-6-one",599,Protein-DNA/RNA Interaction Regulator,Inner Protein,10438625,The role of lysine 55 in determining the specificity of the purine repressor for its operators through minor groove interactions.,No,"Chain A:TYR73,PHE74,ARG190,THR192,ARG196,PHE221,ASP275",2.9,True,1
ASD12240000_1,S100B,Bos taurus,P02638,1MHO,ASD11630001,CA,A,Ion,Inhibitor,calcium(+2) cation,91,Inner Protein Regulator,Inner Protein,9519413,A novel mode of target recognition suggested by the 2.0 A structure of holo S100B from bovine brain.,No,"Chain A:ASP61,ASP63,ASP65,GLU67,GLU72",2.0,True,1
ASD12260000_1,PPCA,Flaveria trinervia,P30694,4BXC,ASD00360002,G6P,A,Lig,Activator,"[(2R,3S,4S,5R,6S)-3,4,5,6-tetrahydroxyoxan-2-yl]methyl dihydrogen phosphate",1967,Inner Protein Regulator,Inner Protein,24043710,Resolving the Activation Site of Positive Regulators in Plant Phosphoenolpyruvate Carboxylase.,Yes,"Chain A:THR170,TRP283,ARG450,MET592,ASP597,GLY634,ARG635,THR665,ARG753,ARG767,ALA768,ILE769",2.86,True,1
ASD12260000_1,,Flaveria trinervia,P30694,4BXH,ASD12260002,EDO,A,Lig,Activator,"1,2-ETHANEDIOL",1002,Inner Protein Regulator,Inner Protein,24043710,Resolving the Activation Site of Positive Regulators in Plant Phosphoenolpyruvate Carboxylase.,No,"Chain A:ARG767,TRP283,ASP287,ASP597,ARG450,ASP289,ALA768,PRO770,ARG635,ILE769",2.24,True,1
ASD12280000_1,,Conus purpurascens,P56529,1JL0,ASD00240001,PUT,A,Lig,Activator,"butane-1,4-diamine",2010,Inner Protein Regulator,Inner Protein,11583148,Structure of a human S-adenosylmethionine decarboxylase self-processing ester intermediate and mechanism of putrescine stimulation of processing as revealed by the H243A mutant.,No,"Chain A:LEU13,GLU15,PHE111,ASP174,THR176,PHE285,TYR318",1.5,True,1
ASD12340000_1,Grik1,Rattus norvegicus,P22756,3C31,ASD12340001,LI,A,Ion,Regulator,lithium(+1) cation,301,Inner Protein Regulator,Protein-Protein Interaction,18549784,Molecular basis of kainate receptor modulation by sodium.,No,"Chain A:GLU96,ILE99,ASP100",1.49,True,1
ASD12340000_1,Grik1,Rattus norvegicus,P22756,3C31,ASD01630003,CL,A,Ion,Regulator,chloride,303,Inner Protein Regulator,Protein-Protein Interaction,18549784,Molecular basis of kainate receptor modulation by sodium.,No,"Chain A:LYS103; Chain B:LYS103,ARG227",1.49,True,2
ASD12340000_1,Grik1,Rattus norvegicus,P22756,3C32,ASD03160008,,A,Ion,Regulator,sodium(+1) cation,301,Inner Protein Regulator,Protein-Protein Interaction,18549784,Molecular basis of kainate receptor modulation by sodium.,No,"Chain A:GLU96,ILE99,ASP100",1.72,True,1
ASD12340000_1,Grik1,Rattus norvegicus,P22756,3C32,ASD01630003,CL,A,Ion,Regulator,chloride,303,Inner Protein Regulator,Protein-Protein Interaction,18549784,Molecular basis of kainate receptor modulation by sodium.,No,"Chain A:LYS103,ARG227; Chain B:LYS103,ARG227",1.72,True,2
ASD12340000_1,Grik1,Rattus norvegicus,P22756,3C33,ASD12340005,K,A,Ion,Regulator,potassium(+1) cation,302,Inner Protein Regulator,Protein-Protein Interaction,18549784,Molecular basis of kainate receptor modulation by sodium.,No,"Chain A:GLU96,ILE99,ASP100,ILE222",1.72,True,1
ASD12340000_1,Grik1,Rattus norvegicus,P22756,3C33,ASD01630003,CL,A,Ion,Regulator,chloride,304,Inner Protein Regulator,Protein-Protein Interaction,18549784,Molecular basis of kainate receptor modulation by sodium.,No,"Chain A:LYS103,ARG227; Chain B:LYS103,ARG227",1.72,True,2
ASD12340000_1,Grik1,Rattus norvegicus,P22756,3C34,ASD12340007,Rb,A,Ion,Regulator,RUBIDIUM ION,302,Inner Protein Regulator,Protein-Protein Interaction,18549784,Molecular basis of kainate receptor modulation by sodium.,No,"Chain A:GLU96,ILE99,ASP100",1.82,True,1
ASD12340000_1,Grik1,Rattus norvegicus,P22756,3C34,ASD01630003,CL,A,Ion,Regulator,chloride,307,Inner Protein Regulator,Protein-Protein Interaction,18549784,Molecular basis of kainate receptor modulation by sodium.,No,"Chain A:LYS103,ARG227; Chain B:LYS103,ARG227",1.82,True,2
ASD12340000_1,Grik1,Rattus norvegicus,P22756,3C35,ASD12340009,Cs,A,Ion,Regulator,CESIUM ION,301,Inner Protein Regulator,Protein-Protein Interaction,18549784,Molecular basis of kainate receptor modulation by sodium.,No,"Chain A:GLU96,ILE99,ASP100",1.97,True,1
ASD12340000_1,Grik1,Rattus norvegicus,P22756,3C35,ASD01630003,CL,A,Ion,Regulator,chloride,314,Inner Protein Regulator,Protein-Protein Interaction,18549784,Molecular basis of kainate receptor modulation by sodium.,No,"Chain A:LYS103,ARG227; Chain B:LYS103",1.97,True,2
ASD12340000_1,Grik1,Rattus norvegicus,P22756,3C36,ASD12340011,NH4,A,Ion,Regulator,azanium,301,Inner Protein Regulator,Protein-Protein Interaction,18549784,Molecular basis of kainate receptor modulation by sodium.,No,"Chain A:GLU96,ILE99,ASP100",1.68,True,1
ASD12340000_1,Grik1,Rattus norvegicus,P22756,3C36,ASD01630003,CL,A,Ion,Regulator,chloride,303,Inner Protein Regulator,Protein-Protein Interaction,18549784,Molecular basis of kainate receptor modulation by sodium.,No,"Chain A:LYS103,ARG227; Chain B:LYS103,ARG227",1.68,True,2
ASD12340000_1,Grik1,Rattus norvegicus,P22756,5MFQ,ASD01200253,2J9,A,Lig,Regulator,"4-cyclopropyl-7-fluoro-3,4-dihydro-2H-1,2,4- benzothiadiazine 1,1-dioxide",901;902,Inner Protein Regulator,Protein-Protein Interaction,28360094,Identification and Structure-Function Study of Positive Allosteric Modulators of Kainate Receptors.,No,"Chain B:THR520,LEU536,SER761,ILE519,LYS531,PHE533,LEU783,TYR764,PRO532,GLY763,MET534,GLN786,LYS762,ILE782,THR535,LEU791",1.9,True,1
ASD12340000_1,Grik1,Rattus norvegicus,P22756,5MFV,ASD01230232,5PX,A,Lig,Regulator,"4-Cyclopropyl-3,4-dihydro-7-hydroxy-2H-1,2,4- benzothiadiazine 1,1-dioxide",901;902,Inner Protein Regulator,Protein-Protein Interaction,28360094,Identification and Structure-Function Study of Positive Allosteric Modulators of Kainate Receptors.,No,"Chain B:THR520,LEU536,SER761,ILE519,LYS531,PHE533,LEU783,TYR764,PRO532,GLY763,MET534,GLN786,LYS762,ILE782,THR535,LEU791",2.181,True,1
ASD12340000_1,Grik1,Rattus norvegicus,P22756,5MFW,ASD01230049,7M6,A,Lig,Regulator,"7-chloro-4-(2-fluoroethyl)-2,3-dihydro-1,2,4- benzothiadiazine 1,1-dioxide",901,Inner Protein Regulator,Protein-Protein Interaction,28360094,Identification and Structure-Function Study of Positive Allosteric Modulators of Kainate Receptors.,No,"Chain B:PRO532,LEU536,GLY763,LYS762,MET534,THR520,THR535,SER761,TYR764,ILE519,LYS531",2.1,True,1
ASD12370000_1,PRKAR1A,Bos taurus,P00514,3PNA,ASD00480003,CMP,A,Lig,Activator,"ADENOSINE-3',5'-CYCLIC-MONOPHOSPHATE",250,Protein-Protein Interaction Regulator,Inner Protein,21081668,Cyclic AMP Analog Blocks Kinase Activation by Stabilizing Inactive Conformation: Conformational Selection Highlights a New Concept in Allosteric Inhibitor Design.,No,"Chain A:GLY169,VAL192,ALA202,SER197,VAL213,THR212,PRO208,PHE198,VAL184,ALA211,GLU200,THR190,ALA210,LEU201,ILE163,GLY199,VAL182,LEU203,ALA189,ARG209",1.503,True,1
ASD12490000_1,speG,Vibrio cholerae serotype O1,Q9KL03,4MHD,ASD02100005,SPD,A,Lig,Regulator,SPERMIDINE,201,Allosteric function,Allosteric position,25623305,A Novel Polyamine Allosteric Site of SpeG from Vibrio cholerae Is Revealed by Its Dodecameric Structure.,Yes,Chain C:TYR78,2.32,True,1
ASD12490000_1,speG,Vibrio cholerae serotype O1,Q9KL03,4MI4,ASD09710001,SPM,A,Lig,Regulator,SPERMINE,201,Allosteric function,Allosteric position,25623305,A Novel Polyamine Allosteric Site of SpeG from Vibrio cholerae Is Revealed by Its Dodecameric Structure.,Yes,"Chain A:GLU33,GLU34,PRO35,MET28,GLU37,TYR36,GLU41,ARG57,TRP31,ASN22,GLU72",1.848,True,1
ASD12490000_1,speG,Vibrio cholerae serotype O1,Q9KL03,4R87,ASD09710001,SPM,E,Lig,Regulator,SPERMINE,202,Allosteric Function,Allosteric Position,25623305,A Novel Polyamine Allosteric Site of SpeG from Vibrio cholerae Is Revealed by Its Dodecameric Structure.,No,"Chain E:SER38,LEU45,ARG57,TYR36,GLU72,MET28,GLU41,ASN22,TRP31,GLU34,GLU37,GLN86,GLU33",2.61,True,1
ASD13000000_1,eutL,Clostridium perfringens,B1BQ33,4TME,ASD13000001,ETA,"A,B,C",Lig,Inhibitor,ETHANOLAMINE,219/220,Inner Protein Regulator,Allosteric Position,25752492,An allosteric model for control of pore opening by substrate binding in the EutL microcompartment shell protein,No,"Chain B:HIS220,LEU218,GLU219,HIS221",1.7,True,1
ASD13020000_1,Pck1,Rattus norvegicus,P07379,4YW8,ASD10200001,1WD,A,Lig,Regulator,3-sulfanylpyridine-2-carboxylic acid,708,Allosteric Function,Allosteric Position,26322521,Inhibition and Allosteric Regulation of Monomeric Phosphoenolpyruvate Carboxykinase by 3-Mercaptopicolinic Acid.,No,"Chain A:ARG437,PHE284,ARG518,ASN515,ALA287,PHE517,TRP516,VAL514,GLY289,GLY434,PRO285,CYS288,PHE525,GLY435,PHE433,SER462,ARG436",1.55,True,1
ASD13030000_1,yjbM,Bacillus subtilis,O31611,5DED,ASD13030001,0O2,A,Lig,Activator,guanosine 5'-(tetrahydrogen triphosphate) 3'- (trihydrogen diphosphate),302,Allosteric Function,Allosteric Position,https://www.ncbi.nlm.nih.gov/pubmed/26460002,Catalytic mechanism and allosteric regulation of an oligomeric (p)ppGpp synthetase by an alarmone,No,"Chain C:THR44,GLU18,LYS21,VAL43,ASN148,THR152,PHE42,GLU41,ARG28,LYS25,GLY45,MET79",2.942,True,1
ASD13050000_1,,Ashbya gossypii,Q756Z6,4Z87,ASD00860009,GDP,A,Lig,Inhibitor,GUANOSINE-5'-DIPHOSPHATE,602,Allosteric Function,Allosteric Position,26558346,Guanine nucleotide binding to the Bateman domain mediates the allosteric inhibition of eukaryotic IMP dehydrogenases.,No,"Chain B:LYS208,ARG167,LYS207,THR206",2.25,True,1
ASD13050000_1,,Ashbya gossypii,Q756Z6,4Z87,ASD00860009,GDP,A,Lig,Inhibitor,GUANOSINE-5'-DIPHOSPHATE,603,Allosteric Function,Allosteric Position,26558346,Guanine nucleotide binding to the Bateman domain mediates the allosteric inhibition of eukaryotic IMP dehydrogenases.,No,"Chain A:MET223,SER166,LYS115,ASN118,GLY147,ILE121,PHE148,LYS210,PRO124,ALA146,SER225,PHE145,THR227,VAL125,LYS140,GLY144,LYS231,ALA123,PRO149,TYR116,GLU117,ARG226,THR165,PHE143,ASP228,ASN122,GLY209",2.25,True,1
ASD13050000_1,,Ashbya gossypii,Q756Z6,4Z87,ASD00860009,GDP,A,Lig,Inhibitor,GUANOSINE-5'-DIPHOSPHATE,604,Allosteric Function,Allosteric Position,26558346,Guanine nucleotide binding to the Bateman domain mediates the allosteric inhibition of eukaryotic IMP dehydrogenases.,No,"Chain A:GLU197,ALA242,ASN118,LYS231,GLU117,SER241,PRO236,PHE120,LYS245,ASN232,LEU229,LEU224,LYS204,LEU203,THR244,GLN246,ASP228,ALA238,ASN200,GLY119,LYS240,SER225,LEU196,TYR235",2.25,True,1
ASD13050000_1,,Ashbya gossypii,Q756Z6,5MCP,ASD00150001,ATP,A,Lig,Inhibitor,ADENOSINE-5'-TRIPHOSPHATE,601,Inner Protein Regulator,Inner Protein,28572600,A nucleotide-controlled conformational switch modulates the activity of eukaryotic IMP dehydrogenases.,No,"Chain E:SER166,GLN170,ARG167,PHE171",2.4,True,1
ASD13050000_1,,Ashbya gossypii,Q756Z6,5MCP,ASD00150001,ATP,A,Lig,Inhibitor,ADENOSINE-5'-TRIPHOSPHATE,602,Inner Protein Regulator,Inner Protein,28572600,A nucleotide-controlled conformational switch modulates the activity of eukaryotic IMP dehydrogenases.,No,"Chain E:GLN170,PHE171",2.4,True,1
ASD13050000_1,,Ashbya gossypii,Q756Z6,5TC3,ASD00150001,ATP,A,Lig,Inhibitor,ADENOSINE-5'-TRIPHOSPHATE,601,Inner Protein Regulator,Inner Protein,28572600,A nucleotide-controlled conformational switch modulates the activity of eukaryotic IMP dehydrogenases.,No,"Chain B:ARG226,MET230,ARG167,LYS207",2.462,True,1
ASD13050000_1,,Ashbya gossypii,Q756Z6,5TC3,ASD00860009,GDP,A,Lig,Inhibitor,GUANOSINE-5'-DIPHOSPHATE,602,Inner Protein Regulator,Inner Protein,28572600,A nucleotide-controlled conformational switch modulates the activity of eukaryotic IMP dehydrogenases.,No,"Chain A:MET223,SER166,LYS115,ASN118,GLY147,ILE121,PHE148,LYS210,PRO124,ALA146,PHE145,THR227,VAL125,LYS140,GLY144,LYS231,ALA123,PRO149,TYR116,GLU117,ARG226,THR165,PHE143,ASP228,SER225,GLY209",2.462,True,1
ASD13050000_1,,Ashbya gossypii,Q756Z6,5TC3,ASD00860009,GDP,A,Lig,Inhibitor,GUANOSINE-5'-DIPHOSPHATE,603,Inner Protein Regulator,Inner Protein,28572600,A nucleotide-controlled conformational switch modulates the activity of eukaryotic IMP dehydrogenases.,No,"Chain A:GLU197,ALA242,GLN233,ASN118,LYS231,GLU117,PRO236,PHE120,LYS245,ASN232,LEU237,LEU229,LEU224,LYS204,LEU203,ASP228,ALA238,ASN200,GLY119,LYS240,SER225,ASN68,LEU196,TYR235",2.462,True,1
ASD13070000_1,,Hepatitis C virus genotype 1b,P26663,5FPT,ASD13070001,3VY,A,Lig,Regulator,(1-methyl-1H-indol-3-yl)acetic acid,1721,Allosteric Function,Allosteric Position,26655740,Detection of Secondary Binding Sites in Proteins Using Fragment Screening.,No,"Chain A:VAL256,TYR502,VAL232,GLY255,ARG253,GLY271,ALA275,LYS272,PRO230,THR298,TYR270,THR269,TRP501,THR254",2.72,True,1
ASD13070000_1,,Hepatitis C virus genotype 1b,P26663,5FPY,ASD13070002,R2N,A,Lig,Regulator,5-bromo-1-methyl-1H-indole-2-carboxylic acid,1721,Allosteric Function,Allosteric Position,26655740,Detection of Secondary Binding Sites in Proteins Using Fragment Screening.,No,"Chain A:ASN556,GLN434,THR448,LYS372,THR411,TYR392,SER370,VAL432,THR433,LYS371,HIS369",2.52,True,1
ASD13100000_1,,Thermotoga maritima,Q9WYL6,4COJ,ASD00870004,DTP,A,Lig,Regulator,2'-DEOXYADENOSINE 5'-TRIPHOSPHATE,654,Allosteric Function,Allosteric Position,https://www.ncbi.nlm.nih.gov/pubmed/26147435,The Crystal Structure of Thermotoga maritima Class III Ribonucleotide Reductase Lacks a Radical Cysteine Pre-Positioned in the Active Site.,No,"Chain B:HIS151,LYS145,HIS158,ALA149,THR154,SER146,PHE155,PRO148,GLU147,SER153,LEU138,LYS150,GLN161,ILE144,GLN157",2.48,True,1
ASD13220000_1,,Pseudomonas syringae pv. syringae,Q6VE93,5KLP,ASD03710003,IHP,"A,B,C",Lig,Activator,inositol hexakisphosphate,401,Allosteric Function,Allosteric Position,27525589,Structure of a pathogen effector reveals the enzymatic mechanism of a novel acetyltransferase family.,No,"Chain B:ARG49,ARG106,SER314,GLU103,HIS290,GLU359,GLN358,ILE225,PHE355,VAL312,HIS317,ARG326,PHE330,LYS226,LYS229,GLU321,LYS53,LYS361,ASN222,SER351,LYS289,ARG362,ASN313,ASN107,GLU315",2.002,True,1
ASD13680000_2,gag-pol,Human immunodeficiency virus type 1 group M subtype B (isolate BH10),P03366,4R5P,ASD13680038,3JY,,Lig,Inhibitor,"[(1R)-2-methoxy-1-{[(1S,3R)-3-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)cyclopentyl]oxy}-2-oxoethyl]phosphonic acid",602,Allosteric function,Allosteric position,25733891,Alpha-carboxy nucleoside phosphonates as universal nucleoside triphosphate mimics.,No,"Chain T: DA705, DC706",2.894,True,1
ASD13680000_2,gag-pol,Human immunodeficiency virus type 1 group M subtype B (isolate BH10),P03366,4RW4,ASD02560102,494,A,Lig,Inhibitor,"(2E)-3-(3-chloro-5-{4-chloro-2-[2-(2,4-dioxo- 3,4-dihydropyrimidin-1(2H)-yl)ethoxy]phenoxy}phenyl)prop- 2-enenitrile",601,Inner Protein Regulator,Allosteric Position,25700160,Structure-Based Evaluation of Non-nucleoside Inhibitors with Improved Potency and Solubility That Target HIV Reverse Transcriptase Variants.,No,Chain A:TYR318,2.674,True,1
ASD13680000_2,gag-pol,Human immunodeficiency virus type 1 group M subtype B (isolate BH10),P03366,4RW6,ASD02560102,494,A,Lig,Inhibitor,"(2E)-3-(3-chloro-5-{4-chloro-2-[2-(2,4-dioxo- 3,4-dihydropyrimidin-1(2H)-yl)ethoxy]phenoxy}phenyl)prop- 2-enenitrile",601,Inner Protein Regulator,Allosteric Position,25700160,Structure-Based Evaluation of Non-nucleoside Inhibitors with Improved Potency and Solubility That Target HIV Reverse Transcriptase Variants.,No,Chain A:TYR318,2.631,True,1
ASD13680000_2,gag-pol,Human immunodeficiency virus type 1 group M subtype B (isolate BH10),P03366,4RW8,ASD02560136,3X6,A,Lig,Inhibitor,"(2E)-3-(3-chloro-5-{2-[2-(2,4-dioxo-3,4-dihydropyrimidin- 1(2H)-yl)ethoxy]phenoxy}phenyl)prop-2-enenitrile",601,Inner Protein Regulator,Allosteric Position,25700160,Structure-Based Evaluation of Non-nucleoside Inhibitors with Improved Potency and Solubility That Target HIV Reverse Transcriptase Variants.,No,Chain A:TYR181,2.878,True,1
ASD13680000_2,gag-pol,Human immunodeficiency virus type 1 group M subtype B (isolate BH10),P03366,4RW9,ASD02560136,3X6,A,Lig,Inhibitor,"(2E)-3-(3-chloro-5-{2-[2-(2,4-dioxo-3,4-dihydropyrimidin- 1(2H)-yl)ethoxy]phenoxy}phenyl)prop-2-enenitrile",601,Inner Protein Regulator,Allosteric Position,25700160,Structure-Based Evaluation of Non-nucleoside Inhibitors with Improved Potency and Solubility That Target HIV Reverse Transcriptase Variants.,No,Chain A:TYR318,2.986,True,1
ASD13680000_2,gag-pol,Human immunodeficiency virus type 1 group M subtype B (isolate BH10),P03366,5OI2,ASD13680044,9VN,A,Lig,Inhibitor,"(2~{S})-2-[4-(4,4-dimethylcyclohexen-1-yl)-2-methyl-5-pyridin-4-yl-thiophen-3-yl]-2-[(2-methylpropan-2-yl)oxy]ethanoic acid",305,Allosteric Fuction,Allosteric Position,29507092,Structure-function analyses unravel distinct effects of allosteric inhibitors of HIV-1 integrase on viral maturation and integration.,No,"Chain A:GLU96,ALA98,GLY94,TYR99,LEU102,ALA129,ALA128,TRP132,GLN95,THR125,TRP131,THR124",2.2,True,1
ASD13680000_2,gag-pol,Human immunodeficiency virus type 1 group M subtype B (isolate BH10),P03366,5OI5,ASD13680042,9VK,A,Lig,Inhibitor,"(2~{S})-2-[4-(4,4-dimethylcyclohexen-1-yl)-2-methyl-5-pyridin-2-yl-thiophen-3-yl]-2-[(2-methylpropan-2-yl)oxy]ethanoic acid",501,Allosteric Fuction,Allosteric Position,29507092,Structure-function analyses unravel distinct effects of allosteric inhibitors of HIV-1 integrase on viral maturation and integration.,No,"Chain A:LEU172,MET178,ALA169,ALA175,GLN168,LYS173,GLU170,HIS171,THR174",2.4,True,1
ASD13680000_2,gag-pol,Human immunodeficiency virus type 1 group M subtype B (isolate BH10),P03366,5OI8,ASD13680044,9VN,A,Lig,Inhibitor,"(2~{S})-2-[4-(4,4-dimethylcyclohexen-1-yl)-2-methyl-5-pyridin-4-yl-thiophen-3-yl]-2-[(2-methylpropan-2-yl)oxy]ethanoic acid",302,Allosteric Fuction,Allosteric Position,29507092,Structure-function analyses unravel distinct effects of allosteric inhibitors of HIV-1 integrase on viral maturation and integration.,No,"Chain A:GLU96,ALA98,GLY94,VAL126,TYR99,LEU102,ALA129,ALA128,TRP132,GLN95,TRP131,ALA125,ALA124",2.35,True,1
ASD13680000_2,gag-pol,Human immunodeficiency virus type 1 group M subtype B (isolate BH10),P03366,5OIA,ASD13680042,9VK,A,Lig,Inhibitor,"(2~{S})-2-[4-(4,4-dimethylcyclohexen-1-yl)-2-methyl-5-pyridin-2-yl-thiophen-3-yl]-2-[(2-methylpropan-2-yl)oxy]ethanoic acid",303,Allosteric Fuction,Allosteric Position,29507092,Structure-function analyses unravel distinct effects of allosteric inhibitors of HIV-1 integrase on viral maturation and integration.,No,"Chain A:LEU172,MET178,ALA169,ALA175,GLN168,LYS173,GLU170,HIS171,THR174",2.2,True,1
ASD14170000_1,proRS,Plasmodium falciparum,Q8I5R7,4WI1,ASD14170001,3O6,"A,B",Lig,Inhibitor,1-(4-fluorophenyl)-3-[4-(4-fluorophenyl)- 1-methyl-3-(trifluoromethyl)-1H-pyrazol-5- yl]urea,"801,801",Inner Protein Regulator,Allosteric Position,27798837,"Biochemical and Structural Characterization of Selective Allosteric Inhibitors of the Plasmodium falciparum Drug Target, Prolyl-tRNA-synthetase.",No,Chain A:GLU404,1.65,True,1
ASD14170000_1,proRS,Plasmodium falciparum,Q8I5R7,5IFU,ASD14170002,GBM,"A,B",Lig,Inhibitor,5-chloro-N-(2-{4-[(cyclohexylcarbamoyl)sulfamoyl]phenyl}ethyl)-2-methoxybenzamide,801,Allosteric Function,Allosteric Position,27798837,"Biochemical and Structural Characterization of Selective Allosteric Inhibitors of the Plasmodium falciparum Drug Target, Prolyl-tRNA-synthetase.",yes,"Chain B:GLY517,TYR285,ILE270,GLU404,ARG403,SER515,ARG514,THR513,LEU287,ILE276,MET521,PHE262,ILE520,SER263,ILE474,ALA291,TYR266,TYR746,ILE516,LEU275,ILE518",2.45,True,1
ASD14300000_1,ppa,Mycobacterium tuberculosis,P9WI55,5KDE,ASD14300001,6RT,A,Lig,Inhibitor,"2,4-bis(aziridin-1-yl)-6-(1-phenylpyrrol-2-yl)-1,3,5-triazine",201,Allosteric Fuction,Allosteric Position,27622287,Discovery of Allosteric and Selective Inhibitors of Inorganic Pyrophosphatase from Mycobacterium tuberculosis.,No,"Chain A:ASP110,ARG101,TRP102,LEU61,PRO63,GLU115,VAL111,HIS104,ASP103,ASP99,LEU62,PHE114,VAL105,PRO112",2.65,True,1
ASD14300000_1,ppa,Mycobacterium tuberculosis,P9WI55,5KDF,ASD14300002,6RU,A,Lig,Inhibitor,"~{N}2,~{N}2,~{N}4,~{N}4-tetramethyl-6-(1-phenylpyrrol-2-yl)-1,3,5-triazine-2,4-diamine",201,Allosteric Fuction,Allosteric Position,27622287,Discovery of Allosteric and Selective Inhibitors of Inorganic Pyrophosphatase from Mycobacterium tuberculosis.,No,"Chain A:ARG101,TRP102,PRO63,HIS104,LEU62,VAL105",2.45,True,1
ASD14580000_1,fbpC,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv),P9WQN9,5KWI,ASD14580001,6Y1,A,Lig,Inhibitor,~{N}-(1-adamantyl)-2-selanyl-benzamide,401,Allosteric Fuction,Allosteric Position,28285521,Exploring Covalent Allosteric Inhibition of Antigen 85C from Mycobacterium tuberculosis by Ebselen Derivatives.,No,"Chain A:PHE252,GLN236,PRO255,ASN235,VAL207,LEU232,CYS209,ARG239,ASN253,PHE254,TYR208",1.3,True,1
ASD14580000_1,fbpC,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv),P9WQN9,5KWJ,ASD14580005,6Y3,A,Lig,Inhibitor,~{N}-(4-aminophenyl)-2-selanyl-benzamide,401,Allosteric Fuction,Allosteric Position,28285521,Exploring Covalent Allosteric Inhibition of Antigen 85C from Mycobacterium tuberculosis by Ebselen Derivatives.,No,"Chain A:PHE252,GLN236,ASN235,VAL207,LEU232,CYS209,ARG239,ASN253,PHE254,TYR208",2.01,True,1
ASD14610000_1,UL44,Human cytomegalovirus (strain AD169),P16790,5IWD,ASD14610002,6EV,A,Lig,Inhibitor,5-methylidene-3-(methylsulfanyl)-2-benzothiophen-4(5H)-one,301,Allosteric Fuction,Allosteric Position,28183184,A Small Covalent Allosteric Inhibitor of Human Cytomegalovirus DNA Polymerase Subunit Interactions.,No,"Chain A:ARG3,LYS4",2.56,True,1
ASD15110000_1,,Plasmodium falciparum (isolate 3D7),Q8I302,5JWC,ASD15110001,4W0,H,Lig,Inhibitor,5-fluoro-3-methyl-2-{4-[4-(trifluoromethoxy)benzyl]phenyl}quinolin-4(1H)-one,609,Allosteric function,Allosteric position,28195463,Target Elucidation by Cocrystal Structures of NADH-Ubiquinone Oxidoreductase of Plasmodium falciparum (PfNDH2) with Small Molecule To Eliminate Drug-Resistant Malaria,No,Chain H:PRO530,2.051,True,1
ASD15160000_1,popp,Ralstonia solanacearum,A0A0S4VB05,5W3T,ASD03710003,IHP,A,Lig,Activator,INOSITOL HEXAKISPHOSPHATE,501,Inner Protein Regulator,Inner Protein,28737762,Mechanism of host substrate acetylation by a YopJ family effector.,No,"Chain A:ASP334,VAL406,ARG416,GLU205,ARG419,LYS408,ARG208,SER327,HIS420,LYS383,HIS384,GLU411,ARG380,LEU457,ASN407,LYS453,ARG409,ASN209,ARG460,SER449,LEU330,LYS331",2.15,True,1
ASD15160000_1,popp,Ralstonia solanacearum,A0A0S4VB05,5W3X,ASD03710003,IHP,A,Lig,Activator,INOSITOL HEXAKISPHOSPHATE,501,Inner Protein Regulator,Inner Protein,28737762,Mechanism of host substrate acetylation by a YopJ family effector.,No,"Chain A:ASP334,VAL406,ARG416,GLU205,ARG419,LYS408,ARG208,SER327,HIS420,LYS383,HIS384,GLU411,ARG380,LEU457,ASN407,LYS453,ARG409,ASN209,ARG460,SER449,LEU330,LYS331",2.0,True,1
ASD15160000_1,popp,Ralstonia solanacearum,A0A0S4VB05,5W3Y,ASD03710003,IHP,A,Lig,Activator,INOSITOL HEXAKISPHOSPHATE,501,Inner Protein Regulator,Inner Protein,28737762,Mechanism of host substrate acetylation by a YopJ family effector.,No,Chain B:SER389,2.2,True,1
ASD15160000_1,popp,Ralstonia solanacearum,A0A0S4VB05,5W40,ASD03710003,IHP,A,Lig,Activator,INOSITOL HEXAKISPHOSPHATE,501,Inner Protein Regulator,Inner Protein,28737762,Mechanism of host substrate acetylation by a YopJ family effector.,No,Chain B:SER389,2.53,True,1
ASD15170000_1,ORF17,Human herpesvirus 8,O40922,5UR3,ASD15170006,8OY,A,Lig,Inhibitor,4-{[6-(cyclohexylmethyl)pyridine-2-carbonyl]amino}-3-(phenylamino)benzoic acid,201,Allosteric function,Allosteric position,,Kaposi's Sarcoma Herpesvirus Protease in Complex with Allosteric Inhibitor,No,"Chain A:PRO192,ILE105,TRP109,ILE44,LEU106,PHE189,ALA139,SER191,LEU110,LEU83,ALA80,PHE76,THR50,VAL52,ALA90,LEU79",1.8,True,1
ASD15170000_1,ORF17,Human herpesvirus 8,O40922,5UTE,ASD15170001,8M4,A,Lig,Inhibitor,4-{[6-(cyclohexylmethyl)pyridine-2-carbonyl]amino}-3-[(4-methoxyphenyl)amino]benzoic acid,201,Allosteric function,Allosteric position,,Kaposi's Sarcoma Herpesvirus Protease in Complex with Allosteric Inhibitor,No,"Chain A:ALA75,ILE105,TRP109,PRO192,ILE44,LEU106,PHE189,ALA139,LEU110,LEU83,ALA80,PHE76,ALA90,LEU79",2.05,True,1
ASD15170000_1,ORF17,Human herpesvirus 8,O40922,5UTN,ASD15170002,8MA,A,Lig,Inhibitor,4-{[6-(cyclohexylmethyl)pyridine-2-carbonyl]amino}-3-[(4-fluorophenyl)amino]benzoic acid,201,Allosteric function,Allosteric position,,Kaposi's Sarcoma Herpesvirus Protease in Complex with Allosteric Inhibitor,No,"Chain A:PRO192,ILE105,TRP109,ILE44,LEU106,PHE189,ALA139,LEU110,LEU83,ALA80,PHE76,THR50,ALA90,LEU79",1.8,True,1
ASD15170000_1,ORF17,Human herpesvirus 8,O40922,5UV3,ASD15170003,8N4,A,Lig,Inhibitor,4-{[6-(cyclohexylmethyl)pyridine-2-carbonyl]amino}-3-{[3-(trifluoromethoxy)phenyl]amino}benzoic acid,201,Allosteric function,Allosteric position,,Kaposi's Sarcoma Herpesvirus Protease in Complex with Allosteric Inhibitor,No,"Chain A:PRO192,ILE105,TRP109,LEU47,ILE44,LEU106,PHE189,ALA139,SER191,LEU110,LEU83,ALA80,PHE76,THR50,LEU193,ALA90,LEU79",1.95,True,1
ASD15170000_1,ORF17,Human herpesvirus 8,O40922,5UVP,ASD15170005,8N7,A,Lig,Inhibitor,6-(cyclohexylmethyl)-N-{2-[(oxan-4-yl)oxy]-4-(1H-tetrazol-5-yl)phenyl}pyridine-2-carboxamide,"201,202",Allosteric function,Allosteric position,,Kaposi's Sarcoma Herpesvirus Protease in Complex with Allosteric Inhibitor,No,"Chain A:SER87,VAL89,ILE105,TRP109,SER191,PRO192,ILE44,ARG91,PHE189,LEU106,ALA80,LEU110,LEU83,ARG82,PHE76,LEU193,ALA90,LEU79",1.94,True,1
ASD15170000_1,ORF17,Human herpesvirus 8,O40922,5V5D,ASD15170006,8OY,A,Lig,Inhibitor,4-{[6-(cyclohexylmethyl)pyridine-2-carbonyl]amino}-3-(phenylamino)benzoic acid,201,Inner Protein Regulator,Inner Protein,28759216,"Allosteric Inhibitors, Crystallography, and Comparative Analysis Reveal Network of Coordinated Movement across Human Herpesvirus Proteases.",No,"Chain A:PRO192,ILE105,TRP109,ILE44,LEU106,PHE189,ALA139,LEU110,LEU83,ALA80,PHE76,THR50,ALA90,LEU79",2.104,True,1
ASD15170000_1,ORF17,Human herpesvirus 8,O40922,5V5E,ASD15170003,8N4,A,Lig,Inhibitor,4-{[6-(cyclohexylmethyl)pyridine-2-carbonyl]amino}- 3-{[3-(trifluoromethoxy)phenyl]amino}benzoic acid,201,Inner Protein Regulator,Inner Protein,28759216,"Allosteric Inhibitors, Crystallography, and Comparative Analysis Reveal Network of Coordinated Movement across Human Herpesvirus Proteases.",No,"Chain A:PRO192,ILE105,TRP109,LEU47,LEU110,ILE44,LEU106,PHE189,ALA139,SER191,GLU45,LEU83,ALA80,PHE76,THR50,LEU193,ALA90,LEU79",2.299,True,1
ASD15220000_1,trpB,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv),P9WFX9,5TCI,ASD02900012,79V,,Lig,Inhibitor,"(2R,3S,4R)-3-(2'-fluoro[1,1'-biphenyl]-4- yl)-4-(hydroxymethyl)azetidine-2-carbonitrile",501,Inner Protein Regulator,Inner Protein,28671682,A small-molecule allosteric inhibitor of Mycobacterium tuberculosis tryptophan synthase.,No,"Chain B:PRO208,ILE38,HIS294,ALA206,GLY207,PHE293,PHE211,TYR200,LEU34,TYR29,TRP191,GLY295,PRO31,VAL30,ILE184,PHE202,PHE188",2.45,True,1
ASD15220000_1,trpB,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv),P9WFX9,5TCJ,ASD02900012,79V,,Lig,Inhibitor,"(2R,3S,4R)-3-(2'-fluoro[1,1'-biphenyl]-4- yl)-4-(hydroxymethyl)azetidine-2-carbonitrile",505,Inner Protein Regulator,Inner Protein,28671682,A small-molecule allosteric inhibitor of Mycobacterium tuberculosis tryptophan synthase.,No,"Chain B:PRO208,ASN185,ILE38,HIS294,ALA206,GLY207,PHE293,PHE211,TYR200,ALA292,LEU34,TYR29,TRP191,GLY295,PRO31,VAL30,ILE184,PHE202,PHE188",2.4,True,1
ASD15240000_1,coaD,Pseudomonas aeruginosa 2192,A0A0X1KGP2,3X1M,ASD11520001,COA,"A,B,C",Lig,Inhibitor,COENZYME A,201,Inner Protein Regulator,Allosteric Position,27041211,Transition of phosphopantetheine adenylyltransferase from catalytic to allosteric state is characterized by ternary complex formation in Pseudomonas aeruginosa,No,"Chain B:PHE10,ARG87,MET104,SER127,PHE69,LYS40,LEU130,ARG132,PRO7,ALA74,SER128,SER93,GLU133,ASN105,THR71,LEU73,ILE134,THR129,HIS17,LEU137,GLN100,LEU108,LEU101,SER38,THR9,LYS41,ILE126,LEU72,TYR97,ASP11,ALA34,ALA36,GLU98,ARG90,ASP94,GLY8",2.5,True,1
ASD15240000_1,coaD,Pseudomonas aeruginosa 2192,A0A0X1KGP2,4RUK,ASD11520001,COA,"A,B,C,D,E,F",Lig,Inhibitor,COENZYME A,201,Inner Protein Regulator,Allosteric Position,27041211,Transition of phosphopantetheine adenylyltransferase from catalytic to allosteric state is characterized by ternary complex formation in Pseudomonas aeruginosa,No,"Chain F:LEU73,LEU130,ASN105,LEU108,ARG132,SER128,ALA34,TYR6,ILE126,PRO12,ARG90,ILE134,PHE69,THR71,ALA36,THR9,GLU133,GLN100,GLY8,THR129,TYR97,LYS41,LEU137,SER38,ASN42,LYS40,HIS17,ARG87,PHE10,PRO7,LEU101,PRO39,ASP94,LEU72,SER127,GLU98,ASP11,ALA74,SER70,ALA37",2.2,True,1
ASD15250000_1,PKG,Plasmodium falciparum (isolate 3D7),Q8I719,4OFG,ASD02408002,PCG,A,Lig,Activator,CYCLIC GUANOSINE MONOPHOSPHATE,601,Inner Protein Regulator,Allosteric Position,25646845,Crystal Structures of the Carboxyl cGMP Binding Domain of the Plasmodium falciparum cGMP-dependent Protein Kinase Reveal a Novel Capping Triad Crucial for Merozoite Egress.,No,"Chain A:ALA485,PHE481,LEU472,ALA494,VAL496,GLU483,LEU486,THR493,ARG473,LEU475,PRO491,ILE446,TYR480,VAL536,SER495,GLY482,ILE465,ARG484,ARG492,GLU490,ASP533,LYS467,GLN532",2.0,True,1
ASD15260000_1,mltF,Pseudomonas aeruginosa BWHPSA013,A0A1I9GEN8,5AA4,,6X4,A,Lig,Activator,[6-[[(2~{R})-1-azanyl-1-oxidanylidene-propan- 2-yl]amino]-6-oxidanylidene-5-[[(4~{R})-5- oxidanyl-5-oxidanylidene-4-[[(2~{S})-2-[[(2~{R})- 2-oxidanylpropanoyl]amino]propanoyl]amino]pentanoyl]amino]hexyl]azanium,1458,Inner Protein Regulator,Allosteric Position,,,No,"Chain A:TYR122,LEU127,ALA208,LEU93,GLY109,SER52,ASP203,TYR265,VAL155,GLU206,MET209,GLY158,LEU188,ALA54,ARG50,LEU156,LEU110,PRO112,TYR94,ASN205,ALA108,ALA162,GLU184,THR111,VAL202,MET154,HIS161,LEU229,SER160,VAL129,LEU90,SER204,LEU201,LYS262,SER159,VAL185,PHE66,TYR266,GLU67,THR55,PRO53,TYR126,THR200,LEU261",2.4,True,1
ASD15270000_1,merR,Pseudomonas aeruginosa,P0A183,5CRL,ASD08960001,HG,A,Ion,Regulator,Mercury (II) Ion,201,Inner Protein Regulator,Allosteric Position,27641146,Structural Analysis of the Hg(II)-Regulatory Protein Tn501 MerR from Pseudomonas aeruginosa.,No,"Chain B:GLU83,SER86,ALA85,HIS81,CYS82",2.8,True,1
ASD15990000_1,amtB,Escherichia coli (strain K12),P69681,6B21,ASD15990001,C9V,A,Lig,Regulator,"[(2R,5R,11R,14S,24E)-14-[(acetyloxy)methyl]-8-{[5-(3,5-dimethyl-1H-pyrrol-2-yl-kappaN)-5-(3,5-dimethyl-2H-pyrrol-2-ylidene-kappaN)pentanoyl]oxy}-5,11-dihydroxy-2-{[(9E)-octadec-9-enoyl]oxy}-5,11,16-trioxo-4,6,10,12,15-pentaoxa-5lambda~5~,11lambda~5~-diphosphatritriacont-24-en-1-yl (9E)-octadec-9-enoatato]",501,Allosteric function,Allosteric position,29507234,Allostery revealed within lipid binding events to membrane proteins.,No,"Chain A:GLY157,ASN73,VAL364,GLU357,HIS156,GLY151,VAL368,PHE75,HIS350,VAL354,ASN72,LEU356,TRP365,ALA360,ILE361,VAL369,LEU152,SER155,LEU353,PHE74,LEU138,PRO142",2.45,True,1
ASD16330000_1,prs,Thermus thermophilus (strain HB8 / ATCC 27634 / DSM 579),Q5SHU3,5T3O,ASD02880002,SO4,B,Ion,Regulator,SULFATE ION,402,Inner Protein Regulator,Inner Protein,28580926,Crystal structure of recombinant phosphoribosylpyrophosphate synthetase 2 from Thermus thermophilus HB27 complexed with ADP and sulfate ions.,No,"Chain B:VAL305,SER307,SER306,SER304,ASP144,GLY302,GLU303",2.2,True,1
ASD16340000_1,LDHA,Oryctolagus cuniculus,P13491,5NQB,ASD16340001,MLI,C,Lig,Inhibitor,MALONATE ION,402,Inner Protein Regulator,Inner Protein,28691704,The self-inhibitory nature of metabolic networks and its alleviation through compartmentalization.,No,Chain D:ASP63,1.58,True,1
ASD16340000_1,LDHA,Oryctolagus cuniculus,P13491,5NQQ,ASD16340002,OAA,C,Lig,Inhibitor,OXALOACETATE ION,402,Inner Protein Regulator,Inner Protein,28691704,The self-inhibitory nature of metabolic networks and its alleviation through compartmentalization.,No,"Chain C:ALA237,THR247,ILE241,HIS192,ILE251,LEU108,TYR246,ASP165,VAL30,ARG105,ASN137,GLN99,ALA250,VAL139,ARG98,LEU164,SER236,VAL240,ARG168",1.872,True,1
ASD16350000_1,gyrB,Staphylococcus aureus (strain N315),P66937,5NPK,ASD16350001,94H,b,Lig,Inhibitor,"~{N}-[(1~{R})-2-azanyl-1-phenyl-ethyl]-4- (1~{H}-pyrrolo[2,3-b]pyridin-3-yl)thiophene- 2-carboxamide",1502,Inner Protein Regulator,Protein-Protein Interaction,28507124,Thiophene antibacterials that allosterically stabilize DNA-cleavage complexes with DNA gyrase.,No,"Chain b:LYS1344,ILE1030,ILE633,GLY1341,MET1027,PRO1343,ALA637,ARG1342,ILE1336,MET1179,GLY1178,LEU1345,GLN631,VAL1031,ARG630,VAL638,GLU634",1.98,True,1
ASD16350000_1,gyrB,Staphylococcus aureus (strain N315),P66937,5NPP,ASD08520007,94K,B,Lig,Inhibitor,~{N}-[(1~{R})-2-azanyl-1-phenyl-ethyl]-5- (2-chlorophenyl)-2-methyl-thiophene-3-carboxamide,1502,Inner Protein Regulator,Protein-Protein Interaction,28507124,Thiophene antibacterials that allosterically stabilize DNA-cleavage complexes with DNA gyrase.,No,"Chain B:LYS1344,ILE1030,ILE633,TYR639,GLY1341,MET1027,PRO1343,ALA637,VAL1177,ARG1342,ILE1336,MET1179,LEU1345,GLN631,VAL1031,ARG630,VAL638,GLU634",2.22,True,1
ASD16370000_1,MYH7,Bos taurus,Q9BE39,5N69,ASD05230002,2OW,A,Lig,Activator,methyl 4-(2-fluoro-3-{[(6-methylpyridin-3- yl)carbamoyl]amino}benzyl)piperazine-1-carboxylate,904,Inner Protein Regulator,Inner Protein,28775348,Mechanistic and structural basis for activation of cardiac myosin force production by omecamtiv mecarbil.,No,"Chain A:TYR722,LEU120,HIS492,ARG721,ARG712,ARG147,LYS146,GLN163,LYS145,GLU774,PHE765,ASN711,THR167,HIS666,ASP168,LEU770,PRO710,GLU497,PRO667,ASN160,GLU170,ILE713,TYR164",2.45,True,1
ASD16380000_1,mecA,Staphylococcus aureus,Q7DHH4,5M18,ASD11870001,MUR,A,Lig,Regulator,MURAMIC ACID,703,Inner Protein Regulator,Inner Protein,28099001,"Conformational Dynamics in Penicillin-Binding Protein 2a of Methicillin-Resistant Staphylococcus aureus, Allosteric Communication Network and Enablement of Catalysis.",No,"Chain A:VAL256,GLN292,GLU150,ARG151,ASP275,ASN164,SER149,GLY279,LEU291,VAL277,GLY166,GLU239,HIS293,GLY152,ALA276,TYR373,ASP288,ILE278,MET372,THR165,ARG241,SER240",1.98,True,1
ASD16380000_1,mecA,Staphylococcus aureus,Q7DHH4,5M19,ASD11870001,MUR,A,Lig,Regulator,MURAMIC ACID,703,Inner Protein Regulator,Inner Protein,28099001,"Conformational Dynamics in Penicillin-Binding Protein 2a of Methicillin-Resistant Staphylococcus aureus, Allosteric Communication Network and Enablement of Catalysis.",No,"Chain A:THR165,GLU239,VAL256,GLY257,TYR373,MET372,ARG241,PRO258,VAL277,GLY166,GLU150,LYS148,HIS293,ARG151,SER240,GLY152,ASN242,ASN164",2.0,True,1
ASD16380000_1,mecA,Staphylococcus aureus,Q7DHH4,5M1A,ASD11870001,MUR,A,Lig,Regulator,MURAMIC ACID,703,Inner Protein Regulator,Inner Protein,28099001,"Conformational Dynamics in Penicillin-Binding Protein 2a of Methicillin-Resistant Staphylococcus aureus, Allosteric Communication Network and Enablement of Catalysis.",No,"Chain A:THR165,GLU239,VAL256,GLY257,TYR373,MET372,THR216,ARG241,PRO258,VAL277,GLY166,GLU150,LYS148,HIS293,ARG151,SER240,GLY152,ASN242,ASN164",2.0,True,1
ASD16390000_1,trpB1,Pyrococcus furiosus (strain ATCC 43587 / DSM 3638 / JCM 8422 / Vc1),Q8U093,5DW0,ASD03160008,,"A,B,C,D",Ion,Regulator,Sodium ion,402,Inner Protein Regulator,Allosteric Position,26553994,Directed evolution of the tryptophan synthase beta-subunit for stand-alone function recapitulates allosteric activation.,No,"Chain D:GLY228,THR292,VAL226,ASP300,GLY227,LEU282,ALA264,SER265,PRO302,LEU299,VAL304,TYR301,SER263,GLU251,GLY303",2.01,True,1
ASD16430000_1,pol,Dengue virus type 3 (strain Sri Lanka/1266/2000),Q6YMS4,5I3P,ASD16440001,68T,A,Lig,Inhibitor,"5-[5-(3-hydroxyprop-1-yn-1-yl)thiophen-2- yl]-2,4-dimethoxy-N-[(3-methoxyphenyl)sulfonyl]benzamide",1003,Inner Protein Regulator,Allosteric Position,27500641,Potent Allosteric Dengue Virus NS5 Polymerase Inhibitors: Mechanism of Action and Resistance Profiling,No,"Chain A:HIS801,THR794,HIS800,TYR758,ASP664,MET765,GLN802,SER796,ARG737,GLU509,ALA799,HIS512,SER710,LEU764,TYR766,LEU511,HIS711,TRP795,HIS798,GLY510,PHE708,CYS709,THR793,LEU514,TRP803,ARG729,MET761",2.45,True,1
ASD16430000_1,pol,Dengue virus type 3 (strain Sri Lanka/1266/2000),Q6YMS4,5I3Q,ASD16430001,68E,A,Lig,Inhibitor,5-[5-(3-hydroxyprop-1-yn-1-yl)thiophen-2- yl]-4-methoxy-2-methyl-N-[(quinolin-8-yl)sulfonyl]benzamide,1003,Inner Protein Regulator,Allosteric Position,27500641,Potent Allosteric Dengue Virus NS5 Polymerase Inhibitors: Mechanism of Action and Resistance Profiling,No,"Chain A:HIS801,THR794,GLU733,TYR758,HIS800,MET765,GLN802,SER796,ARG737,ALA799,HIS512,SER710,LEU764,TYR766,LEU511,HIS711,TRP795,HIS798,GLY510,MET340,PHE708,CYS709,THR793,LEU514,TRP803,ARG729,MET761",1.88,True,1
ASD16430000_1,pol,Dengue virus type 3 (strain Sri Lanka/1266/2000),Q6YMS4,5JJR,ASD16430001,68E,A,Lig,Inhibitor,5-[5-(3-hydroxyprop-1-yn-1-yl)thiophen-2- yl]-4-methoxy-2-methyl-N-[(quinolin-8-yl)sulfonyl]benzamide,1004,Inner Protein Regulator,Allosteric Position,27500641,Potent Allosteric Dengue Virus NS5 Polymerase Inhibitors: Mechanism of Action and Resistance Profiling,No,"Chain A:HIS801,THR794,GLU733,TYR758,HIS800,MET765,GLN802,SER796,ARG737,ALA799,HIS512,SER710,LEU764,TYR766,LEU511,HIS711,TRP795,HIS798,GLY510,MET340,PHE708,CYS709,THR793,LEU514,TRP803,ARG729,MET761",1.99,True,1
ASD16430000_1,pol,Dengue virus type 3 (strain Sri Lanka/1266/2000),Q6YMS4,5JJS,ASD16430004,6L2,A,Lig,Inhibitor,"5-[5-(3-hydroxyprop-1-yn-1-yl)thiophen-2- yl]-2,4-dimethoxy-N-{[(1R,3R)-3-methoxycyclohexyl]sulfonyl}benzamide",1004,Inner Protein Regulator,Allosteric Position,27500641,Potent Allosteric Dengue Virus NS5 Polymerase Inhibitors: Mechanism of Action and Resistance Profiling,No,"Chain A:HIS801,THR794,TYR758,HIS800,MET765,GLN802,SER796,ARG737,ALA799,HIS512,SER710,LEU764,TYR766,LEU511,HIS711,TRP795,HIS798,GLY510,ILE797,PHE708,CYS709,THR793,LEU514,TRP803,ARG729,MET761",1.65,True,1
ASD16440000_1,,Dengue virus 2,A0A097PIE2,5K5M,ASD16440001,68T,A,Lig,Inhibitor,"5-[5-(3-hydroxyprop-1-yn-1-yl)thiophen-2- yl]-2,4-dimethoxy-N-[(3-methoxyphenyl)sulfonyl]benzamide",1003,Inner Protein Regulator,Allosteric Position,27500641,Potent Allosteric Dengue Virus NS5 Polymerase Inhibitors: Mechanism of Action and Resistance Profiling.,No,"Chain A:HIS801,ALA799,LEU515,TYR758,TRP803,GLU802,MET765,LEU512,SER796,ARG737,GLY511,SER710,LEU764,TYR766,THR793,HIS711,HIS513,TRP795,HIS798,PHE708,CYS709,THR794,LYS800,ARG729,MET761",2.01,True,1
ASD16500000_1,UGP,Leishmania major,Q4QDU3,5NZK,ASD10090002,PHE,A,Lig,Inhibitor,PHENYLALANINE,601,Allosteric function,Allosteric position,,Decoding Allosteric Networks in Biocatalysts: Rational Approach to Therapies and Biotechnologies,No,"Chain A:CYS247,ARG249,ARG248,PHE305,VAL246,THR250,ARG373,PRO372,GLY409,ASP62,VAL370,SER374,ASP253,VAL371,HIS410",2.45,True,1
ASD16500000_1,UGP,Leishmania major,Q4QDU3,5NZL,ASD05250001,STL,A,Lig,Inhibitor,RESVERATROL,601,Allosteric function,Allosteric position,,Decoding Allosteric Networks in Biocatalysts: Rational Approach to Therapies and Biotechnologies,No,"Chain A:CYS247,ARG249,ARG248,GLY409,VAL246,THR250,ARG373,ASP62,ARG375,VAL370,SER374,VAL371,PRO372",2.4,True,1
ASD16500000_1,UGP,Leishmania major,Q4QDU3,5NZM,ASD16500001,9ET,A,Lig,Inhibitor,Murrayamine-I,601,Allosteric function,Allosteric position,,Decoding Allosteric Networks in Biocatalysts: Rational Approach to Therapies and Biotechnologies,No,"Chain A:CYS247,ARG249,SER252,ARG248,GLY409,THR250,ARG373,PRO411,VAL370,SER374,VAL413,VAL371,PRO372,HIS410",2.35,True,1
ASD16530000_1,MYH11,Gallus gallus,P10587,5M05,ASD16530001,52E,A,Lig,Inhibitor,"4-{[(2-chloro-3-fluorobenzyl)carbamoyl](methyl)amino}- 3,4-dideoxy-5-O-(isoquinolin-3-ylcarbamoyl)- D-erythro-pentitol",901,Inner Protein Regulator,Inner Protein,27815532,Highly selective inhibition of myosin motors provides the basis of potential therapeutic application.,No,"Chain A:LEU95,CYS717,VAL710,PHE517,LYS773,MET497,SER117,VAL100,LEU92,PHE120,GLY709,ASN708,ARG146,PRO722,ALA90,ASP88,ASN723,PHE721,ASN494,ARG724,TYR116,LEU711,GLY118,MET89,TYR586,PHE493,PHE498,GLY713,GLU501,ILE714,GLN490,LEU119,GLU712,ILE716,GLU504",2.675,True,1
ASD16530000_1,MYH11,Gallus gallus,P10587,5T45,ASD16530001,52E,A,Lig,Inhibitor,"4-{[(2-chloro-3-fluorobenzyl)carbamoyl](methyl)amino}- 3,4-dideoxy-5-O-(isoquinolin-3-ylcarbamoyl)- D-erythro-pentitol",901,Inner Protein Regulator,Inner Protein,27815532,Highly selective inhibition of myosin motors provides the basis of potential therapeutic application.,No,"Chain A:LEU95,CYS717,VAL710,PHE517,MET497,SER117,VAL100,LEU92,PHE120,GLY709,ASN708,ARG146,PRO722,ALA90,ASP88,ASN723,PHE721,ASN494,ARG724,TYR116,LEU711,GLY118,MET89,TYR586,PHE493,PHE498,GLY713,GLU501,ILE714,GLN490,LEU119,GLU712,ILE716",2.8,True,1
ASD16540000_1,pyrR,Bacillus subtilis (strain 168),P39765,4P86,,5GP,A,Lig,Regulator,GUANOSINE-5'-MONOPHOSPHATE,182 183,Allosteric Function,Allosteric Position,,,No,"Chain A:VAL107,THR113,GLY111,LYS40,PRO85,THR110,LEU108,ILE39,TYR178,VAL164,VAL114,ASP106,LYS161,ASP105,THR156,TYR109,ARG42,ARG112,GLU160,MET163,ARG138,VAL162",1.93,True,1
ASD16590000_1,Enpp2,Rattus norvegicus,Q64610,5M0E,ASD16590002,7CR,A,Lig,Inhibitor,"[3,5-bis(chloranyl)phenyl]methyl 4-[(3~{R})-3-oxidanyl-3-(2-oxidanylidene-3~{H}-1,3-benzoxazol-6-yl)propyl]piperazine-1-carboxylate",922,Allosteric function,Allosteric position,28165241,Rational Design of Autotaxin Inhibitors by Structural Evolution of Endogenous Modulators.,No,"Chain A:ASP171,GLU308,TYR214,ARG244,LEU243,THR209,VAL277,ALA304,ASN230,TYR306,PHE210,MET512,ILE167,HIS474,ARG284,TRP260,SER276,LEU216,LYS208,HIS359,TRP275,TRP254,ASP311,PHE274,VAL356,ALA217,PHE305,SER169,HIS315,LEU213,PHE273,ASP473",1.95,True,1
ASD16590000_1,Enpp2,Rattus norvegicus,Q64610,5M0M,ASD16590001,7CF,A,Lig,Inhibitor,"[3,5-bis(chloranyl)phenyl]methyl (3~{R})-3-[[(4~{R})-4-[(3~{R},5~{S},7~{S},8~{R},9~{S},10~{S},13~{R},14~{S},17~{R})-10,13-dimethyl-3,7-bis(oxidanyl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1~{H}-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]pyrrolidine-1-carboxylate",925,Allosteric function,Allosteric position,28165241,Rational Design of Autotaxin Inhibitors by Structural Evolution of Endogenous Modulators.,No,"Chain A:ASP171,HIS251,TRP275,PHE241,LEU243,THR209,PHE249,ASN250,PRO258,VAL277,ALA304,TYR306,PHE210,ARG74,ILE167,ARG284,THR272,TRP260,SER276,LEU216,LEU78,TRP254,ILE261,TYR214,PHE274,VAL356,SER81,ALA217,PHE305,PHE273,TYR82,SER169,LEU213,LYS248",2.1,True,1
ASD16590000_1,Enpp2,Rattus norvegicus,Q64610,5M0S,ASD16590003,7CW,A,Lig,Inhibitor,"[3,5-bis(chloranyl)phenyl]methyl ~{N}-[2-[[(4~{R})-4-[(3~{R},5~{S},7~{S},8~{R},9~{S},10~{S},13~{R},14~{S},17~{R})-10,13-dimethyl-3,7-bis(oxidanyl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1~{H}-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethyl]carbamate",925,Allosteric function,Allosteric position,28165241,Rational Design of Autotaxin Inhibitors by Structural Evolution of Endogenous Modulators.,No,"Chain A:HIS251,TRP275,LYS248,LEU243,PHE249,ASN250,PRO258,VAL277,ALA304,TYR306,PHE210,ILE167,ARG284,THR272,TRP260,SER276,LEU216,LEU78,TRP254,ILE261,TYR214,PHE274,VAL356,SER81,ALA217,PHE305,TYR82,SER169,LEU213,PHE273",2.1,True,1
ASD16600000_1,kmo,Pseudomonas fluorescens,Q84HF5,5Y66,,7ZR,A,Lig,Inhibitor,"3,4-dimethoxy-N-[4-(3-nitrophenyl)-1,3-thiazol-2-yl]benzenesulfonamide",502,Allosteric function,Allosteric position,29208702,Biochemistry and structural studies of kynurenine 3-monooxygenase reveal allosteric inhibition by Ro 61-8048,No,"Chain A:ASN369,LEU388,GLU425,GLN96,GLY389,GLY99,PHE400,LEU428,ARG386,ILE401,TYR404,ILE423,GLN424,ARG84,GLU385,ARG100,MET406,GLU368,ARG403,TYR382,GLN390,PRO402,GLU372,GLN422,GLU387,GLY421,ARG420",2.34,True,1
ASD16620000_1,glgC,Escherichia coli (strain K12),P0A6V1,5L6V,ASD00030001,AMP,A,Lig,Inhibitor,ADENOSINE MONOPHOSPHATE,501,Allosteric Fuction,Allosteric Position,27545622,Structural Basis of Glycogen Biosynthesis Regulation in Bacteria.,No,"Chain C:ARG130,ILE127",2.667,True,1
ASD16630000_1,pyk,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv),P9WKE5,5WSB,ASD00030001,AMP,A,Lig,Activator,ADENOSINE MONOPHOSPHATE,503,Allosteric function,Allosteric position,29215013,Allosteric pyruvate kinase-based 'logic gate' synergistically senses energy and sugar levels in Mycobacterium tuberculosis.,No,"Chain A:LYS72,LYS218,ASP244,GLY243,SER191,ALA241,PHE192,GLU220",2.25,True,1
ASD16630000_1,pyk,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv),P9WKE5,5WSB,ASD00360002,G6P,A,Lig,Activator,ALPHA-D-GLUCOSE-6-PHOSPHATE,501,Allosteric function,Allosteric position,29215013,Allosteric pyruvate kinase-based 'logic gate' synergistically senses energy and sugar levels in Mycobacterium tuberculosis.,No,"Chain A:PRO453,PRO452,ALA397,MET419,GLY450,GLY377,LYS418,ASN460,VAL456,MET425,VAL416,THR396,GLN420,ARG351,ASP378,THR374,GLN375,GLY457,PHE395,THR459,PRO417,ALA451,SER376,VAL380,THR455,ALA449,TRP398,THR379,GLY454,PHE373,SER458",2.25,True,1
ASD16640000_1,FBP,Leishmania major,O97193,5OFU,ASD00030001,AMP,A,Lig,Inhibitor,ADENOSINE MONOPHOSPHATE,401,Inner Protein regulator,Inner Protein,28882541,"Structures of Leishmania Fructose-1,6-Bisphosphatase Reveal Species-Specific Differences in the Mechanism of Allosteric Inhibition.",No,"Chain A:ARG25,VAL166,SER19,PHE28,THR29,TYR113,TYR15,HIS23,SER24,ASP112,ARG140,LYS18,GLY26,ILE16,ILE17,PRO21,ASP27,GLN20,MET32,SER183",2.62,True,1
ASD16660000_1,msbA,Escherichia coli O157:H7,P60753,6BPL,ASD16660001,AU7,A,Lig,Inhibitor,(2E)-3-{6-[(1S)-1-(2-chloro-6-cyclopropylphenyl)ethoxy]-4-cyclopropylquinolin-3-yl}prop-2-enoic acid,602,Allosteric function,Allosteric position,,,No,"Chain A:VAL178,ILE292,MET160,ILE172,ALA259,LEU171,LEU263,SER260,SER290,LEU174,ILE258,MET291,PRO176,SER168,ILE182,ILE170,SER179,ALA175,PHE157,ARG296,MET295,LYS299,SER186,LEU298,ILE255,LEU294,ARG190,ALA262,ASN303,THR302",2.908,True,1
ASD16660000_1,msbA,Escherichia coli O157:H7,P60753,6BPP,ASD16660002,E1M,A,Lig,Inhibitor,"(2E)-3-{6-[(1S)-1-(3-amino-2,6-dichlorophenyl)ethoxy]-4-cyclopropylquinolin-3-yl}prop-2-enoic acid",601,Allosteric function,Allosteric position,,,No,"Chain A:VAL178,ILE292,ILE172,ALA259,LEU171,LEU263,SER260,SER290,LEU174,ILE258,MET291,PRO176,GLN256,ILE182,ILE170,SER179,ALA175,PHE157,ARG296,MET295,LYS299,LEU298,ILE255,LEU294,ARG190,ALA262,ASN303,THR302",2.92,True,1
ASD16680000_1,,Corynebacterium glutamicum,H7C677,4CYD,ASD00860002,CMP,A,Lig,Inhibitor,"ADENOSINE-3',5'-CYCLIC-MONOPHOSPHATE",1228,Allosteric function,Allosteric position,25469635,The Crystal Structures of Apo and Camp-Bound Glxr from Corynebacterium Glutamicum Reveal Structural and Dynamic Changes Upon Camp Binding in Crp/Fnr Family Transcription Factors.,No,"Chain C:LEU134,ARG135,ASN138",1.82,True,1
ASD16690000_1,ATCase,Plasmodium falciparum,O15804,6FBA,ASD00330004,D48,A,Lig,Inhibitor,"naphthalene-2,3-diol",402,Allosteric function,Allosteric position,29476738,Identification of a non-competitive inhibitor of Plasmodium falciparum aspartate transcarbamoylase.,No,"Chain B:PRO335,LEU334,THR110,SER113,PRO333,CYS112,ARG109,ALA356,ARG336,THR108",2.0,True,1
ASD16700000_1,nrdE,Bacillus subtilis (strain 168),P50620,6CGN,ASD03910004,DA,A,Lig,Regulator,2'-DEOXYADENOSINE-5'-MONOPHOSPHATE,801,Allosteric function,Allosteric position,29712847,An endogenous dAMP ligand inBacillus subtilisclass Ib RNR promotes assembly of a noncanonical dimer for regulation by dATP.,No,"Chain A:PRO92,ARG90,SER35,PHE91,ASN42,VAL33,SER93,HIS34,VAL38,ARG117,ALA97,PHE89,PHE37,LYS30,LYS88",2.26,True,1
ASD16710000_1,,Leeuwenhoekiella blandensis (strain CECT 7118 / CCUG 51940 / MED217),A3XHF9,5OLK,ASD00870004,DTP,A,Lig,Inhibitor,2'-DEOXYADENOSINE 5'-TRIPHOSPHATE,1001,Protein-Protein Interaction,Protein-Protein Interaction,29388911,Novel ATP-cone-driven allosteric regulation of ribonucleotide reductase via the radical-generating subunit.,No,"Chain A:VAL75,GLN72,ARG12,VAL20,ILE9,VAL68,ALA27,VAL71,TYR91,LYS23,ILE24,LEU21,LYS11,PRO18,ALA17,PHE19,ARG102",2.45,True,1
ASD16720000_1,,Schistosoma mansoni,G4V8J4,6FMU,ASD16720001,DVK,A,Lig,Inhibitor,2-[4-(4-azanylbutyl)piperazin-1-yl]ethanol,602,Allosteric function,Allosteric position,29800515,Fragment-Based Discovery of a Regulatory Site in Thioredoxin Glutathione Reductase Acting as 'Doorstop' for NADPH Entry.,No,"Chain A:ASP325,VAL469,LEU537,ALA470,LEU321,GLY536,TYR479,ARG322,GLY483,HIS538,SER485,GLY323,TYR296,ALA481,THR471,PRO439,LEU484,PHE324,GLN440,SER295,CYS482",1.8,True,1
ASD16720000_1,,Schistosoma mansoni,G4V8J4,6FMZ,ASD16720002,DVQ,A,Lig,Inhibitor,2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanol,601,Allosteric function,Allosteric position,29800515,Fragment-Based Discovery of a Regulatory Site in Thioredoxin Glutathione Reductase Acting as 'Doorstop' for NADPH Entry.,No,"Chain A:ILE431,LEU120,LYS399,LEU441,ARG229,CYS159,VAL297,SER117,ASN156,TRP148,VAL155,LYS163,THR257,GLN440,ILE113,TYR296,GLU140,GLY114,CYS301,LEU150,ARG260,THR442,VAL444,PHE280,GLY228,ASP137,GLY151,GLY152,ALA256,PRO439,VAL157,LYS162,GLY149,GLY258,ALA226,SER276,ASP277,THR471,THR472,GLU259,LEU397,GLY432,ILE160,VAL400,ALA445,GLY118,GLY158,PRO443,ARG393,ASP433,ILE434,THR153,VAL139,GLU300,TYR138,PRO261,LYS227,PHE474,GLY119,CYS154,LEU136,GLY115,GLY116",1.8,True,1
ASD16720000_1,,Schistosoma mansoni,G4V8J4,6FP4,ASD16720003,E1T,A,Lig,Inhibitor,"1,8-naphthyridine-2-carboxylic acid",604,Allosteric function,Allosteric position,29800515,Fragment-Based Discovery of a Regulatory Site in Thioredoxin Glutathione Reductase Acting as 'Doorstop' for NADPH Entry.,No,"Chain A:GLU300,LEU321,THR472,LYS438,VAL473,GLN440,PHE474,TYR296,LEU441,THR471,PRO439,PHE324,LYS162",2.501,True,1
ASD16720000_1,,Schistosoma mansoni,G4V8J4,6FTC,ASD03080094,EPE,A,Lig,Inhibitor,4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID,602,Allosteric function,Allosteric position,29800515,Fragment-Based Discovery of a Regulatory Site in Thioredoxin Glutathione Reductase Acting as 'Doorstop' for NADPH Entry.,No,"Chain A:ASP325,VAL469,LEU537,ALA470,LEU321,TYR479,ARG322,GLY483,HIS538,GLY323,TYR296,SER485,THR471,ALA481,LEU484,PHE324,GLN440,SER295,CYS482",1.8,True,1
ASD16740000_1,,Trypanosoma cruzi (strain CL Brener),Q4D9Z4,4KS0,ASD01120132,FDP,A,Lig,Activator,"FRUCTOSE-2,6-DIPHOSPHATE",1004,Allosteric Function,Allosteric Position,26064527,Structures of pyruvate kinases display evolutionarily divergent allosteric strategies.,No,"Chain A:PRO490,VAL480,ALA407,LYS487,TYR489,GLY488,THR424,VAL399,ARG457,SER401,ARG405,HIS481,ASP451,ASP483,ARG425,GLY404,GLU452,ASN402,LEU400,SER403,ALA482,LYS454,SER406,VAL486",2.8,True,1
ASD16750000_1,padR,Bacillus subtilis subsp. spizizenii (strain ATCC 23059 / NRRL B-14472 / W23),E0TW95,5X13,ASD10030001,HC4,A,Lig,Regulator,4'-HYDROXYCINNAMIC ACID,301,Allosteric function,Allosteric position,29136175,Structural basis of effector and operator recognition by the phenolic acid-responsive transcriptional regulator PadR,No,"Chain A:ARG164,LYS160,ALA161",1.7,True,1
ASD16750000_1,padR,Bacillus subtilis subsp. spizizenii (strain ATCC 23059 / NRRL B-14472 / W23),E0TW95,5X14,ASD10030003,FER,A,Lig,Regulator,3-(4-HYDROXY-3-METHOXYPHENYL)-2-PROPENOIC ACID,201,Allosteric function,Allosteric position,29136175,Structural basis of effector and operator recognition by the phenolic acid-responsive transcriptional regulator PadR,No,"Chain A:TYR135,LEU158,ASP130,SER134,PHE33,VAL157,HIS154,ALA161,GLU165,GLN32,ARG164,GLU29,LYS127,LEU30,LEU131",1.68,True,1
ASD16750000_1,padR,Bacillus subtilis subsp. spizizenii (strain ATCC 23059 / NRRL B-14472 / W23),E0TW95,5Y8T,ASD10030001,HC4,A,Lig,Regulator,4'-HYDROXYCINNAMIC ACID,301,Allosteric function,Allosteric position,29136175,Structural basis of effector and operator recognition by the phenolic acid-responsive transcriptional regulator PadR.,No,"Chain A:TYR135,LEU158,SER134,PHE33,HIS154,ALA161,GLU165,GLN32,ARG164,GLU29,LYS127,VAL157,LEU131",2.0,True,1
ASD16770000_1,Ptpn5,Mus musculus,P54830,6H8S,ASD16770001,FSZ,A,Lig,Activator,1-[3-piperidin-4-yl-5-(trifluoromethyl)phenyl]guanidine,601,Allosteric function,Allosteric position,30207464,"Allosteric Activation of Striatal-Enriched Protein Tyrosine Phosphatase (STEP, PTPN5) by a Fragment-like Molecule.",No,"Chain A:ILE370,ARG494,GLU341,PHE482,HIS464,ILE487,ARG493,CYS465,ALA458,TYR345,VAL454,SER486,LYS343,GLU456,VAL344,VAL451,ILE468,GLY462,GLU342,SER466,GLN490,GLN459,GLU455",1.771,True,1
ASD16780000_1,11438625,Medicago truncatula,G7JFL4,6CZM,ASD01580014,HIS,A,Lig,Inhibitor,HISTIDINE,402,Allosteric function,Allosteric position,30072492,Guarding the gateway to histidine biosynthesis in plants:Medicago truncatulaATP-phosphoribosyltransferase in relaxed and tense states.,No,"Chain C:VAL309,ALA278,SER346,VAL277,ALA323,ILE324,LEU349,GLY347,ASN279,VAL348",2.88,True,1
ASD16790000_1,hisG,Campylobacter jejuni (strain RM1221),Q5HSJ4,4YB5,ASD01580014,HIS,"A,B,C,D,E,F",Lig,Inhibitor,HISTIDINE,304,Allosteric Function,Allosteric Position,27191057,Campylobacter jejuni adenosine triphosphate phosphoribosyltransferase is an active hexamer that is allosterically controlled by the twisting of a regulatory tail.,No,"Chain F:HIS266,LEU290,VAL248,LEU231,MET230,GLY247,SER288,SER269,VAL268,GLU249,ALA264,TYR228,THR252,ARG250,LEU256,ILE289,SER287,MET267,PRO251,LEU265,PRO246,HIS232",2.24,True,1
ASD16800000_1,pol,Human immunodeficiency virus 1,F2WR39,4TSX,ASD01670001,LF0,A,Lig,Inhibitor,"(2S)-tert-butoxy[4-(3,4-dihydro-2H-chromen-6-yl)-2-methylquinolin-3-yl]ethanoic acid",301,Allosteric Function,Allosteric Position,25421939,The mechanism of H171T resistance reveals the importance of N -protonated His171 for the binding of allosteric inhibitor BI-D to HIV-1 integrase.,No,"Chain A:GLU96,ALA98,GLY94,VAL126,TYR99,LEU102,ALA129,ALA128,TRP132,GLN95,THR125,TRP131,THR124,ALA133",1.94,True,1
ASD16820000_1,aroA,Geobacillus sp. GHH01,L8A208,5J6F,ASD16820001,PRE,A,Lig,Inhibitor,PREPHENIC ACID,404,Protein-Protein Interaction,Protein-Protein Interaction,27502275,Interdomain Conformational Changes Provide Allosteric Regulation en Route to Chorismate.,No,"Chain A:ASP47,MET54,PHE79,LYS80,ARG27,GLN86,ILE78,LEU83,ALA82,ARG50,GLY35,VAL31,GLU51,LYS38,TYR46,ILE34,PRO48,ARG45",2.75,True,1
ASD16830000_1,,Staphylococcus aureus (strain Mu50 / ATCC 700699),A0A0J9X1X5,4CJN,ASD16830001,QNZ,B,Lig,Inhibitor,quinazolinone,1673,Allosteric Function,Allosteric Position,25629446,Discovery of Antibiotic (E)-3-(3-Carboxyphenyl)-2-(4-Cyanostyryl)Quinazolin-4(3H)-One.,No,"Chain B:GLU294,TYR297,GLY296,ILE144,ASN104,TYR105,ASP295,GLU145,ASN146,LYS316,LYS273",1.947,True,1
ASD16840000_1,qdtf,Providencia alcalifaciens,F8RC03,4XCZ,ASD16840001,T3Q,A,Lig,Regulator,"[(3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl][hydroxy-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl] hydrogen phosphate",403,Allosteric function,Allosteric position,25574689,New Role for the Ankyrin Repeat Revealed by a Study of the N-Formyltransferase from Providencia alcalifaciens.,No,"Chain A:LYS336,ASP346,GLY337,GLU280,TYR380,MET342,THR338,ASN334,ILE309,HIS314,TYR343,LYS345,TRP305,THR339,LEU303,ASP371,ILE310,TYR313",1.5,True,1
ASD16850000_1,,Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1),Q9I000,5UXM,ASD05860010,TRP,A,Lig,Inhibitor,TRYPTOPHAN,502,Allosteric function,Allosteric position,29608284,A Pseudoisostructural Type II DAH7PS Enzyme from Pseudomonas aeruginosa: Alternative Evolutionary Strategies to Control Shikimate Pathway Flux.,No,"Chain A:THR227,TRP185,LEU224,ALA177,LEU89,ASP178,PRO102,LYS105,LEU88,GLN223,VAL103,THR96,ARG225,GLU226,GLN90,ALA92,PRO222,LEU179,SER228,VAL93",1.54,True,1
ASD16860000_1,,Corynebacterium glutamicum (strain ATCC 13032 / DSM 20300 / JCM 1318 / LMG 3730 / NCIMB 10025),Q8NNL5,5HUD,ASD05860010,TRP,"A,B,C,D",Lig,Activator,TRYPTOPHAN,"A:509,B:515,C:532,D:528",Allosteric Function,Allosteric Position,29178787,Inter-Enzyme Allosteric Regulation of Chorismate Mutase in Corynebacterium glutamicum: Structural Basis of Feedback Activation by Trp.,No,"Chain D:ALA251,GLY242,LEU117,ALA202,ARG249,ALA120,GLN118,PRO130,VAL121,ASP203,LEU248,CYS241,THR124,SER247,LYS133,LEU207,ALA240,ALA250,VAL131,LEU204,LEU116,ASP252",2.15,True,1
ASD16860000_1,,Corynebacterium glutamicum (strain ATCC 13032 / DSM 20300 / JCM 1318 / LMG 3730 / NCIMB 10025),Q8NNL5,5HUE,ASD05860010,TRP,A,Lig,Activator,TRYPTOPHAN,503,Allosteric Function,Allosteric Position,29178787,Inter-Enzyme Allosteric Regulation of Chorismate Mutase in Corynebacterium glutamicum: Structural Basis of Feedback Activation by Trp.,No,"Chain A:VAL121,ALA202,LEU204,ALA250,LYS133,VAL131,PRO130,GLN118,ASP252,ALA251,ARG249,LEU117,LEU207,SER247,LEU248,ASP203,ALA120,THR124",2.65,True,1
ASD16870000_1,,Physcomitrella patens subsp. patens,A9S498,5W6Y,ASD05860010,TRP,A,Lig,Activator,TRYPTOPHAN,401,Allosteric function,Allosteric position,28963347,Evolution of allosteric regulation in chorismate mutases from early plants.,No,"Chain B:HIS130,TYR136,VAL133,ARG134,GLU141,ARG135,ALA138,ASP140",1.995,True,1
ASD16880000_1,,Cyanophage S-TIM5,H6WFU3,4P9D,ASD02040015,TTP,A,Lig,Inhibitor,THYMIDINE-5'-TRIPHOSPHATE,203,Allosteric function,Allosteric position,25404739,The First Crystal Structure of a dTTP-bound Deoxycytidylate Deaminase Validates and Details the Allosteric-Inhibitor Binding Site.,No,Chain B:LYS2,2.9,True,1
ASD16900000_1,ispA,Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1),Q9HWY4,3ZL6,ASD01670005,NVU,A,Lig,Inhibitor,"2-(1,2-benzoxazol-3-yl)ethanoic acid",1297,Allosteric function,Allosteric position,25760619,Structural Characterization of Substrate and Inhibitor Binding to Farnesyl Pyrophosphate Synthase from Pseudomonas Aeruginosa.,No,"Chain A:ILE290,ARG293,LEU286,PHE218,TYR289,LEU50,HIS76,GLY215,LYS44,VAL46,ARG47,ILE185,ILE214,ARG45",1.85,True,1
ASD16910000_1,pol,Human immunodeficiency virus 1,F2WR52,6NCJ,ASD16910001,KJJ,A,Lig,Inhibitor,"(2~{S})-2-[4-(8-fluoranyl-5-methyl-3,4-dihydro-2~{H}-chromen-6-yl)-2-methyl-6-[[(1~{S},2~{R})-2-phenylcyclopropyl]methyl]-7,8-dihydro-5~{H}-1,6-naphthyridin-3-yl]-2-[(2-methylpropan-2-yl)oxy]ethanoic acid",305,Allosteric function,Allosteric position,30609350,"5,6,7,8-Tetrahydro-1,6-naphthyridine Derivatives as Potent HIV-1-Integrase-Allosteric-Site Inhibitors.",No,"Chain A:GLU96,ALA98,GLY94,VAL126,CYS130,TYR99,LEU102,ALA129,ALA128,TRP132,GLN95,THR125,TRP131,LYS127,THR124",2.0,True,1
ASD16930000_1,nrdA,Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1),Q9I4I1,5IM3,ASD00870004,DTP,"A,B",Lig,Regulator,2'-DEOXYADENOSINE 5'-TRIPHOSPHATE,"1,001",Allosteric Fuction,Allosteric Position,27133024,Structural Mechanism of Allosteric Activity Regulation in a Ribonucleotide Reductase with Double ATP Cones.,No,"Chain B:LYS48,ILE101,PRO43,TYR44,VAL34,ALA52,ILE98,ASP46,GLN102,ARG37,THR45,TYR121,ILE49,VAL105,LYS55,VAL42,LYS36",2.298,True,1
ASD16940000_1,,Plasmodium falciparum (isolate 3D7),Q7KQK0,5T3N,ASD16940001,75G,A,Lig,Inhibitor,"(2S,4aR,6R,7R,7aS)-6-(6-amino-2-chloro-9H-purin-9-yl)-7-hydroxy-2-sulfanyltetrahydro-2H,4H-2lambda~5~-furo[3,2-d][1,3,2]dioxaphosphinin-2-one",503,Inner Protein regulator,Inner Protein,27738107,Disrupting the Allosteric Interaction between the Plasmodium falciparum cAMP-dependent Kinase and Its Regulatory Subunit.,Yes,"Chain A:GLU377,ILE366,ILE340,ALA359,ASN423,ALA387,ALA379,LEU428,ARG386,LEU380,PRO385,ILE438,CYS437,LYS425,ILE390,ALA388,LYS361,TYR374,LEU378,GLY376,LYS367,TYR424,VAL427,LYS384,THR389,TYR369,PHE375",2.4,True,1
ASD17010000_1,pbpX_2,Streptococcus pneumoniae,A0A0E8T757,5OJ0,ASD17010001,9WT,A,Lig,Regulator,Cefepime,801,Allosteric function,Allosteric position,29357220,"Allostery, Recognition of Nascent Peptidoglycan, and Cross-linking of the Cell Wall by the Essential Penicillin-Binding Protein 2x of Streptococcus pneumoniae.",No,"Chain A:ILE371,ASN397,GLY336,SER337,GLY453,ASP373,THR526,ALA551,PHE450,SER395,SER396,GLN552,GLU334,GLY549,TRP374,ASN377,TYR568,THR370,SER548,GLN447,ARG372,THR550,PHE570,LYS547,LYS340,GLN452",2.66,True,1
ASD17020000_1,rex,Thermoanaerobacter ethanolicus JW 200,D5KM69,3WGG,ASD17020001,8NA,A,Lig,Regulator,alpha-Diphosphopyridine nucleotide,301,Allosteric function,Allosteric position,25527330,"Binding mode of the oxidized alpha-anomer of NAD(+) to RSP, a Rex-family repressor",No,"Chain B:ASN101,GLN97,TYR102,PHE105,THR103,ALA98,SER104,ARG128",2.1,True,1
ASD17140000_1,grin1,Xenopus laevis,A0A1L8F5J9,5TPW,ASD01310003,ZN,B,Ion,Inhibitor,ZINC ION,401,Inner Protein regulator,Inner Protein,27916457,Molecular Basis for Subtype Specificity and High-Affinity Zinc Inhibition in the GluN1-GluN2A NMDA Receptor Amino-Terminal Domain.,No,"Chain B:HIS44,SER43,HIS128,ARG291,ASN264,THR265,GLU266,TRP284,ASP283,ASP282",2.909,True,1
ASD17220000_1,cueR,Escherichia coli (strain K12),P0A9G4,4WLW,ASD17220001,AG,A,Ion,Activator,SILVER ION,200,Allosteric Function,Allosteric Position,26293965,TRANSCRIPTION. Allosteric transcriptional regulation via changes in the overall topology of the core promoter.,No,"Chain A:GLY114,PRO113,PRO121,ILE123,ILE122,ASP119,CYS120,CYS112,LEU108",2.8,True,1
ASD17300000_1,lacS,Saccharolobus solfataricus (strain ATCC 35092 / DSM 1617 / JCM 11322 / P2),P22498,5IXE,ASD10438004,14O,,Lig,ActivatorA,5-fluoro-1H-indole,501,Allosteric Fuction,Allosteric Position,27389009,Full and Partial Agonism of a Designed Enzyme Switch.,No,"Chain A:TRP433,LEU153,SER435,PHE222,VAL37,VAL48,TRP151,GLY33,SER220,PHE17,GLY221,ASP32,TYR431,ALA434,PRO152,TRP36,TYR34,PRO223,HIS150",1.75,True,1
ASD17330000_1,,Ixodes ricinus,V5HCK7,5N70,,PROPEPTID,B,Pep,Inhibitor,ALA-PHE-ARG-ILE-PRO-LEU-THR-ARG,8,Allosteric Fuction,Allosteric Position,29396291,Novel Structural Mechanism of Allosteric Regulation of Aspartic Peptidases via an Evolutionarily Conserved Exosite.,Yes,"Chain B:PHE6,LEU10,PRO9,ILE8,ARG7",1.81,True,1
ASD17350000_1,Rps6ka3,Mus musculus,P18654,5O1S,ASD17350001,9HB,A,Lig,Inhibitor,Dimethyl fumarate,802,Allosteric function,Allosteric position,30341347,Dimethyl fumarate is an allosteric covalent inhibitor of the p90 ribosomal S6 kinases.,No,"Chain A:TYR595,ARG667,LEU660,VAL662,CYS599,HIS661,SER603,ASP600,ALA598,ILE633,LEU710,TRP602",1.9,True,1
ASD17370000_1,ambP1,Fischerella ambigua UTEX 1903,V5TDZ4,5Z45,ASD00330030,MG,A,Ion,modulator,MAGNESIUM ION,402,Allosteric function,Allosteric position,29677386,Molecular Insight into the Mg2+-Dependent Allosteric Control of Indole Prenylation by Aromatic Prenyltransferase AmbP1,No,"Chain A:GLU63,ASP40,GLU64,ASP65,ASN41,GLN68,HIS62",2.601,True,1
ASD17370000_1,ambP1,Fischerella ambigua UTEX 1903,V5TDZ4,5Z46,ASD00330030,MG,A,Ion,modulator,MAGNESIUM ION,402,Allosteric function,Allosteric position,29677386,Molecular Insight into the Mg2+-Dependent Allosteric Control of Indole Prenylation by Aromatic Prenyltransferase AmbP1,No,"Chain A:GLU63,ASP40,GLU64,ASP65,ASN41,GLN68,HIS62",1.999,True,1
ASD17400000_1,leuA2,Leptospira biflexa serovar Patoc (strain Patoc 1 / ATCC 23582 / Paris),B0SN40,4OV4,ASD02470006,KIV,A,Lig,Regulator,3-METHYL-2-OXOBUTANOIC ACID,402,Allosteric function,Allosteric position,25128527,Subdomain II of alpha-isopropylmalate synthase is essential for activity: inferring a mechanism of feedback inhibition.,Yes,"Chain A:LEU75,THR178,HIS99,GLU231,ASN177,HIS147,ASN243,HIS207,ASN174,GLU146,VAL179,GLY145,GLU45,PRO176,ARG14,VAL101,HIS209,ASP15,SER144",2.0,True,1
ASD17400000_1,leuA2,Leptospira biflexa serovar Patoc (strain Patoc 1 / ATCC 23582 / Paris),B0SN40,4OV9,ASD17400002,VPM,A,Lig,Regulator,(2S)-2-hydroxy-2-(propan-2-yl)butanedioic acid,402,Allosteric function,Allosteric position,25128527,Subdomain II of alpha-isopropylmalate synthase is essential for activity: inferring a mechanism of feedback inhibition.,Yes,"Chain A:LEU75,THR178,HIS99,ASN177,HIS207,GLY145,GLU239,ASN174,VAL179,GLU45,PRO176,VAL101,GLU146,PHE48,GLU231,HIS147,ARG14,ASN243,GLN18,SER144,ASP15,HIS209",2.2,True,1
ASD17420000_1,,Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1),Q9HVB9,5BQ1,ASD17420001,CO2,A,Gas,Regulator,CARBON DIOXIDE,"302,303",Allosteric function,Allosteric position,26457866,Carbon Dioxide 'Trapped' in a beta-Carbonic Anhydrase.,No,"Chain A:GLY103,VAL104,ASN65,ALA45,ARG64,HIS98,ARG46,CYS42,VAL62,TRP39,SER43,CYS101,VAL47,ASN50,ASP44,GLY102,PRO48,ALA49,ALA67,VAL66",1.6,True,1
ASD80060000_2,,Vibrio cholerae,,3IRW,ASD06980001,C2E,R,Lig,Regulator,"9,9'-[(2R,3R,3aS,5S,7aR,9R,10R,10aS,12S,14aR)- 3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro- 2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine- 2,9-diyl]bis(2-amino-1,9-dihydro-6H-purin- 6-one)",1,Protein-DNA/RNA Interaction Regulator,Inner DNA/RNA,19898477,Structural basis of ligand binding by a c-di-GMP riboswitch.,No,Chain R:ALA47,2.7,True,1
ASD80060000_2,,Vibrio cholerae,,3MUM,ASD06980001,C2E,R,Lig,Regulator,"9,9'-[(2R,3R,3aS,5S,7aR,9R,10R,10aS,12S,14aR)- 3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro- 2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine- 2,9-diyl]bis(2-amino-1,9-dihydro-6H-purin- 6-one)",1,Protein-DNA/RNA Interaction Regulator,Inner DNA/RNA,20690679,Structural and biochemical determinants of ligand binding by the c-di-GMP riboswitch .,No,Chain R:ALA47,2.9,True,1
ASD80060000_2,,Vibrio cholerae,,3MXH,ASD06980001,C2E,R,Lig,Regulator,"9,9'-[(2R,3R,3aS,5S,7aR,9R,10R,10aS,12S,14aR)- 3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro- 2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine- 2,9-diyl]bis(2-amino-1,9-dihydro-6H-purin- 6-one)",1,Protein-DNA/RNA Interaction Regulator,Inner DNA/RNA,20690679,Structural and biochemical determinants of ligand binding by the c-di-GMP riboswitch .,No,Chain R:ALA47,2.3,True,1
ASD80060000_2,,Vibrio cholerae,,3OWI,ASD01260003,GLY,A,Lig,Regulator,2-aminoethanoic acid,89,Inner DNA/RNA Regulator,Inner DNA/RNA,21145485,Structural insights into ligand recognition by a sensing domain of the cooperative glycine riboswitch.,No,Chain A:GLY36,2.845,True,1
ASD80060000_2,,Vibrio cholerae,,3OWW,ASD01260003,GLY,A,Lig,Regulator,2-aminoethanoic acid,89,Inner DNA/RNA Regulator,Inner DNA/RNA,21145485,Structural insights into ligand recognition by a sensing domain of the cooperative glycine riboswitch.,No,Chain A:GLY36,2.802,True,1
ASD80060000_2,,Vibrio cholerae,,3OWZ,ASD01260003,GLY,A,Lig,Regulator,2-aminoethanoic acid,89,Inner DNA/RNA Regulator,Inner DNA/RNA,21145485,Structural insights into ligand recognition by a sensing domain of the cooperative glycine riboswitch.,No,Chain A:GLY36,2.949,True,1
ASD80060000_2,,Vibrio cholerae,,3OXE,ASD01260003,GLY,A,Lig,Regulator,2-aminoethanoic acid,89,Inner DNA/RNA Regulator,Inner DNA/RNA,21145485,Structural insights into ligand recognition by a sensing domain of the cooperative glycine riboswitch.,No,Chain A:GLY36,2.899,True,1
ASD80060000_2,,Vibrio cholerae,,3OXM,ASD01260003,GLY,A,Lig,Regulator,2-aminoethanoic acid,89,Inner DNA/RNA Regulator,Inner DNA/RNA,21145485,Structural insights into ligand recognition by a sensing domain of the cooperative glycine riboswitch.,No,Chain A:GLY36,2.95,True,1
ASD80060000_2,,Vibrio cholerae,,3Q3Z,ASD06980001,C2E,A,Lig,Regulator,"9,9'-[(2R,3R,3aS,5S,7aR,9R,10R,10aS,12S,14aR)- 3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro- 2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine- 2,9-diyl]bis(2-amino-1,9-dihydro-6H-purin- 6-one)",2,Protein-DNA/RNA Interaction Regulator,Inner DNA/RNA,21518891,Structural basis of differential ligand recognition by two classes of bis-(3'-5')-cyclic dimeric guanosine monophosphate-binding riboswitches.,No,Chain A:ALA70,2.51,True,1
